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Abstract 
I 
Abstract 
This dissertation describes the synthetic work on several natural products including 
nucleosides, alkaloids, and polyketides. 
The first and main part of this thesis focuses on the total synthesis of the nucleoside 
antibiotics herbicidin C and its hydrolysis product aureonuclemycin. Due to their diverse 
biological activity, the herbicidins are considered as promising herbicides for agricultural 
application. In cooperation with Bayer CropScience AG, a flexible and efficient access to the 
herbicidins was developed and the challenges and successes of this synthesis are described in 
detail. More specifically, the route to the undecose moiety integrates a stereoselective C-
glycosylation with several reagent-controlled stereoselective transformations. The nucleobase 
was introduced by a surprisingly facile and highly diastereoselective late-stage N-glycosylation. 
In addition to that, natural herbicidin A was transformed into promising derivatives and all 
compounds, including the intermediates of the total synthesis, were provided to Bayer 
CropScience AG for a structure activity relationship study (SAR). A list of all provided 
derivatives is given at the end of the thesis. 
The progress toward the synthesis of stephadiamine is described in the second chapter of 
this thesis. The natural product is the first example of a C-norhasubanan alkaloid natural product 
and despite its structural beauty, no total synthesis of stephadiamine has been reported to date. 
The proposed racemic retrosynthetic analysis of stephadiamine makes use of a Curtius 
rearrangement and a late lactonization. The propellane skeleton of this alkaloid was envisioned 
to be made by means of a homoconjugated addition/Mannich cascade of the key enamine in an 
extremely efficient manner. An alternative strategy is proposed for future work, which includes 
a Tsuji-Trost allylation arising the potential for an enantioselective synthesis of stephadiamine. 
In chapter III, the progress toward the divergolides C and D is presented. Attention was 
focused on the large scale preparation of the volatile side chain, and its unusual isolation 
method is pointed out in detail. In addition, the assembly of the three main building blocks is 
discussed.  
The preparation of Legionella autoinducer 1 (LAI-1) is described in chapter IV. The 
bacterial signaling molecule LAI-1 belongs to the class of -hydroxyketones (AHKs). Given the 
effects of LAI-1 on virulence and motility of the bacteria L. pneumophila, this signaling 
molecule has the potential for clinical or technical applications. For a deeper understanding of 
the signaling circuit in L. pneumophila and in order to gain more insight in the mechanism of 
cell-cell communication, synthetic LAI-1 was prepared and provided to the research group of H. 
Hilbi, who investigates the gene regulation by AHK-mediated signaling. 
Chapter V includes the experimental procedures for the preparation of all compounds, 
backed up by full analytical characterization. In addition, 
1
H- and 
13
C-NMR spectra as well as 
crystallographic details are given. 
  
Summary 
III 
Summary 
Chapter I: The Total Synthesis of Herbicidin C and Aureonuclemycin 
The herbicidins, congener of the large family of nucleoside antibiotics,
[1]
 show a high 
diversity of biological activity. These molecules are not only promising lead structures in search 
of new herbicides and the development of biological tools, but have been the focus of synthetic 
interest for the last decades.
[2]
 Thus, several approaches towards the herbicidins were described 
in the literature. T. Gallagher and co-workers provided by far the most thorough investigation of 
the herbicidins.
[3]
 However other research groups, such as the groups of D. A. Whiting,
[4]
 A. H. 
Haines,
[5]
 P. Sinaÿ,
[6]
 and P. Vogel
[7]
 published different approaches toward the herbicidin 
skeleton. Despite considerable efforts, only one completed total synthesis of a herbicidin has 
been reported to date by the group of S. Ichikawa.
[8]
  
 
 
 
The biological and structural features render the herbicidins challenging targets for both 
lead compound research and total synthesis. Thus, scientific collaboration between our research 
group and Bayer CropScience AG was established to investigate the relationship between the 
structure and the biological activity of the herbicidins (SAR study).
[9]
 In particular, we 
developed a synthetic route to two members of this family, namely herbicidin C (Ic) and 
aureonuclemycin (Ii),
[10]
 which offered the possibility to gain access to a broad range of 
potentially bioactive derivatives. These compounds were further investigated by Bayer 
CropScience AG in the course of bioactivity testings. 
Furthermore, herbicidin A (Ia), provided by Bayer CropScience AG, was transformed into 
promising derivatives in the course of this thesis. 
With this work, we contribute to expand the chemistry of the herbicidins and provide a 
platform for the preparation of structurally related, potentially bioactive derivatives thereof. 
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Chapter II: Synthesis Toward the Alkaloid Stephadiamine 
The natural product stephadiamine (V) is the first example of a C-norhasubanan alkaloid 
natural product, originally isolated from stephania japonica in 1984.
[11]
 Its pentacyclic skeleton, 
which structurally resembles the more famous class of hasubanan alkaloids, and the bridging 
lactone moiety, makes stephadiamine (V) a challenging target for total synthesis. Despite its 
structural beauty, no total synthesis of V has been reported to date. 
The proposed racemic retrosynthetic analysis of V makes use of a Curtius rearrangement 
and a late lactonization. The propellane skeleton of V could be made by means of a 
cyclopropane opening through key enamine IV, which will ultimately be derived from 
carboxylic acid II. 
 
 
 
In the forward sense, starting from acid II, tetralone III was readily prepared on gram scale, 
including an elegant aryl CH olefination step.[12] We anticipated that enamine IV should be 
accessible through alkylation and reaction with methylamine.
[13]
 The remaining steps will 
include installation of the final five-membered ring and the formation of the lactone moiety to 
yield stephadiamine (V) in an extremely efficient manner. 
An alternative strategy was proposed, which includes a Tsuji-Trost allylation arising the 
potential for an enantioselective synthesis of stephadiamine V. For this route, the previously 
prepared tetralone III could be applied. 
 
Chapter III: Synthetic Studies Toward Divergolides C and D 
Divergolides C (IX) and D (X) were isolated by C. Hertweck and co-workers in 2011 from 
an endophyte (Streptomyces sp. HKI0576) of the mangrove tree Bruguiera gymnorrhiza.
[14]
 
Although being structurally different, the divergolides show remarkable biological activities to 
be potent lead structures for anti-infective and antitumor drugs. Hertweck and co-workers 
suggested that divergolides C (IX) and D (X) originate from a common biological precursor. 
We envisioned a total synthesis of this intermediate followed by a biomimetic conversion to 
both divergolides C (IX) and D (X).  
This part of the thesis was focused on the preparation of side chain VII in large quantities, 
as well as its assembly with the previously synthesized building blocks VI and VIII. Towards 
Summary 
V 
this end, we were successful in coupling all three intermediates. The closure of the macrocycle 
and the final biomimetic conversion to divergolides C (IX) and D (X) have not been 
accomplished, but are currently under investigation in the Trauner group. 
 
 
 
Chapter IV: Synthesis of a Bacterial Signaling Molecule 
The signaling molecules cholera autoinducer-1 (CAI-1) (XI) and Legionella autoinducer 1 
(LAI-1) (XII) belong to the class of -hydroxyketones (AHKs). Given the effects of CAI-1 (XI) 
and LAI-1 (XII) on virulence, biofilm formation and extracellular filaments of V. cholerae or L. 
pneumophila, these signaling molecules or derivatives thereof have the potential for clinical or 
technical applications.  
For a deeper understanding of the signaling circuit and in order to gain more insight in the 
mechanism of cell-cell communication, the research group of H. Hilbi investigates the gene 
regulation by AHK-mediated signaling in L. pneumophila. For this research, synthetic 
LAI-1 (XII) is needed in pure form. The project aimed at providing the Hilbi group with pure 
LAI-1 (XII) for further investigation of the biochemical effects in signaling circuits of bacteria. 
 
 
 
Chapter V: Experimental Procedures and Analytical Data 
Chapter V includes the experimental procedures for the preparation of all compounds, 
backed up by full analytical characterization. In addition, 
1
H- and 
13
C-NMR spectra as well as 
crystallographic details are given there. 
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1. Introduction 
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Chapter I: The Total Synthesis of 
Herbicidin C and Aureonuclemycin 
1. Introduction 
Already at the beginning of plant cultivation, humans were looking for methods to enhance 
plant growth and protect their seeds and crops in order to secure their sustentation. The 
Egyptians, for example, made use of remaining Nile slurry after floods to manure their fields. In 
the ancient world, farmers of many cultures employed stall manure and dung as primitive 
'fertilizers' to increase their harvest.
[15]
 As early as in the 8
th
 century BC, Homer mentioned such 
habits in his epic 'Odyssey',
[16]
 where 'men should come and draw it (heaps of mule and cow 
dung) away to manure the great close.' 
Around 350 BC, philosophers like Aristotle started to develop theories concerning the 
reason for the positive effects of soil on plant growth.
[15]
 More than 2000 years later in 1809, the 
final version of the 'humus theory' was written down by Albrecht Thaer:
[17]
 'Die Fruchtbarkeit 
des Bodens hängt eigentlich ganz vom Humus ab; denn außer Wasser ist er es allein, der den 
Pflanzen die Nahrung gibt. So wie Humus eine Erzeugung des Lebens ist, ist er auch die 
Bedingung des Lebens. Er gibt die Nahrung dem Organismus, ohne ihn läßt sich daher kein 
Leben, wenigstens der vollkommenen Tiere und Pflanzen, auf dem Erdboden denken' - thus, the 
fertility of soil is just dependent on the humus; only humus and water give nutriment to the 
plants. Humus is both, creation and precondition of life and it allows survival of the organism; 
without humus, no life on earth is imaginable, at least for animal and plants. 
This view was refined when people realized that inorganic salts, as in guano and Chile 
saltpeter, can improve their agricultural yields. From 1840 onwards, Justus von Liebig 
systematically investigated the influence of mineral salts such as nitrates, phosphates, and 
sulfates on the growth of plants and finally published his 'mineral salt theory'.
[18]
 His work is 
often connected to the beginning of modern science of plant nutrition. As a result of this 
research, superphosphate was produced in England and Germany and applied as mineral 
fertilizer besides guano and Chile saltpeter. With the knowledge that ammonium sulfate can be 
used as nitrogenous fertilizer and with the development of the Haber-Bosch process in 1909, the 
way has been opened for the production of fertilizers in large amounts.
[19]
 
Apart from fertilization, weed control is another very effective method to increase the 
harvest. Already in the middle of the 18
th
 century, people started to use iron sulfate, copper 
sulfate, and sulfuric acid to kill weeds, later sodium chlorate and dinitro-ortho-cresol 
followed.
[20]
 Altering the soil's pH value, fertility, and salinity as well as mechanical control like 
tilling and manual removal of unwanted plants, were and still are efficient practices to control 
weeds. 
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The first and widely applied herbicide was 2,4-dichlorophenoxyacetic acid (1) (2,4-D, 
Figure 1), which was used to selectively kill dicotyledons (dicots, plants whose seed has two 
embryonic leaves) and keep the monocotyledons (monocots, plants whose seed has one 
embryonic leave) alive. Thus 2,4-D (1) became very successful to protect wheat, corn, rice, and 
other cereal grasses.
[21]
 Originally, it was developed during World War II to secure the crop 
production for war periods,
[22]
 but in the Vietnam War it was abused by the U.S. military as 
defoliant for forests. It became famous as 'Agent Orange', a term which turned into a collective 
name for all the different herbicide mixtures consisting of the free acids and different alkyl 
esters of 2,4-D (1) and 2,4,5-trichlorophenoxyacetic acid (2) (2,4,5-T) in varying compositions. 
The fatal effects on humans, however, were not caused by the herbicide itself, but by an 
impurity of the 2,4,5-T (2) production, namely 2,3,7,8-tetrachlorobenzodioxin (3) (TCDD, 
Figure 1). The latter is highly toxic and cost the health and lives of hundreds of thousands of 
people.
[23]
  
 
 
Figure 1. Structures of 2,4-D (1), 2,4,5-T (2) and 2,3,7,8-TCDD (3). 
In the middle of the 20
th
 century other, important classes of synthetic herbicides were 
developed, such as the triazines. A famous member of this family is atrazine (4) (Figure 2), 
which can inhibit the photosynthesis of plants and thus destroy unwanted weed.
[24]
 Its use is 
controversial, since atrazine (4) does not decompose within a few weeks after application, 
therefore leading to accumulation in the ground water.
[25]
 Nevertheless, atrazine (4) is still one 
of the most widely used herbicides in the world, although forbidden in Europe. 
 
 
Figure 2. Structures of the synthetic herbicides atrazine (4) and glyphosate (5). 
Another example from the 1970s is glyphosate (5) (Figure 2), which is commercially 
available under the trade name Roundup and is used for nonselective weed control. However, 
due to the development of resistant crop plants, it is increasingly applied in selective weed 
control.
[26]
 Glyphosate (5) acts as an inhibitor of the shikimic acid pathway and, as a result, the 
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plant's biosynthesis of amino acids is blocked leading to its death.
[27]
 Since the shikimic acid 
pathway does not exist in animals, glyphosate (5) shows only weak toxicity compared to other 
herbicides. Additionally, the fact that compound 5 has only a short life time in the soil makes it 
the most used herbicide in the U.S.A.
[24a,28]
 
The number of different herbicide classes is enormous and the variety of chemical structures 
and their mode of action extremely large. Hence, the search for new active agents is mainly 
based on empirical ways and only few herbicides were designed by a completely non-empirical 
method, which was developed based on the knowledge of the active site of the target enzyme. In 
fact, the exact molecular target is known only for some herbicide classes. Nevertheless, some 
general modes of action were determined by physiological and biochemical testing. Herbicides 
can prevent amino acid, lipid, or carotenoid biosynthesis, and in addition to that, they can 
interfere with the photosynthesis, disrupt cell division or cause rapid photobleaching.
[24]
 
On the way to new herbicides, natural products can serve as lead structures for new active 
ingredients.
[29]
 In this sense, the herbicidins are promising nucleoside antibiotics
[1]
 with 
interesting biological activities (Figure 3).
[30]
 Amongst others, it was found that congeners of 
this class selectively kill dicots and are non-toxic towards fish.
[30a-d,30g-i]
 Especially this 
selectivity in the biological activity makes the herbicidins promising herbicides for agricultural 
application. 
 
 
Figure 3. The class of herbicidins. 
Chapter I: The Total Synthesis of Herbicidin C and Aureonuclemycin 
4 
The herbicidins are not only promising lead structures in search of new herbicides and the 
development of biological tools, but have been the focus of synthetic interest for the last 
decades.
[2]
 Thus, several approaches towards the herbicidins were described in the literature. 
T. Gallagher and co-workers provided by far the most thorough investigation of the 
herbicidins,
[3]
 however other research groups, such as the groups of D. A. Whiting,
[4]
 A. H. 
Haines,
[5]
 P. Sinaÿ,
[6]
 and P. Vogel
[7]
 published different approaches toward the herbicidin 
skeleton. Despite considerable efforts, only one completed total synthesis of a herbicidin by the 
group of S. Ichikawa has been reported to date.
[8]
  
In order to find a flexible synthetic access to this class of natural products and to provide 
unnatural derivatives thereof, collaboration between the Trauner research group and Bayer 
CropScience AG was established. At the beginning of this project, no study on the biological 
mode of action, binding site or target enzyme of the herbicidins was published. The main focus 
of our work was the investigation of the relationship between structure and biological activity of 
the herbicidins (SAR = structure activity relationship study).
[9]
 With this study, we hoped to 
improve the compounds herbicidal activity against weeds and to be non-toxic to agricultural 
crops, like corn or rice. 
 
Hence, this project was focused on the following main aspects: 
 development of a efficient and flexible total synthesis of the herbicidin skeleton; 
 providing synthetic intermediates to Bayer CropScience AG for biological activity testing; 
 derivatization of herbicidin A (6).i 
 
 
 
 
 
 
i
 Herbicidin A (6) was provided by Bayer CropScience AG in gram quantities. 
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2. Isolation, Biology and Structural Features of the 
Herbicidin Family 
The herbicidins (612), SI2245 (13), and aureonuclemycin (14) belong to the same class of 
nucleoside antibiotics and have been isolated from different strains of bacteria Streptomyces 
(Figure 4).
[30]
 Although all of these natural products have the same skeleton, different names 
were given to SI2245 (13)
[30g]
 and aureonuclemycin (14).
[30h]
 However, in this thesis the term 
'herbicidins' is used to describe all of these structurally related natural products (614). 
 
 
Figure 4. The herbicidin family. 
Due to their interesting biological activity, the herbicidins have come under scrutiny of 
many research groups. For example, herbicidins A (6) and B (7) are efficient inhibitors of 
Xanthomonas oryzae, a bacterium that causes leaf blight infection in rice crops. Furthermore, 
reduced seed germination and diminished algal growth as well as selective toxicity towards 
dicotyledonous plants, but no toxicity against animals, was observed.
[30a-d,30g-i]
  
Structurally, the herbicidins show a number of intriguing characteristics (Figure 4). Their 
common carbohydrate moiety contains a linear chain of eleven carbon atom, which is folded 
into a tricyclic furano-pyrano-pyran skeleton to from the three rings A, B, and C. This tricyclic 
backbone includes nine stereogenic centers. Adenine as the nucleobase resides in a sterically 
congested concave position. In addition, the hemiketal at C-7 fuses the pyrano-pyran system in 
such a way that all of its substituents adopt axial orientations. The individual members of the 
herbicidin family differ in three positions, namely C-2, C-8 and C-11. While residues R
1
 and R
3
 
are either a proton or methyl group, side chain R
2
 can be a proton or an ester derived from (E)-
2-(hydroxymethyl)-2-butenoic acid, isobutyric acid, tiglic acid, and acetic acid. 
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3. Previous Work on Herbicidins 
As a consequence of their structural beauty and their potent biological activities, the 
herbicidins have attracted much attention from the synthetic community in the past decades.
[3-8]
 
In general, two different strategies regarding the N-glycosylation were discussed: the 
nucleobase could be introduced either prior to or subsequent to the formation of the tricyclic 
carbohydrate moiety. Thus these strategies are called 'early-' or 'late-stage' glycosylation 
respectively.
[1-2,3b]
 The majority of all groups chose a late-stage adenylation strategy, but never 
succeeded up to now.
[3-7]
 The only successful approach to herbicidin B (7) was accomplished by 
the group of S. Ichikawa. They started with adenosine and carried the purine base through the 
whole synthesis.
[2,8,31]
  
Retrosynthetically, it was reasoned that the hemiacetal at C-7 would occur spontaneously to 
form ring B of the tricyclic skeleton (Scheme 1). The published studies mainly focused on the 
combination of C6- plus C5-building blocks, a strategy, which includes the most obvious and 
logical disconnection between C-5 and C-6 for the herbicidin undecose.
[3-6,8]
 
 
 
Scheme 1. Spontaneous formation of hemiacetal at C-7 and retrosynthetic disconnection to C6- 
and C5-building blocks. 
3.1. Unsuccessful C6 plus C5 Approaches Toward the Herbicidin 
Backbone 
Between 1988 and 1999, six different groups published on the synthesis of the 
herbicidins.
[3-8]
 The strategies toward the undecose moiety are very similar and often the 
C-glycosylation was realized through an addition of a C6- to a xylofuranose-derived C5-building 
block. For example, D. A. Whiting and co-workers employed stannane 16, prepared from glucal 
15, for a transmetallation with n-BuLi (Scheme 2).
[4]
 The resulting organolithium species 
reacted further with aldehyde 18 to give alcohol 19 in low yields and as a 2:1 mixture of 
separable diastereomers. Further attempts to deoxygenate the C-5 position failed, which led to 
an alternative plan to alkylate 16 with triflate 20 through a nucleophilic substitution reaction, 
furnishing compound 21 directly. The reaction occurred in slightly better yields than the 
addition to the aldehyde 8. However the installation of the ketone at C-7 was not successful. 
Hence, the rings A and C of the herbicidins' undecose sugar were assembled, but the position 
C-7 remained to be oxidized. 
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Scheme 2. D. A. Whiting's approach toward the herbicidin backbone. 
The very same aldehyde 18 was later used as C5-building block by A. H. Haines and co-
workers.
[5]
 Their aim was to link it with ketone 23 derived from L-rhamnose (22) by an aldol 
addition reaction. Remarkably, this is the only example that made use of an open-chain C6-
carbohydrate building block to access the undecose moiety. However, the reaction with 
LiHMDS was low-yielding and gave a 1:1 mixture of diastereomers 24. After separation, one 
isomer was deprotected resulting in the formation of ring B by spontaneous hemiacetal 
formation at C-7 (Scheme 3). The resulting stereochemistry at C-7 was not determined and 
further investigations towards the formation of ring C were not published. It is worth 
mentioning that the stereochemistry at C-8, C-9 and C-10 of diol 25 was the opposite 
configuration as in the herbicidins. This was attributed to the availability of the starting 
materials: 1-deoxy-L-fructose derivative 23 prepared from naturally occurring L-rhamnose (22) 
was easier accessible than the respective 1-deoxy-D-fructose derivative, which would be needed 
for the assembly of the herbicidin undecose with the correct stereochemistry.  
 
 
Scheme 3. A. H. Haines' approach toward the herbicidin backbone. 
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A molecular tethering approach followed by a radical cyclization was investigated by P. 
Sinaÿ and co-workers (Scheme 4). In this case,  silaketal 26 was prepared by linkage of the 
respective D-glucose- and D-xylose-derived precursors. This intermediate underwent radical 8-
endo-trig cyclization and after removal of the silyl tether with TBAF, compound 27 with the 
complete rings A and C was obtained. Luckily, C-glycoside 27, which bears the correct 
stereochemistry at C-4 and C-6, was isolated as the main diastereomer in surprisingly high yield 
of 43%.
[6]
 Further transformations towards the closure of ring B were not reported. Since both 
alcohols at C-3 and C-7 in 27 are secondary, it might be challenging to distinguish them in order 
to set different oxidation states in the further course of the synthesis. 
 
 
Scheme 4. P. Sinaÿ's approach toward the herbicidin backbone. 
In contrast to the approaches described so far, the investigations on the synthesis of the 
herbicidins by the group of T. Gallagher were more thorough and they date back to 1988.
[3]
 
Strategically, the very same aldehyde 18, which was later used by D. A. Whiting and A. H. 
Haines (vide supra, Scheme 2 and Scheme 3), was combined with the enolate derived from C6-
building block 28 to yield the aldol condensation product 29 as a single diastereomer with an 
unknown double bond configuration. The hydrogenation of the alkene and concomitant 
debenzylation yielded hemiacetal 30, a key compound for further investigations. This 
intermediate already possessed all three rings A, B, and C of the herbicidin skeleton and only 
adjustment of the oxidation state at C-11 and cleavage of the ether bridge were needed. 
However, the reason for the face-stereoselective reduction of the double bond remained 
unclear.
[3e]
 
 
Scheme 5. T. Gallagher's synthesis of key building block 30. 
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In order to install the right oxidation state at C-11, diol 30 was protected as carbonate to 
yield 31 and the bridgehead was brominated selectively (32). Methoxide-induced cleavage of 
carbonate 32 and silver(I)-mediated hydrolysis of the resulting -bromoether provided aldehyde 
33, which was further oxidized to ester 34. Deprotection of the acetonide gave the free undecose 
35, corresponding to herbicidin C. However, its glycosylation was not described.
[3e]
 
 
 
Scheme 6. T. Gallagher's adjustment of the oxidation state at C-11. 
In a further attempt, an alternative route from key compound 30 to herbicidin C (8) was 
envisioned employing the glycosylation at an earlier stage.
[3b]
 Thus, the acetonide in 31 was 
swapped to acetate protecting groups and the resulting diastereomeric mixture of 36 was 
glycosylated under Lewis acidic conditions (37, Scheme 7). The following deprotection of the 
base-labile substrate 37 under Zemplén conditions afforded 38 in low yield (20%). The 
remaining functionalization at C-11 with the previously established radical-mediated 
bromination and the following ring opening (as used for the synthesis of 34) to herbicidin C (8) 
was unsuccessful. 
 
 
Scheme 7. Attempts of T. Gallagher and co-workers towards the synthesis of herbicidin C (8). 
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So far, only late-stage glycosylation attempts were considered by the Gallagher group. In a 
second, early-stage glycosylation approach to the ether bridged analog 38, -bromoketone 39 
prepared from D-glucose, was connected to xylo-nucleoside aldehyde 40, and transformed into a 
single isomer of 41 with unknown double bond configuration (Scheme 8).
[3a]
 Further 
investigations to 38 have not been reported so far. 
 
 
Scheme 8. T. Gallagher's early-stage glycosylation attempt. 
In summary, a variety of different studies toward the synthesis of the herbicidins have been 
published, with strategies that were limited mainly to early-stage glycosylations. The respective 
undecose sugars were targeted by coupling of C6- and C5-precursors. While the groups of D. A. 
Whiting, A. H. Haines, and P. Sinaÿ were only able to establish two rings of the furano-pyrano-
pyran skeleton, the Gallagher group prepared the whole tricyclic undecose sugar moiety. Its 
glycosylation with adenine has not been met with success so far. 
 
3.2. Ichikawa's Total Synthesis of Herbicidin B Through Early-Stage 
Glycosylation 
The main difference of S. Ichikawa's route compared to other attempts is the early 
introduction of the adenine nucleobase.
[8]
 Analogously to other groups, two different building 
blocks were prepared separately and eventually connected through a samarium diiodide aldol-
type C-glycosylation. The synthesis of the C6-building block 48 started with glucurono-
lactone (42) that was rearranged and acetylated to carbohydrate derivative 43. Further 
transformation with HBr to compound 44 and elimination of the bromine gave glycal 45 
(Scheme 9).
[32]
 The subsequent change to the right silyl protecting groups was crucial for the 
success of the whole synthesis. Two TBS-protecting groups did not result in the required axial 
orientation of the substituents due to too little steric repulsion, while TIPS groups could not be 
removed later. As a result, the acetates of 45 were cleaved and the resulting diol was treated 
with TBSCl followed by TBDPSCl (46). Epoxidation of glycal 46 with DMDO gave bicycle 
47 as single diastereomer. Opening of the resulting oxirane with thiophenol and subsequent 
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Dess-Martin periodinane oxidation provided phenylthioulose 48, in which all substituents are 
already oriented in an axial manner. 
 
 
Scheme 9. S. Ichikawa's synthesis of C6-building block 48. 
Adenosine (49) served as the starting material for the synthesis of the C5-nucleoside 53 as 
second building block (Scheme 10). In order to establish the right stereochemistry at C-3, the 
respective alcohol had to be inverted. Thus, adenosine (49) was protected with MeI 
regioselectively at the sterically less accessible secondary C-2 position in 42% yield.
[33]
 
Protection of the primary alcohol with a trityl group gave compound 50, and an 
oxidation/reduction sequence inverted the configuration of the alcohol at C-3 (51). 
Subsequent protection afforded 52, which was transformed into aldehyde 53. 
 
 
Scheme 10. S. Ichikawa's synthesis of C5-building block 53. 
The coupling of phenylthioulose 48 with aldehyde 53 was achieved through a samarium 
diiodide mediated aldol-type C-glycosylation to give 54 as a mixture of only two diastereomers 
with unknown stereochemistry (Scheme 11). Dehydration with Burgess' inner salt provided 55 
as a single isomer. The stereochemistry of the double bond was not assigned. Reduction of the 
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alkene occurred face-selective with HCOONH4 as dihydrogen donor in presence of palladium 
on charcoal (56). Final deprotection with SmI2 and TBAF afforded herbicidin B (7). 
 
 
Scheme 11. S. Ichikawa's connection of 48 with 53 and transformation to herbicidin B (7). 
In summary, the first and until then only total synthesis of a member of the herbicidin 
family was accomplished by S. Ichikawa and co-workers based on an early-stage glycosylation 
strategy. It required a heavy optimization of the protecting groups in order to achieve a 
'conformational flip' in the C6-building block 48 so that a face-stereoselective reduction of the 
double bond in 55 could be realized. 
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4. The Right Side Approach: A Preliminary Study 
4.1. Retrosynthetic Analysis and Strategy of the Right Side 
Approach 
The strategy we have chosen for the synthesis of the herbicidin skeleton is novel in its 
building blocks, as we did not envision a C6 plus C5 approach. One major aim was to provide a 
flexible synthesis with respect to potential derivatives for SAR studies. Based on the fact that 
the common C6 plus C5 strategy entailed low-yielding or unselective aldol or C-glycosylation 
reactions, a novel and more efficient approach was necessary. 
Retrosynthetically, we expected that herbicidin C (8) should be accessible through a 
challenging late-stage glycosylation from the sterically congestive concave side of the undecose 
sugar 34 (Scheme 12). In the construction of the latter, we decided not to combine two 
separately prepared sugar units, but to start with the synthesis of ring A of the herbicidins 
undecose and to install rings B and C successively. Thus, compound 34, which had already 
been synthesized by T. Gallagher and co-workers, could be prepared in a more straight forward 
fashion by double epoxide opening from compound 58, via intermediate 57. Alcohol 58 was 
proposed to stem from dihydropyran 59 and the respective ,-epoxyaldehyde by a 
stereoselective organometallic mediated addition. Prior to this, the organometal compound 59 
would be prepared from lactone 60, which could be derived from diacetone glucose 61, a 
glucose derivative. 
 
 
Scheme 12. Retrosynthetic analysis for the right side approach of herbicidin C (8). 
This fast and efficient synthesis should give access to undecose 34 under complete 
stereocontrol. A high flexibility would be ensured by the potential to alter the steps and by the 
late introduction of the nucleobase. 
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4.2. Results and Discussion of the Right Side Approach – Synthesis of 
the Carbohydrate Backbone 
Initially, the preparation of lactone 60 from commercially available diacetone glucose 61 
was the main focus (Scheme 13, top). It has been described that the unsaturated lactone 63 can 
be prepared by initial esterification of diacetone glucose 61 with 2-bromoacetyl bromide (67) 
and subsequent regioselective acetonide deprotection/diol cleavage with H5IO6.
[34]
 
Intramolecular Wittig reaction with the resulting aldehyde 62 afforded the unsaturated 
lactone 63. The reported low yield of 22% was improved to 40% by using DBU as a base 
instead of propylene oxide. The structure of intermediate 67 was confirmed by X-ray 
crystallography (Scheme 13, bottom). However, the reason for the selective cleavage of only 
one acetonide with H5IO6 remained unclear.
ii
 It was speculated that primary acetonides react 
more readily than secondary acetonides because they are less sterically hindered.
[35]
 Subsequent 
hydrogenation with hydrogen gas and palladium on charcoal gave key lactone 60 in quantitative 
yield. 
 
 
Scheme 13. Synthesis of the key intermediate lactone 60 (top) and X-ray analysis of 
compounds 67 and 60 (bottom). 
In order to improve the total yield of this sequence, the order of steps was altered: selective 
deprotection of one acetonide and following diol cleavage with H5IO6 resulted in aldehyde 64, 
 
ii
 Selective deprotection of diacetone glucose 61 was also achieved with AcOH to yield triol 68 (see 
Experimental Section). 
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which was subjected to intermolecular Wittig reaction with ylide 65 (Scheme 13, top).
[36]
 The 
resulting Z-ester was isolated as the unsaturated lactone 63 in 39% yield, but in addition to that, 
23% of E-ester 66 was also formed. The latter could be transformed into the desired lactone 60 
by a short reduction/saponification/lactonization sequence. Finally, the overall yield from 
diacetone glucose 61 to lactone 60 was improved from 24% (intramolecular Wittig route) to 
51% (intermolecular Wittig route). In addition, the identity of key compound 60 was confirmed 
by X-ray analysis (Scheme 13, bottom). The only drawback was that the yield of the overall 
sequence was too low to efficiently prepare decagrams of material, which would be required for 
the completion of the synthesis of herbicidin C (8). Nevertheless, rings A and B of the 
herbicidin undecose were successfully installed at that stage of the route and only ring C 
remained to be assembled. 
The conceptual next level of the synthesis was the transformation of lactone 60 into a 
lithiated glycal species 69, which could be trapped with electrophiles to yield substituted 
dihydropyrans 70 (Scheme 14). 
 
 
Scheme 14. Conceptual transformation of lactone 60 to dihydropyran 70. 
The synthesis of organometallic compounds like 69 have been achieved by direct 
deprotonation of glycals.
[37]
 Thus, lactone 60 was reduced with DIBAL-H to the corresponding 
lactol 71 as a 2:1 mixture of diastereomers. The major isomer could be analyzed X-ray 
crystallography (Scheme 15). We expected the elimination to take place readily due to the 
thermodynamic stability of the dihydropyran thus formed. Even though 71 was isolated as 
diastereomeric mixture, elimination of both of these isomers should result in the desired 
product 72.  
A range of dehydrating conditions was screened (Table 1). It was found that both, 
p-toluenesulfonic acid and phosphorus pentoxide led to decomposition of the substrate 71 
(Table 1, entries 1 and 2). No or minute amounts of the desired product 72 were observed with 
oxalic acid (Table 1, entry 3) as well as tosyl chloride (Table 1, entries 4 and 5) and mesyl 
chloride at room temperature (Table 1, entry 6). It was pleasing to find that the use of mesyl 
chloride at elevated temperature raised the amount of product 72. The reaction could be 
optimized up to 58% yield after adjusting the temperature and reaction time (Table 1, entries 
79). 
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Scheme 15. Preparation of dihydropyran 72 from lactone 60 and undesired dimerization of 
lactol 71. 
An undesired dimerization of lactol 71 occurred when the elimination reaction with mesyl 
chloride was carried out under high concentration (Scheme 15). After 20 h at 50 °C and a 
concentration of 385 mM, two of three possible diastereomeric dimers were isolated, namely 
unsymmetrical dimer 73 and C2-symmetric dimer 74. As expected, the 
1
H-NMR spectrum of 74 
shows only half of the signals compared to that of 73. The structure of the major product 74 was 
confirmed by X-ray crystallography, but the second possible C2-symmetric diastereomer could 
not be identified. 
Table 1. Conditions of the elimination to dihydropyran 72. 
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With glycal 72 in hand, deprotonation with several bases was attempted (Scheme 16). 
Disappointingly, only protonated starting material 72 was recovered after treatment with t-BuLi, 
Schlosser's base, LDA, and HMDS bases and subsequent D2O-quench. 
 
 
Scheme 16. Unsuccessful deprotonation attempts of glycal 72. 
At this time, another common route to prepare organolithium species 69 from lactone 60 via 
the stannane 76 was pursued (Scheme 17). Initial attempts to deprotonated 60 resulted in the 
opening of the lactone ring, and the respective carboxylic acid was isolated. However, when the 
enolate was trapped with N-phenyl-bis(trifluoromethanesulfonimide) as soon as it was 
generated, the resulting sensitive lactone triflate could be converted directly into stannane 76 
through Stille cross-coupling reaction. The trimethyl tin group was then exchanged to lithium 
and the organometallic species reacted further with aldehyde 77 to afford the sensitive 
alcohol 78 as a 1.2:1 mixture of diastereomers. It is worth pointing out that compound 78 
already possesses all carbon atoms, which are needed for the undecose moiety of the 
herbicidins. The remaining steps would be ring closure and installation of oxygen functionalities 
at C-6, C-7, C-9, and C-10. 
 
 
Scheme 17. Synthesis of stannane 76 and organolithium addition to aldehyde 77. 
For this purpose, the synthetic route should be slightly modified. The first epoxide should 
be introduced by employing the ,-epoxyaldehyde 80 instead of unsaturated aldehyde 77 with. 
The synthesis of 80 was described by K. A. Jørgensen and A. Córdova,
[38]
 but due to its 
instability and volatility, the isolation in preparative amounts was not possible. Therefore, the 
desired addition of stannane 76 to ,-epoxyaldehyde 80 could not be further investigated 
(Scheme 18). 
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Scheme 18. Attempts of the preparation of alcohol 58. 
At this stage of the synthesis, it was questionable if compound 78 could be converted to the 
herbicidin framework in an efficient and stereochemical distinct manner. Although all eleven 
carbon atoms of the undecose skeleton have been assembled and two of three rings were 
installed, stereoselective functionalization of C-6, C-7, C-8, C-9, and C-10 remained. In 
addition, the preparation of large amounts of material, especially at the beginning of the 
sequence, was not practical. Thus, a new retrosynthetic analysis was developed. 
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5. The Left Side Approach 
5.1. Retrosynthetic Analysis and Strategy of the Left Side Approach 
For our second retrosynthetic analysis of herbicidin C (8), we considered that the 
stereochemistry at C-6, C-8, C-9, and C-10 should be set at an early stage of the synthesis, 
because the functionalization at an advanced point of the reaction sequence might be difficult. 
Preferentially, the C-6 asymmetric center had to be selectively established, since the early 
stereocontrol of this position seemed to be crucial for the whole synthesis. 
Thus, we reasoned that the challenging late-stage glycosylation could be stereochemically 
controlled by a neighboring benzoate at C-2, thereby yielding hemiacetal 81 as a logical 
precursor. This intermediate, in turn, could be traced back to C-glycoside 82, wherein C-7 and 
C-11 already possess the correct oxidation state. Further retrosynthetic simplification of the side 
chain would give ester 83, which could ultimately be derived from D-glucose (84).  
This novel strategy started with the synthesis of the ring C of the herbicidin skeleton and 
installed rings B and A at a later stage. Hence it was named 'the left side approach'. 
 
 
Scheme 19. Retrosynthetic analysis for the left side approach of herbicidin C (8). 
5.2. Results and Discussion of the Left Side Approach – Total 
Synthesis of Herbicidin C and Aureonuclemycin 
Following our new approach, D-glucose (84) was converted into the protected anhydro 
sugar 86 by combining a practical, large-scale synthesis for 1,6-anhydrohexopyranoses 
(85)[39] with a standard benzylation protocol (Scheme 20).[40] Reaction of compound 86 with 
allyltrimethylsilane in the presence of a Lewis acid
[41]
 gave the known -allyl-C-glycoside 87 in 
66% yield.
[40,42]
 A second compound was isolated in impure form that was more likely the 
-allyl-C-glycoside. At this early stage, glycoside 87 already has the C-6 position in the correct 
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axial orientation and the right stereochemistry at C-8, C-9, and C-10 (herbicidin nomenclature). 
In course of the synthesis, the ring will have to be inverted. 
 
 
Scheme 20. Synthesis of C-glycoside 87. 
Mechanistically it was anticipated that the selective axial allylation of anhydro sugar 86 
would proceed via the oxonium ion 89, since it was reported that the leaving group has no 
influence on the selectivity of the C-glycosylation.
[43]
 Therefore it is reasonable that TMSOTf 
activates the primary alcohol as a leaving group so that the oxonium ion 89 is formed (Scheme 
21). The conformation of this intermediate is presumably unfavored, since all substituents are in 
axial orientations, thus a conformational flip to the more favored all-equatorial conformation 90 
should occur. This in turn, could be attacked by the nucleophile allyltrimethylsilane in an axial 
orientation, following the rules of the half-chair model
[44]
 to provide 91.
[42-43]
 The primary TMS 
group is then presumably cleaved during aqueous work-up to give the desired -allyl-C-
glycoside 87. The corresponding -isomer 94 could thus be formed by nucleophilic axial attack 
at the unfavored conformer 89, resulting in the all-axial intermediate 92, which would 
immediately adopt the favored all-equatorial position (93). Compound 94 would then be 
obtained after deprotection through aqueous work-up.  
 
 
Scheme 21. Mechanism of the axial C-glycosylation to form - and -allyl-glucopyranosides 87 
and 94. 
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The next stage of the synthesis was the preparation of the bissilyl ether 98, in order to 
orthogonally protect the remaining C-7 and C-11 alcohols (Scheme 22). These positions would 
later be oxidized in the herbicidins undecose. Therefore, compound 87 was selectively 
debenzylated through a two-step protocol
[45]
 involving the formation of iodo ether 95 and 
subsequent elimination to diol 96.
iii
 After TBS protection, the desired intermediate 98 was 
obtained. 
During these investigations, we found that, by permutation of the steps (TBS protection 
99 followed by formation of iodo ether 100 and elimination), the sequence gives rise to 
carbohydrate building block 101, which could be protected, as e.g. acetate, to have three out of 
four alcohols orthogonally protected (Scheme 22). This building block might find further 
applications in carbohydrate chemistry. 
 
 
Scheme 22. Preparation of the silyl ether 98 and carbohydrate building block 101. 
After modification of ring C of the herbicidin backbone, we sought to establish the 
framework of ring A. Thus, the allyl side chain of intermediate 98 was elongated by Grubbs' 
cross-metathesis with methyl acrylate,
[47]
 which afforded unsaturated ester 83 in excellent 
yield.
iv
 The initially reluctant Sharpless dihydroxylation
[48]
 of the electron deficient double bond 
in 83 was finally forced to completion by a fourfold increased osmium tetroxide concentration. 
Subsequent acetonide formation yielded methyl ester 103 in a high diastereomeric ratio 
(Scheme 23).
v
 The reaction time of the diol protection under acidic conditions was highly 
optimized since the primary TBS ether is also cleaved in acidic media. 
 
 
iii
 As a side product the primary TMS ether 97 was observed since Zn was activated with TMSCl and 1,2-
dibromoethane (see Experimental Section).
[46]
 
iv
 Cis-ester 102 was observed in 4% yield (see Experimental Section). 
v
 In addition to minor diastereomer 104, both intermediate diols 105 and 106, as well as the side products 
free primary alcohol 107 and acetal 108 have been fully characterized (see Experimental Section). 
Chapter I: The Total Synthesis of Herbicidin C and Aureonuclemycin 
22 
 
Scheme 23. Synthesis of ester 103. 
In order to attach the remaining carbon atoms and to install an additional stereocenter, 
ester 103 was converted into aldehyde 109 with DIBAL-H. As a side reaction, over-reduction 
with DIBAL-H was observed, so we decided to fully reduce ester 103 with LiAlH4. At the stage 
of the corresponding alcohols 110 and 111, it was possible to separate the diastereomers 
resulting from Sharpless dihydroxylation. Addition of vinylmagnesium bromide to aldehyde 
109 gave a mixture of two separable allyl alcohols 112 and 113 in low diastereomeric ratios and 
unreliable yields (Scheme 24).  
 
 
Scheme 24. Attempts to synthesize vinyl alcohols 112 and 113. 
In search of a more efficient transformation of ester 103, we found that the most practical 
method was the conversion of 103 to vinyl ketone 105, which should be reduced by reagent 
controlled reactions like the Corey-Bakshi-Shibata (CBS) reduction. The double bond in 115 is 
intended to serve as a carbonyl equivalent later. Thus, saponification of the diastereomeric 
mixture of ester 103, obtained after Sharpless dihydroxylation, provided the corresponding acid, 
which was immediately converted into Weinreb amide 114 (Scheme 25). In order to access 
isomerically pure material for analytical reasons, the diastereomers were separated after 
reduction with LiAlH4 at the stage of alcohol 111, as described above. Ley oxidation and 
subsequent formation of the Weinreb amide provided another practical route to 114, however 
this resolution step was not mandatory for further scale-up of the synthesis. Reaction with 
vinylmagnesium bromide then provided vinyl ketone 115 and ketone 116 in good yields. This 
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route becomes even more efficient due to the fact that side product 116 could be recycled to the 
desired ketone 115 by means of a Hofmann-type elimination.  
 
 
Scheme 25. Transformation of ester 103 into vinyl ketone 115. 
Installation of the next stereocenter (C-2 in herbicidin) proved to be more challenging than 
anticipated. Reduction of the carbonyl group in 115 with stoichiometric amounts of the 
R-configured CBS reagent (R)-117 gave again a mixture of the separable alcohols 112 and 113, 
this time in high and reliable yields, and moderate diastereomeric ratios (Scheme 26). 
Unfortunately, we eventually established that the undesired diastereomer 112 was formed as a 
major product under these conditions (vide infra). 
 
 
Scheme 26. Synthesis of the undesired diastereomer 112. 
This result was unexpected, since the generally accepted transition-state model for CBS 
reductions with (R)-CBS-Me reagent predicts the opposite configuration of alcohol 112 
(Scheme 27). According to the established model, the vinyl group in unsaturated ketone 115 
was regarded as the 'small substituent (S)', whereas the acetonide including the whole 
carbohydrate moiety was defined as 'large substituent (L)'. In the CBS transition-state model, 
ketone 115 is orientated in such a way that the steric repulsion of the methyl group of the 
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catalyst (R)-117 and the substituents of 115 is diminished. The reduction will then occur face-
selectively from one side of the ketone, which would result in the desired diastereomer 113. 
This prediction, however, does not correspond to our experimental findings. 
Since this transition-state model seemed not to be applicable to our reaction, it was 
considered that the CBS reagent was coordinated unexpectedly to our substrate 115 due to 
substrate constrains. As a result, the validity of the CBS model was overcome. 
 
 
Scheme 27. Stereochemical consideration of the transition-state model for the 
diastereoselective Corey-Bakshi-Shibata reduction predicts the desired diastereomer 113. 
The structure of the major isomer 112 was only established after further synthetic 
transformations, which also served as training ground for our eventually successful synthesis. 
Benzoylation of alcohol 112 followed by removal of the silyl groups afforded diol 118 (Scheme 
28, top). In order to oxidize C-7 and C-11, diol 118 was subjected to a variety of common 
oxidation methods, such as Dess-Martin periodinane oxidation (DMP), Pinnick oxidation, 
pyridinium dichromate oxidation (PDC), pyridinium chlorochromate oxidation (PCC), and Ley 
oxidation. Most of these methods furnished intractable mixtures with little or no desired 
product. Only oxidation with 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and 
(diacetoxyiodo)benzene (DAIB) in the presence of water proved efficient. Notably, under these 
conditions, only the primary hydroxy group was oxidized to the corresponding carboxylic acid, 
whilst the secondary alcohol remained unaffected. Ester formation with 
(trimethylsilyl)diazomethane followed by oxidation with DMP then provided ketone 119. 
Cleavage of the acetonide with trifluoroacetic acid resulted in a mixture of isomeric hemiacetals 
with compound 120 as the major isomer. When this mixture was subjected to ozonolysis, the 
whole carbohydrate moiety rearranged and gave the tricyclic herbicidin core 121. Acetylation of 
the more accessible hemiacetal yielded undecose 122 as a single diastereomer in 57% yield over 
three steps. The undesired stereochemistry at C-2 resulting from the CBS reduction (vide supra) 
was indicated by a clear cross-signal of protons H-2 and H-4 in the 2D-NOESY-NMR spectrum 
of tricycle 122 and was later confirmed by the X-ray structures of the deprotected triol 123 and 
intermediate 120 (Scheme 28, bottom). However, conformational investigations showed that the 
6-membered ring in 119 flipped during the cyclization process to 122. Whereas the coupling 
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constant of proton H-8 to H-9 in 119 is J = 7.1 Hz, the corresponding coupling in tricycle 122 
has a size of J = 3.4 Hz, indicating that both protons, H-8 and H-9, now adopt equatorial 
positions. 
 
 
Scheme 28. Establishment of the tricyclic core 122 (top) and X-ray structures of 
compounds 120 and 123 (bottom). 
In order to correct the stereochemistry at C-2, we revisited the diastereoselective reduction 
of ketone 115 (Scheme 29). Simple reduction with BH3·SMe2 gave a 1.4:1 mixture of 
diastereomers in favor of the desired diastereomer 113. However, use of the S-configured CBS-
Me enantiomer (S)-117 in stoichiometric amounts provided the desired alcohol 113 in 
d.r. = 14:1. These results suggested a matched case of substrate 115 and the (S)-CBS-Me 
reagent. Notably, the amount of (S)-117 could be reduced to catalytic quantities (10 mol-%) 
while keeping the d.r. value at 14:1. 
With our stereochemical problem solved, we could proceed with the total synthesis (Scheme 
29). First, a benzoyl group was installed at C-2 to assist the late-stage glycosylation. Subsequent 
deprotection with TBAF yielded diol 124, which was converted into ketoester 82 by using the 
previously established oxidation/esterification sequence. Reiteration of our cyclization 
conditions (TFA, O3, Ac2O) provided undecose 125 as a mixture of diastereomers in 72% yield 
over three steps. Tricycle 125 contains all three rings A, B, and C of the herbicidin framework 
as well as the right stereochemistry in all positions. Glycosylation of adenine and final 
deprotection remained to be performed. 
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Scheme 29. Establishment of the undecose skeleton 125. 
With compound 125 in hand, we proceeded to investigate the crucial late-stage 
glycosylation. Much to our satisfaction, the reaction was successful by using a modification of 
the silyl-Hilbert-Johnson (or Vorbrüggen) protocol. Under these conditions, glycosylamine 126 
was obtained. After deprotection with potassium carbonate, 127 was isolated in 53% yield over 
two steps (Scheme 30). 
 
 
Scheme 30. Glycosylation of compound 125. 
In order to complete the total synthesis of herbicidin C (8), the benzyl protecting groups had 
to be cleaved off. However, this transformation was more difficult than initially expected. First, 
intermediate 126 was subjected to a variety of debenzylation conditions to potentially yield 
glycoside 128 (Table 2). Hydrogenation with different palladium catalysts proved to be 
unsuccessful and only starting material was recovered (Table 2, entries 13). This is not 
surprising since it was described that amines,
[49]
 as well as nucleobases
[50]
 can poison and thus 
inactivate the palladium catalyst. However other examples show that depending on the 
substrate, the hydrogenation can be successful in presence of a nucleobase.
[50-51]
 On the other 
hand, transfer hydrogenation with HCOONH4 as a hydrogen source and reduction with Raney 
nickel led to decomposition of 126 (Table 2, entries 4 and 5). The same results were obtained 
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with Lewis acids (Table 2, entries 6 and 7) and radical deprotection conditions (Table 2, entries 
8 and 9), since only intractable mixtures were isolated. 
Table 2. Conditions to debenzylate intermediate 126. 
 
 
Next, we investigated the deprotection of compound 127. Again, no reaction was observed 
with palladium as catalyst (Table 3, entries 13). Only 20% of a not further characterized 
monobenzylated product was isolated when substrate 127 was applied to radical lithium 4,4'-di-
tert-butyldiphenyl (LDBB) deprotection conditions (as indicated by 
1
H-NMR spectroscopy and 
mass spectrometry) (Table 3, entry 4). 
Table 3. Conditions to debenzylate compound 127. 
 
 
Since debenzylation was found to be impossible at the end of the synthesis, the two 
remaining benzyl protecting groups in 127 had to be swapped for acetyl groups at this stage 
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yielding tricyclic intermediate 129 (Scheme 31).
vi
 Glycosylation under the previously 
established conditions were also successful with substrate 129, and glycosylamine 131 was 
isolated in 55% yield. Global deprotection under Zemplén conditions gave herbicidin C (8) as a 
colorless solid. The identity of our synthetic material was confirmed by detailed spectroscopic 
studies, including NMR titration with an authentic sample of the natural product. Saponification 
of the base-labile herbicidin C (8) under mild conditions yielded aureonuclemycin (14), the 
third member of the herbicidin class.  
 
Scheme 31. Total syntheses of herbicidin C (8) and aureonuclemycin (14). 
Overall, we developed an efficient and flexible total synthesis of two complex undecose 
nucleoside antibiotics, namely herbicidin C (8) and aureonuclemycin (14). Our route integrates 
a stereoselective C-glycosylation with several reagent-controlled stereoselective transformations 
and a surprisingly facile and highly diastereoselective late-stage N-glycosylation. Our synthetic 
strategy could give rise to several other members of the class and opens the opportunity to 
prepare a wide range of derivatives, which could be investigated in course of the SAR study. 
 
vi
 Monobenzylated compound 130 was observed as a side product of the reductive double debenzylation 
(see Experimental Section). 
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6. Preparation of Compounds for SAR Study with Bayer 
CropScience AG 
The biological and structural features make the herbicidins interesting targets for both, total 
synthesis and lead structure search. Every isolated intermediate of the synthetic route developed 
was sent to Bayer CropScience AG for biological activity testing, regardless of its structurally 
resemblance to the natural product. A list of all the compounds that were prepared for testing is 
attached in the appendices. 
In addition, herbicidin A (6) was provided by Bayer CropScience AG for derivatization of 
the actual natural product. Different one- or two-step transformations were envisioned for the 
derivatization of herbicidin A (6) to furnish potentially bioactive compounds (Scheme 32).  
 
 
Scheme 32. Envisioned derivatives of herbicidin A (6) for structure-activity relationship (SAR) 
study. 
First, we focused on the ester side chain. Reduction of the double bond should give 
saturated ester 132, while saponification would provide herbicidin B (7), which itself could be 
esterified with alkyl carboxylic acids to yield herbicidin analogs of type 133. Next, we 
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envisioned modifications of the nucleobase, such as N-oxide formation (134) or its removal 
(135). Further transformation could target the hemiaminal at C-7 by converting the free 
hydroxy group to a cyclic thiocarbonate 136 or by removing the latter (137). Finally, the 
more flexible ring-opened derivatives 138 and 139, derived from oxide formation and 
peracetylation, would complete the attempt to modify most of the structural skeleton of 
herbicidin A (6), although much more derivatives are conceivable. 
6.1. Derivatization of Herbicidin A 
First, hydrogenation of herbicidin A (6) was expected to give alcohol 132. After reduction 
with hydrogen gas and Adams' catalyst (PtO2), saturated ester 140 was isolated as a 1:1 mixture 
of diastereomers (Scheme 33). Mechanistically, it was anticipated that intermediate 132 
undergoes elimination of water and is again subjected to reduction. 
 
 
Scheme 33. Hydrogenation of herbicidin A (6). 
The saponification of herbicidin A (6) to herbicidin B (7) in high yields was a challenge. 
The herbicidins, like other nucleoside natural products, are sensitive towards even mild basic 
reaction conditions (such as NaOMe or NH3 in MeOH).
[3b,8,10,52]
 The transformation of 
herbicidin A (6) to herbicidin B (7) described in the literature were typically carried out with 
phosphate buffer under careful control of the pH value, but even in these cases the reported 
yields were only 49%.
[30b,30f]
 
We reasoned that removal of the ester side chain of herbicidin A (6) might be more 
efficient, when hydrazine was used as a nucleophile since the formation of a 5-membered 
pyrazolidinone ring from the Michael system and hydrazine is feasible. Indeed, the yield of 
herbicidin B (7) was increased to 73% under these conditions. However, no byproduct derived 
from the side chain and hydrazine was detected (Scheme 34). 
Further attempts to acylate herbicidin B (7) with butyric acid chloride failed and only 
intractable mixtures of products were obtained. 
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Scheme 34. Saponification of herbicidin A (6) to herbicidin B (7) 
Next, we modified the nucleobase of herbicidin A (6) to afford derivatives for the 
bioactivity screening. The N-oxidation of adenine and adenosine with peracids is known to be 
regioselective for the 1'-position.
[53]
 Thus, oxidation of herbicidin A (6) with m-CPBA afforded 
herbicidin N-oxide 134 in 53% yield (Scheme 35). 
 
 
Scheme 35. Formation of N-oxide 134 from herbicidin A (6). 
To prove that the bioactivity of herbicidin A (6) is based on the nucleobase, the latter was 
removed by methanolysis with amberlyst 15 at room temperature in 53% yield and 2:1 d.r. and 
the resulting derivative 135 was subjected to biological activity tests (Scheme 36). The 
methanolysis of herbicidin A (6) under harsher conditions (amberlyst 15, MeOH, 90 °C) was 
described in the literature.
[30e]
 However, not only adenine was removed, but also the hemiacetal 
at C-7 was transformed into the respective methoxy ketal. 
 
 
Scheme 36. Removal of the nucleobase of herbicidin A (6). 
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In order to prepare a cyclized derivative of herbicidin A (6), the hemiacetal at C-7 and the 
free alcohol at C-9 were converted into thiocarbonate 136. This intermediate could potentially 
be deoxygenated under Barton-McCombie conditions. However, attempts to obtain the desired 
product 137 failed, presumably due to the poor solubility of substrate 136 in most organic 
solvents.  
 
 
Scheme 37. Cyclization and unsuccessful deoxygenation of herbicidin A (6). 
Due to its tricyclic undecose core, the herbicidin skeleton is relatively stiff. A more flexible 
derivative would be herbicidin oxime 138, which was prepared from herbicidin A (6) and 
hydroxylamine (Scheme 38). By comparison of the coupling constants of the respective 
1
H-NMR signals, it was shown that the 6-membered ring in 138 was inverted in order to have 
the substituents at C-8, C-9, and C-10 in equatorial position. Whereas the coupling constant of 
proton H-8 to H-9 in 6 has a size of J = 3.3 Hz, the corresponding coupling constant in oxime 
138 is J = 9.1 Hz, indicating an axial-axial coupling of H-8 and H-9. This ring-opened 
derivative should provide information on the importance of the tricyclic undecose core on the 
bioactivity. 
 
 
Scheme 38. Preparation of herbicidin oxime 138. 
According to our plans (vide supra, Scheme 32), we expected the peracetylation of 
herbicidin A (6) to give a second ring-opened compound 139. Interestingly, only bisacetylation 
was observed yielding derivative 142, although the reaction was carried out in a mixture of 
Ac2O and AcOH as solvent (Scheme 39). It was speculated that the hydroxy group at C-9 is less 
reactive and/or sterically less accessible towards electrophiles. If the hemiketal at C-7 was 
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acetylated during the reaction and hydrolyzed back to the hemiketal during aqueous work-up 
remained unclear. The structure of 142 was also confirmed by X-ray crystallography. 
 
 
Scheme 39. Acetylation of herbicidin A (6). 
Overall, herbicidin A (6) was derivatized at different positions of the molecule. Variations 
at the ester side chain, the nucleobase, the hemiketal, and the ring B provided a few derivatives 
which were sent to Bayer CropScience AG to give first insights of the relationship between the 
structure and the activity of the herbicidins. 
6.2. Derivatives from the Right Side Approach 
Our synthesis of the herbicidins possesses the potential to afford interesting derivatives for 
SAR study. Although these intermediates are structurally far away from the actual natural 
products, it was considered interesting to prepare compounds that have reduced complexity 
compared to the herbicidin skeleton to further investigate their bioactivity. Thus, cleavage of the 
acetonide in unsaturated lactone 63 and concomitant acetylation gave acetate 143 as a 4:1 
mixture of diastereomers. Stereoselective N-glycosylation provided derivative 144. This 
glycosylamine represents a reduced form of the herbicidin framework with ring C of the 
herbicidins undecose being completely absent. 
 
 
Scheme 40. Preparation of derivative 144 from unsaturated lactone 63, an intermediate from 
the right side approach. 
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6.3. Derivatives from the Left Side Approach 
In search for interesting derivatives for SAR testing, we were inspired by the antiviral drug 
aciclovir (146) (Scheme 41). The selective antiherpetic agent was discovered in the late 1970s 
and due to its extreme selectivity and low cytotoxicity, it was considered as the beginning of a 
new era in antiviral chemotherapy. Structurally, the carbohydrate moiety of guanosine (145) 
was reduced by the two carbon atoms C-2 and C-3.  
 
 
Scheme 41. Structural relationship of guanosine (145) and the antiviral drug aciclovir (146). 
In analogy, we designed a herbicidin derivative lacking two of its carbon atoms, namely C-2 
and C-3. The resulting compound 147 should immediately flip to its presumably more stable 
conformer 148. This derivative should be accessible from the left side approach of the total 
synthesis. 
 
 
Scheme 42. Structural relationship of herbicidin C (8) and derivative 148. 
TBS ether 98 was chosen as a potential precursor to 148. Its double bond was ozonolyzed 
and the secondary ozonide was reduced to afford alcohol 149 (Scheme 43). The chain 
elongation through formation of a chloromethyl ether with paraformaldehyde under acidic 
conditions and following reaction with adenine failed, due to the instability of the TBS ethers 
under these conditions. 
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Scheme 43. Attempts to synthesize TBS-protected glycosylamine 150. 
Therefore we decided to change the TBS ethers to more stable acetate groups (Scheme 44). 
Thus, diol 96 was protected with acetic anhydride and the resulting diacetate 151 was again 
ozonolyzed and subsequent reductive work-up gave alcohol 152. Unfortunately, the formation 
of a chloromethyl ether with paraformaldehyde and HCl or trimethylsilyl chloride was again 
unsuccessful and we decided to elongate the chain with the help of a Pummerer reaction to 
methylthiomethyl (MTM) ether 153. Direct coupling of 153 with adenine and sulfuryl chloride, 
as well as silylated adenine in the presence of N-bromosuccinimide were not successful and 
only decomposition of the substrate was observed. Therefore we converted thioether 153 with 
N-iodosuccinimide in the presence of acetic acid to acetate 154, which was then N-glycosylated 
under our previously established conditions to provide glycosylamine 155.  
 
 
Scheme 44. Synthesis of glycosylamine 155. 
At this stage of the synthesis, we realized that further transformation toward the desired 
derivative 148 would be more challenging than initially anticipated. The yields of the 
glycosylation were lower than expected and the purification was only efficient with HPLC. We 
decided to stop the preparation of the herbicidin derivative 148 at this point since compound 96 
was needed for the ongoing total synthesis. Nevertheless, compound 155 is still an interesting 
intermediate which was sent to Bayer CropScience AG for activity testing. 
Finally, we were able to utilize both routes of our total synthesis to prepare interesting 
intermediates for SAR testing. Although derivative 148 was not completed, progress was made 
towards finishing this analog and only adjustment of the oxidation states remained. 
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7. Conclusions 
In summary, we have achieved the first total synthesis of two complex undecose nucleoside 
antibiotics, namely herbicidin C (8) and aureonuclemycin (14). The first approach converged 
from the ring A of the herbicidin undecose. Establishment of the second ring B was achieved by 
following literature protocols. However, the route was not efficient enough to prepare decagram 
quantities of material and was thus abandoned. Nevertheless, we eventually assembled all 
carbon atoms of the undecose moiety although the right oxidation states and stereochemistry at 
several atoms were not established. Furthermore, the closure of the last ring C was not realized. 
In our second attempt to synthesize the undecose sugar, ring C was first constructed already 
with the right stereochemistry of its substituents. The advanced intermediate 98 was elongated 
with an open chained form of ring A. Thereby, we had to overcome unexpected stereochemical 
problems, but finally the whole undecose carbohydrate was arranged into the desired tricyclic 
herbicidin core 129. The challenging late-stage glycosylation from the sterically more 
congestive concave side proceeded surprisingly facile and was stereochemically controlled by a 
neighboring group. Global deprotection then provided the natural products herbicidin C (8) and 
aureonuclemycin (14). 
In further synthetic investigations, we prepared a range of simple derivatives of herbicidin 
A (6) for SAR study on the herbicidins in cooperation with Bayer CropScience AG. These 
synthetic transformations included variation of the ester side chain, modification of the 
nucleobase, derivatization of the hemiketal, and synthesis of a ring-opened derivative of 
herbicidin A (6).  
In addition, our synthetic approaches were used in order to prepare structurally less complex 
derivates of the herbicidin framework. From the right side approach, derivative 144 was 
prepared, which lacks ring C but has the complete adenine moiety established at ring A. The left 
side approach afforded the incomplete derivative 155, which also has the adenine attached. 
However, the oxidation states and the final deprotection remained to be established. 
With this work, we contribute to expand the chemistry of the herbicidins and provide a 
platform for the preparation of structurally related, potentially bioactive derivatives thereof. 
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8. Introduction 
The history of alkaloid natural products and their connection to humankind is long and 
ambivalent. Mostly isolated from plant sources,
[55]
 these natural products and their parent 
organisms have been and are still used as food spices, currency, ritual tools, hallucinogenic 
drugs and poison.
[56]
 One of the most prominent and early applications of an alkaloidal poison is 
reported in the context of the execution of Socrates in 399 BC by means of drinking an extract 
of poison hemlock (Conium maculatum), the main biologically active compound of which is 
coniine (156).
[57]
 Other poisonous alkaloid containing plants and the corresponding natural 
products have also been misused by humankind. Curare for example, with its main neurotoxic 
ingredient tubocurarine (157), was used as an arrow poison by South American indigenous 
people.
[58]
 Strychnine (158), gained from Strychnos nux-vomica, was applied as doping agent, 
analgesic and poison.
[59]
 Furthermore, the addictive effect of tobacco and the hallucinogenic 
nature of Atropa belladonna are based on the biologically active alkaloids nicotine (159)
[60]
 and 
atropine (160)
[58]
 respectively (Figure 5). 
 
 
Figure 5. Famous alkaloid structures: coniine (156), tubocurarine (167), strychnine (158), 
nicotine (159), and atropine (160), as well as their natural sources: Conium maculatum,
[61]
 
Chondrodendron tomentosum,
[62]
 Strychnos nux-vomica,
[61]
 Nicotiana rustica,
[61]
 Atropa 
belladonna.
[61]
 
 
vii
 This project was performed in cooperation with A. Hager, a PhD student in the Trauner group. The 
chapter was written together and can be found also in her PhD thesis.
[54]
 Both authors contributed equally 
to this work. 
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Although only a limited number of simple amino acid derived building blocks are involved 
in the biogenesis of alkaloids, the incorporation of other polyketide and terpenoid structures 
allow for a broad structural diversity and complexity within these natural products.
[55,58]
 As a 
result, a variety of biological activities are known among alkaloids. For example, they can 
activate, block or deactivate several ion channels, or alternatively bind to DNA affecting protein 
biosynthesis.
[63]
  
One of the most famous and historically important alkaloids is ()-morphine (161), the 
main component of opium (Figure 6).
[64]
 Its ambiguous biological activities are both, blessing 
and curse to mankind: on one hand alkaloid 161 releases pain, on the other it makes addictive. 
Most likely, opium poppy (Papaver somniferum), the main source of ()-morphine (161), was 
cultivated and used by Sumerians as medicine and hallucinogenic drug already more than 4000 
years ago.
[65]
 In the following centuries, the use of opium, the dry milky juice of the opium 
poppy fruit, became widely common in China, the Arabian countries, and throughout the whole 
world. The addiction to ()-morphine (161) provoked wars and is still one of the major 
problems worldwide. However, ()-morphine (161) is used as one of the most potent analgesic 
drugs up to date.
[64]
  
Although Papaver somniferum has been cultivated for centuries, it was only in 1804 that 
()-morphine (161) was isolated and identified as the main biologically active ingredient of 
opium poppy by F. Sertürner (Figure 6).
[66]
 Since then, several biological studies and chemical 
syntheses of morphine and its analogs have been performed.
[67]
 In fact, this natural product and 
its intriguing structure is still an inspiration for synthetic chemists even nowadays. 
 
 
Figure 6. Papaver somniferum (left),
[61]
 the natural source of ()-morphine (161) (middle) and a 
portrait of its discoverer F. Sertürner (right).
[68]
 
During the last centuries many other alkaloids with the common morphinan skeleton have 
been isolated and characterized (Figure 7).
[69]
 The backbone features a benzylic all carbon 
quaternary center in C-13 and a nitrogen containing stereocenter with (R)-configuration at C-9. 
In 1964, Y. Inubushi and co-workers were able to isolate a new alkaloid showing a modified 
morphinan skeleton.
[70]
 Hasubanonine (162) eventually turned out to be the parent compound of 
the new class of hasubanan natural products, all possessing the typical hasubanan skeleton, 
isomeric to the morphinans. Mostly isolated from various Stephania species, which were also 
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used in traditional Chinese medicine, more than 40 hasubanans have been identified to date.
[69a]
 
In contrast to the morphinans, the nitrogen substituent in the hasubanan skeleton is moved from 
C-9 to the C-14 position, forming a 5-membered ring, which now incorporates a nitrogen 
containing tetrasubstituted carbon center (NTC). The resulting aza-propellane skeleton can vary 
in its oxidation states. In addition, the hasubanans differ from morphinans in their absolute 
stereochemistry since they represent the opposite enantiomeric series of the skeleton.
[71]
 
Although the biological activities of hasubanan alkaloids are not as remarkable as those of the 
morphine derived structures, they have been the subject of extensive chemical research since the 
1970s, culminating in various total syntheses of these natural products.
[72]
  
 
 
Figure 7. The structures of morphinan, hasubanan and norhasubanan skeletons, as well as the 
corresponding parent compounds morphine (161), hasubanonine (162) and stephadiamine 
(163). 
Along with the investigation of Stephania species, another new alkaloid type related to the 
morphinans was discovered. Thus far, the only identified representative of these norhasubanan 
alkaloids is stephadiamine (163).
[11]
 As in the case of hasubanans, the norhasubanan core 
possesses the opposite configuration of the morphinan skeleton and an NTC center at C-14 
position. Additionally, one of the rings is rearranged forming a pentacyclic system with a 
second NTC center, featuring a primary amine (Figure 7). 
Many synthetic routes to morphinan and hasubanan structures have been developed in the 
last century and still a huge synthetic interest in this type of compounds exists. Thus, it is 
surprising that no synthetic approach to the norhasubanan stephadiamine (163) has yet been 
published, despite its structural beauty. Therefore, the goal of this work was the development of 
the first and efficient total synthesis of stephadiamine (163) with the potential of an 
enantioselective NTC installation. 
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9. Isolation, Biology and Properties of Stephadiamine 
9.1. Isolation and Structure 
The common scrambler Stephania japonica, often found in south-east Asia and the Pacific 
region, is known to possess various medicinal properties. Parts of this plant and its extracts are 
used in the Chinese and Taiwanese folk medicine as anti-diarrheal, anti-febrile drugs, and as a 
remedy against malaria and cholera.
[11,73]
 Biological investigations of alcoholic extracts of this 
species have shown that S. japonica is a rich source of hasubanan alkaloids.
[69b,74]
 In the course 
of metabolome investigations of S. japonica in 1984, T. Ibuka and co-workers were able to 
isolate and characterize a minor component of the ethanolic plant extract representing a novel 
type of alkaloidal structure, the pentacyclic stephadiamine (163), which was isolated as a 
colorless solid (Figure 8).
[11]
 
 
 
Figure 8. Leaves of Stephania japonica (left)
[75]
 and the structure of stephadiamine (163) (right). 
The quantity of the obtained novel natural product was not adequate for chemical 
degradation studies. Nevertheless, T. Ibuka and co-workers established the structure of the 
molecule using IR and 
1
H-NMR spectroscopic analysis as well as mass spectrometry. 
Eventually, they were able to obtain X-ray structures of stephadiamine (163) and its derivative 
N-p-bromobenzoyl stephadiamine (164), clarifying the connectivity and the absolute 
stereochemistry of the compound (Figure 9).
[11]
 Strictly, the lactonic C-norhasubanan 163 is not 
a member of hasubanan the alkaloid family. This type of skeleton has not been previously found 
in nature and to our knowledge, stephadiamine (163) is the only representative of norhasubanan 
alkaloids identified thus far. 
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Figure 9. Structure and X-ray analysis of stephadiamine (163) (top) and N-p-bromobenzoyl 
stephadiamine (164) (bottom). 
The basic pentacyclic core of the natural product 163 features a tetralin system, which is 
bridged by a 6-membered lactone moiety and connected to a pyrrolidine ring further bridged by 
two methylene groups forming a propellane structure (Figure 10). Stephadiamine (163) 
possesses four stereogenic centers, two of which are benzylic. An all-carbon quaternary 
stereocenter at C-13 and an oxygen containing chiral center at C-10 are joined by two NTCs at 
the C-7 and C-14 position. One of the latter includes a tertiary amine portion (C-14), whereas 
the second (C-7) bears a primary amine as the nitrogen substituent. However, in contrast to 
hasubanan alkaloids, the former ring C is rearranged to a 5-membered system and the 6-
membered lactone moiety forms the new ring E (Figure 8). In addition, hasubanan alkaloids 
show only one nitrogen atom, whereas stephadiamine (163) possesses two nitrogen 
functionalities. 
 
 
Figure 10. Skeletons of hasubanonine (162) and stephadiamine (163). 
The synthetic challenge presented by the complex structure of stephadiamine (163) with 
two contiguous NTC centers and the fact that it has not been synthesized thus far prompted us to 
develop a total synthesis of this natural product.  
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9.2. Biosynthetic Considerations 
The structural resemblance of the morphinan, hasubanan and norhasubanan skeleton 
discloses a connection of the biogenesis of the natural products belonging to these three classes 
of alkaloids. The broad interest in morphine (161) culminated in extensive studies on the 
biosyntheses of several benzyltetrahydroisoquinoline alkaloids.
[76]
 It was shown that in nature, 
()-morphine (161) is derived from dopamine (166) and 4-hydroxyphenylacetaldehyde (167), 
two simple building blocks originating from the amino acid tyrosine (165) (Scheme 45).
[58]
 
 
 
Scheme 45. Biosynthesis of ()-morphine (161). 
It was suggested that both building blocks are combined in an enzyme promoted Pictet-
Spengler-type reaction to the benzyltetrahydroisoquinoline core of (S)-norcoclaurine (168), 
which is then oxidized and methylated to yield (S)-reticuline [(S)-169]. An enzyme catalyzed 
oxidation/reduction process forms its (R)-enantiomer (R)-169, a key compound in all morphinan 
alkaloid biosyntheses. Compound (R)-169 is cyclized via an enzymatically formed diradical 170 
to salutaridine (171), by a selective intramolecular o,p-phenoloxidative coupling, which is one 
of the most important reactions in the morphinan biosyntheses. In tetracycle 171, the major 
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framework of ()-morphine (161) is already established.[77] Finally, further enzyme catalyzed 
transformations afford 161.
[58]
  
In the case of the parent hasubanan alkaloid hasubanonine (162), the biogenesis was 
investigated less thoroughly. Feeding experiments of 
14
C-labelled isoquinolines to S. japonica 
performed by A. R. Battersby in the early 1980s led to the proposal that, in analogy to morphine 
biogenesis, phenoloxidative coupling of tyrosine derived isoquinoline 172, an oxidized version 
of (R)-reticuline [(R)-169], is involved in the formation of hasubanonine (162) (Scheme 46).
[78]
 
However, the detailed sequence of the transformations involved in the biosynthesis of 
hasubanonine (162), especially the installation of the 5-membered pyrrolidine moiety was yet to 
be explained. In the case of cepharatine A (174), another hasubanan alkaloid, Y.-H. Zhang and 
co-workers suggested the incorporation of sinoacutine (173), the enantiomer of salutaridine 
(171), which is involved in morphine biosynthesis (Scheme 46).
[73]
 
 
 
Scheme 46. Proposed biosyntheses of hasubanan alkaloids hasubanonine (162) and 
cepharatine A (174). 
Unfortunately, the biogenesis of our target compound stephadiamine (163) was not 
investigated. However, its resemblance to the morphinan and hasubanan structures again 
suggests the incorporation of L-tyrosine (165). Further speculation along these lines would 
result in the assumption that a Pictet-Spengler-type reaction and a phenoloxidative coupling are 
also involved in stephadiamine biosynthesis. In addition, a skeletal rearrangement leading to 
dearomatization and ring contraction to form rings C and E would have to take place. 
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10. Results and Discussion – Toward Stephadiamine
viii
 
10.1. Strategy and Retrosynthetic Analysis of Stephadiamine 
One of the major challenges posed by the envisioned total synthesis of stephadiamine (163) 
is the assembly of the two contiguous NTC centers. Among many methods for the synthesis of 
NTC centers, Curtius rearrangement is a powerful tool and has been applied successfully in total 
syntheses of various alkaloids, even in sterically hindered cases.
[79]
 The retrosynthetic strategy 
we have chosen involves a Curtius rearrangement, which would introduce the NTC center at 
C-7 position comprising a primary amine as substituent. Thus, stephadiamine 163 could be 
traced back to carboxylic acid 175 (Scheme 47). At this stage, we envisaged to introduce the 
lactone moiety in 175 by means of an intramolecular bromine replacement leading to diester 
176 as a logical precursor. The propellane skeleton of bromide 176 could be assembled by 
means of a benzylic bromination and a homoconjugated addition/Mannich cascade, involving 
dimethyl cyclopropane-1,1-dicarboxylate (177) and enamine 178 as reaction partners. In turn, 
enamine 178 could be derived from -tetralone 179 through a stepwise enamine 
formation/alkylation sequence. The tetralone system 179 is known to be accessible from the 
simple commercially available building block 2-(2,3-dimethoxyphenyl)acetic acid (180) in 
several steps involving a CH activation process and a cyclization reaction.[12] 
 
 
Scheme 47. Retrosynthetic analysis of stephadiamine (163). 
The synthetic approach toward stephadiamine (163) is both novel and challenging in its 
nature. Not only does it involve a cyclopropane opening/aminoalkylation cascade, which is 
 
viii
 The experimental work of this chapter was performed together with N. Vrielink, an undergraduate 
researcher in the Trauner group. 
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scarcely represented in literature and, to our knowledge, has never been used in total synthesis 
thus far. The strategy also requires the formation of known enamine 178 as one of the 
intermediates, which is has been described to be oxygen and temperature sensitive.
[13c]
 In 
addition, the assembly of tetralone 179 relies on a novel type of chemistry involving a CH 
activation process. 
Despite its challenging nature, the envisioned approach offers a high flexibility. For 
example, -tetralone 179 represents a key intermediate, which could function as a branching 
point for various synthetic approaches toward the total synthesis of stephadiamine (163). 
Furthermore, the assembly of enamine 178 starting from -tetralone 179 can proceed through 
several different approaches by interchanging alkylation and enamine formation processes. 
Finally, the cyclopropane opening reaction (176) requires an activation of dimethyl 
cyclopropane-1,1-dicarboxylate 177 with a Lewis acid.
[80]
 At this stage, the use of a chiral 
Lewis acid could hold promise to even access 163 in enantioenriched form.  
10.2. Assembly of -tetralone 
Our first goal in the total synthesis of stephadiamine (163) was to access dimethoxy 
-tetralone 179. Several syntheses of this compound have been described in the literature, which 
will be shortly discussed herein (Scheme 48). 
 
 
Scheme 48. Literature known syntheses of -tetralone 179. 
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The earliest synthesis was published in 1950/1952 by M. D. Soffer and co-workers along 
the lines of their work toward morphine. It focused on the dearomatization of 
trimethoxynaphthalene 182 under Birch conditions as a key step.
[81]
 Unfortunately, they needed 
5 steps to synthesize 182 starting from dihydroxynaphthalene 181 and the final dearomatization 
step provided the desired tetralone 179 in unsatisfactory yield of only 31%. More than 30 years 
later, M. A. McKervey and co-workers published a rhodium(II) catalyzed CH insertion of 
diazoketone 183 providing the desired 5,6-dimethoxytetralone (179) only as a minor 
regioisomer and mostly the undesired para-cyclized product 184.
[82]
 In 2005, Á. Gorka and co-
workers synthesized 179 starting from benzaldehyde derivative 185.
[83]
 First, they assembled the 
diester 186 in 6 steps and then cyclized it in a low yielding two step protocol to 179. A shorter 
route to -tetralone 179 was developed by E. V. Cabrera and co-workers in 2011, who 
converted the commercially available 7-methoxy-1-tetralone (187) to epoxide 188 in four steps. 
In the final step, under strongly acidic conditions, the epoxide 188 was opened to -tetralone 
179.
[84]
 
All described routes described thus far are lengthy, include low yielding steps, and/or 
employ expensive catalysts. In addition, the starting materials are not easily available and the 
key intermediates have to be prepared over several steps. Eventually, it seemed that the best, 
shortest and most elegant way to assemble 179 would be a synthesis based on a procedure 
published by J.-Q. Yu and co-workers in 2010 (Scheme 49).
[12]
 The synthesis commences with a 
elegant palladium catalyzed aryl CH olefination of dimethoxyphenylacetic acid 180 with 
tert-butyl acrylate as a coupling partner. This step necessitated careful optimization as the 
procedure reported by J.-Q. Yu and co-workers lead only to mixtures of starting material and 
traces of product. However, application of oxygen overpressure of 3 bar in an autoclave 
apparatus furnished the corresponding unsaturated ester 189 exclusively. Without further 
purification, a reduction/esterification sequence was performed providing the diester 190 in 
84% over three steps. The synthesis of -tetralone 179 was accomplished by means of a 
cyclization/decarboxylation process, which gave 179 in 70% yield. This short protocol provided 
the desired -tetralone 179 in only four steps, three of which were carried out without column 
chromatography, in an overall yield of 59% on multigram scale.  
Next, -tetralone 179 was converted to the corresponding cyclopropane 191 in 88% yield, 
which could serve as an alternative precursor for the assembly of enamine 178 (vide supra, 
Scheme 47). The structure of 191 was confirmed by X-ray crystallography (Scheme 49). 
 
10. Results and Discussion - Toward Stephadiamine 
47 
 
Scheme 49. Synthesis of -tetralone 179,
[12]
 the assembly of the corresponding cyclopropane 
191, and X-ray structure of 191. 
With -tetralone 179 and cyclopropane 191 in hand, first attempts toward the synthesis of 
enamine structure 178 were undertaken. 
10.3. Toward Tricyclic Enamine 
As outlined in the retrosynthetic analysis, the preparation of enamine 178, a key 
intermediate in the total synthesis of stephadiamine (163), could start directly from 
tetralone 179 with a subsequent amination/alkylation sequence (Scheme 50). Alternatively, it is 
also reasonable that the formation of 178 could be achieved by means of a cyclopropane-
opening reaction of 191, followed by a cyclization with methylamine as nucleophile. 
 
 
Scheme 50. Envisioned assembly of the tricyclic enamine structure 178.  
10.3.1. Previous Work on the Formation of the Key Enamine 
Enamine 178 presents a methoxy substitution pattern, typical for morphinan and hasubanan 
alkaloids (vide supra, Figure 10). Thus, the synthesis of this portion was of great interest to 
synthetic chemists. It is therefore astonishing that compound 178 was synthesized only once by 
F. C. Tahk and co-workers in 1970 in the context of their work on cepharamine (Scheme 
51).
[13c]
 The enamine 178, which was described as air sensitive, was made from cyclopropane 
191 by means of a homoconjugated addition of methylamine followed by cyclization. To 
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achieve this transformation, Tahk and co-workers had to apply harsh conditions including 
heating as well as high pressure and long reaction times. Unfortunately, only analytical amounts 
of the product 178 could be isolated and characterized despite the fact that 1 gram of starting 
material was employed in this reaction. 
 
 
Scheme 51. Literature known syntheses of enamine 178 and its derivatives. 
In the same year D. A. Evans and co-workers published their work on the synthesis of the 
hasubanan carbocyclic system (Scheme 51).
[13b,85]
 One of the key intermediates used in this 
approach was enamine 194, which lacked the two methoxy groups present in 178. Starting from 
tetralone 192, Evans et al. achieved the assembly of tricycle 194 via enamine 193 by a two step 
protocol involving amination of tetralone 192 and alkylation of enamine 193 with 
bromochloroethane. This procedure is high yielding and could be performed on gram scale.  
In addition to the described protocols, the formation of enamines of type 178 was the 
subject of two other publications.
[86]
 Both are based on the sequence established by Evans and 
co-workers. Yet, the synthesis of a system containing two methoxy groups as present in 178 
using the Evans protocol has not been reported to date. 
With this information in background, the synthesis enamine 178 was attempted following 
one of the described procedures or variations of them. 
10.3.2. Studies toward Enamine System 
Initially, attempts in the synthesis of enamine 178 focused on the homoconjugated addition 
of amine nucleophiles to cyclopropane 191 as described by Tahk and co-workers (vide supra, 
Scheme 51). In order to improve the yield of the transformation, cyclopropane 191 was 
subjected to several reaction conditions involving methylamine or benzylamine as nucleophiles 
with the expectation that enamines 178 and 195 or the corresponding imines 196 and 197 would 
be formed (Table 4). First, reaction conditions including methylamine solutions and methyl 
amine hydrochloride salt were investigated (Table 4, entries 17). As it is known that acids such 
as ytterbium(III) triflate or p-toluenesulfonic acid can activate cyclopropane substituted ketones 
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and force the cyclopropane opening, they were also explored as additives.
[80]
 Despite the 
variation of temperature and solvents only starting material was re-isolated in most cases 
without observing the formation of the desired products. In the presence of acidic additives, 
decomposition and formation of complex mixtures occurred (Table 4, entries 1 and 2).  
Table 4. Screening conditions applied for synthesis of enamine 178 and 195 and corresponding 
imines 196 and 197. 
 
 
As Tahk and co-workers used freshly condensed methylamine gas, a closer examination of 
these conditions was undertaken (Table 4, entries 8 and 9). Methylamine gas was condensed at 
78 °C in a high pressure vessel and cyclopropane 191 was dissolved therein. Heating in the 
presence of ytterbium(III) triflate with toluene as solvent lead to the formation of complex 
mixtures (Table 4, entry 8). However, when methylamine was used as solvent without any 
additives at 100 °C over several days, a 1.5:1 mixture of a new compound and starting material 
191 was obtained (Table 4, entry 9). 
1
H-NMR spectroscopy suggested the formation of imine 
196. Unfortunately, we were not able to fully characterize the new component as all separation 
attempts lead to decomposition of the material. Figure 11 shows 
1
H-NMR spectrum of the crude 
mixture of 196 and 191. 
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Figure 11. 
1
H-NMR spectrum (200 MHz, CDCl3) of the crude mixture of 196 and 191. 
At this point, the suitability of benzylamine as nucleophilic reaction partner was 
investigated, since the corresponding products might be more stable than the methylated 
derivatives (Table 4, entries 10). Similar conditions as used in the methylamine screening 
were applied. In most cases, either decomposition or recovery of starting material was observed. 
As mentioned above, Tahk and co-workers were able to obtain only analytical amounts of 
the desired enamine 178 even though they performed the reaction with large quantities of 
starting material 191. In our case, isolation of the desired enamine 178 following the same 
strategy was not met with success. Supposedly, the envisioned cyclopropane opening might be 
hindered due to the presence of two adjacent methoxy substituents, which cause compound 191 
to be sterically hindered and also to be a more electron rich system disfavoring nucleophilic 
attack. 
Although these first attempts were unsuccessful, one interesting and promising result was 
obtained, when cyclopropane 191 was treated with methylamine in the presence of titanium(IV) 
chloride at room temperature (Scheme 52). Under these conditions, the cyclopropane ring was 
opened by a chlorine anion, presumably after the activation of the keto group by titanium(IV) 
chloride. Methyl amine is most likely not involved in the formation of compound 198. Further 
development and optimization of this reaction could prove chloride 198 as a building block for 
the synthesis of enamine 178. Furthermore, treatment of 198 with methyl amine could force an 
intramolecular ring closure to occur providing an elegant entry to enamine 178 (Scheme 52). 
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Scheme 52. Cyclopropane opening reaction leading to the formation of chloride 198 and 
envisioned formation of enamine 178. 
At this stage of the synthesis, we decided to test the conditions for the enamine formation 
published by Evans and co-workers.
[85]
 In this context, we first aimed for enamine 199, which 
should then be alkylated to afford the desired compound 178 (Scheme 53). 
 
 
Scheme 53. Envisioned stepwise formation of 178 via enamine 199 as possible precursor. 
Following this strategy, we tried to reproduce the reaction of unsubstituted -tetralone 192 
to enamine 193 as described by Evans et al. (vide supra, Scheme 51). Unfortunately, treatment 
of commercially available 192 with methylamine solution in the presence of titanium(IV) 
chloride at room temperature did not lead to the formation of the desired enamine 193. In 
addition, conditions such as MeNH2/amberlyst-15/toluene/T,
[87]
 MeNH2/TiCl4/ 
NEt3/CH2Cl2,
[88]
 and MeNH2·HCl/p-TsOH/toluene/T
[89]
 proved unsuccessful as only starting 
material was recovered. Eventually, we found that heating of -tetralone 192 with neat 
methylamine at 100 °C in an autoclave apparatus (7 bar) furnished the desired enamine 193 in 
quantitative yields (Scheme 54). 
 
 
Scheme 54. Formation of the enamine structure 193. 
The conversion of tetralone 192 was monitored by 
1
H-NMR spectroscopy. A comparison of 
the crude reaction spectrum with the starting material indicated the formation of enamine 193. 
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The signal of benzylic proton (H-2) disappeared at the expense of a new proton signal at 
5.25 ppm (enamine-H). Furthermore, a new methyl group (H-11) attached to a nitrogen atom 
was detected at 2.80 ppm in the 
1
H-NMR spectrum. All of these new signals suggested the 
quantitative formation of the desired enamine 193. Due to the instability of the compound, 
further characterization attempts were not performed. 
   
Figure 12. 
1
H-NMR spectra (CDCl3) of -tetralone 192 and the desired enamine 193. 
Having successfully established conditions for the enamine formation, the same procedure 
was applied to the dimethoxytetralone system 179. Treatment of tetralone 179 with 
methylamine at high temperatures in an autoclave apparatus led to the quantitative formation of 
the desired dimethoxyenamine 199 (Scheme 55).  
 
 
Scheme 55. Formation of enamine 199. 
As in the test reaction, the conversion of 179 was monitored by 
1
H-NMR spectroscopy 
(Figure 13). Comparison of the spectra again revealed quantitative formation of enamine 199. In 
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analogy to the spectrum of enamine 193, the 
1
H-spectrum of 199 shows a new peak at 5.47 ppm 
corresponding to the enamine proton H-2 and lacks a methylene group, which is present in the 
starting material (peak H-2 in the spectrum of 179). In addition, another new peak suggesting 
the presence of a methyl group attached to a nitrogen atom appeared (peak H-13). Hence, the 
crude proton spectrum of the reaction indicated the formation of the desired compound 199. No 
further characterization could be performed due to the instability of the product.  
 
 
Figure 13. 
1
H-NMR spectra (in CDCl3) of -tetralone 179 and crude enamine 199. 
At this point, we envisioned the alkylation of enamine 199 to access the tricyclic enamine 
178, a key intermediate in the total synthesis of stephadiamine 163 (Scheme 56). Several 
conditions, among them the alkylation condition developed by Evans, were investigated using 
the crude enamine 199. Thus far, no conclusive results were obtained. This topic is currently 
being investigated by N. Vrielink as a part of her Master project in the Trauner laboratories. 
 
 
Scheme 56. Envisioned installation of the ethylene bridge forming enamine 178.
Chapter II: Synthesis Toward the Alkaloid Stephadiamine 
54 
11. Summary, Conclusions and Future Directions 
In summary, first attempts toward the total synthesis of the norhasubanan 
stephadiamine (163) have been made. The literature known synthetic route to -tetralone 179, 
one of the key intermediates in the envisioned synthesis, was optimized. Following these high 
yielding and reliable procedures, compound 179 could be synthesized in multigram quantities in 
59% yield over four steps. In addition, the cyclopropane system 191 was prepared, which could 
possibly serve as a valuable precursor for the formation of enamine 178. 
Furthermore, first experiments aiming at the formation of the tricyclic enamine system 178 
were performed. Although these attempts remained unsuccessful, some promising results were 
obtained implying the formation of imine 196 as mixture with starting material 191. 
Additionally, cyclopropane 196 could be opened with titanium(IV) chloride presumably 
forming the primary chloride 198, which in future could open alternative routes for the synthesis 
of enamine 178. Finally, we were able to accomplish the syntheses of rather unstable bicyclic 
enamine structures 193 and 199, precursors for the formation of the desired tricyclic enamine 
systems 178 and 194. Alkylation reactions of enamine 199 were performed to install the 
ethylene bridge, unfortunately with no success so far. 
In the future, attempts toward the cyclopropane opening/aminoalkylation cascade could be 
made (Scheme 57). This key step of the synthesis would provide access to the propellane 
skeleton 200 featuring the first NTC center of stephadiamine (163). Intermolecular 
cyclopropane opening reactions are enhanced by activation of the adjacent carbonyl group with 
Lewis acids, such as ytterbium or scandium triflates.
[80]
 This fact would also provide the 
potential to apply chiral Lewis acid catalysis to form the correspondent quaternary benzylic 
stereocenter in enantioselective manner, eventually leading to an asymmetric synthesis of 
stephadiamine (163).  
 
 
Scheme 57. Envisioned synthetic route to stephadiamine (163) via cyclopropane 
opening/aminoalkylation strategy. 
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A subsequent selective bromination of diester 200 in the benzylic position should lead to 
bromide 176, which in turn can be converted to lactone 175 by means of hydrolysis and lactone 
formation. The final step in the total synthesis of stephadiamine (163) is envisioned to be a 
Curtius rearrangement forming the second NTC center. This route is currently under 
investigation by N. Vrielink as a part of her Master's project in the Trauner laboratories. 
In addition, we developed a second alternative synthetic strategy for the synthesis of 
stephadiamine (163) starting from -tetralone 179 since the pursued synthetic route proved to be 
more challenging than expected (Scheme 58). This new route would start with an alkylation of 
tetralone 179 forming nitrile 201. Alkylations of this type on similar systems are known in the 
literature and can be performed using enamine catalysis to avoid double alkylation processes.
[90]
 
Next, nitrile 201 could be converted to enol ether 202, which in turn should smoothly undergo 
enantioselective Tsuji-Trost allylation forming the benzylic quaternary stereocenter in 203 even 
in an asymmetric way.
[91]
 Enantioselective Tsuji-Trost allylation is a powerful method for 
installation of hindered stereocenters
[92]
 and has been applied successfully in total synthesis.
[93]
 
The diester moiety present in compound 204 could be then introduced using either Grubbs' 
metathesis or an ozonolysis/Wittig olefination sequence. The propellane motif of diester 200 is 
likely to be incorporated into substrate 204 by means of a reduction of the Michael system and 
the nitrile portion,
[90b]
 followed by an intramolecular imine formation to give imine 205, which 
would then cyclize to propellane 200. Most likely, these transformations could take place as a 
cascade reaction in a one pot process providing propellane 200 directly from nitrile 204.  
 
 
Scheme 58. Alternative synthetic route to stephadiamine (163). 
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Finally, after N-methylation, the same sequence as described in the first synthetic strategy 
toward stephadiamine (163) could be employed to accomplish the synthesis of the natural 
product. This sequence involves benzylic bromination of diester 200, hydrolysis and 
intramolecular lactone formation (175) as well as a closing Curtius rearrangement.[79c,94] 
This second strategy includes the powerful enantioselective Tsuji-Trost allylation and the 
cascade reduction/double cyclization reaction as key steps, which forms the first NTC-center of 
stephadiamine (163). Thus, this strategy is a short efficient alternative representing a modern 
and interesting route for the first asymmetric synthesis to this natural product. Overall, the 
versatile -tetralone 179 turned out to be a flexible key building block and could serve as 
starting material in additional alternative entries to stephadiamine (163) leaving room for further 
investigations. 
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Chapter III: Synthetic Studies Toward 
Divergolides C and D 
12. Introduction 
'Mir erschien jetzt alles so einfach, dass ich kaum glauben konnte, dass in der Zwischenzeit 
niemand die gleiche Idee gehabt haben könnte. – Everything now seemed so simple to me that I 
could hardly believe that nobody else (…) could have had the same idea (…).' 
(Feodor Lynen) 
Feodor Lynen was still surprised when he made this statement a few years after the 
publication of the groundbreaking results of the structural elucidation of acetyl coenzyme A 
(206) (acetyl-CoA, Figure 14).
[95]
 The structural mystery of the 'activated acetic acid', one of the 
key building blocks in metabolism, was solved. Earlier in 1947, biochemist Fritz Lipmann 
discovered the new coenzyme named 'coenzyme A' from pigeon liver extracts, which was able 
to transfer acetyl groups.
[96]
 The structure of this molecule featured pantothenate, adenosine, 
phosphate and sulfur units. However, the exact chemical constitution of compound 206, and 
especially the nature of the bond between acetate and coenzyme were so complicated that they 
remained unclear. It was attributed to the genius of Lynen to reveal the 'activated acetate' as 
thioester
[97]
 of coenzyme A.
[98]
  
 
 
Figure 14. Structure and X-ray analysis
[99]
 of acetyl coenzyme A (206). 
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The structural elucidation of acetyl-CoA (206) was the prerequisite for the exploration and 
understanding of many anabolic and catabolic pathways of the cell. Being the key building 
block of the acetate pathway, acetyl-CoA 206 is the central precursor for many natural 
metabolites like ketone bodies, fatty acids, steroids, terpenes, or polyketides. In addition to that, 
acetyl-CoA (206) enters the citric acid cycle to generate energy and several biosynthetic 
intermediates (Scheme 59).
[49]
 
 
 
Scheme 59. Acetyl coenzyme A (206) as central precursor for many biological metabolites. 
Among biological metabolites, the polyketides are a large and structurally diverse class of 
natural products, which is biosynthetically related to fatty acids. Depending on the genetic code 
of the producing enzyme complex, they are divided into three different types. Type I polyketide 
synthases (PKSs) are found in bacteria and fungi, and are often responsible for the formation of 
macrolide structures like erythromycin A (207) (Figure 15). These PKSs are very large, but 
single multifunctional proteins, containing several individual domains. Type I PKSs can be 
divided into 'iterative', i.e. repeating, and 'non-iterative' systems. Iterative systems use their 
functional domains repeatedly to produce a particular polyketide, while the more important non-
iterative PKSs possess a distinct active site for every single enzyme-catalyzed step leading to 
more diverse polyketide chains. In contrast, type II PKSs are complexes, composed of 
numerous individual monofunctional proteins. The occurrence of these systems is restricted to 
bacteria and they usually produce aromatic polyketides, e.g. doxorubicin (208). Type II PKSs 
are known to be of the iterative type only. The third types of PKSs are responsible for the chain 
extension of cinnamoyl-CoA starter units, thus leading to flavonoids, e.g. naringenin (209) 
(Figure 15), and stilbenes. These type III PKSs differ from the other systems as they employ 
only one single active site to perform all synthetic transformations. They are usually found in 
plants, bacteria, and fungi.
[58]
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Figure 15. Structural examples of polyketides of the three different types: erythromycin A (207) 
(type I), doxorubicin (208) (type II), naringenin (209) (type III). 
Within the type I polyketides, the ansa macrolides (or ansamycins) comprise a family of 
mostly bioactive natural products predominantly isolated from actinomycetes.
[100]
 The name 
'ansa macrolides', as initially introduced by A. Lüttringhaus
[101]
 and later used by V. Prelog and 
W. Oppolzer,
[102]
 was derived from the basket-like shape of these molecules possessing a 
'handle' (Latin: ansa = 'handle'). This 'handle' is fused via an amide bond to a mono- or bicyclic 
aromatic ring as can be found for example in geldanamycin (210)
[103]
 or rifamycin SV (211)
[104]
 
(Figure 16). Thus, these molecules are lactams in contrast to the previously mentioned 
macrolactone erythromycin A (207).  
 
 
Figure 16. Structures of ansa macrolides geldanamycin (210) and rifamycin SV (211). 
Among the ansa macrolide natural products, several molecules with biologically interesting 
activity were identified. Geldanamycin (210) is a prominent compound in anti-tumor research 
which inhibits the heat shock protein 90 (HSP90).
[105]
 In contrast to that, rifamycin SV (211) is a 
highly active antibacterial agent and the first member of the rifamycin family that was used in 
clinical trials. Further synthetic modifications of this natural product led to more potent 
drugs.
[58]
  
Structurally, ansa macrolides 210 and 211 can be subdivided into two different types. While 
geldanamycin (210) shows a benzenic quinone core, the ansa-polyketide 'handle' of rifamycin 
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SV (211) is connected to a naphtohydroquinone moiety. Despite the structural difference, the 
use of similar building blocks is often encountered in the biosynthesis of ansalactams. For 
instance, both type I polyketide natural products, 210 and 211, are derived from the same starter 
unit 3-amino-5-hydroxy-benzoic acid (AHBA) (212) (vide infra, Scheme 60).
[106]
 
Divergolides AD (213216)[14] are another family of the large class of 3,5-AHBA-derived 
natural products (Figure 17).
[107]
 Like most ansamycins, they also show remarkable anti-
infective and antitumoral activities.
[14]
 Despite this fact, no total synthesis of a divergolide has 
yet been reported.  
During the isolation process of 213216, the fermentation extract showed a complex 
metabolome. Due to little amounts, C. Hertweck and co-workers were only able to isolate and 
fully characterize the structures of divergolides AD (213216). It is very likely that more, 
presumably highly bioactive natural products and metabolites could be found in these extracts. 
Since our group is interested in the synthesis of naphthalenic ansa macrolactams,
[108]
 we set out 
to support the search and structural elucidation of new compounds of the divergolide class by 
means of total synthesis. 
 
 
Figure 17. Structures of divergolides AD (213216). 
Hence, this project was focused on the following aspects: 
 total synthesis of divergolides C (215) and D (216) from a common precursor, which itself 
is more likely a metabolite of the divergolide biosynthesis; 
 structural characterization of the intermediates which could correspond to the natural 
metabolites; 
 providing the synthetic precursors to the Hertweck group to support the investigation of 
metabolites of the divergolide biogenesis. 
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13. Isolation, Biology and Structural Features of the 
Divergolide Family 
Mangroves are trees that grow in saline sediments along the tropical and subtropical coast. 
The family consists of various species. Among them, the mangrove tree Bruguiera gymnorrhiza 
is predominant at the Chinese coast. Thus, it is not surprising that the bark and the roots of these 
trees are used in traditional Chinese folk medicine to treat diarrhea, throat inflammation and 
hemostasis for centuries.
[14]
 While several chemical components of the plant itself were subject 
to various investigations,
[109]
 the biological potential of the endophytes (bacteria or fungi that 
live within the plant) were insufficiently explored.
[110]
 Therefore, the Hertweck group 
investigated the cultured endophyte strain Streptomyces sp. HKI0576 in detail, which was 
isolated from the stem of B. gymnorrhiza with several other strains of bacteria Streptomyces 
spp. The first extracts of this strain afforded a complex metabolome with a vast variety of 
different compounds. However, only trace amounts of the new structures could be isolated. 
After scale up of the fermentation process, four new ansamycins, namely divergolides AD 
(213216), were obtained and structurally elucidated by NMR spectroscopy and mass 
spectrometry techniques (vide supra, Figure 17). In addition to that, the structure of divergolide 
A was confirmed by X-ray crystallography (Figure 18).
[14]
 
 
 
Figure 18. Structure and X-ray analysis of divergolide A (213). 
Interestingly, although being structurally different, all four natural products 213216 show 
useful biological activities. During an antibacterial screening
[14]
 it was found that divergolide A 
(213) exhibits the strongest activity against Mycobacterium vaccae, whereas divergolide D 
(216) is more active against Bacillus subtilis and Staphylococcus aureus. In contrast to that, 
divergolide C (215) is the only of all four compounds that displays activity against 
Enterococcus faecalis, albeit just moderate. Further cytotoxicity screenings against 40 tumor 
cell lines revealed that only divergolide D (216) showed mentionable activity. In particular, cell 
lines corresponding to lung cancer (LXFA 629L), pancreatic cancer (PANC-1), renal cancer 
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(RXF 486L), and sarcoma (Saos-2) were most sensitive toward natural product 216, with IC50 
values ranging from 1.0 to 2.0 µM. Overall, it was noticed that among the ansamycins 213216, 
divergolide A (213) could be a promising compound for the development of anti-infectives, 
whereas divergolide D (216) might be a potent lead structure for antitumor drugs.
[14]
 
Over the past years, our group got interested in the synthesis of naphthalenic ansa 
macrolactams.
[108]
 Thus, this project is focused on the total synthesis of divergolides C (215) and 
D (216), since these natural products incorporate a naphthalene core. The structures of 215 and 
216, including the numbering of the carbon skeleton suggested by Hertweck and co-workers, 
are shown in Figure 19.
[14]
 Both compounds show a tetracyclic scaffold in which a highly 
substituted naphthalenic moiety is connected with a polyketide ansa bridge. Whereas the 
aromatic nucleus of divergolide C (215) is a hydroquinone derivative, divergolide D (216) 
possesses a naphtoquinone as the central unit. The naphthalenic portions are extended by a 
7-membered lactam ring in case of 215, and a 5-membered lactam in 216. The remaining 
polyketide ansa chains form macrolactones of different sizes: 15-membered in 215 and even 
19-membered in compound 216. Interestingly, two different allylic hydroxy groups at C-11 and 
C-12 are incorporated in the formation of the cyclic esters. In addition to that, divergolide C 
(215) shows four stereogenic centers at C-4'', C-8, C-11, and C-12, one of which (C-4'') is 
quaternary and benzylic. In contrast, divergolide D (216) possesses even five stereocenters at C-
5', C-2'', C-8, C-11, and C-12. A remarkable attribute of both compounds is the unprecedented 
isobutenyl side chain at C-12, which is an unusual extender unit in type I polyketide 
synthesis.
[14]
 These outstanding structural features make the divergolides C (215) and D (216) 
interesting targets for total synthesis. 
 
 
Figure 19. Structures of divergolides C (215) and D (216) with carbon skeleton numbering 
suggested by C. Hertweck and co-workers.
[14]
 
Although the structures of divergolides AD (213216) differ from each other, it is 
anticipated that they stem from the same biosynthetic precursor (Scheme 60).
[14]
 Unfortunately, 
all isotope labeling experiments performed by Hertweck and co-workers, which could support 
the proposed biosynthesis, failed because insufficient amounts of isolated metabolites were 
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available. Nevertheless, Hertweck suggested that the starter unit AHBA (212), which itself is 
derived from the aminoshikimate pathway,
[111]
 has been condensed by a type I PKS with two 
methylmalonyl-CoA, three malonyl-CoA, one ethylmalonyl-CoA, and one unprecedented 
isobutyrylmalonyl-CoA extender units (Scheme 60).
[112]
 The unusual isobutyrylmalonyl-CoA 
unit
[113]
 was observed in this class of natural products for the first time.
[114]
 The resulting 
polyketide chain 217 is considered to have been intercepted by a Baeyer-Villigerase
[115]
 to give 
ester 218 as a common precursor, which can undergo optional acyl migration to provide 
different ester pattern for the divergolide framework. After oxidation of the aromatic ring in 
intermediate 218, the highly reactive polyketide side chain of 219 can undergo three different 
cyclization reactions to provide the diverse aromatic cores of the divergolides AD (213219) 
(Scheme 60).  
 
Scheme 60. Proposed biosynthesis of divergolides A (213) and B (214) proposed by C. 
Hertweck and co-workers.
[14]
 
Chapter III: Synthetic Studies Toward Divergolides C and D 
64 
In particular, the exomethylene-2H-benzopyran of divergolide B (214) could be formed 
after nucleophilic attack of the phenolic hydroxy group in 219 to the adjacent carbonyl group. 
Subsequent water elimination would result in chromene 214 (path a, Scheme 60). In the second 
scenario, the very same phenolic hydroxy group in 219 might attack the more distant carbonyl 
function (path b1, Scheme 60), resulting in a hemiketal that could further cyclize by a Michael 
attack on the side chain double bond to the intriguing ring system of divergolide A (213) (path 
b2, Scheme 60).
[14]
 
On the other hand, the naphthalenic moieties of divergolides C (215) and D (216) might be 
formed after oxidation of hydroquinone 219 to the corresponding benzoquinone 220 and further 
cyclization to naphtoquinone 221 (path c, Scheme 60). As suggested by Hertweck and co-
workers, this intermediate 221 could be a common biosynthetic precursor for the installment of 
the 5- and 7-membered lactams to give divergolides C (215) and D (216), respectively. Along 
these lines, divergolide C (215) is likely to result from an intramolecular attack of the carbonyl-
activated methylene in compound 221 to the naphtoquinone in a vinylogous fashion (path a, 
Scheme 61). Alternatively, an aldol reaction could provide the pyrrolidone moiety of 
divergolide D (216) (path b, Scheme 61).
[14]
 The specific stage of the biosynthesis at which the 
acyl migration step occurs to form the different scaffold of divergolides C (215) and D (216), is 
yet to be identified. This of course leads to further speculation if this event happens before, 
during, or after the cyclization processes. 
 
 
Scheme 61. Proposed biosynthesis of divergolides C (215) and D (216) by C. Hertweck and co-
workers.
[14]
 
The most remarkable feature of Hertweck's proposal is that all four divergolides AD 
(213216) fit into one biosynthetic scheme. Derived from one precursor 219, flexible and 
diverse cyclization modes lead to different natural products of one family, thus called 
divergolides. This biosynthetic proposal is an inspiring basis for a divergent total synthesis 
approach to divergolides C (215) and D (216). 
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14. Results and Discussion of the Synthetic Studies Toward 
Divergolides C and D
ix
 
14.1. Retrosynthetic Analysis for Divergolide C and D 
According to Hertweck's proposed biosynthesis, divergolides C (215) and D (216) could be 
derived from one common precursor.
[14]
 Inspired by this hypothesis, we designed a synthesis for 
both natural products relying on a biomimetic key step. This approach is based on the synthesis 
of macrocycle 222 as parent compound for 215 and 216. Intermediate 222 is the equivalent to 
the proposed biosynthetic precursor 221, although the esterification pattern in 222 fits only to 
divergolide C (215). For the synthesis of divergolide D (216), an acyl migration step has to take 
place in analogy to the biosynthetic ideal. Macrocycle 222 could be prepared from three 
different building blocks, such as naphthaldehyde 223, western side chain 224, and eastern side 
chain 225. Naphthalene 223 should then be connected with 224 by means of a metallate 
addition. Further amide coupling with western side chain 225 and marcocyclization through 
Grubbs' metathesis could provide a protected derivative of precursor 222. 
 
 
Scheme 62. Retrosynthesis of divergolides C (215) and D (216). 
 
ix
 This project was performed in cooperation with A. Hager and C. A. Kuttruff, both PhD students of the 
Trauner research group. 
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14.2. Attachment of the Western Side Chain 
14.2.1. First Strategy 
The first stage of the synthetic work toward divergolides C (215) and D (216) was the 
preparation of naphthalene building block 222. Thus, we envisioned the connection of 
bromonaphthalene 226
x
 with aldehyde 227 to provide ketone 228 after DMP oxidation (Scheme 
63). For this coupling large amounts of aldehyde 227 in high enantiomeric purity were needed.  
 
 
Scheme 63. Planned synthesis of naphthalene building block 228. 
The preparation of the respective alcohol 232 or its enantiomer has been described several 
times in the literature. For example, E.-i. Negishi and co-workers reported the synthesis of 232 
through a tandem reaction of a zirconium-catalyzed asymmetric carboalumination of an alkene 
(ZACA)
[117]
 and a lipase-catalyzed acetylation.
[118]
 However, this route seemed not practicable 
for us to yield large amounts of alcohol 232. 
A. H. Hoveyda and co-workers published another synthesis of 232 by a zirconium-catalyzed 
ethylmagnesation of 7-membered heterocycles.
[119]
 Thus, we were able to prepare ether 230 
from 4-penten-1-ol (229) and allyl bromide (Scheme 64). Conversion of 230 into 
tetrahydrooxepine 231 by means of a ring closing metathesis (RCM) and subsequent treatment 
with EtMgBr and the zirconium catalyst gave alcohol 232, however in unreliable and low yields 
(<50%). Furthermore, determination of the optical rotation indicated only small 
enantioselectivity of the reaction. This disappointing result might be caused by the low quality 
of the commercially available zirconium catalyst. As already mentioned by Hoveyda et al., the 
freshly prepared and enantio-resolved catalyst gave the best results.
[119]
 Another drawback of 
this method was the enormous costs of both catalysts which only allowed small scale reactions. 
Hence, the isolation of little amounts of volatile alcohol 232 was extremely difficult. 
 
 
x
 The synthesis of 226 was performed by C. A. Kuttruff and was part of his PhD thesis.
[116]
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Scheme 64. Unsuccessful synthesis of alcohol 232. 
14.2.2. Second Strategy 
Looking for alternatives, we finally focused on a slightly modified strategy for the synthesis 
of naphthalene building block 228 that required the preparation of naphthaldehyde 223 from 
bromonaphthalene 226 and its coupling to a C1-shorter western side chain 224. Bromide 224 
should be transmetallated to serve as a nucleophile for the attack on naphthaldehyde 223 and, 
after oxidation, the earlier proposed naphthalene 228 would be obtained (Scheme 65). 
 
 
Scheme 65. Modified strategy for the synthesis of naphthalene building block 228. 
The enantioselective preparation of bromide 224 was envisioned through a 1,4-addition of a 
monoorganocopper reagent to auxiliary containing Michael system 237 (Scheme 66). Although 
this method was laid out earlier by Hoveyda and co-workers to establish the proposed absolute 
stereochemistry of their zirconium mediated transformations, no experimental details were 
reported in this publication.
[120]
 For our purpose, we synthesized Koga's auxiliary 236, which 
was known to control 1,4-additions in a highly selective manner.
[121]
 Along these lines, we 
esterified D-pyroglutamic acid (233) to the corresponding ethyl ester 234 that was further 
reduced to alcohol 235 (Scheme 66). Reduction of 234 with NaBH4 in the presence of LiCl 
provided alcohol 235 in high yields.
[122]
 However, the success of this reaction was dependent on 
the purity of the starting material. Thus, when highly pure ester 234, obtained after distillation, 
was used, this reaction could be driven to completion only by LiBH4.
[123]
 It was speculated that 
impurities or solvent residues might accelerate the reduction with NaBH4 and LiCl on decagram 
scale. Protection of alcohol 235 then gave Koga's auxiliary 236, which was acylated to provide 
Michael acceptor 237. The highly stereoselective 1,4-addition of a monoorganocopper reagent 
afforded compound 238 as a single diastereomer in high yield. Its absolute stereochemistry was 
proven by X-ray analysis (Scheme 66). Neither the X-ray structure of the starting material 237, 
nor the one of the product 238 show clear hints of a sterically unhindered trajectory for the 
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nucleophilic attack of the cuprate to explain the stereoselective outcome of the reaction. It was 
proposed that a different conformation and additional complexation of the substrate 237 with 
the reaction partners might be the reason for the stereoselective 1,4-addition.
[124]
 The following 
cleavage of the auxiliary
xi
 was more reluctant than anticipated, but combination of LiOMe and 
LiAlH4 gave alcohol 239 that was directly converted into bromide 224 using Appel-type 
conditions. Another route from alcohol 239 to bromide 224 was a mesylation/substitution 
sequence. However, this way was lower yielding and less practicable. The side chain 224 turned 
out to be also extremely volatile so that unusual isolation methods were requested and the 
diminished yield was attributed to these isolation processes (see experimental section). 
Although this sequence is longer than the previously described catalytic ways (vide supra, 
Scheme 64), it allowed the preparation of decagram quantities of compound 238,
xii
 which was in 
turn converted into bromide 224.  
Overall, the enantiopure western side chain 224 was synthesized in sufficient quantity for 
full characterization and to proceed with the coupling to the naphthalene part. 
 
 
Scheme 66. Synthesis of western side chain 224. 
Since bromide side chain 224 was one carbon atom shorter than originally envisioned, we 
had to extend bromonaphthalene 226 by formation of naphthaldehyde 223. Lithiation of 224 
and quenching of the resulting anion with DMF provided compound 223 in good yield of 86% 
as well as protodemetallated byproduct 240 in 10% yield (Scheme 67, top). In order to attach 
the western side chain 224, we had to optimize the reaction conditions carefully. Thus, 
conversion of naphthaldehyde 223 with 2.2 eq of bromide 224 and 4.5 eq of t-BuLi at 78 °C 
resulted in nucleophilic attack of the t-Bu anion into the aldehyde of naphthalene 223. After 
 
xi
 For the cleavage of the auxiliary see also PhD thesis of A. Hager.
[54]
 
xii
 The synthesis of large amounts of compound 238 was performed together with A. Hager. 
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DMP oxidation we isolated ketone 241 in 74% yield over two steps (Scheme 67, bottom). This 
promising result showed that attack of large nucleophiles is possible in general, although 
aldehyde 223 is sterically crowded by the neighboring MOM and methoxy groups. On the other 
hand we realized that no transmetallation on 224 had taken place at 78 °C. Therefore, 5 eq of 
bromide 224 were treated with an excess (15 eq) of t-BuLi and the mixture was allowed to 
warm to 0 °C to form the lithiated side chain. After reaction with naphthaldehyde 223 and 
oxidation, the desired product 228 was isolated together with the co-polar side product 242 as a 
1.3:1 mixture. Separation was only successful by HPLC. Compound 242 was presumably 
formed after t-BuLi had activated and cleaved THF
[125]
 and the resulting anion had reacted with 
naphthaldehyde 223. The best result of this alkylation reaction was obtained, when a mixture of 
bromide 224 (5 eq) and t-BuLi (10 eq) was stirred at 0 °C to undergo the transmetallation 
efficiently. The resulting lithiated side chain was attached to 223, and after subsequent DMP 
oxidation, we finally observed naphthalene building block 228 in 67% over 2 steps. No 
byproduct was detected (Scheme 67, bottom).  
 
 
Scheme 67. Preparation of naphthaldehyde 223 (top) and attachment of western side 
chain 228 (bottom). 
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Interestingly, NMR analysis revealed that the methylene groups in 228, 241, and 242 turned 
diastereotopic as soon as a side chain was attached to the carbonyl group. Since we did not 
observe any Boc-rotamers or NMR signal splitting in bromonaphthalene 226 and 
naphthaldehyde 223, we attributed these findings to a hindered rotation around the axis between 
the carbonyl group and the naphthalene moiety (Scheme 68). Thus, in case of the desired 
product 228 the two diastereomers 228a and 228b could be seen in the NMR spectra as a 1:1 
mixture. 
 
 
Scheme 68. Rotation around the axis between the carbonyl group and the naphthalene moiety. 
In order to show that the diastereomers 228a and 228b can be converted into each other by 
means of heating, we set out for high temperature 
1
H-NMR experiments to follow the rotation 
around the axis. Indeed, at 60 °C the signals of the two diastereomers converged to one set of 
peaks in the NMR spectrum as it is illustrated for the methoxy protons of the MOM protecting 
group (Figure 20, box). 
 
Figure 20. 
1
H-NMR spectrum (400 MHz, dmso-d6) of compound 228 at 22 °C and 
diastereomeric equilibration at elevated temperature (box). 
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14.3. Attachment of the Eastern Side Chainxiii 
The next stage of the synthesis was the coupling of the eastern side chain 225
xiv
 to the 
naphthalene building block 228 (Scheme 69). At the beginning of this investigation we decided 
to keep the Boc protecting group in 228 as it was reported that it can support the subsequent 
ring closing metathesis.
[126]
 In addition, we envisioned a global deprotection of the MOM and 
Boc protecting groups under acidic conditions at the end of the synthesis to reduce the amount 
of steps. 
 
Scheme 69. Envisioned coupling of the eastern side chain 225 to naphthalene building 
block 228. 
Along these lines, naphthalene building block 228 was deprotonated with LDA and the 
resulting anion was subjected to acid chloride 244, which was prepared from carboxylic 
acid 225 and Ghosez's reagent or oxalyl chloride (Scheme 70). However, none of the desired 
product 243 was isolated and only staring material 228 was recovered. 
 
 
Scheme 70. Unsuccessful synthesis of compound 243. 
We realized soon that the direct acylation of Boc-protected naphthalene 228 with side 
chain 244 is more challenging than anticipated. The electronically withdrawing and sterically 
demanding effects of Boc protecting group might deactivate the nucleophilic nitrogen of 
naphthalene 228 in such a fashion that no reaction occurred. Therefore, we decided to remove 
 
xiii
 The experimental work of this chapter was performed together with D. W. Terwilliger, an 
undergraduate researcher in the Trauner group. 
xiv
 The synthesis of 225 was performed by A. Hager and was part of her PhD thesis.
[54]
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the protecting groups of 228 already at this stage prior to the side chain coupling. Acidic 
deprotection of both protecting groups with a freshly prepared solution of HCl in MeOH 
provided free aminonaphthalene 245 in quantitative yield (Scheme 71). It is worth noting that in 
compound 245 free rotation around the axis between the carbonyl group and the naphthalene 
moiety is enabled again. With aminonaphthalene 245 in hand, further studies regarding the 
coupling with side chain 225 could be made. Indeed, the successful amide coupling of free 
amine 245 with carboxylic acid 225 with EDC and HOBt was indicated by 
1
H-NMR 
spectroscopy and high resolution mass spectrometry. The resulting naphthalene 246 
incorporates both side chains and carbon atoms of the divergolides. 
After the assembly of all three building blocks, the ring closing metathesis could be 
progressed to furnish the macrocycle. This is currently under investigation in the Trauner group 
by D. W. Terwilliger in course of his Master project. 
 
 
Scheme 71. Attachment of western side chain 225 to building block 245. 
14.4. Targeting the Acyl Migration 
In divergolides C (215) and D (216), the lactone moiety of the macrocycle is connected to 
different positions. Whereas in divergolide C (215), the cyclic ester is closed at the C-12 
position, the C-11 position of divergolide D (216) serves as connection point. In the 
biosynthetic proposal (vide supra, Scheme 61) as well as in our biomimetic key step of our 
synthesis we hoped for a spontaneous acyl migration during the cyclization step. However, if no 
acyl migration took place, our eastern side chain 225 would only provide divergolide C (215) 
(Scheme 72). For the synthesis of divergolide D (216) a different substitution pattern of the side 
chain is necessary, as depicted in compound 249. 
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Scheme 72. Different macrocyclic connections of divergolide C (215) and D (216). 
In order to address the different substitution patterns, change of the protecting groups of 247 
was envisioned to yield a silyl ether of type 248. This compound would allow the preparation of 
side chain 249, which should result in the formation of divergolide D (216). Along these lines, 
MOM ether 247
xv
 was converted into TBS ether 250 in excellent yields. Unfortunately, the 
MOM protective group could not be cleaved under acidic conditions (such as CSA, 
B-bromocatecholborane, AlCl3, Sc(OTf)3, Bi(OTf)3, MgBr2/EtSH), most of which gave 
intractable mixtures with little or no desired product 251. Similar results were obtained with 
TBDPS ether 252 that was prepared from 247. Again, deprotection conditions (such as PPTS, 
CSA, B-bromocatecholborane, HCl, AlCl3, TFA) were not successful to yield 253. 
 
 
Scheme 73. Unsuccessful attempts to prepare silyl ethers 251 and 253. 
At this point, we decided to focus on the eastern side chain 225 as building block for the 
macrolide synthesis. No further experiments were carried out to synthesize the alternative side 
chain 249. 
 
xv
 Compound 247 was prepared by A. Hager.
[54]
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15. Conclusions and Further Work 
In summary, progress toward the synthesis of divergolides C (215) and D (216) was 
achieved. Especially the installation of the side chains was investigated. In particular, we were 
attempting to prepare the longer western side chain 232 through enantioselective zirconium-
catalyzed ring opening, following Hoveyda's methodology. However, only little amounts of 
desired alcohol 232 were observed and due to the high costs of the catalysts we changed the 
strategy for the side chain installation. In this context, we extended bromonaphthalene 226 by 
one carbon atom through forming the respective aldehyde 223. The shorter side chain 224, now 
needed for the attachment, was prepared by a diastereoselective monoorganocuprate addition to 
a Koga's auxiliary-derived Michael acceptor 237. After removal of the auxiliary and conversion 
to the respective bromide 224, we were able to prepare preparative amounts of enantiopure 
western side chain 224, which was more challenging than initially expected. After some 
optimization, we were successful in the coupling of this side chain 224 to the naphthaldehyde 
223 to yield naphthalene building block 228. Since double acylation of the nitrogen of 
compound 228 failed, we removed the Boc and MOM protective groups to obtain the free 
aminonaphthalene 246, which was ready for the attachment of the second side 225 chain 
through amide coupling to afford intermediate 246. Finally, all three building blocks 223, 224, 
and 225 were assembled and investigations towards the closure of the macrocycle can be made. 
This is currently progressed by D. W. Terwilliger as a part of his Master project in the Trauner 
group.  
In future, ring closing metathesis should provide macrocycle 254 and after a 
deprotection/oxidation sequence, general precursor 222 should be readily available (Scheme 
74). This intermediate 222 would be more likely a metabolite in the divergolide biosynthesis. 
The final biomimetic cyclization and an optional acyl migration step should result in the first 
total synthesis of the divergolides C (215) and D (216). The natural products might be observed 
even during the oxidation step. 
In order to address the acyl migration step, we tried to synthesize the alternative eastern side 
chain 249 that should directly give divergolide D (216) (Scheme 72). However, these attempts 
were not successful and no further experiments towards a different substitution pattern at the 
eastern side chain were carried out. 
Overall, we advanced the synthesis of macrocycle 222, which presumably is a natural 
product itself. This fact will be investigated together with the group of C. Hertweck. 
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Scheme 74. Overview of the remaining steps to divergolides C (215) and D (216). 
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Chapter IV: Synthesis of a Bacterial 
Signaling Molecule 
16. Introduction 
'It is time to close the book on infectious diseases (…).' 
(William H. Stewart) 
When the U.S. Surgeon General William H. Stewart made this infamous statement in the 
late 1960's,
[127]
 it was believed that the fight against infectious diseases had been won. 
Unfortunately, this turned out to be a big mistake.
[128]
 Infectious diseases are still one of the 
primary causes of death worldwide.
[129]
 Although a wide range of antibiotics is available,
[130]
 the 
increasing resistance of bacteria against existing drugs is a huge problem in the health care 
sector.
[131]
 Thus, the search for new, antibiotic independent treatment options for bacterial 
transmitted diseases is gaining importance.  
In this context, it is necessary to understand the complex biochemical processes that allow 
the communication of cells in bacterial strains.
[132]
 For the cell-to-cell communication some 
bacteria use quorum sensing, a sophisticated molecular mechanism that is based on the 
production of small signaling molecules, the so-called autoinducers. When a specific cell 
density ('quorum') of a growing population is reached or the diffusion pathways of the signaling 
compounds through the cell membranes are limited, the amount of autoinducers increases. Upon 
passing a threshold concentration, the group responds with a population-wide alteration in 
specific gene expression. Quorum sensing is realized by bacteria to coordinate processes like 
bioluminescence, biofilm formation, or virulence factor production which would be ineffective 
if only individual cells undertook them. Thus, quorum sensing is a mechanism that allows 
bacterial strains to count their own cell numbers and determine the population density to 
function as multicellular organisms.
[132-133]
 
A variety of different autoinducers have been identified,
[132,134]
 but a novel class of signaling 
molecules, the -hydroxyketones (AHKs), was found in different types of bacteria and attracted 
attention of the scientific community.
[135]
 Over the past few years, AHK have been extensively 
investigated in the pathogens Vibrio cholerae and Legionella pneumophila.
[133]
 Among them, 
the cholera autoinducer-1 (CAI-1) (255) and Legionella autoinducer-1 (LAI-1) (256) are the 
predominant and most efficient signaling molecules in their respective species (Figure 21). 
 
 
Figure 21. The structures of the signaling molecules cholera autoinducer-1 (CAI-1) (255) and 
Legionella autoinducer 1 (LAI-1) (256). 
Chapter IV: Synthesis of a Bacterial Signaling Molecule 
78 
The bacteria strains V. cholerae and L. pneumophila are causative agent for fatal diseases. 
Whereas V. cholerae is responsible for the devastating diarrheal disease cholera,
[136]
 the 
Legionnaires' disease or the milder form thereof, the Pontiac fever, is caused in more than 85% 
of all clinical cases by L. pneumophila.
[137]
 
Given the effects of CAI-1 (255) and LAI-1 (256) on virulence, biofilm formation and 
extracellular filaments of V. cholerae or L. pneumophila, these signaling molecules or 
derivatives thereof have the potential for clinical or technical applications. 
For a deeper understanding of the signaling circuit and in order to gain more insight in the 
mechanism of cell-cell communication, the research group of H. Hilbi investigates the gene 
regulation by -hydroxyketone-mediated signaling in L. pneumophila. For this research, 
synthetic LAI-1 (256) is needed in pure form. Hence, this project aimed at providing the Hilbi 
group with pure Legionella autoinducer 1 (LAI-1) (256) for further investigation of the 
biochemical effects in signaling circuits of bacteria. 
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17. Autoinducer Regulatory Circuits in V. Cholerae and 
L. Pneumophila 
V. cholerae and L. pneumophila colonize and grow in different ecological niches. 
According to changes in the environment the bacteria response with the respective gene 
expression to secure the survival of the species. The gene regulation proceeds through quorum 
sensing, which is dependent on the population density (as determined by the cell number per 
volume) or the growth phase (as determined by the growth rate).
[133]
 The quorum sensing 
circuits of V. cholerae and L. pneumophila are detailed in the following sections. 
17.1. Quorum Sensing in V. Cholerae 
The species V. cholerae are extracellular and pathogen bacteria, which are spread through 
contaminated water and food to provoke the infection disease cholera in humans. The 
facultative anaerobic organism regulates the gene expression through quorum sensing 
depending on the population density. In V. cholerae two parallel signaling circuits were 
identified, using different autoinducers.
[133,135b]
 Here, only the -hydroxyketone (AHK) 
mediated signaling is described.  
Autoinducer CAI-1 (255) is produced by the enzyme CqsA (cholera quorum sensing 
autoinducer synthase) and recognized by the receptor CqsS (cholera quorum sensing sensor 
kinase) (Scheme 75, right). At low cell density, no or little amounts of autoinducers are present 
and the strain forms biofilm and expresses virulence factors. When the cell number is increased, 
the concentration of signaling molecules is raised and both processes are decelerated by quorum 
sensing.
[133,135b]
 
In particular, in the absence of CAI-1 (255) (at a low cell density) the regulator protein 
LuxO is phosphorylated by the active phosphotransferase LuxU (Scheme 75, right). In 
combination with sigma factor RpoN and the small nucleotide protein Fis, phospho-LuxO 
induces the expression of the quorum regulatory sRNAs Qrr1Qrr4. These sRNAs, together 
with the RNA chaperone Hfq, prevent the formation of the master regulating protein HapR by 
blocking the respective mRNA. The main regulator HapR would transcript several effector 
proteins, which could repress virulence traits and biofilm formation. On the other hand, in the 
presence of large amounts of CAI-1 (255) (at high bacterial density), the activity of LuxU is 
inhibited, regulator LuxO is dephosphorylated and inactive, the Qrr1Qrr4 sRNAs are not 
formed, and HapR is produced. As a result, CAI-1 (255) represses the virulence and biofilm 
formation in V. cholerae. In addition, the two-component system VarAS promotes the formation 
of the sRNAs CsrBCD, which inhibit the activity of the global regulatory protein CsrA and 
regulate the expression of HapR. This phase of the life cycle allows the bacteria to leave the 
host cell and also further distribution in the environment to infect further hosts.
[133,135b]
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A complete understanding of the complex relationships of the AHK regulated signaling 
pathway in V. cholerae allows for a systematical treatment of infections in future. Thus, it could 
be clinically reasonable to apply AHK directly to the human body to repress virulence of the 
pathogen by manipulating the quorum sensing signaling circuit. 
 
 
Scheme 75. AHK regulatory circuits in L. pneumophila (left) and V. cholerae (right).
xvi
 
17.2. Quorum Sensing in L. Pneumophila 
Legionellosis, including its two distinct forms Legionnaires' disease and the milder Pontiac 
fever, is an infection disease that exists worldwide.
[137]
 The human disease is caused by different 
strains of the genus Legionella, among them the main elicitor L. pneumophila. Transmission of 
the pathogen typically happens through inhalation of contaminated aerosols. In contrast to 
V. cholerae, bacteria of the species L. pneumophila are intracellular pathogens that translocate 
their virulence factors directly into the host cell. Afterwards, the vacuoles of the cell are 
modified in such a fashion that the Legionella can reproduce there unlimitedly. Through 
interaction with the host, different cell functions like the formation of intracellular membrane 
are affected.
[138]
 Subsequent lysis of the vacuoles and distribution of the bacteria cells enables 
new infection of further cells. 
 
xvi
 Scheme adopted from the literature.
[133]
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Thus, two characteristic phases of a life circle of L. pneumophila are distinguished:
[139]
 First, 
during the growing phase within the vacuole, the multiplication and growth of the cells is 
assisted by strong metabolic activity. Second, the stationary growth phase is reached, when the 
bacteria culture has reached a maximum regarding absolute cell numbers and the vacuole is 
destroyed. Then, virulence factors are produced and the stress resistance of the cells as well as 
motility by flagella formation is improved. As a result, the bacteria can reversibly switch 
between a stationary growth phase and a mobile infection state. 
The signaling circuit in L. pneumophila that is regulated by AHK autoinducers is only 
linked to the stationary growth phase and is not dependent on the cell density as in V. cholerae. 
The underlying mechanisms of the pathway are investigated only to some extent, but it is 
known that the AHK LAI-1 (256) plays a major role in the signaling circuit.
[133]
 In contrast to 
V. cholerae, no other autoinducer classes were found in L. pneumophila.
[135a]
 
In analogy, LAI-1 (256) is produced by the enzyme LqsA (legionella quorum sensing 
autoinducer synthase) and detected by the receptor LqsS (legionella quorum sensing sensor 
kinase) (Scheme 75, left). The main regulator LqsR, which expresses virulence and motility of 
the bacteria, is controlled in combination with sigma factor RpoS and the two-component 
system LetAS. LetAS itself upregulates the production of small RNAs RsmYZ, which, together 
with the RNA chaperone Hfq, blocks the global repressor for traits CsrA. Although this 
signaling pathway is not fully understood, it was found that AHK signaling molecules promote 
the expression of virulence traits and increases motility. This part of the life cycle allows 
L. pneumophila to leave the growth and replication phase and enter the mobile infection state. 
Notably, while CAI-1 (255) represses virulence in V. cholerae, the opposite effect of 
LAI-1 (256) was observed in L. pneumophila.
[133]
 
In order to complete the picture of the quorum sensing signaling circuit, the group of H. 
Hilbi investigates the effects autoinducer LAI-1 (256) on L. pneumophila. For this research, it 
could be possible to gain compound 256 from Escherichia coli, as described for CAI-1 
(255),
[135b]
 but the direct synthesis of LAI-1 (256) would provide pure material in large amounts. 
Thus, we decided to prepare and provide LAI-1 (256) to the Hilbi group to support further 
signaling research. 
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18. Synthesis of LAI-1
xvii
 
The autoinducer LAI-1 (256) was prepared by following a similar procedure for the 
synthesis of CAI-1 (255).
[135b]
 The commercially available (S)-2-hydroxybutyric acid (257) was 
protected as a TBDPS ether by a two step protocol to yield carboxylic acid 258. Formation of 
Weinreb amide 259 followed by reaction with undecanemagnesium bromide provided 
ketone 260 in low, but unoptimized yield. Final deprotection with TBAF and HPLC purification 
gave LAI-1 (256) in pure form. Overall, more than 35 mg of the title compound was prepared 
and handed over to the group of H. Hilbi for further investigation of the signaling circuit. 
 
 
Scheme 76. Synthesis of autoinducer LAI-1 (256). 
 
19. Conclusions and Outlook 
Overall, we were successful in the preparation of -hydroxyketone autoinducer 
LAI-1 (256), which is regarded as the main signaling molecule of the quorum sensing circuit of 
L. pneumophila. Weinreb amide 259, derived from (S)-2-hydroxybutyric acid (257), was 
converted into title compound 256 through attack of a Grignard reagent and subsequent 
deprotection with a total yield of 15% over 5 steps. The limiting step of that short sequence was 
the Grignard reaction that could potentially be optimized. Nevertheless, LAI-1 (256) was 
provided to the group of H. Hilbi to further investigate the AHK signaling pathways in 
L. pneumophila. 
 
 
 
xvii
 The synthesis of LAI-1 (256) was performed with Felix Fahrnbauer, an undergraduate researcher in 
the Trauner group. 
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All reactions were performed under an atmosphere of argon and in oven-dried glassware 
(200 °C oven temperature) unless specified otherwise. Tetrahydrofuran (THF) and diethyl ether 
(Et2O) was distilled prior to use from sodium and benzophenone, triethylamine (NEt3) and N,N-
Diisopropylethylamine (DIPEA) from calcium hydride. N,N-dimethylformamide (DMF), 
acetonitrile (MeCN), dichloromethane (CH2Cl2), toluene, benzene, xylene, methanol (MeOH), 
ethanol (EtOH), ethyl acetate (EtOAc), and acetone were purchased from Acros Organics as 
'extra dry' reagents under inert gas atmosphere and over molecular sieves. All other reagents 
were purchased from commercial sources and were used without further purification. Petroleum 
ether (PE) refers to fractions of isohexanes, which boil between 40 and 80 °C. 
Analytical thin-layer chromatography (TLC) was carried out using pre-coated glass plates 
(silica gel 60 F254) from Merck, and visualized by exposure to ultraviolet light (UV, 254 nm) 
and by staining with aqueous acidic ceric ammonium molybdate(IV) (CAM) solution. Flash 
column chromatography was performed using Merck silica gel 60 (40-63 µm particle size). For 
reversed phase (RP) TLC, pre-coated glass plates (silica gel C18 RP-18W/UV254) from 
Macherey-Nagel were used, and preparative RP columns were performed on Waters silica gel 
(Preparative C18, 125Å, 55-105 µm). 
Proton nuclear magnetic resonance (
1
H-NMR) spectra were recorded on a Varian 300, Varian 
400, Inova 400 or Varian 600 spectrometer. Chemical shifts ( scale) are expressed in parts per 
million (ppm) and are calibrated using residual protic solvent as an internal reference (CHCl3: 
 = 7.26 ppm, MeOH-d3:  = 3.31 ppm, DMSO-d5:  = 2.50 ppm, acetic acid-d3:  = 2.04 ppm, 
CHDCl2:  = 5.32 ppm).
[140]
 Data for 
1
H-NMR spectra are reported as follows: chemical shift ( 
ppm) (multiplicity, coupling constants (Hz), integration). Couplings are expressed as: 
s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, or combinations 
thereof. Carbon nuclear magnetic resonance (
13
C-NMR) spectra were recorded on the same 
spectrometers at 75, 100 and 150 Hz, respectively. Carbon chemical shifts ( scale) are also 
expressed in parts per million (ppm) and are referenced to the central carbon resonances of the 
solvents (CDCl3:  = 77.16 ppm, MeOH-d4:  = 49.00 ppm, DMSO-d5:  = 39.52 ppm, acetic 
acid-d3:  = 179.00 ppm, CHDCl2:  = 53.84 ppm).
[140]
 In order to assign the 
1
H- and 
13
C-NMR 
spectra, a range of 2D-NMR experiments (COSY, HSQC, HMBC, NOESY) were used as 
appropriate. The numbering of the proton and carbon atoms does not correspond to the IUPAC 
nomenclature. 
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Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR System) equipped 
with an attenuated total reflection (ATR) measuring unit. IR data is reported in frequency of 
absorption (cm
‒1
). The IR bands are characterized as: w = weak, m = medium, s = strong, 
br = broad, or combinations thereof. 
Mass spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 (electron 
ionization, EI) or on a Thermo Finnigan LTQ FT (electrospray ionization, ESI) instrument. 
Melting points (mp) were measured on a Büchi Melting Point B-540 or SRS MPA120 EZ-Melt 
apparatus and are uncorrected. 
Optical rotations were measured at the given temperature (T in [°C]) on a Perkin-Elmer 241 or 
Krüss P8000-T polarimeter using a sodium lamp ( = 589 nm, D-line). Measurements were 
carried out in a cell with a path length (l) of 0.5 dm. Concentrations (c) are expressed in 
g/(100 mL). Specific rotations      
 ) were calculated using the equation     
  = 100·/(c·l) and 
are reported in 10
‒1
 deg cm
2
 g
‒1
. 
High performance liquid chromatography (HPLC) was performed with HPLC grade solvents 
and deionized water that was purified on a TKA MicroPure water purification system. All 
solvents were degassed with helium gas prior to use. Unless noticed otherwise, all experiments 
were carried out at room temperature; the column used is specified as appropriate. Analytical 
HPLC spectra were recorded on a ultra high performance liquid chromatography (UHPLC) 
system from the Agilent 1260 Infinity series (1260 degasser, 1260 Binary Pump VL, 1260 ALS 
auto sampler, 1260 TCC thermostatted column compartment, 1260 DAD diode array detector), 
which was computer-controlled through Agilent ChemStation software. Preparative HPLC was 
performed on a computer-operated Varian system (Galaxie Chromatography Software, two 
PrepStar pumps Model SD-1, manual injection, ProStar 335 Photo Diode Array Detector, 380-
LC Evaporative Light Scattering Detector). 
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21. Experimental Procedures 
21.1. Experimental Data of Chapter I 
(3aR,5R,6S,6aR)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-tetrahydro-2H-
furo[2,3-d][1,3]dioxol-6-yl 2-bromoacetate (67)
[34]
 
 
A stirred solution of diacetone-D-glucose 61 (15.0 g, 57.6 mmol, 1.0 eq), DMAP (70.4 mg, 
0.576 mmol, 10 mol%), and pyridine (6.96 mL, 86.4 mmol, 1.5 eq) in CH2Cl2 (125 mL) was 
cooled to 0 °C, and 2-bromoacetyl bromide was added dropwise. The reaction mixture was 
stirred for 40 min at 0 °C, then quenched at 0 °C with water (1.2 mL) and allowed to warm to 
room temperature. After stirring for an additional 15 min at room temperature, the resulting 
solution was diluted with EtOAc (200 mL). The organic phase was washed with water 
(2 x 30 mL) and brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [CH2Cl2:acetone 99:1] provided bromo ester 67 (21.3 g, 56.0 mmol, 97%) as a 
white solid. 
Bromo ester 67: 
Rf = 0.39 [Petrol:EtOAc 4:1]. 
    
   = 39.6 (c = 0.93, MeOH). 
mp: 51 – 53 °C.  
1
H-NMR (400 MHz, CDCl3): δ = 5.90 (d, J = 3.7 Hz, 1H, H-1), 5.32 (d, J = 2.8 Hz, 1H, H-3), 
4.51 (d, J = 3.7 Hz, 1H, H-2), 4.27 – 4.19 (m, 2H, H-4, H-5), 4.11 (dd, J = 8.8, 5.6 Hz, 1H, H-
6a), 4.01 (dd, J = 8.7, 4.5 Hz, 1H, H-6b), 3.87 (d, J = 12.3 Hz, 1H, H-14a or H-14b), 3.84 (d, 
J = 12.3 Hz, 1H, H-14a or H-14b), 1.52 (s, 3H, 3 x H-12), 1.41 (s, 3H, 3 x H-8), 1.32 (s, 3H, 
3 x H-9 or 3 x H-11), 1.31 (s, 3H, 3 x H-9 or 3 x H-11) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 166.08 (C-13), 112.64 (C-10), 109.66 (C-7), 105.24 (C-1), 
83.16 (C-2), 79.99 (C-4), 77.78 (C-3), 72.35 (C-5), 67.59 (C-6), 27.01 (C-8), 26.86 (C-12), 
26.37 (C-11), 25.38 (C-9 or C-14), 25.35 (C-9 or C-14) ppm. 
IR (ATR): ṽ = 2983 (m), 1769 (m), 1741 (m), 1383 (m), 1268 (m), 1205 (m), 1135 (m), 1069 
(s), 1018 (s), 841 (m) cm
1
. 
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HRMS (ESI): calcd. for C14H25BrNO7
+
: 398.0809 [M+NH4]
+
    
  found:    398.0806 [M+NH4]
+
. 
 
(3aR,5S,6S,6aR)-5-formyl-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxol-6-yl 
2-bromoacetate (62)
[34]
 
 
A solution of bromo ester 67 (6.71 g, 17.6 mmol, 1.0 eq) in Et2O/MeOH (9:1, 50 mL) was 
cooled to 0 °C, and formic acid (25 mL) followed by periodic acid (4.81 g, 21.2 mmol, 1.2 eq) 
were added. The reaction mixture was stirred at 0 °C for 10 min, then allowed to warm to room 
temperature and stirred for an additional 30 min until complete consumption of the starting 
material (as indicated by TLC analysis). The mixture was diluted with EtOAc (100 mL) and the 
organic phase was washed with water (2 x 20 mL), aq. NaHCO3 (3 x 30 mL of a saturated 
solution), aq. Na2S2O3 (3 x 10 mL of a saturated solution), dried (MgSO4) and concentrated in 
vacuo to provide aldehyde 62 (3.44 g, 11.1 mmol, 63%) as a white solid. 
Aldehyde 62: 
Rf = 0.24 [PE:EtOAc 1:1] (streaking). 
    
   = 17.3 (c = 1.0, MeOH). 
mp: 66 – 67 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 9.65 (s, 1H, H-5), 6.09 (d, J = 3.5 Hz, 1H, H-1), 5.53 (dd, 
J = 3.4, 0.3 Hz, 1H, H-3), 4.74 (dd, J = 3.4, 0.8 Hz, 1H, H-4), 4.59 (d, J = 3.5 Hz, 1H, H-2), 
3.78 (d, J = 12.5 Hz, 1H, H-10a or H-10b), 3.76 (d, J = 12.9 Hz, 1H, H-10a or H-10b), 1.51 (s, 
3H, 3 x H-8), 1.33 (s, 3H, 3 x H-7) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 197.07 (C-5), 166.05 (C-9), 113.32 (C-6), 105.64 (C-1), 
83.24 (C-4), 82.79 (C-2), 78.55 (C-3), 26.92 (C-8), 26.39 (C-7), 24.71 (C-10) ppm. 
IR (ATR): ṽ = 3456 (w), 2987 (m), 1742 (s), 1376 (w), 1263 (m), 1160 (m), 1013 (s), 851 
(w) cm
1
. 
HRMS (ESI): calcd. for C10H17BrNO6
+
: 326.0234 [M+NH4]
+
    
  found:    326.0234 [M+NH4]
+
. 
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1-[(3aR,5R,6S,6aR)-6-hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxol-5-yl] 
ethane-1,2-diol (68)
[141]
 
 
A solution of diacetone-D-glucose 61 (5.05 g, 19.4 mmol, 1.0 eq) in a mixture of acetic acid 
(90 mL) and water (60 mL) was stirred at room temperature for 24 h. The reaction mixture was 
concentrated in vacuo to afford triol 68 (4.31 g, 19.6 mmol, quant.) as a white solid. 
Rf = 0.21 [EtOAc]. 
    
   = 15.2 (c = 0.10, MeOH). 
mp: 160 – 161 °C. 
1
H-NMR (400 MHz, CD3OD): δ = 5.87 (d, J = 3.7 Hz, 1H, H-1), 4.48 (d, J = 3.7 Hz, 1H, H-2), 
4.20 (d, J = 2.7 Hz, 1H, H-3), 4.01 (dd, J = 8.4, 2.7 Hz, 1H, H-4), 3.91 – 3.85 (m, 1H, H-5), 
3.76 (dd, J = 11.5, 3.1 Hz, 1H, H-6a or H-6b), 3.59 (dd, J = 11.5, 6.0 Hz, 1H, H-6a or H-6b), 
1.45 (s, 3H, 3 x H-9), 1.29 (s, 3H, 3 x H-8) ppm. 
13
C-NMR (100 MHz, CD3OD): δ = 112.65 (C-7), 106.33 (C-1), 86.48 (C-2), 81.30 (C-4), 75.46 
(C-3), 70.37 (C-5), 65.23 (C-6), 27.00 (C-9), 26.38 (C-8) ppm. 
IR (ATR): ṽ = 3424 (s), 3317 (s), 2978 (m), 2927 (m), 1378 (m), 1263 (w), 1215 (m), 1037 (s), 
1010 (s), 962 (m), 884 (m), 850 (m), 792 (w) cm
1
. 
HRMS (ESI): calcd. for C9H20NO6
+
: 238.1285 [M+NH4]
+
     
  found:   238.1285 [M+NH4]
+
. 
 
(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodec-9-en-11-one (63) 
 
A solution of aldehyde 62 (200 mg, 0.647 mmol, 1.0 eq) and PPh3 (170 mg, 0.647 mmol, 
1.0 eq) in MeCN (2 mL) was stirred at room temperature for 9 h. 1,8-Diazabicyclo[5.4.0]undec-
7-ene (98.5 mg, 0.647 mmol, 1.0 eq) was added, and the mixture was stirred at room 
temperature for an additional 24 h, before it was diluted with Et2O (30 mL). The organic phase 
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was washed with water (2 x 20 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [CH2Cl2:acetone 99:1] afforded unsaturated lactone 63 (55.5 mg, 0.262 mmol, 
40%) as a white solid. 
Unsaturated lactone 63: 
Rf = 0.59 [PE:EtOAc 1:1]. 
    
   = +28.9 (c = 0.56, MeOH). 
mp: 70 °C. 
1
H-NMR (600 MHz, CDCl3) δ = 6.96 (dd, J = 9.8, 5.7 Hz, 1H, H-5), 6.23 (d, J = 9.8 Hz, 1H, H-
6), 6.02 (d, J = 3.7 Hz, 1H, H-1), 4.82 (d, J = 3.8 Hz, 1H, H-2), 4.81 (d, J = 3.2 Hz, 1H, H-3), 
4.62 (dd, J = 5.7, 3.1 Hz, 1H, H-4), 1.53 (s, 3H, 3 x H-10), 1.35 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 160.94 (C-7), 138.76 (C-5), 125.51 (C-6), 112.70 (C-8), 
105.43 (C-1), 84.05 (C-2), 82.56 (C-3), 67.72 (C-4), 26.88 (C-10), 26.31 (C-9) ppm. 
IR (ATR): ṽ = 2924 (w), 1729 (s), 1384 (w), 1212 (m), 1068 (s), 1017 (s), 888 (m), 826 
(m) cm
1
. 
HRMS (ESI): calcd. for C10H16NO5
+
: 239.1023 [M+NH4]
+
     
  found:   239.1022 [M+NH4]
+
. 
 
(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecan-11-one (60) 
 
To a solution of unsaturated lactone 63 (246 mg, 1.16 mmol) in EtOAc (5 mL) was added 
palladium on charcoal (10 wt%, 47.0 mg), and the flask was purged with hydrogen gas five 
times. The mixture was then stirred under hydrogen atmosphere at room temperature for 15 h. 
The catalyst was removed by filtration through a pad of Celite, and the Celite was washed with 
EtOAc (20 mL). After concentrating the filtrate in vacuo, flash column chromatography 
[PE:EtOAc 4:13:1] afforded lactone 60 (238 mg, 1.11 mmol, 96%) as a white solid. 
Lactone 60: 
Rf = 0.46 [PE:EtOAc 1:1]. 
    
   = +32.4 (c = 0.67, MeOH). 
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mp: 53 – 57 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 5.94 (d, J = 3.8 Hz, 1H, H-1), 4.69 (m, 
2H, H-2, H-3), 4.54 (ddd, J = 3.6, 3.6, 3.6 Hz, 1H, H-4), 2.65 (ddd, 
J = 17.6, 11.0, 6.6 Hz, 1H, H-6b), 2.45 (ddd, J = 17.5, 6.1, 4.4 Hz, 1H, 
H-6a), 2.27 – 2.06 (m, 2H, H-5a, H-5b), 1.50 (s, 3H, 3 x H-10), 1.32 (s, 3H, 3 x H-11) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 169.33 (C-7), 112.36 (C-8), 105.04 (C-1), 84.23 (C-2 or C-3), 
83.85 (C-2 or C-3), 71.48 (C-4), 26.72 (C-9), 26.30 (C-10), 25.06 (C-6), 21.79 (C-5) ppm. 
IR (ATR): ṽ = 2982 (w), 2946 (w), 1738 (s), 1389 (w), 1183 (m), 1040 (s), 918 (m) cm‒1. 
HRMS (EI): calcd. for C10H15O5
+
: 215.0914 [M+H]
+
     
  found:   215.0927 [M+H]
+
. 
 
(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodec-9-en-11-one (63) and 
methyl (2E)-3-[(3aR,5R,6S,6aR)-6-hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3] 
dioxol-5-yl]prop-2-enoate (65)
[36]
 
 
To a solution of diacetone-D-glucose 61 (3.00 g, 11.5 mmol, 1.0 eq) in EtOAc (215 mL) was 
added periodic acid (2.89 g, 12.7 mmol, 1.1 eq) and the resulting solution was stirred at room 
temperature for 2.5 h. During the reaction a white solid precipitated, which was removed by 
filtration through a pad of Celite. The Celite was washed with EtOAc (100 mL) and the filtrate 
was concentrated in vacuo. The crude sugar was then dried by azeotropic distillation with 
benzene (50 mL). A phosphonium ylide was prepared in a separate flask by adding dropwise a 
solution of n-BuLi in hexanes (2.5 M, 5.52 mL, 13.8 mmol, 1.2 eq) to a solution of 
(methoxycarbonylmethyl)triphenylphosphonium bromide (5.73 g, 13.8 mmol, 1.2 eq) in THF 
(180 mL) at 0 °C. This mixture was stirred at 0 °C for 30 min, and then a solution of the 
previously obtained crude sugar in THF (30 mL) was added dropwise. The reaction mixture was 
allowed to warm to room temperature and stirred at this temperature for 18 h. Water (50 mL) 
was added and the mixture was extracted with EtOAc (3 x 60 mL). The combined organic 
fractions were dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 4:13:12:11:1] afforded unsaturated lactone 63 (959 mg, 4.52 mmol, 39%) as 
a white solid as well as trans-ester 65 (632 mg, 2.59 mmol, 23%) as colorless oil. 
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Unsaturated lactone 63: 
Analytical data were identical with the material obtained earlier (vide supra). 
Rf = 0.59 [PE:EtOAc 1:1]. 
    
   = +28.9 (c = 0.56, MeOH). 
mp: 70 °C. 
1
H-NMR (600 MHz, CDCl3) δ = 6.96 (dd, J = 9.8, 5.7 Hz, 1H, H-5), 6.23 (d, J = 9.8 Hz, 1H, H-
6), 6.02 (d, J = 3.7 Hz, 1H, H-1), 4.82 (d, J = 3.8 Hz, 1H, H-2), 4.81 (d, J = 3.2 Hz, 1H, H-3), 
4.62 (dd, J = 5.7, 3.1 Hz, 1H, H-4), 1.53 (s, 3H, 3 x H-10), 1.35 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 160.94 (C-7), 138.76 (C-5), 125.51 (C-6), 112.70 (C-8), 
105.43 (C-1), 84.05 (C-2), 82.56 (C-3), 67.72 (C-4), 26.88 (C-10), 26.31 (C-9) ppm. 
IR (ATR): ṽ = 2924 (w), 1729 (s), 1384 (w), 1212 (m), 1068 (s), 1017 (s), 888 (m), 826 
(m) cm
1
. 
HRMS (ESI): calcd. for C10H16NO5
+
: 239.1023 [M+NH4]
+
 
  found:   239.1022 [M+NH4]
+
. 
Trans-ester 65: 
Rf = 0.38 [PE:EtOAc 1:1]. 
    
   = ‒48.9° (c = 0.34, MeOH). 
1
H-NMR (600 MHz, CDCl3) δ = 6.92 (dd, J = 15.7, 4.3 Hz, 1H, H-5), 6.24 (d, J = 15.7 Hz, 1H, 
H-6), 5.97 (d, J = 3.7 Hz, 1H, H-1), 4.85 – 4.82 (m, 1H, H-4), 4.56 (d, J = 3.7 Hz, 1H, H-2), 
4.23 (d, J = 2.8 Hz, 1H, H-3), 3.73 (s, 3H, 3 x H-8), 2.29 (br s, 1H, H-12), 1.49 (s, 3H, 3 x H-
11), 1.31 (s, 3H, 3 x H-10) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 166.67 (C-7), 141.22 (C-5), 123.79 (C-6), 112.15 (C-9), 
104.84 (C-1), 85.08 (C-2), 79.76 (C-4), 76.11 (C-3), 51.94 (C-8), 26.87 (C-11), 26.27 (C-10). 
IR (ATR): ṽ = 3432 (m), 2957 (m), 1707 (s), 1311 (w), 1215 (m), 1072 (s), 1009 (s), 790 
(w) cm
1
. 
HRMS (ESI): calcd. for C11H20NO6
+
: 262.1285 [M+NH4]
+
     
  found:   262.1284 [M+NH4]
+
. 
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Methyl 3-[(3aR,5R,6S,6aR)-6-hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxol-
5-yl]propanoate (261) 
 
To a solution of unsaturated ester 65 (2.44 g, 10.0 mmol) in MeOH (40 mL) was added 
palladium on charcoal (10 wt%, 203 mg) and the flask was purged with hydrogen gas five 
times. The mixture was then stirred under hydrogen atmosphere at room temperature for 22 h. 
The catalyst was removed by filtration through a pad of Celite, and the Celite was washed with 
MeOH (60 mL). The filtrate was then concentrated in vacuo to afford ester 261 (2.47 g, 
10.0 mmol, quant.) as a white solid. 
Ester 261: 
Rf = 0.31 [PE:EtOAc 1:1]. 
    
   = ‒24.7 (c = 0.34, MeOH). 
mp: 80 – 81 °C. 
1
H-NMR (400 MHz, CD3OD): δ = 5.83 (d, J = 3.8 Hz, 1H, H-1), 4.46 (d, J = 3.8 Hz, 1H, H-2), 
4.12 – 4.06 (m, 1H, H-4), 3.95 (d, J = 2.7 Hz, 1H, H-3), 3.67 (s, 3H, 3 x H-8), 2.49 – 2.42 (m, 
2H, H-6a, H-6b), 1.99 – 1.88 (m, 2H, H-5a, H-5b), 1.43 (s, 3H, 3 x H-11), 1.29 (s, 3H, 3 x H-
10) ppm. 
13
C-NMR (100 MHz, CD3OD): δ = 175.49 (C-7), 112.44 (C-9), 105.82 (C-1), 86.91 (C-2), 
80.96 (C-4), 75.92 (C-3), 52.09 (C-8), 31.41 (C-6), 26.96 (C-11), 26.35 (C-10), 24.55 (C-5). 
IR (ATR): ṽ = 3372 (s), 2991 (m), 1735 (s), 1372 (w), 1164 (m), 1082 (m), 788 (w) cm‒1. 
HRMS (ESI): calcd. for C11H18NaO6
+
: 269.0996 [M+Na]
+     
  found:   269.0994 [M+Na]
+
. 
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3-[(3aR,5R,6S,6aR)-6-hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d][1,3]dioxol-5-yl] 
propanoic acid (262): 
 
A solution of ester 261 (2.47 g, 10.0 mmol, 1.0 eq) and potassium carbonate (2.76 g, 
20.0 mmol, 2.0 eq) in a mixture of MeOH and water (4:1, 50 mL) was stirred at room 
temperature for 22 h. The reaction mixture was concentrated under reduced pressure to a total 
volume of ca. 20 mL and then diluted with water (50 mL). After extracting the mixture with 
EtOAc (50 mL), the aqueous layer was acidified to pH 1 with aq. HCl (1 N, ca. 45 mL). The 
acidic aqueous layer was further extracted with EtOAc (6 x 100 mL). The combined organic 
fractions were then dried (MgSO4) and concentrated in vacuo to afford carboxylic acid 262 
(2.30 g, 9.90 mmol, 99%) as a white solid. 
Carboxylic acid 262: 
Rf = 0.71 [EtOAc:MeOH (0.5% formic acid) 9:1]. 
    
   = ‒22.9 (c = 0.44, MeOH). 
mp: 96 – 97 °C. 
1
H-NMR (400 MHz, CD3OD): δ = 5.83 (d, J = 3.8 Hz, 1H, H-1), 4.47 (d, J = 3.8 Hz, 1H, H-2), 
4.14 – 4.08 (m, 1H, H-4), 3.96 (d, J = 2.7 Hz, 1H, H-3), 2.46 – 2.39 (m, 2H, H-6a, H-6b), 1.98 –
 1.86 (m, 2H, H-5a, H-5b), 1.43 (s, 3H, 3 x H-10), 1.29 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (100 MHz, CD3OD): δ = 177.08 (C-7), 112.44 (C-8), 105.82 (C-1), 86.91 (C-2), 
81.06 (C-4), 75.92 (C-3), 31.45 (C-6), 26.97 (C-10), 26.35 (C-9), 24.55 (C-5). 
IR (ATR): ṽ = 3361 (m), 2988 (m), 1715 (s), 1382 (m), 1195 (s), 997 (s), 866 (m) cm‒1. 
HRMS (ESI): calcd. for C10H15O6
‒
: 231.0874 [M‒H]‒     
 
 found:   231.0872 [M‒H]‒. 
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(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecan-11-one (60) 
 
A solution of carboxylic acid 262 (2.28 g, 9.82 mmol, 1.0 eq) and triethylamine (2.72 mL, 
19.6 mmol, 2.0 eq) in CH2Cl2 (200 mL) was cooled to 0 °C and thionyl chloride (1.42 mL, 
19.6 mmol, 2.0 eq) was added dropwise. The mixture was allowed to warm to room temperature 
and stirred at this temperature for 20 min. The mixture was then quenched with aq. NH4Cl 
(100 mL of a saturated solution) and the mixture extracted with CH2Cl2 (3 x 150 mL). The 
combined organic fractions were washed with water (200 mL), dried (MgSO4) and then 
concentrated in vacuo. Flash column chromatography [PE:EtOAc 4:13:12:1] afforded 
lactone 60 (1.09 g, 5.09 mmol, 52%) as a white solid. 
Lactone 60: 
Analytical data were identical with the material obtained earlier (vide supra). 
Rf = 0.46 [PE:EtOAc 1:1]. 
    
   = +32.4 (c = 0.67, MeOH). 
mp: 53 – 57 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 5.94 (d, J = 3.8 Hz, 1H, H-1), 4.69 (m, 2H, H-2,H-3), 4.54 
(ddd, J = 3.6, 3.6, 3.6 Hz, 1H, H-4), 2.65 (ddd, J = 17.6, 11.0, 6.6 Hz, 1H, H-6b), 2.45 (ddd, 
J = 17.5, 6.1, 4.4 Hz, 1H, H-6a), 2.27 – 2.06 (m, 2H, H-5a, H-5b), 1.50 (s, 3H, 3 x H-10), 1.32 
(s, 3H, 3 x H-11) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 169.33 (C-7), 112.36 (C-8), 105.04 (C-1), 84.23 (C-2 or C-3), 
83.85 (C-2 or C-3), 71.48 (C-4), 26.73 (C-9), 26.30 (C-10), 25.07 (C-6), 21.79 (C-5) ppm. 
IR (ATR): ṽ = 2982 (w), 2946 (w), 1738 (s), 1389 (w), 1183 (m), 1040 (s), 918 (m) cm‒1. 
HRMS (EI): calcd. for C10H15O5
+
: 215.0914 [M+H]
+     
  found:   215.0927 [M+H]
+
. 
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(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecan-11-ol (71): 
 
A solution of lactone 60 (380 mg, 1.77 mmol, 1.0 eq) in CH2Cl2 (6 mL) was cooled to ‒78 °C 
and a solution of diisobutylaluminium hydride in CH2Cl2 (1.0 M, 1.95 mL, 1.95 mmol, 1.1 eq) 
was added dropwise. After stirring the mixture at ‒78 °C for 20 min, the reaction was quenched 
at ‒78 °C by addition of aq. Rochelle salt (1.5 mL of a saturated solution) and water (1 mL). 
The mixture was allowed to warm to room temperature, stirred at this temperature for an 
additional 3 h and was then extracted with CH2Cl2 (3 x 5 mL). The combined organic fractions 
were dried (MgSO4) and concentrated in vacuo to afford lactol 71 (374 mg, 1.73 mmol, 98%) as 
a white solid consisting of two diastereomers (d.r. 1.9:1, as determined by 
1
H-NMR 
spectroscopy) as an inseparable mixture. 
Lactol 71: 
Rf = 0.41 [PE:EtOAc 1:1].  
1
H-NMR (600 MHz, CDCl3) (mixture of isomers, major isomer quoted): 
δ = 5.90 (d, J = 3.8 Hz, 1H, H-1), 5.23 – 5.21 (m, 1H, H-7), 4.47 (d, J = 3.8 Hz, 1H, H-2), 4.23 
(br s, 2H, H-3, H-4), 2.88 (br s, 1H, H-11), 2.17 – 2.09 (m, 1H, H-5a or H-5b), 1.93 – 1.86 (m, 
2H, H-5a or H-5b, H-6a or H-6b), 1.55 – 1.50 (m, 1H, H-6a or H-6b), 1.49 (s, 3H, 3 x H-10), 
1.31 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 111.51 (C-8), 
105.32 (C-1), 91.29 (C-7), 84.85 (C-2), 73.37 (C-4), 72.58 (C-3), 26.78 (C-10), 26.30 (C-9), 
23.66 (C-6), 17.95 (C-5). 
IR (ATR): ṽ = 3429 (s), 2931 (s), 1374 (m), 1208 (m), 1079 (s), 820 (m) cm‒1. 
HRMS (EI): calcd. for C10H15O5
‒
: 215.0925 [M‒H]‒     
 
 found:   215.0931 [M‒H]‒. 
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(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodec-10-ene (72): 
 
A solution of lactol 71 (79.5 mg, 0.368 mmol, 1.0 eq) and triethylamine (816 µL, 5.89 mmol, 
16 eq) in CH2Cl2 (15 mL) was cooled to 0 °C and methanesulfonyl chloride (37.1 µL, 
0.478 mmol, 1.3 eq) was added dropwise. The mixture was heated to 50 °C and stirred at this 
temperature for 2.5 h. After cooling to room temperature, volatile material was removed in 
vacuo, and the residue was subjected to gravity column chromatography [CH2Cl2] to afford 
dihydropyran 72 (42.2 mg, 0.213 mmol, 58%) as a white solid. 
Dihydropyran 72: 
Rf = 0.79 [PE:EtOAc 2:1]. 
    
   = +98.7 (c = 0.79, MeOH). 
mp: 39 – 40 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 6.31 – 6.28 (m, 1H, H-7), 5.94 (d, J = 3.8 Hz, 1H, H-1), 
4.69 – 4.65 (m, 1H, H-6), 4.60 (d, J = 3.8 Hz, 1H, H-2), 4.52 – 4.48 (m, 1H, H-4), 4.13 (br s, 
1H, H-3), 2.40 – 2.33 (m, 1H, H-5a or H-5b), 4.60 (dd, J = 18.7, 4.4 Hz, 1H, H-5a or H-5b), 
1.52 (s, 3H, 3 x H-10), 1.33 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 141.94 (C-7), 111.94 (C-8), 105.00 (C-1), 97.24 (C-6), 84.25 
(C-2), 75.92 (C-3), 72.50 (C-4), 26.66 (C-10), 26.27 (C-9), 20.72 (C-5) ppm. 
IR (ATR): ṽ = 2936 (m), 1662 (m), 1376 (w), 1208 (m), 1076 (s), 829 (m) cm‒1. 
HRMS (EI): calcd. for C10H14O4
+
: 198.0887 [M]
+      
  found:   198.0886 [M]
+
. 
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(2R,6R)-11-{[(2R,6R,11S)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecan-11-
yl]oxy}-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecane (73) and (2R,6R)-11-
{[(2R,6R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecan-11-yl]oxy}-4,4-
dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodecane (74) 
 
A solution of lactol 71 (333 mg, 1.54 mmol, 1.0 eq) and triethylamine (500 µL, 3.61 mmol, 
2.3 eq) in CH2Cl2 (4 mL) was cooled to 0 °C and methanesulfonyl chloride (164 µL, 2.00 mmol, 
1.3 eq) was added dropwise. The mixture was heated to 50 °C and stirred at this temperature for 
20 h. After cooling to room temperature, volatile material was removed in vacuo, and the 
residue was subjected to gravity column chromatography [CH2Cl2] to afford dimer 73 (68.5 mg, 
0.165 mmol, 21%) as a colorless oil and C2-symmetric dimer 74 (91.9 mg, 0.222 mmol, 29%) as 
a white solid. 
Dimer 73: 
Rf = 0.40 [PE:EtOAc 2:1]. 
    
   = +15.4 (c = 0.36, MeOH).  
1
H-NMR (600 MHz, CDCl3): δ = 5.95 (d, J = 3.8 Hz, 1H, 
H-11), 5.89 (d, J = 3.8 Hz, 1H, H-1), 4.99 (br s, 1H, H-7), 
4.59 – 4.56 (m, 1H, H-17), 4.55 (d, J = 3.8 Hz, 1H, H-12), 4.47 (d, J = 3.7 Hz, 1H, H-2), 4.33 
(d, J = 2.1 Hz, 1H, H-3), 4.24 – 4.42 (m, 1H, H-4), 4.12 – 4.09 (m, 1H, H-14), 4.06 (d, 
J = 1.9 Hz, 1H, H-13), 2.23 – 2.19 (m, 1H, H-15a or H-15b), 2.14 – 2.06 (m, 1H, H-5a or H-5b), 
1.93 – 1.85 (m, 2H, H-5a or H-5b, H-6a or H-6b), 1.83 – 1.73 (m, 2H, H-15a or H-15b, H-16a 
or H-16b), 1.62 – 1.55 (m, 1H, H-16a or H-16b), 1.55 – 1.48 (m, 1H, H-6a or H-6b), 1.50 (s, 
3H, 3 x H-10 or 3 x H-20), 1.49 (s, 3H, 3 x H-10 or 3 x H-20), 1.33 (s, 3H, 3 x H-9 or 3 x H-
19), 1.32 (s, 3H, 3 x H-9 or 3 x H-19) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 111.50 (C-8 or C-18), 111.49 (C-8 or C-18), 105.46 (C-11), 
105.29 (C-1), 100.50 (C-17), 96.73 (C-7), 84.85 (C-2), 84.61 (C-12), 79.68 (C-13), 73.44 (C-4), 
73.30 (C-3), 72.30 (C-14), 26.88 (C-10 or C-20), 26.82 (C-10 or C-20), 26.36 (C-9 or C-19), 
26.32 (C-9 or C-19), 25.60 (C-16), 24.06 (C-15), 23.65 (C-6), 18.56 (C-5) ppm. 
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IR (ATR): ṽ = 2934 (s), 1445 (w), 1372 (m), 1213 (m), 1164 (m), 1068 (s), 1010 (s), 947 (m), 
902 (m), 825 (m), 756 (w) cm
‒1
. 
HRMS (ESI): calcd. for C20H34NO9
+
: 432.2228 [M+NH4]
+
 
  found:   432.2227 [M+NH4]
+
. 
C2-symmetric dimer 74: 
Rf = 0.34 [PE:EtOAc 4:1].  
    
   = +208.2 (c = 1.0, MeOH). 
mp: 149 – 153 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 5.91 (d, J = 3.8 Hz, 2H, 2 x H-1), 5.10 (br s, 2H, 2 x H-7), 
4.48 (d, J = 3.8 Hz, 2H, 2 x H-2), 4.23 – 4.21 (m, 2H, 2 x H-4), 3.97 (d, J = 2.1 Hz, 2H, 2 x H-
3), 2.10 – 2.04 (m, 2H, 2 x H-5a or 2 x H-5b), 1.99 – 1.89 (m, 4H, 2 x H-5a or 2 x H-5b, 2 x H-
6a or 2 x H-6b), 1.49 (s, 6H, 6 x H-10), 1.52 – 1.44 (m, 2H, 2 x H-5a or 2 x H-5b), 1.31 (s, 6H, 
6 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 111.47 (2 x C-8), 105.31 (2 x C-1), 91.80 (2 x C-7), 84.68 
(2 x C-2), 73.25 (2 x C-4), 72.97 (2 x C-3), 26.78 (2 x C-10), 26.27 (2 x C-9), 23.32 (2 x C-6), 
18.47 (2 x C-5) ppm. 
IR (ATR): ṽ = 2936 (s), 1443 (w), 1376 (m), 1214 (m), 1134 (m), 1077 (s), 1016 (s), 982 (s), 
902 (m), 827 (m), 745 (w) cm
‒1
. 
HRMS (ESI): calcd. for C20H34NO9
+
: 432.2228 [M+NH4]
+
     
  found:   432.2228 [M+NH4]
+
. 
 
[(2R,6R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodec-10-en-11-yl]trimethyl-
stannane (76): 
 
A solution of lactone 60 (50.0 mg, 1.77 mmol, 1.0 eq) and N-phenyl-
bis(trifluoromethanesulfonimide) (91.6 mg, 0.256 mmol, 1.1 eq) in THF (3 mL) was added 
slowly (over 45 min) with the aid of a syringe pump to a ‒78 °C cold solution of potassium 
hexamethyldisilazide (0.5 M in toluene, 606 µL, 0.303 mmol, 1.3 eq) in THF (1 mL). After 
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complete addition, the reaction mixture was stirred for an additional 10 min at ‒78 °C, and was 
then allowed to warm to room temperature. Volatile material was removed in vacuo, and the 
residue was subjected to flash column chromatography [PE:Et2O 4:1 (+ 0.5% NEt3)] to afford 
triflate 263. The sensitive compound 263 was immediately dissolved in THF (6 mL) and 
hexamethyldistannane (72.5 µL, 0.350 mmol, 1.5 eq), lithium chloride (98.8 mg, 2.33 mmol, 
10 eq) followed by tetrakis(triphenylphosphine)palladium(0) (13.5 mg, 11.7 µmol, 5 mol%) 
were added. The mixture was stirred at room temperature for 24 h, and then volatile material 
was removed in vacuo. The residue was subjected to column chromatography [PE:Et2O 9:1] to 
afford stannane 76 (52.4 mg, 0.145 mmol, 62% over two steps) as a colorless oil. 
Stannane 76: 
Rf = 0.22 [PE:Et2O 9:1]. 
    
   = +41.4 (c = 0.24, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 5.92 (d, J = 3.8, 1H, H-1), 4.79 – 4.71 (m, 1H, H-6), 4.58 (d, 
J = 3.8 Hz, 1H, H-2), 4.52 – 4.49 (m, 1H, H-4), 4.05 (br s, 1H, H-3), 2.40 – 2.32 (m, 1H, H-5a), 
2.28 – 2.21 (m, 1H, H-5b), 1.52 (s, 3H, 3 x H-10), 1.33 (s, 3H, 3 x H-9), 0.15 (s, 9H, 3 x H-
11) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 160.87 (C-7), 111.77 (C-8), 107.77 (C-6), 105.10 (C-1), 
84.59 (C-2), 75.55 (C-3), 72.79 (C-4), 26.72 (C-10), 26.30 (C-9), 21.49 (C-5), 9.65 (C-
11) ppm. 
IR (ATR): ṽ = 2924 (s), 1623 (w), 1373 (w), 1077 (s), 1016 (m), 767 (m) cm‒1. 
HRMS (EI): calcd. for C13H22O4Sn
+
: 362.0535 [M]
+      
  found:   362.0541 [M]
+
. 
 
Ethyl (2E)-4-[(2R,6R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.0
2,6
]dodec-10-en-11-yl]-
4-hydroxybut-2-enoate (78) and (1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo 
[6.4.0.0
2,6
]dodec-10-ene (72): 
 
A solution of stannane 76 (46.5 mg, 0.129 mmol, 1.0 eq) in THF (5 mL) was cooled to ‒78 °C 
and a solution of n-butyllithium in hexanes (2.4 M, 64.6 µL, 0.155 mmol, 1.2 eq) was added 
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dropwise. The mixture was stirred at ‒78 °C for 15 min, then aldehyde 77 (18.7 µL, 
0.155 mmol, 1.2 eq) was added and the resulting solution was stirred at ‒78 °C for an additional 
15 min. The reaction was quenched with aq. NH4Cl (4 mL of a saturated solution) and the 
mixture extracted with Et2O (3 x 25 mL). The combined organic fractions were washed with 
brine (25 mL), then dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 9:14:13:1] afforded alcohol 78 (23.1 mg, 70.8 µmol, 55%) as a colorless oil 
consisting of two diastereomers in a ratio of 1.2:1 (as determined by 
1
H-NMR spectroscopy) as 
an inseparable mixture, as well as protodemetallated product 72 (7.40 mg, 37.3 µmol, 29%) as a 
white solid. 
Alcohol 78: 
Rf = 0.52 [PE:EtOAc 1:1]. 
1
H-NMR (600 MHz, CDCl3) (mixture of isomers, both 
isomers quoted, minor isomer primed): δ = 6.96 – 6.89 (m, 
2H, H-9, H-9'), 6.14 – 6.06 (m, 2H, H-10, H-10'), 5.92 – 5.88 (m, 2H, H-1, H-1'), 4.86 – 4.83 
(m, 1H, H-6), 4.81 – 4.78 (m, 1H, H-6'), 4.67 – 4.60 (m, 4H, H-2, H-2', H-8, H-8'), 4.50 – 4.47 
(m, 2H, H-4, H-4'), 4.23 – 4.17 (m, 6H, H-3, H-3', H-15a, H-15b, H-15a', H-15b'), 2.43 – 2.33 
(m, 4H, H-5a, H-5b, H-5a', H-5b'), 1.52 (br s, 6H, 3 x H-14, 3 x H-14'), 1.33 (br s, 6H, 3 x H-13, 
3 x H-13'), 1.30 – 1.27 (m, 6H, 3 x H-16, 3 x H-16') ppm. 
13
C-NMR (150 MHz, CDCl3) (mixture of isomers, both isomers quoted, minor isomer primed): 
δ = 166.55 (C-11), 166.49 (C-11'), 150.61 (C-7), 150.47 (C-7'), 146.21 (C-9), 145.71 (C-9'), 
121.97 (C-10'), 121.58 (C-10), 112.07 (C-12), 112.06 (C-12'), 104.87 (C-1'), 104.86 (C-1), 
95.29 (C-6'), 94.69 (C-6), 84.08 (C-2'), 84.03 (C-2), 77.44 (C-3 or C-3'), 77.39 (C-3 or C-3'), 
72.08 (C-4), 72.03 (C-4'), 71.44 (C-8), 71.30 (C-8'), 60.69 (C-15'), 60.67 (C-15), 26.58 (C-14 
and C-14'), 26.21 (C-13), 26.20 (C-13'), 21.47 (C-5'), 21.46 (C-5), 14.34 (C-16 and C-16'). 
IR (ATR): ṽ = 3420 (m), 2962 (s), 1703 (m), 1374 (m), 1081 (s), 1016 (s), 865 (w) cm‒1. 
HRMS (EI): calcd. for C16H26NO7
+
: 344.1704 [M+NH4]
+     
  found:   344.1704 [M+NH4]
+
. 
Protodemetallated product 72: 
Analytical data were identical with the material obtained earlier (vide supra). 
Rf = 0.79 [PE:EtOAc 2:1]. 
    
   = +98.7 (c = 0.79, MeOH). 
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mp: 39 – 40 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 6.31 – 6.28 (m, 1H, H-7), 5.94 (d, J = 3.8 Hz, 1H, H-1), 
4.69 – 4.65 (m, 1H, H-6), 4.60 (d, J = 3.8 Hz, 1H, H-2), 4.52 – 4.48 (m, 1H, H-4), 4.13 (br s, 
1H, H-3), 2.40 – 2.33 (m, 1H, H-5a or H-5b), 4.60 (dd, J = 18.7, 4.4 Hz, 1H, H-5a or H-5b), 
1.52 (s, 3H, 3 x H-10), 1.33 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 141.94 (C-7), 111.94 (C-8), 105.00 (C-1), 97.24 (C-6), 84.25 
(C-2), 75.92 (C-3), 72.50 (C-4), 26.66 (C-10), 26.27 (C-9), 20.72 (C-5). 
IR (ATR): ṽ = 2936 (m), 1662 (m), 1376 (w), 1208 (m), 1076 (s), 829 (m) cm‒1. 
HRMS (EI): calcd. for C10H14O4
+
: 198.0887 [M]
+
      
  found:   198.0886 [M]
+
. 
 
1,6-Anhydro-2,3,4-tri-O-benzyl-β-D-glucopyranose (86)[39-40] 
 
A stirred solution of D-(+)-glucose monohydrate 84 (100 g, 505 mmol, 1.0 eq) in pyridine (1 L, 
dried over KOH pellets) was cooled to 16 °C (internal temperature) and a solution of 
p-toluenesulfonyl chloride (144 g, 757 mmol, 1.5 eq) in pyridine (300 mL, dried over KOH 
pellets) was added dropwise, keeping the internal temperature of the reaction mixture between 
15 and 20 °C with the aid of a water-ice bath. After complete addition, stirring was continued 
for 90 additional min at 20 °C. The mixture was brought to pH 9 by addition of aq. NaOH 
(10 wt%, ca. 600 mL), then stirred for 60 min at room temperature. The pH was lowered to 7 by 
carefully adding conc. aq. HCl (ca. 20 mL), and the solvents were evaporated in vacuo. 
Azeotropic removal of pyridine and water residues with toluene (3 x 500 mL) gave a solid that 
was suspended in EtOH (500 mL) and filtered through a pad of florisil (14 x 5 cm, 100 – 200 
mesh). Washing with ethanol (3.5 L) was continued until the filtrate was free of sugar 
derivatives (indicated by TLC) and subsequent removal of the solvent in vacuo (15 h rotary 
evaporator, 10 mbar; followed by 3 d high-vacuum, 10
‒2
 mbar) provided a brown oil. The crude 
1,6-anhydro-glucose 85 was dissolved in DMF (500 mL) and the solution was carefully added 
to a stirred, cooled suspension (water-ice bath) of sodium hydride (60 wt% in mineral oil, 202 g, 
5.05 mol, 10 eq) in DMF (500 mL). After 25 min, benzyl bromide (360 mL, 3.03 mol, 6.0 eq) 
was added dropwise with the aid of a dropping funnel (caution: exothermic reaction!) and the 
reaction mixture was allowed to warm slowly to room temperature over 15 h. The reaction was 
then quenched carefully by dropwise addition of MeOH (300 mL) over a period of 3 h 
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(dropping funnel), followed by addition of water (500 mL). The mixture was divided into four 
aliquots and each aliquot was diluted with EtOAc (1 L) and water (500 mL), followed by 
separation of the phases. Each aqueous phase was extracted with EtOAc (2 x 500 mL) and all 
organic extracts were combined. The resulting organic fraction (ca. 8 L) was again divided into 
eight parts and every part (ca. 1 L) was washed successively with water (2 x 500 mL), aq. 
NaHCO3 (2 x 500 mL of a saturated solution), aq. KHSO4 (500 mL of a saturated solution) and 
brine (500 mL) and dried (MgSO4). Removal of the solvent in vacuo gave a brown oil that was 
purified by flash column chromatography [PE:EtOAc 9:14:1], to provide the crude 
tribenzylated anhydro sugar 86, which was crystallized from EtOH (150 mL), affording pure 
product 86 (56.3 g, 130 mmol, 26%) as white needles. Concentration of the mother liquors and 
flash column chromatography [PE:EtOAc 9:14:1] followed by recrystallization afforded 
additional material of 86 (7.15 g, 16.5 mmol), raising the total yield to 29%. 
Anhydro sugar 86: 
Rf = 0.46 [PE:EtOAc 3:1]. 
    
   = 30.4 (c = 1.0, CHCl3). 
mp: 89 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.27 (m, 13H, 2 x H-11, 2 x H-12, H-13, 2 x H-15, 
2 x H-16, H-17, 2 x H-20, H-21), 7.26 – 7.24 (m, 2H, 2 x H-19), 5.48 (s, 1H, H-1), 4.64 – 4.54 
(m, 5H, H-5, H-7a, H-7b, H-8a, H-8b), 4.47 (d, J = 12.1 Hz, 1H, H-9a or H-9b), 4.42 (d, 
J = 12.1 Hz, 1H, H-9a or H-9b), 3.92 (dd, J = 7.2, 1.0 Hz, 1H, H-6a), 3.69 (dd, J = 7.1, 5.9 Hz, 
1H, H-6b), 3.62 – 3.60 (m, 1H, H-3), 3.38 – 3.35 (m, 2H, H-2, H-4) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.06 (C-10 or C-14 or C-18), 138.02 (C-10 or C-14 or C-
18), 137.98 (C-10 or C-14 or C-18), 128.59 (2 x C-11 or 2 x C-12 or 2 x C-15 or 2 x C-16 or 
2 x C-19 or 2 x C-20), 128.56 (2 x C-11 or 2 x C-12 or 2 x C-15 or 2 x C-16 or 2 x C-19 or 
2 x C-20), 128.56 (2 x C-11 or 2 x C-12 or 2 x C-15 or 2 x C-16 or 2 x C-19 or 2 x C-20), 
128.08 (2 x C-11 or 2 x C-12 or 2 x C-15 or 2 x C-16 or 2 x C-19 or 2 x C-20), 127.96 (C-13 or 
C-17 or C-21), 127.96 (2 x C-11 or 2 x C-12 or 2 x C-15 or 2 x C-16 or 2 x C-19 or 2 x C-20), 
127.95 (C-13 or C-17 or C-21), 127.95 (C-13 or C-17 or C-21), 127.86 (2 x C-11 or 2 x C-12 or 
2 x C-15 or 2 x C-16 or 2 x C-19 or 2 x C-20), 100.75 (C-1), 76.99 (C-4), 76.33 (C-2), 76.24 
(C-3), 74.53 (C-5), 72.16 (C-9), 71.91 (C-7 or C-8), 71.32 (C-7 or C-8), 65.56 (C-6) ppm. 
IR (ATR): ṽ = 2961 (m), 2902 (m) 1454 (m), 1090 (s), 1022 (m), 748 (s) cm‒1. 
HRMS (ESI): calcd. for C27H28NaO5
+
: 455.1829 [M+Na]
+
     
  found:   455.1825 [M+Na]
+
. 
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[(2R,3R,4R,5S,6R)-3,4,5-Tris(benzyloxy)-6-(prop-2-en-1-yl)oxan-2-yl]methanol (87)
[40,42]
 
 
A solution of tribenzylated anhydro glucose 86 (50.1 g, 116 mmol, 1.0 eq) and 
allyltrimethylsilane (55.2 mL, 348 mmol, 3.0 eq) in MeCN (500 mL) was cooled to 0 °C and 
trimethylsilyl trifluoromethanesulfonate (21.0 mL, 116 mmol, 1.0 eq) was added dropwise. The 
reaction mixture was stirred at room temperature for 22 h, then quenched with aq. NaHCO3 
(550 mL of a saturated solution) and diluted with water (300 mL). The mixture was extracted 
with CH2Cl2 (3 x 400 mL) and the combined organic fractions were washed with brine (1 L), 
then dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 
9:16:15:14:13:11:11:2] afforded alkene 87 (36.4 g, 76.7 mmol, 66%) as a white 
solid. 
Alkene 87: 
Rf = 0.21 [PE:EtOAc 3:1]. 
    
   = 44.4 (c = 0.69, CH2Cl2). 
mp: 78 – 79 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.27 (m, 15H, 2 x H-14, 2 x H-15, H-16, 2 x H-18, 
2 x H-19, H-20, 2 x H-22, 2 x H-23, H-24), 5.77 (dddd, J = 17.3, 10.2, 6.9, 6.9 Hz, 1H, H-2), 
5.14 – 5.07 (m, 2H, H-1a, H-1b), 4.94 (d, J = 10.9 Hz, 1H, H-11a or H-11b), 4.87 (d, 
J = 10.9 Hz, 1H, H-12a or H-12b), 4.83  (d, J = 10.9 Hz, 1H, H-11a or H-11b), 4.71 (d, 
J = 11.6 Hz, 1H, H-10a or H-10b), 4.63 (d, J = 11.6 Hz, 2H, H-10a or H-10b, H-12a or H-12b), 
4.04 – 4.07 (m, 1H, H-4), 3.82 (dd, J = 9.1, 8.7 Hz, 1H, H-6), 3.78 – 3.75 (m, 1H, H-9a or H-
9b), 3.71 (dd, J = 9.4, 5.8 Hz, 1H, H-5), 3.66 – 3.63 (m, 1H, H-9a or H-9b), 3.56 – 3.53 (m, 1H, 
H-8), 3.50 (dd, J = 9.8, 8.4 Hz, 1H, H-7), 2.55 – 2.46 (m, 2H, H-3a, H-3b), 1.79 (dd, J = 6.4, 
6.4 Hz, 1H, H-25) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.77 (C-17), 138.27 (C-13), 138.16 (C-21), 134.62 (C-2), 
128.65 (2 x C-15 or 2 x C-19 or 2 x C-23), 128.60 (2 x C-15 or 2 x C-19 or 2 x C-23), 128.55 
(2 x C-15 or 2 x C-19 or 2 x C-23), 128.23 (2 x C-22), 128.06 (C-16 or C-20 or C-24), 128.02 
(2 x C-18), 127.99 (C-16 or C-20 or C-24), 127.95 (2 x C-14), 127.79 (C-16 or C-20 or C-24), 
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117.35 (C-1), 82.36 (C-6), 80.25 (C-5), 78.23 (C-7), 75.58 (C-11), 75.28 (C-12), 73.78 (C-4), 
73.33 (C-10), 71.69 (C-8), 62.48 (C-9), 30.13 (C-3) ppm. 
IR (ATR): ṽ = 3344 (br, m), 3032 (m), 2900 (m), 2336 (w), 1453 (m), 1094 (s), 1026 (s), 693 
(s) cm
‒1
. 
HRMS (ESI): calcd. for C30H38NO5
+
: 492.2744 [M+NH4]
+
     
  found:   492.2742 [M+NH4]
+
. 
 
[(3aR,5R,6R,7S,7aS)-6,7-Bis(benzyloxy)-2-(iodomethyl)-hexahydro-2H-furo[3,2-b]pyran-5-
yl]methanol (95): 
 
A solution of 12 (23.7 g, 49.9 mmol, 1.0 eq) in CH2Cl2 (170 mL) was cooled to 0 °C and iodine 
(13.9 g, 54.9 mmol, 1.1 eq) was added in one portion. The mixture was stirred at 0 °C for 
55 min until complete consumption of the starting material (as indicated by TLC analysis). The 
reaction was quenched with aq. Na2S2O3 (150 mL of a saturated solution) and the biphasic 
system was stirred vigorously at room temperature for 30 min. The organic phase was separated 
and the aqueous layer was extracted further with CH2Cl2 (2 x 200 mL). The combined organic 
fractions were washed with water (200 mL) and brine (200 mL), then dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [PE:EtOAc 9:14:12:1] afforded 
iodides 95 (20.6 g, 40.4 mmol, 81%) as a colorless oil consisting of two diastereomers in a ratio 
of 2.7:1 (as determined by 
1
H-NMR spectroscopy) as an inseparable mixture. 
Iodides 95: 
Rf = 0.46 [PE:EtOAc 1:1]. 
1
H-NMR (400 MHz, CDCl3) (mixture of isomers, major isomer 
quoted): δ = 7.44 – 7.27 (m, 10H, 2 x H-13, 2 x H-14, H-15, 2 x H-
17, 2 x H-18, H-19), 4.91 (d, J = 11.7 Hz, 1H, H-10a or H-10b), 
4.88 (d, J = 11.3 Hz, 1H, H-11a or H-11b), 4.75 (d, J = 11.8 Hz, 1H, H-10a or H-10b), 4.60 (d, 
J = 11.1 Hz, 1H, H-11a or H-11b), 4.16 – 4.08 (m, 1H, H-2), 4.06 (dd, J = 5.6, 5.6 Hz, 1H, H-
5), 3.88 (dd, J = 8.7, 5.5 Hz, 1H, H-6), 3.75 – 3.65 (m, 3H, H-9a, H-9b, H-8), 3.51 – 5.45 (m, 
1H, H-7), 3.35 (dd, J = 9.9, 5.4 Hz, 1H, H-1a or H-1b), 3.31 – 3.26 (m, 1H, H-1a or H-1b), 
2.31 – 2.23 (m, 1H, H-3a or H-3b), 2.01 – 1.93 (m, 1H, H-3a or H-3b), 1.92 (s, 1H, H-20) ppm. 
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13
C-NMR (100 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 138.41 (C-12), 
138.12 (C-16), 128.55 (2 x C-13 or 2 x C-14 or 2 x C-17 or 2 x C-18), 128.47 (2 x C-13 or 
2 x C-14 or 2 x C-17 or 2 x C-18), 128.23 (2 x C-13 or 2 x C-14 or 2 x C-17 or 2 x C-18), 
128.04 (2 x C-13 or 2 x C-14 or 2 x C-17 or 2 x C-18), 127.98 (C-15 or C-19), 127.76 (C-15 or 
C-19), 83.06 (C-5), 82.58 (C-6), 78.26 (C-2), 75.15 (C-8), 75.10 (C-7), 74.59 (C-4), 74.35 (C-
11), 72.99 (C-10), 62.19 (C-9), 36.85 (C-3), 9.83 (C-1) ppm. 
IR (ATR): ṽ = 3448 (br, m), 2874 (m), 1453 (m), 1363 (w), 1026 (s), 1094 (s), 695 (s) cm‒1. 
HRMS (ESI): calcd. for C23H27INaO5
+
: 533.0795 [M+Na]
+
    
  found:    533.0794 [M+Na]
+
. 
 
(2R,3S,4R,5R,6R)-4,5-Bis(benzyloxy)-6-(hydroxymethyl)-2-(prop-2-en-1-yl)oxan-3-ol (96) 
and (2R,3S,4R,5R,6R)-4,5-bis(benzyloxy)-2-(prop-2-en-1-yl)-6-{[(trimethylsilyl)oxy] 
methyl} oxan-3-ol (101) 
 
A suspension of zinc dust (26.4 g, 404 mmol, 10 eq) in THF (100 mL), containing 1,2-
dibromoethane (348 µL, 4.04 mmol, 0.1 eq), was heated to 70 °C for one minute. After cooling 
to room temperature, chlorotrimethylsilane (516 µL, 4.04 mmol, 0.1 eq) was added and the 
suspension was stirred for 15 min until gas evolution had ceased.
[46]
 A solution of the 
diastereomeric mixture of iodides 95 (20.6 g, 40.4 mmol, 1.0 eq) in THF (150 mL) was added, 
followed by water (50 mL), and the reaction mixture was stirred for 1 h at room temperature. 
The solid was removed by filtering the suspension through a pad of Celite and the residue was 
washed with Et2O (300 mL). The filtrate was washed with aq. HCl (1 N, 200 mL) and the 
phases separated. The aqueous layer was extracted further with Et2O (2 x 300 mL). The 
combined organic fractions were washed with aq. NaHCO3 (500 mL of a saturated solution) and 
brine (500 mL), then dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 4:13:12:11:1] afforded diol 96 (14.0 g, 36.4 mmol, 90%) as a white solid. 
Diol 96: 
Rf = 0.52 [PE:EtOAc 1:1]. 
    
   = 32.8 (c = 0.63, CHCl3). 
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mp: 89 – 90 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.39 – 7.28 (m, 10H, 2 x H-13, 2 x H-14, H-15, 2 x H-17, 
2 x H-18, H-19), 5.82 (dddd, J = 17.1, 10.2, 7.0, 7.0 Hz, 1H, H-2), 5.17 – 5.12 (m, 1H, H-1a), 
5.12 – 5.07 (m, 1H, H-1b), 4.74 (d, J = 11.6 Hz, 1H, H-10a or H-10b), 4.69 (d, J = 11.4 Hz, 1H, 
H-11a or H-11b), 4.65 (d, J = 11.6 Hz, 1H, H-10a or H-10b), 4.63 (d, J = 11.4 Hz, 1H, H-11a or 
H-11b), 4.00 (ddd, J = 9.0, 5.0, 3.7 Hz, 1H, H-4), 3.93 (dd, J = 11.4, 7.0 Hz, 1H, H-9a or H-9b), 
3.89 – 3.84  (m, 1H, H-8), 3.75 (dd, J = 6.1, 6.1 Hz, 1H, H-6), 3.69 (dd, J = 6.3, 3.6 Hz, 1H, 
H-5), 3.63 (dd, J = 11.4, 3.3 Hz, 1H, H-9a or H-9b), 3.48 (dd, J = 5.6, 5.6 Hz, 1H, H-7), 2.50 –
 2.34 (m, 2H, H-3a, H-3b) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.01 (C-12), 137.49 (C-16), 134.64 (C-2), 128.77 (2 x C-
14 or 2 x C-18), 128.71 (2 x C-14 or 2 x C-18), 128.21 (C-15 or C-19), 128.18 (C-15 or C-19), 
128.06 (2 x C-17), 127.84 (2 x C-13), 117.51 (C-1), 78.58 (C-6), 75.98 (C-7), 74.42 (C-8), 
74.03 (C-10), 73.54 (C-11), 71.68 (C-4), 69.87 (C-5), 61.05 (C-9), 32.50 (C-3) ppm. 
IR (ATR): ṽ = 3375 (br, m), 2915 (m), 2362 (w), 1453 (m), 1088 (s), 990 (s), 694 (s) cm‒1. 
HRMS (ESI): calcd. for C23H28NaO5
+
: 407.1829 [M+Na]
+
     
  found:   407.1832 [M+Na]
+
. 
TMS ether 101: 
Trimethylsilylether 101 was obtained as a colorless oil in 9% yield when zinc was activated 
with 0.5 eq of 1,2-dibromoethane and 0.5 eq of chlorotrimethylsilane.
[46]
 
Rf = 0.61 [PE:EtOAc 3:1]. 
    
   = 20.4 (c = 1.1, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.27 (m, 10H, 2 x H-
13, 2 x H-14, H-15, 2 x H-17, 2 x H-18, H-19), 5.84 (dddd, J = 
17.1, 10.2, 6.9 Hz, 1H, H-2), 5.17 – 5.12 (m, 1H, H-1a), 5.08 – 5.05 (m, 1H, H-1b), 4.68 (d, 
J = 11.7 Hz, 1H, H-10a or H-10b), 4.65 (d, J = 11.7 Hz, 1H, H-11a or H-11b), 4.63 (d, 
J = 11.7 Hz, 1H, H-11a or H-11b), 4.59 (d, J = 11.7 Hz, 1H, H-10a or H-10b), 3.94 – 3.89 (m, 
2H, H-4, H-8), 3.89 – 3.81 (m, 2H, H-9a, H-9b) 3.78 (dd, J = 5.1, 5.1 Hz, 1H, H-6), 3.66 – 3.62 
(m, 2H, H-5, H-7), 2.98 – 2.95 (m, 1H, H-21), 2.47 – 2.34 (m, 2H, H-3a, H-3b), 0.10 (s, 9H, 
9 x H-20) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.09 (C-12), 137.67 (C-16), 134.88 (C-2), 128.65 (2 x C-
14 or 2 x C-18), 128.62 (2 x C-14 or 2 x C-18), 128.06 (2 x C-17 and C-15 or C-19), 128.04 (C-
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15 or C-19), 127.79 (2 x C-13), 117.04 (C-1), 77.41 (C-6), 75.30 (C-8), 74.20 (C-7), 73.31 (C-
10), 72.68 (C-11), 70.93 (C-4), 69.05 (C-5), 60.92 (C-9), 33.65 (C-3), 0.28 (3 x C-20) ppm. 
IR (ATR): ṽ = 3467 (br, w), 2924 (m), 1454 (w), 1250 (m), 1074 (s), 838 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C26H36NaO6Si
+
:  479.2224 [M+Na]
+    
 
 found:     479.2223 [M+Na]
+
. 
 
Tert-butyldimethyl{[(2R,3R,4R,5S,6R)-3,4,5-tris(benzyloxy)-6-(prop-2-en-1-yl)oxan-2-
yl]methoxy}silane (98): 
 
To a solution of alcohol 87 (388 mg, 0.818 mmol, 1.0 eq) and imidazole (140 mg, 2.05 mmol, 
2.5 eq) in DMF (1.5 mL) was added tert-butyldimethylsilyl chloride (148 mg, 0.982 mmol, 
1.2 eq) and the resulting mixture was stirred at room temperature for 72 h. The mixture was 
diluted with water (10 mL) and extracted with EtOAc (3 x 25 mL). The combined organic 
fractions were washed with aq. LiCl (10 wt%, 3 x 25 mL) and brine (25 mL), then dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 
99:149:119:1] afforded silyl ether 98 (360 mg, 0.611 mmol, 75%) as a colorless oil. 
Silyl ether 98: 
Rf = 0.52 [PE:EtOAc 9:1]. 
    
   = 33.9 (c = 1.2, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.28 (m, 15H, 2 x H-
14, 2 x H-15, H-16, 2 x H-18, 2 x H-19, H-20, 2 x H-22, 2 x H-
23, H-24), 5.84 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 1H, H-2), 5.14 – 5.09 (m, 1H, H-1a), 5.09 –
 5.05 (m, 1H, H-1b), 4.93 (d, J = 10.9 Hz, 1H, H-11a or H-11b), 4.88 (d, J = 10.9 Hz, 1H, H-12a 
or H-12b), 4.82 (d, J = 10.9 Hz, 1H, H-11a or H-11b), 4.71 (d, J = 11.6 Hz, 1H, H-10a or H-
10b), 4.68 (d, J = 10.9 Hz, 1H, H-12a or H-12b), 4.65 (d, J = 11.6 Hz, 1H, H-10a or H-10b), 
4.13 – 4.07 (m, 1H, H-4), 3.82 (dd, J = 8.9, 8.9 Hz, 1H, H-6), 3.82 – 3.78 (m, 2H, H-9a, H-9b), 
3.71 (dd, J = 9.2, 5.7 Hz, 1H, H-5), 3.58 (dd, J = 9.6, 8.8 Hz, 1H, H-7), 3.53 – 3.50 (m, 1H, H-
8), 2.56 – 2.48 (m, 1H, H-3a or H-3b), 2.48 – 2.42 (m, 1H, H-3a or H-3b), 0.91 (s, 9H, 9 x H-
28), 0.06 (s, 6H, 3 x H-25, 3 x H-26) ppm. 
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13
C-NMR (100 MHz, CDCl3): δ = 138.88 (C-17), 138.62 (C-13 or C-21), 138.47 (C-13 or C-
21), 134.98 (C-2), 128.58 (2 x C-15 or 2 x C-19 or 2 x C-23), 128.55 (2 x C-15 or 2 x C-19 or 
2 x C-23), 128.53 (2 x C-15 or 2 x C-19 or 2 x C-23), 128.13 (2 x C-14 or 2 x C-18 or 2 x C-
22), 128.09 (2 x C-14 or 2 x C-18 or 2 x C-22), 127.89 (2 x C-14 or 2 x C-18 or 2 x C-22), 
127.87 (C-16 or C-20 or C-24), 127.86 (C-16 or C-20 or C-24), 127.75 (C-16 or C-20 or C-24), 
116.80 (C-1), 82.55 (C-6), 80.50 (C-5), 78.22 (C-7), 75.59 (C-11), 75.14 (C-12), 73.53 (C-4), 
73.16 (C-10), 72.71 (C-8), 62.89 (C-9), 30.13 (C-3), 26.11 (3 x C-28), 18.49 (C-27), 4.94 (C-
25 or C-26), 5.22 (C-25 or C-26) ppm. 
IR (ATR): ṽ = 3066 (w), 3031 (w), 2927 (s), 2856 (s), 1454 (m), 1360 (w), 1252 (m), 1090 (s), 
1028 (m), 912 (w), 836 (m), 697(m) cm
‒1
. 
HRMS (ESI): calcd. for C36H52NO5Si
+
: 606.3609 [M+NH4]
+
    
  found:    606.3614 [M+NH4]
+
. 
 
{[(3aR,5R,6R,7S,7aS)-6,7-bis(benzyloxy)-2-(iodomethyl)-hexahydro-2H-furo[3,2-b]pyran-
5-yl]methoxy}(tert-butyl)dimethylsilane (99) 
 
A solution of alkene 98 (188 mg, 0.319 mmol, 1.0 eq) in THF (1 mL) was cooled to 0 °C and 
iodine (502 mg, 1.98 mmol, 6.2 eq) was added in one portion. The mixture was stirred at 0 °C 
for 60 min until complete consumption of the starting material (as indicated by TLC analysis). 
The reaction was quenched with aq. Na2S2O3 (2 mL of a saturated solution) and the biphasic 
system was stirred vigorously at room temperature for 30 min. The mixture was diluted with 
water (10 mL) and extracted with EtOAc (3 x 20 mL). The combined organic fractions were 
washed with water (20 mL) and brine (20 mL), then dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [PE:EtOAc 19:19:1] afforded iodides 99 (149 mg, 
0.238 mmol, 75%) as a colorless oil consisting of two diastereomers (d.r. 4:1, as determined by 
1
H-NMR spectroscopy) as an inseparable mixture. 
Iodides 99: 
Rf = 0.34 [PE:EtOAc 9:1]. 
1
H-NMR (400 MHz, CDCl3) (mixture of isomers, major isomer 
quoted): δ = 7.43 – 7.28 (m, 10H, 2 x H-13, 2 x H-14, H-15, 2 x H-
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17, 2 x H-18, H-19), 4.96 – 4.87 (m, 2H, H-10a or H-10b, H-11a or H-11b), 4.78 – 4.74 (m, 1H, 
H-H-10a or H-10b), 4.71 – 4.66 (m, 1H, H-4), 4.60 (d, J = 11.2 Hz, 1H, H-11a or H-11b), 
4.24 – 4.12 (m, 1H, H-2), 4.02 (dd, J = 5.1, 5.1 Hz, 1H, H-5), 3.86 (dd, J = 9.7, 5.3 Hz, 1H, H-
6), 3.84 – 3.74 (m, 3H, H-7, H-9a, H-9b), 3.68 – 3.62 (m, 1H, H-8), 3.36 (dd, J = 9.7, 5.7 Hz, 
1H, H-1a or H-1b), 3.32 – 3.26 (m, 1H, H-1a or H-1b), 2.31 – 2.22 (m, 1H, H-3a or H-3b), 1.95 
(ddd, J = 13.7, 5.7, 3.7 Hz, 1H, H-3a or H-3b), 0.90 (s, 9H, 9 x H-23), 0.07 (s, 3H, 3 x H-20 or 
3 x H-21), 0.05 (s, 3H, 3 x H-20 or 3 x H-21) ppm. 
13
C-NMR (100 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 138.68 (C-12 or 
C-16), 138.65 (C-12 or C-16), 128.49 (2 x C-14 or 2 x C-18), 128.45 (2 x C-14 or 2 x C-18), 
128.10 (2 x C-13 or 2 x C17), 128.04 (2 x C-13 or 2 x C17), 127.79 (C-15 or C-19), 127.68 (C-
15 or C-19), 85.51 (C-5), 83.69 (C-6), 79.00 (C-2), 77.02 (C-8), 75.49 (C-4), 74.68 (C-11), 
74.37 (C-7), 73.01 (C-10), 63.64 (C-9), 37.62 (C-3), 26.07 (3 x C-23), 18.41 (C-22), 10.00 (C-
1), 5.20 (C-20 or C-21), 5.26 (C-20 or C-21) ppm. 
IR (ATR): ṽ = 2928 (s), 2856 (s), 1454 (m), 1361 (m), 1252 (m), 1086 (s), 905 (w), 834 (s), 776 
(m), 696 (s) cm
‒1
. 
HRMS (ESI): calcd. for C29H45INO5Si
+
: 642.2106 [M+NH4]
+
    
  found:    642.2111 [M+ NH4]
+
. 
 
(2R,3S,4R,5R,6R)-4,5-bis(benzyloxy)-6-{[(tert-butyldimethylsilyl)oxy]methyl}-2-(prop-2-
en-1-yl)oxan-3-ol (100): 
 
A suspension of zinc dust (137 mg, 2.10 mmol, 10 eq) in THF (1 mL), containing 1,2-
dibromoethane (9.05 µL, 0.105 mmol, 0.5 eq), was heated to 70 °C for one minute. After 
cooling to room temperature, chlorotrimethylsilane (13.4 µL, 0.105 mmol, 0.5 eq) was added 
and the suspension was stirred for 15 min until gas evolution had ceased. A solution of the 
diastereomeric mixture of iodides 99 (131 mg, 0.210 mmol, 1.0 eq) in THF (4 mL) was added 
followed by water (1 mL), and the reaction mixture was stirred for 1 h at room temperature. The 
solid was removed by filtering the suspension through a pad of Celite and the residue was 
washed with Et2O (50 mL). The filtrate was diluted with water (10 mL) and the phases were 
separated. The aqueous layer was extracted further with Et2O (2 x 20 mL). The combined 
organic fractions were washed with aq. NaHCO3 (30 mL of a saturated solution) and brine 
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(30 mL), then dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 19:19:1] afforded alcohol 100 (74.0 mg, 0.148 mmol, 71%) as a colorless oil. 
Alcohol 100: 
Rf = 0.15 [PE:EtOAc 9:1]. 
    
   = 19.1 (c = 0.87, CHCl3).  
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.26 (m, 10H, 2 x H-
13, 2 x H-14, H-15, 2 x H-17, 2 x H-18, H-19), 5.84 (dddd, J = 17.1, 10.2, 6.9, 6.9 Hz, 1H, H-
2), 5.16 – 5.11 (m, 1H, H-1a), 5.08 – 5.04 (m, 1H, H-1b), 4.69 – 4.54 (m, 4H, H-10a, H-10b, H-
11a, H-11b), 3.95 – 3.83 (m, 4H, H-4, H-5 or H-8, H-9a, H-9b), 3.79 (dd, J = 4.7, 4.7 Hz, 1H, 
H-6 or H-7), 3.71 – 3.68 (m, 1H, H-6 or H-7), 3.62 (br s, 1H, H-5 or H-8), 3.02 (br s, 1H, H-24), 
2.47 – 2.33 (m, 2H, H-3a, H-3b), 0.88 (s, 9H, 9 x H-23), 0.04 (s, 3H, 3 x H-20 or 3 x H-21), 
0.02 (s, 3H, 3 x H-20 or 3 x H-21) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.06 (C-12 or C-16), 137.69 (C-12 or C-16), 134.95 (C-2), 
128.65 (2 x C-14 and 2 x C-18), 128.07 (C-15 or C-19), 128.04 (C-15 or C-19), 128.03 (2 x C-
13 or 2 x C-17), 127.80 (2 x C-13 or 2 x C-17), 117.03 (C-1), 76.99 (C-6 or C-7), 75.56 (C-5 or 
C-8), 73.83 (C-6 or C-7), 73.11 (C-10 or C-11), 72.59 (C-10 or C-11), 70.76 (C-4), 68.98 (C-10 
or C-11), 61.40 (C-9), 34.03 (C-3), 26.03 (3 x C-23), 18.36 (C-22), 5.17 (C-20 or C-21), 5.20 
(C-20 or C-21) ppm. 
IR (ATR): ṽ = 3490 (br w), 2928 (s), 2857 (m), 1455 (w), 1253 (m), 1081 (br, s), 834 (m), 778 
(w), 698 (w) cm
‒1
. 
HRMS (ESI): calcd. for C29H42NaO5Si
+
: 521.2694 [M+Na]
+    
 
 found:    521.2696 [M+Na]
+
. 
 
{[(2R,3R,4S,5S,6R)-3,4-Bis(benzyloxy)-5-[(tert-butyldimethylsilyl)oxy]-6-(prop-2-en-1-
yl)oxan-2-yl]methoxy}(tert-butyl)dimethylsilane (97): 
 
To a solution of diol 96 (14.0 g, 36.4 mmol, 1.0 eq) and imidazole (12.4 g, 182 mmol, 5.0 eq) in 
DMF (30 mL) was added tert-butyldimethylsilyl chloride (16.5 g, 109 mmol, 3.0 eq) and the 
resulting mixture was stirred at room temperature for 42 h. Upon completion of the reaction, as 
monitored by TLC, the mixture was diluted with water (200 mL) and extracted with EtOAc 
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(3 x 300 mL). The combined organic fractions were washed with aq. LiCl (10 wt%, 
3 x 300 mL) and brine (300 mL), then dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [PE:EtOAc 99:149:124:1] afforded bis-silyl ether 97 (20.0 g, 32.6 mmol, 
90%) as a white solid. 
Bis-silyl ether 97: 
Rf = 0.62 [PE:EtOAc 9:1]. 
    
   = 31.3 (c = 1.3, CHCl3). 
mp: 55 – 57 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.39 – 7.21 (m, 10H, 2 x H-13, 2 x H-14, H-15, 2 x H-17, 
2 x H-18, H-19), 5.84 (dddd, J = 17.1, 10.2, 6.9, 6.9 Hz, 1H, H-2), 5.15 – 5.02 (m, 2H, H-1a, H-
1b), 4.91 (d, J = 11.3 Hz, 1H, H-10a or H-10b), 4.82 (d, J = 10.8 Hz, 1H, H-11a or H-11b), 4.81 
(d, J = 11.3 Hz, 1H, H-10a or H-10b), 4.63 (d, J = 10.8 Hz, 1H, H-11a or H-11b), 3.96 – 3.89 
(m, 1H, H-4), 3.84 (dd, J = 9.1, 5.9 Hz, 1H, H-5), 3.81 – 3.74 (m, 2H, H-9a, H-9b), 3.69 – 3.63 
(m, 1H, H-6), 3.54 – 3.46 (m, 2H, H-7, H-8), 2.55 – 2.40 (m, 2H, H-3a, H-3b), 0.92 (s, 9H, 
9 x H-23), 0.90 (s, 9H, 9 x H-27), 0.09 (s, 6H, 3 x H-20, 3 x H-21), 0.06 (s, 3H, 3 x H-24 or 
3 x H-25), 0.05 (s, 3H, 3 x H-24 or 3 x H-25) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 139.04 (C-12), 138.60 (C-16), 135.26 (C-2), 128.53 (2 x C-
14 or 2 x C-18), 128.41 (2 x C-14 or 2 x C-18), 128.05 (2 x C-17), 127.80 (C-15 or C-19), 
127.65 (2 x C-13), 127.49 (C-15 or C-19), 116.66 (C-1), 83.43 (C-6), 78.56 (C-7), 76.32 (C-4), 
75.59 (C-10), 75.15 (C-11), 73.57 (C-5), 72.71 (C-8), 63.03 (C-9), 29.25 (C-3), 26.12 (3 x C-23 
or 3 x C-27), 26.05 (3 x C-23 or 3 x C-27), 18.51 (C-26), 18.12 (C-22), 4.40 (C-20 or C-21), 
4.50 (C-20 or C-21), 4.92 (C-24 or C-25), 5.20 (C-24 or C-25) ppm. 
IR (ATR): ṽ = 2928 (s), 1462 (w), 1252 (m), 1088 (s), 834 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C35H60NO5Si2
+
: 630.4005 [M+NH4]
+
    
  found:    630.4010 [M+NH4]
+
. 
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Methyl (2E)-4-[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]but-2-enoate (83) and (2Z)-4-
[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-
butyldimethylsilyl)oxy]methyl}oxan-2-yl]but-2-enoate (102) 
 
Grubbs' catalyst, 2
nd
 generation (172 mg, 0.203 mmol, 7 mol%) was added in one portion to a 
solution of alkene 97 (1.78 g, 2.90 mmol, 1.0 eq) and methyl acrylate (1.31 mL, 14.5 mmol, 
5.0 eq) in toluene (15 mL), and the reaction mixture was stirred for 22 h at 60 °C. After cooling 
to room temperature, volatile material was removed in vacuo, and the residue was subjected to 
flash column chromatography [PE:EtOAc 100:049:119:1] to afford trans-ester 83 (1.77 g, 
2.64 mmol, 91%) as a colorless oil, as well as cis-ester 102 (86.5 mg, 0.129 mmol, 4%) as 
colorless oil, in addition to recovered starting material 97 (78.5 mg, 0.128 mmol, 4%). 
Trans-ester 83: 
Rf = 0.32 [PE:EtOAc 9:1]. 
    
   = 48.2 (c = 0.51, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.20 (m, 10H, 
2 x H-15, 2 x H-16, H-17, 2 x H-19, 2 x H-20, H-21), 6.98 
(ddd, J = 15.6, 7.5, 7.4 Hz, 1H, H-3) 5.92 (dd, J = 15.7, 0.7 Hz, 1H, H-2), 4.88 (d, J = 11.3 Hz, 
1H, H-12a or H-12b), 4.80 (d, J = 11.3 Hz, 1H, H-12a or H-12b), 4.80 (d, J = 10.8 Hz, 1H, H-
13a or H-13b), 4.62 (d, J = 10.8 Hz, 1H, H-13a or H-13b), 3.99 (ddd, J = 10.2, 5.2, 5.2 Hz, 1H, 
H-5), 3.83 (dd, J = 9.1, 5.9 Hz, 1H, H-6), 3.79 – 3.74 (m, 2H, H-10a, H-10b), 3.73 (s, 3H, 
3 x H-11), 3.62 (dd, J = 8.9, 8.9 Hz, 1H, H-7), 3.52 – 3.44 (m, 2H, H-8, H-9), 2.67 – 2.56 (m, 
2H, H-4a, H-4b), 0.90 (s, 9H, 9 x H-25), 0.89 (s, 9H, 9 x H-29), 0.08 (s, 6H, 3 x H-22, 3 x H-
23), 0.05 (s, 3H, 3 x H-26 or 3 x H-27), 0.04 (s, 3H, 3 x H-26 or 3 x H-27) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 166.88 (C-1), 146.11 (C-3), 138.88 (C-14), 138.46 (C-18), 
128.56 (2 x C-16 or 2 x C-20), 128.43 (2 x C-16 or 2 x C-20), 128.04 (2 x C-19), 127.86 (C-17 
or C-21), 127.62 (2 x C-15), 127.55 (C-17 or C-21), 123.00 (C-2), 83.20 (C-7), 78.33 (C-8), 
75.73 (C-5), 75.61 (C-12), 75.19 (C-13), 73.24 (C-6), 73.05 (C-9), 62.91 (C-10), 51.53 (C-11), 
27.90 (C-4), 26.10 (3 x C-29), 26.02 (3 x C-25), 18.50 (C-28), 18.10 (C-24), 4.42 (C-22 or C-
23), 4.50 (C-22 or C-23), 4.97 (C-26 or C-27), 5.23 (C-26 or C-27) ppm. 
IR (ATR): ṽ = 2928 (s), 1726 (s), 1471 (w), 1252 (m), 1089 (s), 835 (s), 697 (w) cm‒1. 
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HRMS (ESI): calcd. for C37H62NO7Si2
+
: 688.4059 [M+NH4]
+
    
  found:    688.4065 [M+NH4]
+
. 
Cis-ester 102: 
Rf = 0.54 [PE:EtOAc 9:1]. 
    
   = 19.8 (c = 0.74, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.20 (m, 10H, 2 x H-
15, 2 x H-16, H-17, 2 x H-19, 2 x H-20, H-21), 6.34 (ddd, 
J = 11.6, 7.4, 6.5 Hz, 1H, H-3) 5.88 (ddd, J = 11.5, 1.9, 1,9 Hz, 1H, H-2), 4.90 (d, J = 11.3 Hz, 
1H, H-12a or H-12b), 4.81 (d, J = 11.3 Hz, 1H, H-12a or H-12b), 4.81 (d, J = 11.0 Hz, 1H, H-
13a or H-13b), 4.60 (d, J = 11.0 Hz, 1H, H-13a or H-13b), 3.99 (ddd, J = 12.0, 5.9, 3.5 Hz, 1H, 
H-5), 3.85 (dd, J = 9.2, 5.9 Hz, 1H, H-6), 3.76 – 3.68 (m, 3H, H-7, H-10a, H-10b), 3.71 (s, 3H, 
3 x H-11), 3.49 (ddd, J = 9.6, 4.4, 1.8 Hz, 1H, H-9), 3.45 (dd, J = 9.8, 8.6 Hz, 1H, H-8), 3.31 –
 3.24 (m, 1H, H-4a or H-4b), 3.01 – 2.95 (m, 1H, H-4a or H-4b), 0.91 (s, 9H, 9 x H-25), 0.88 (s, 
9H, 9 x H-29), 0.08 (s, 3H, 3 x H-22 or 3 x H-23), 0.07 (s, 3H, 3 x H-22 or 3 x H-23), 0.03 (s, 
3H, 3 x H-26 or 3 x H-27), 0.03 (s, 3H, 3 x H-26 or 3 x H-27) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 166.83 (C-1), 147.14 (C-3), 139.01 (C-14), 138.62 (C-18), 
128.49 (2 x C-16 or 2 x C-20), 128.40 (2 x C-16 or 2 x C-20), 127.95 (2 x C-19), 127.74 (C-17 
or C-21), 127.64 (2 x C-15), 127.47 (C-17 or C-21), 120.86 (C-2), 83.34 (C-7), 78.48 (C-8), 
76.16 (C-5), 75.66 (C-12), 75.00 (C-13), 73.43 (C-6), 72.98 (C-9), 63.02 (C-10), 51.23 (C-11), 
26.09 (3 x C-29), 26.03 (3 x C-25), 25.28 (C-4), 18.48 (C-28), 18.09 (C-24), 4.40 (C-22 or C-
23), 4.53 (C-22 or C-23), 4.98 (C-26 or C-27), 5.24 (C-26 or C-27) ppm. 
IR (ATR): ṽ = 2928 (s), 1724 (s), 1462 (w), 1252 (m), 1087 (s), 834 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C37H62NO7Si2
+
: 688.4059 [M+NH4]
+
    
  found:    688.4058 [M+NH4]
+
. 
 
Methyl (4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolane-4-
carboxylate (103), Methyl (4R,5S)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-
butyldimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-
dimethyl-1,3-dioxolane-4-carboxylate (104), Methyl (2S,3R)-4-[(2R,3S,4S,5R,6R)-4,5-
bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl} 
oxan-2-yl]-2,3-dihydroxybutanoate (105), Methyl (2R,3S)-4-[(2R,3S,4S,5R,6R)-4,5-
bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl} 
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oxan-2-yl]-2,3-dihydroxybutanoate (106), Methyl (4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-
bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-(hydroxymethyl)oxan-2-yl]methyl}2,2-
dimethyl-1,3-dioxolane-4-carboxylate (107), and {[(2R,3R,4S,5S,6R)-3,4-bis(benzyloxy)-5-
[(tert-butyldimethylsilyl)oxy]-6-(2,2-dimethoxyethyl)oxan-2-yl]methoxy}(tert-butyl) 
dimethylsilane (108) 
 
A solution of K3Fe(CN)6 (7.38 g, 22.4 mmol, 3.0 eq), K2CO3 (3.10 g, 22.4 mmol, 3.0 eq), 
MeSO2NH2 (709 mg, 7.45 mmol, 1.0 eq) and (DHQD)2PHAL (2.32 g, 2.98 mmol, 0.4 eq) in 
water (37 mL) was added to a solution of unsaturated ester 83 (5.00 g, 7.45 mmol, 1.0 eq) in 
t-BuOH (37 mL). To the biphasic system was added a solution of OsO4 in t-BuOH (2.5 wt%, 
1.49 mL, 0.119 mmol, 1.6 mol%) and the mixture was stirred vigorously at room temperature 
for 19 h. An excess of solid Na2SO3 (23 g) was added in one portion and the mixture was stirred 
for an additional 30 min. Water (100 mL) was added and the aqueous layer was extracted with 
EtOAc (3 x 150 mL). The combined organic fractions were washed successively with aq. HCl 
(1 N, 150 mL) and brine (150 mL), then dried (MgSO4) and concentrated in vacuo to afford 
crude diols 105 and 106 as a mixture of two diastereomers (d.r. 14:1, as determined by 
1
H-NMR 
spectroscopy). The crude product was dissolved in CH2Cl2 (150 mL) and 2,2-dimethoxypropane 
(8.70 mL, 70.6 mmol, 10 eq), as well as (1R)-()-10-camphorsulfonic acid (164 mg, 
0.706 mmol, 10 mol%) were added in succession. The reaction mixture was stirred at room 
temperature for 60 min, then quenched with aq. NaHCO3 (150 mL of a saturated solution). The 
biphasic system was extracted with EtOAc (250 mL, 2 x 150 mL) and the combined organic 
fractions were washed with brine (250 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [PE:EtOAc 49:119:19:14:1] afforded acetonides 103 and 104 
(4.56 g, 6.12 mmol, 82% over two steps) as a colorless oil consisting of two diastereomers (d.r. 
14:1, as determined by 
1
H-NMR spectroscopy) as an inseparable mixture. An analytical sample 
of the mixture was purified by HPLC [Dynamax Microsorb 60-8 C18 (250 x 21.4 mm), 
gradient, water (A)/MeOH (B); 0 min 85% B, 50 min 85% B, 70 min 90% B, 85 min 90% B, 
100 min 92% B, 180 min 92% B; flow rate 21 mL/min; detection 205 nm: tR(103) = 137.1 min, 
tR(104) = 149.3 min] for full characterization of both isomers. 
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Major acetonide 103: 
Rf = 0.25 [PE:EtOAc 9:1]. 
    
   = 36.9 (c = 1.0, CHCl3). 
1
H-NMR (400 MHz, CDCl3): δ = 7.38 – 7.21 (m, 10H, 2 x H-
18, 2 x H-19, H-20, 2 x H-22, 2 x H-23, H-24), 4.90 (d, 
J = 11.2 Hz, 1H, H-15a or H-15b), 4.81 (d, J = 10.8 Hz, 1H, H-16a or H-16b), 4.79 (d, 
J = 11.3 Hz, 1H, H-15a or H-15b), 4.58 (d, J = 10.8 Hz, 1H, H-16a or H-16b), 4.27 (ddd, 
J = 10.3, 7.9, 2.5 Hz, 1H, H-3), 4.21 – 4.15 (m, 1H, H-5), 4.19 (d, J = 7.9 Hz, 1H, H-2), 3.84 
(dd, J = 9.3, 6.1 Hz, 1H, H-6), 3.81 – 3.77 (m, 1H, H-10a or H-10b), 3.77 (s, 3H, 3 x H-11), 
3.70 (dd, J = 11.1, 4.8 Hz, 1H, H-10a or H-10b), 3.60 (dd, J = 8.9, 8.9 Hz, 1H, H-7), 3.50 – 3.45 
(m, 1H, H-9), 3.42 (dd, J = 9.8, 8.5 Hz, 1H, H-8), 2.20 (ddd, J = 14.6, 12.2, 2.4 Hz, 1H, H-4a or 
H-4b), 1.97 (ddd, J = 14.7, 10.2, 2.1 Hz, 1H, H-4a or H-4b), 1.43 (s, 6H, 3 x H-13, 3 x H-14), 
0.91 (s, 9H, 9 x H-28), 0.88 (s, 9H, 9 x H-32), 0.10 (s, 3H, 3 x H-25 or 3 x H-26), 0.08 (s, 3H, 
3 x H-25 or 3 x H-26), 0.04 (s, 3H, 3 x H-29 or 3 x H-30), 0.03 (s, 3H, 3 x H-29 or 3 x H-
30) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 171.05 (C-1), 138.99 (C-17), 138.44 (C-21), 128.57 (2 x C-
19 or 2 x C-23), 128.43 (2 x C-19 or 2 x C-23), 128.14 (2 x C-22), 127.90 (C-20 or C-24), 
127.62 (2 x C-18), 127.53 (C-20 or C-24), 111.05 (C-12), 83.33 (C-7), 79.29 (C-2), 78.63 (C-8), 
75.61 (C-15), 75.27 (C-16), 75.21 (C-3), 73.18 (C-6 or C-9), 73.15 (C-6 or C-9), 73.06 (C-5), 
63.18 (C-10), 52.53 (C-11), 28.71 (C-4), 27.28 (C-13 or C-14), 26.09 (3 x C-32), 26.07 (3 x C-
28), 25.92 (C-13 or C-14), 18.46 (C-31), 18.17 (C-27), 4.48 (C-25 or C-26), 4.48 (C-25 or C-
26), 4.98 (C-29 or C-30), 5.23 (C-29 or C-30) ppm. 
IR (ATR): ṽ = 2928 (s), 1765 (m), 1497 (w), 1252 (m), 1087 (s), 834 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C40H68NO9Si2
+
: 762.4427 [M+NH4]
+
    
  found:    762.4437 [M+NH4]
+
. 
Minor acetonide 104: 
Rf = 0.25 [PE:EtOAc 9:1]. 
    
   = 16.8 (c = 0.25, CHCl3). 
1
H-NMR (400 MHz, CDCl3): δ = 7.37 – 7.20 (m, 10H, 
2 x H-18, 2 x H-19, H-20, 2 x H-22, 2 x H-23, H-24), 4.88 
(d, J = 11.2 Hz, 1H, H-15a or H-15b), 4.81 (d, J = 10.7 Hz, 1H, H-16a or H-16b), 4.80 (d, 
J = 11.2 Hz, 1H, H-15a or H-15b), 4.63 (d, J = 10.8 Hz, 1H, H-16a or H-16b), 4.44 (d, 
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J = 8.0 Hz, 1H, H-2), 4.27 – 4.22 (m, 1H, H-3), 4.18 – 4.13 (m, 1H, H-5), 3.84 – 3.71 (m, 3H, 
H-6, H-10a, H-10b), 3.75 (s, 3H, 3 x H-11), 3.61 – 3.50 (m, 3H, H-7, H-8, H-9), 2.24 – 2.11 (m, 
2H, H-4a, H-4b), 1.44 (s, 6H, 3 x H-13, 3 x H-14), 0.91 (s, 9H, 9 x H-28 or 9 x H-32), 0.89 (s, 
9H, 9 x H-28 or 9 x H-32), 0.09 (s, 3H, 3 x H-25 or 3 x H-26 or 3 x H-29 or 3 x H-30), 0.08 (s, 
3H, 3 x H-25 or 3 x H-26 or 3 x H-29 or 3 x H-30), 0.04 (s, 3H, 3 x H-25 or 3 x H-26 or 3 x H-
29 or 3 x H-30), 0.04 (s, 3H, 3 x H-25 or 3 x H-26 or 3 x H-29 or 3 x H-30) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 171.30 (C-1), 138.95 (C-17), 138.58 (C-21), 128.54 (2 x C-
19 or 2 x C-23), 128.42 (2 x C-19 or 2 x C-23), 128.06 (2 x C-22), 127.82 (C-20 or C-24), 
127.69 (2 x C-18), 127.52 (C-20 or C-24), 110.66 (C-12), 83.26 (C-7), 78.39 (C-2 or C-8), 
78.28 (C-2 or C-8), 77.09 (C-3), 75.64 (C-15), 75.17 (C-16), 73.23 (C-5 or C-6), 73.17 (C-5 or 
C-6), 72.81 (C-9), 62.71 (C-10), 52.43 (C-11), 27.14 (C-13 or C-14), 26.72 (C-4), 26.13 (3 x C-
28 or 3 x C-32), 26.04 (3 x C-28 or 3 x C-32), 25.98 (C-13 or C-14), 18.55 (C-27 or C-31), 
18.11 (C-27 or C-31), 4.45 (C-25 or C-26 or C-29 or C-30), 4.53 (C-25 or C-26 or C-29 or C-
30), 4.94 (C-25 or C-26 or C-29 or C-30), 5.24 (C-25 or C-26 or C-29 or C-30) ppm. 
IR (ATR): ṽ = 2928 (s), 1763 (m), 1462 (w), 1252 (m), 1088 (s), 834 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C40H68NO9Si2
+
: 762.4427 [M+NH4]
+
    
  found:    762.4437 [M+NH4]
+
. 
Major diol 105: 
In order to characterize the diols 105 and 106, an analytical sample of the crude mixture, 
obtained after asymmetric dihydroxylation, was purified by HPLC [Dynamax Microsorb 60-8 
C18 (250 x 21.4 mm), gradient, water (A)/MeOH (B); 0 min 80% B, 2 min 80% B, 40 min 90% 
B, 100 min 90% B; flow rate 19 mL/min; detection 205 nm: tR(105) = 73.3 min, 
tR(106) = 77.2 min] to yield both isomers as colorless oils. 
Rf = 0.41 [PE:EtOAc 3:1]. 
    
   = 15.3 (c = 0.35, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.35 – 7.25 (m, 8H, 2 x H-
15, 2 x H-16, H-17, 2 x H-20, H-21), 7.35 – 7.25 (m, 2H, 
2 x H-19), 4.88 (d, J = 11.4 Hz, 1H, H-12a or H-12b), 4.79 (d, 
J = 10.9 Hz, 1H, H-13a or H-13b), 4.77 (d, J = 11.2 Hz, 1H, 
H-12a or H-12b), 4.54 (d, J = 11.1 Hz, 1H, H-13a or H-13b), 4.28 (br s, 1H, H-2), 4.13 – 4.06 
(m, 2H, H-3, H-5), 3.82 (dd, J = 9.2, 5.9 Hz, 1H, H-6), 3.80 (s, 3H, 3 x H-11), 3.78 (dd, 
J = 10.5, 1.4 Hz, 1H, H-10a or H-10b), 3.68 – 3.58 (m, 3H, H-7, H-9, H-10a or H-10b), 3.38 (br 
s, 1H, H-30 or H-31), 3.33 (dd, J = 9.0, 9.0 Hz, 1H, H-8), 2.38 (br s, 1H, H-30 or H-31), 2.08 –
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 1.98 (m, 2H, H-4a, H4b), 0.91 (s, 9H, 9 x H-25), 0.88 (s, 9H, 9 x H-29), 0.09 (s, 3H, 3 x H-22 
or 3 x H-23), 0.07 (s, 3H, 3 x H-22 or 3 x H-23), 0.05 (s, 3H, 3 x H-26 or 3 x H-27), 0.04 (s, 3H, 
3 x H-26 or 3 x H-27) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 173.85 (C-1), 138.82 (C-14), 138.29 (C-18), 128.57 (2 x C-
16 or 2 x C-20), 128.43 (2 x C-16 or 2 x C-20), 128.12 (2 x C-19), 127.92 (C-17 or C-21), 
127.64 (2 x C-15), 127.57 (C-17 or C-21), 83.02 (C-7), 78.43 (C-8), 75.50 (C-12), 75.05 (C-13), 
73.54 (C-5), 73.48 (C-2), 73.20 (C-6), 73.06 (C-9), 70.62 (C-3), 63.55 (C-10), 52.73 (C-11), 
28.10 (C-4), 26.10 (3 x C-29), 26.02 (3 x C-25), 18.57 (C-28), 18.13 (C-24), 4.43 (C-22 or C-
23), 4.49 (C-22 or C-23), 5.12 (C-26 or C-27), 5.30 (C-26 or C-27) ppm. 
IR (ATR): ṽ = 3475 (m), 2928 (s), 1741 (m), 1462 (w), 1252 (m), 1084 (s), 834 (s), 776 (m), 
697 (w) cm
‒1
. 
HRMS (ESI): calcd. for C37H60NaO9Si2
+
: 727.3668 [M+Na]
+
 
  found:    727.3674 [M+Na]
+
. 
Minor diol 106: 
Rf = 0.41 [PE:EtOAc 3:1]. 
    
   = 27.9 (c = 0.19, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.35 – 7.25 (m, 8H, 2 x H-
15, 2 x H-16, H-17, 2 x H-20, H-21), 7.22 – 7.19 (m, 2H, 
2 x H-19), 4.86 (d, J = 11.3 Hz, 1H, H-12a or H-12b), 4.78 (d, J = 11.1 Hz, 1H, H-13a or H-
13b), 4.77 (d, J = 11.3 Hz, 1H, H-12a or H-12b), 4.52 (d, J = 11.1 Hz, 1H, H-13a or H-13b), 
4.19 – 4.16 (m, 1H, H-3), 4.13 (ddd, J = 12.3, 6.1, 2.5 Hz, 1H, H-5), 4.10 – 4.08 (m, 1H, H-2), 
3.83 – 3.80 (m, 1H, H-6), 3.80 (s, 3H, 3 x H-11), 3.78 – 3.74 (m, 2H, H-9, H-10a or H-10b), 
3.63 (dd, J = 9.0, 9.0 Hz, 1H, H-7), 3.55 – 3.51 (m, 2H, H-10a or H-10b, H-31), 3.33 (dd, 
J = 9.0, 9.0 Hz, 1H, H-8), 3.09 (br d, J = 6.9 Hz, 1H, H-30), 2.22 (ddd, J = 15.2, 12.2, 9.2 Hz, 
1H, H-4a or H-4b), 1.91 (ddd, J = 15.2, 2.8, 2.8 Hz, 1H, H-4a or H-4b), 0.90 (s, 9H, 9 x H-25), 
0.86 (s, 9H, 9 x H-29), 0.08 (s, 3H, 3 x H-22 or 3 x H-23), 0.07 (s, 3H, 3 x H-22 or 3 x H-23), 
0.01 (s, 3H, 3 x H-26 or 3 x H-27), 0.01 (s, 3H, 3 x H-26 or 3 x H-27) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 173.42 (C-1), 138.78 (C-14), 138.24 (C-18), 128.57 (2 x C-
16 or 2 x C-20), 128.44 (2 x C-16 or 2 x C-20), 128.05 (2 x C-19), 127.94 (C-17 or C-21), 
127.65 (2 x C-15), 127.58 (C-17 or C-21), 83.04 (C-7), 78.54 (C-8), 77.02 (C-5), 75.65 (C-12), 
75.05 (C-13), 74.32 (C-2), 73.11 (C-6 and C-9), 73.00 (C-3), 63.35 (C-10), 52.64 (C-11), 27.46 
(C-4), 26.04 (3 x C-25 or 3 x C-29), 26.00 (3 x C-25 or 3 x C-29), 18.50 (C-28), 18.09 (C-24), 
4.43 (C-22 or C-23), 4.52 (C-22 or C-23), 5.21 (C-26 or C-27), 5.37 (C-26 or C-27) ppm. 
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IR (ATR): ṽ = 3474 (m), 2928 (s), 1744 (m), 1462 (w), 1252 (m), 1086 (s), 834 (s), 776 (m), 
696 (w) cm
‒1
. 
HRMS (ESI): calcd. for C37H60NaO9Si2
+
: 727.3668 [M+Na]
+
    
  found:    727.3673 [M+Na]
+
. 
Alcohol 107: 
When diol 105 was transformed into acetonide 103 employing (1R)-()-10-camphorsulfonic 
acid, a side reaction was observed. Primary tert-butyldiphenylsilyl ether in compound 103 was 
cleaved during acetonide formation in acidic media when applied to extended reaction times. 
Alcohol 107 was then isolated as a colorless oil as a side product. 
Rf = 0.17 [PE:EtOAc 3:1]. 
    
   = 40.5 (c = 0.95, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.34 (m, 2H, 2 x H-
18), 7.34 – 7.26 (m, 6H, 2 x H-19, H-20, 2 x H-23, H-24), 
7.25 – 7.22 (m, 2H, 2 x H-22), 4.90 (d, J = 11.4 Hz, 1H, H-
15a or H-15b), 4.83 – 4.79 (m, 2H, H-15a or H-15b, H-16a or H-16b), 4.60 (d, J = 10.8 Hz, 1H, 
H-16a or H-16b), 4.29 – 4.24 (m, 1H, H-3), 4.20 (d, J = 7.8 Hz, 1H, H-2), 4.20 – 4.16 (m, 1H, 
H-5), 3.86 (dd, J = 9.0, 5.9 Hz, 1H, H-6), 3.79 (s, 3H, 3 x H-11), 3.79 – 3.76 (m, 1H, H-10a or 
H-10b), 3.70 (dd, J = 11.8, 4.2 Hz, 1H, H-10a or H-10b), 3.61 (dd, J = 8.8, 8.8 Hz, 1H, H-7), 
3.57 – 3.53 (m, 1H, H-9), 3.53 – 3.48 (m, 1H, H-8), 2.23 – 2.17 (m, 1H, H-4a or H-4b), 2.07 –
 2.00 (m, 1H, H-4a or H-4b), 1.45 (s, 6H, 3 x H-13, 3 x H-14), 0.92 (s, 9H, 9 x H-28), 0.11 (s, 
3H, 3 x H-25 or 3 x H-26), 0.08 (s, 3H, 3 x H-25 or 3 x H-26) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.97 (C-1), 138.84 (C-17), 138.09 (C-21), 128.59 (2 x C-
19 or 2 x C-23), 128.42 (2 x C-19 or 2 x C-23), 128.20 (2 x C-22), 128.01 (C-20 or C-24), 
127.52 (C-20 or C-24), 127.44 (2 x C-18), 111.18 (C-12), 82.82 (C-7), 79.30 (C-2), 78.08 (C-8), 
75.47 (C-3), 75.37 (C-15), 75.25 (C-16), 73.31 (C-5), 72.91 (C-6), 72.39 (C-9), 62.34 (C-10), 
52.64 (C-11), 28.95 (C-4), 27.24 (C-13 or C-14), 26.01 (3 x C-28), 25.99 (C-13 or C-14), 18.13 
(C-27), 4.52 (C-25 or C-26), 4.53 (C-25 or C-26) ppm. 
IR (ATR): ṽ = 3492 (br w), 2930 (s), 1763 (m), 1454 (w), 1208 (br m), 1086 (br s), 836 (s), 778 
(m), 696 (w) cm
‒1
. 
HRMS (ESI): calcd. for C34H50NaO9Si
+
: 653.3116 [M+Na]
+
    
  found:    653.3113 [M+Na]
+
. 
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Ketal 108: 
When trans-ester 83 was transformed into acetonide 103 using OsO4 (vide supra), a side 
reaction was observed. Diols 105 and/or 106 were cleaved when the amount of OsO4 was 
increased to 3.2 mol%. Ketal 108 was isolated as colorless oil as a side product after the acidic 
protection step. 
Rf = 0.37 [PE:EtOAc 9:1]. 
    
   = 35.2 (c = 0.60, CHCl3).  
1
H-NMR (400 MHz, CDCl3): δ = 7.37 – 7.20 (m, 10H, 2 x H-14, 
2 x H-15, H-16, 2 x H-18, 2 x H-19, H-20), 4.89 (d, J = 11.3 Hz, 
1H, 11a or H-11b), 4.80 (d, J = 11.0 Hz, 1H, H-12a or H-12b), 
4.78 (d, J = 11.2 Hz, 1H, H-11a or H-11b), 4.59 (d, J = 11.0 Hz, 1H, H-12a or H-12b), 4.54 (dd, 
J = 8.5, 3.1 Hz, 1H, H-1), 4.07 – 4.00 (m, 1H, H-3), 3.84 – 3.77 (m, 2H, H-4, H-8a or H-8b), 
3.74 – 3.68 (m, 1H, H-8a or H-8b), 3.60 (dd, J = 9.0, 9.0 Hz, 1H, H-5), 3.56 – 3.50 (m, 1H, H-
7), 3.45 – 3.39 (m, 1H, H-6), 3.37 (s, 3H, 3 x H-9 or 3 x H-10), 3.33 (s, 3H, 3 x H-9 or 3 x H-
10), 2.07 – 1.89 (m, 2H, H-2a, H-2b), 0.91 (s, 9H, 9 x H-24), 0.90 (s, 9H, 9 x H-28), 0.09 (s, 
3H, 3 x H-21 or 3 x H-22), 0.07 (s, 3H, 3 x H-21 or 3 x H-22), 0.05 (s, 3H, 3 x H-25 or 3 x H-
26), 0.05 (s, 3H, 3 x H-25 or 3 x H-26) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.96 (C-13), 138.53 (C-17), 128.52 (2 x C-15 or 2 x C-19), 
128.40 (2 x C-15 or 2 x C-19), 127.99 (2 x C-18), 127.80 (C-16 or C-20), 127.66 (2 x C-14), 
127.49 (C-16 or C-20), 102.35 (C-1), 83.37 (C-5), 78.60 (C-6), 75.58 (C-11), 75.09 (C-12), 
73.14 (C-3 or C-4 or C-7), 73.09 (C-3 or C-4 or C-7), 73.08 (C-3 or C-4 or C-7), 63.22 (C-10), 
54.03 (C-9 or C-10), 53.05 (C-9 or C-10), 28.13 (C-2), 26.12 (3 x C-24 or 3 x C-28), 26.05 
(3 x C-24 or 3 x C-28), 18.50 (C-27), 18.08 (C-23), 4.36 (C-21 or C-22), 4.56 (C-21 or C-
22), 4.98 (C-25 or C-26), 5.19 (C-25 or C-26) ppm. 
IR (ATR): ṽ = 2929 (s), 2857 (m), 1730 (br w), 1462 (w), 1360 (w), 1252 (m), 1093 (s), 833 (s), 
776 (s), 696 (m) cm
‒1
. 
HRMS (ESI): calcd. for C36H60NaO7Si2
+
: 683.3770 [M+Na]
+
    
  found:    683.3771 [M+Na]
+
. 
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[(4R,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-
butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-yl] 
methanol (111) and [(4S,5S)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyl-
dimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-
1,3-dioxolan-4-l]methanol (110): 
 
A suspension of lithium aluminum hydride (167 mg, 4.39 mmol, 1.0 eq) in Et2O (8 mL) was 
cooled to 0 °C and a solution of the diastereomeric mixture of ester 103 (188 mg, 0.319 mmol, 
1.0 eq) in Et2O (35 mL) was added via cannula. The resulting mixture was stirred at 0 °C for 
10 min, then quenched carefully with aq. Rochelle salt (50 mL of a saturated solution). The 
mixture was allowed to warm to room temperature and stirred at this temperature for an 
additional 4 h. The resulting solution was then extracted with Et2O (3 x 100 mL) and the 
combined organic fractions were washed with (brine), dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [PE:EtOAc 49:119:19:16:14:12:1] afforded 
major alcohol 111 (3.00 g, 4.18 mmol, 94%) and minor alcohol 110 (210 mg, 0.293 mmol, 6%), 
both as a colorless oils. 
Major alcohol 111: 
Rf = 0.47 [PE:EtOAc 3:1]. 
    
   = 35.4 (c = 0.98, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.34 (m, 2H, 2 x H-
17), 7.33 – 7.25 (m, 6H, 2 x H-18, H-19, 2 x H-22, H-23), 
7.23 – 7.20 (m, 2H, 2 x H-21), 4.89 (d, J = 11.3 Hz, 1H, H-14a or H-14b), 4.80 (d, J = 11.0 Hz, 
1H, H-15a or H-15b), 4.78 (d, J = 11.5, 1H, H-14a or H-14b), 4.57 (d, J = 10.8 Hz, 1H, H-15a 
or H-15b), 4.15 – 4.09 (m, 1H, H-5), 4.01 (ddd, J = 8.5, 8.5, 4.3 Hz, 1H, H-3), 3.85 – 3.81 (m, 
2H, H-2, H-6), 3.79 (dd, J = 11.1, 1.7 Hz, 1H, H-10a or H-10b), 3.75 (br dd, J = 11.7, 3.5 Hz, 
1H, H-1a or H-1b), 3.72 – 3.66 (m, 2H, H-1a or H-1b, H-10a or H-10b), 3.57 (dd, J = 9.0, 
9.0 Hz, 1H, H-7), 3.50 – 3.46 (m, 1H, H-9), 3.44 – 3.39 (m, 1H, H-8), 2.05 – 1.90 (m, 3H, H-4a, 
H-4b, H-32), 1.40 (s, 3H, 3 x H-12 or 3 x H-13), 1.39 (s, 3H, 3 x H-12 or 3 x H-13), 0.91 (s, 9H, 
9 x H-27), 0.89 (s, 9H, 9 x H-31), 0.10 (s, 3H, 3 x H-24 or 3 x H-25), 0.08 (s, 3H, 3 x H-24 or 
3 x H-25), 0.06 (s, 3H, 3 x H-28 or 3 x H-29), 0.05 (s, 3H, 3 x H-28 or 3 x H-29) ppm. 
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13
C-NMR (150 MHz, CDCl3): δ = 138.91 (C-16), 138.36 (C-20), 128.58 (2 x C-18 or 2 x C-22), 
128.43 (2 x C-18 or 2 x C-22), 128.14 (2 x C-21), 127.92 (C-19 or C-23), 127.65 (2 x C-17), 
127.55 (C-19 or C-23), 108.87 (C-11), 83.21 (C-7), 81.71 (C-2), 78.52 (C-8), 75.55 (C-14), 
75.23 (C-15), 74.59 (C-3), 73.49 (C-5), 73.24 (C-9), 73.12 (C-6), 63.30 (C-10), 62.69 (C-1), 
28.23 (C-4), 27.41 (C-12 or C-13), 27.21 (C-12 or C-13), 26.14 (3 x C-31), 26.06 (3 x C-27), 
18.55 (C-30), 18.15 (C-26), 4.43 (C-24 or C-25), 4.48 (C-24 or C-25), 4.99 (C-28 or C-29), 
5.21 (C-28 or C-29) ppm. 
IR (ATR): ṽ = 3476 (br w), 2929 (s), 2857 (s), 1462 (w), 1379 (w), 1252 (m), 1081 (br s), 834 
(s), 776 (m), 733 (w), 696 (w) cm
‒1
. 
HRMS (ESI): calcd. for C39H68NO8Si2
+
: 734.4478 [M+NH4]
+
    
  found:    734.4478 [M+NH4]
+
. 
Minor alcohol 110: 
Rf = 0.55 [PE:EtOAc 3:1]. 
    
   = 20.6 (c = 0.34, CHCl3). 
1
H-NMR (400 MHz, CDCl3): δ = 7.37 – 7.24 (m, 8H, 2 x H-17, 
2 x H-18, H-19, 2 x H-22, H-23), 7.23 – 7.18 (m, 2H, 2 x H-
21), 4.89 (d, J = 11.3 Hz, 1H, H-14a or H-14b), 4.79 (d, J = 11.1 Hz, 1H, H-15a or H-15b), 4.78 
(d, J = 11.4 Hz, 1H, H-14a or H-14b), 4.54 (d, J = 11.1 Hz, 1H, H-15a or H-15b), 4.11 – 4.02 
(m, 2H, H-3, H-5), 3.98 – 3.92 (m, 1H, H-2), 3.85 – 3.54 (m, 7H, H-1a, H-1b, H-6, H-7, H-9, H-
10a, H-10b), 3.30 (dd, J = 9.2, 9.2 Hz, 1H, H-8), 2.72 – 2.64 (m, 1H, H-32), 2.25 (ddd, J = 16.1, 
11.9, 4.2 Hz, 1H, H-4a or H-4b), 1.99 (ddd, J = 15.0, 7.3, 2.9 Hz, 1H, H-4a or H-4b), 1.39 (s, 
3H, 3 x H-13), 1.38 (s, 3H, 3 x H-12), 0.91 (s, 9H, 9 x H-27), 0.88 (s, 9H, 9 x H-31), 0.09 (s, 
3H, 3 x H-24 or 3 x H-25), 0.08 (s, 3H, 3 x H-24 or 3 x H-25), 0.05 (s, 3H, 3 x H-28 or 3 x H-
29), 0.05 (s, 3H, 3 x H-28 or 3 x H-29) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.83 (C-16), 138.31 (C-20), 128.56 (2 x C-18 or 2 x C-22), 
128.43 (2 x C-18 or 2 x C-22), 128.09 (2 x C-21), 127.91 (C-19 or C-23), 127.66 (2 x C-17), 
127.56 (C-19 or C-23), 108.21 (C-11), 83.20 (C-7), 80.13 (C-2), 78.65 (C-8), 75.78 (C-3), 75.63 
(C-14), 75.13 (C-15), 73.17 (C-6), 73.10 (C-9), 72.86 (C-5), 63.82 (C-9), 63.24 (C-1), 27.24 (C-
13), 27.18 (C-4), 27.13 (C-12), 26.21 (3 x C-31), 26.04 (3 x C-27), 18.73 (C-30), 18.11 (C-26), 
4.35 (C-24 or C-25), 4.51 (C-24 or C-25), 5.11 (C-28 or C-29), 5.25 (C-28 or C-29) ppm. 
IR (ATR): ṽ = 3479 (br w), 2929 (s), 2857 (s), 1462 (w), 1379 (w), 1252 (m), 1089 (br s), 834 
(s), 776 (m), 753 (w), 696 (w) cm
‒1
.  
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HRMS (ESI): calcd. for C39H68NO8Si2
+
: 734.4478 [M+NH4]
+    
  
found:    734.4480 [M+NH4]
+
. 
 
(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-
butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-N-methoxy-N,2,2-trimethyl-1,3-
dioxolane-4-carboxamide (114): 
 
To a solution of alcohol 111 (2.06 g, 2.87 mmol, 1.0 eq), tetra-n-propylammonium perruthenate 
(202 mg, 0.574 mmol, 20 mol%), and N-methylmorpholine-N-oxide (1.35 g, 11.5 mmol, 4.0 eq) 
in MeCN (100 mL) was added water (1 mL), and the resulting solution was stirred at room 
temperature for 30 min. The solvent was evaporated in vacuo and azeotropic removal of water 
residues with toluene (1 x 20 mL) provided the crude product, which was subjected to flash 
column chromatography [PE:EtOAc 9:13:13:1 + 1% AcOH]. The obtained carboxylic acid 
was subsequently dissolved in CH2Cl2 (300 mL) and 1,1'-carbonyldiimidazole (1.16 g, 
7.18 mmol, 2.5 eq) was added successively in ten equal portions and the mixture was stirred at 
room temperature for 10 min after each addition. Complete consumption of carboxylic acid was 
monitored by TLC analysis ('mini-workup' with MeOH), thereafter N,O-dimethylhydroxyl-
amine hydrochloride (700 mg, 7.18 mmol, 2.5 eq) was added in one portion and the mixture 
was stirred for an additional 4 h. The reaction was quenched with water (100 mL) and the 
organic phase was separated. The aqueous layer was extracted further with EtOAc 
(3 x 250 mL). The combined organic fractions were washed with brine (250 mL), then dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 9:14:1] 
afforded Weinreb amide 114 (1.61 g, 2.08 mmol, 72% over two steps) as a colorless oil. 
Weinreb amide 114: 
Rf = 0.47 [PE:EtOAc 3:1]. 
    
   = 27.2 (c = 0.92, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.22 (m, 10H, 
2 x H-19, 2 x H-20, H-21, 2 x H-23, 2 x H-24, H-25), 4.88 
(d, J = 11.3 Hz, 1H, H-16a or H-16b), 4.80 (d, J = 10.8 Hz, 1H, H-17a or H-17b), 4.78 (d, 
J = 11.3 Hz, 1H, H-16a or H-16b), 4.63 (d, J = 10.8 Hz, 1H, H-17a or H-17b), 4.54 – 4.40 (m, 
2H, H-2, H-3), 4.15 (ddd, J = 11.7, 6.0, 2.3 Hz, 1H, H-5), 3.85 – 3.78 (m, 3H, H-6, H10a, H-
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10b), 3.74 (s, 3H, 3 x H-12), 3.59 – 3.53 (m, 2H, H-7, H-8), 3.49 – 3.42 (m, 1H, H-9), 3.22 (br 
s, 3H, 3 x H-11), 2.08 – 2.01 (m, 1H, H-4a or H-4b), 1.99 – 1.93 (m, 1H, H-4a or H-4b), 1.45 (s, 
3H, 3 x H-14 or 3 x H-15), 1.44 (s, 3H, 3 x H-14 or 3 x H-15), 0.92 (s, 9H, 9 x H-29), 0.90 (s, 
9H, 9 x H-33), 0.11 (s, 3H, 3 x H-26 or 3 x H-27), 0.08 (s, 3H, 3 x H-26 or 3 x H-27), 0.06 (s, 
3H, 3 x H-30 or 3 x H-31), 0.05 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.40 (C-1), 139.02 (C-18), 138.65 (C-22), 128.52 (2 x C-
20 or 2 x C-24), 128.40 (2 x C-20 or 2 x C-24), 128.06 (2 x C-23), 127.78 (C-25), 127.65 
(2 x C-19), 127.49 (C-21), 110.62 (C-13), 83.21 (C-7), 78.17 (C-8), 77.58 (C-2), 75.50 (C-16), 
75.11 (C-17), 75.08 (C-3), 73.15 (C-5 or C-6), 73.12 (C-5 or C-6), 72.87 (C-9), 62.69 (C-10), 
61.77 (C-12), 32.48 (C-11), 28.11 (C-4), 27.64 (C-14 or C-15), 26.38 (C-14 or C-15), 26.14 
(3 x C-33), 26.10 (3 x C-29), 18.50 (C-32), 18.18 (C-28), 4.45 (C-26 or C-27), 4.48 (C-26 or 
C-27), 4.85 (C-30 or C-31), 5.26 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 2930 (s), 1669 (m), 1252 (m), 1086 (s), 833 (s), 697 (w) cm‒1. 
HRMS (ESI): calcd. for C41H71N2O9Si2
+
: 791.4693 [M+NH4]
+
    
  found:    791.4694 [M+NH4]
+
. 
 
(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-
butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-N-methoxy-N,2,2-trimethyl-1,3-
dioxolane-4-carboxamide (114): 
 
To a solution of the diastereomeric mixture of ester 103 (13.1 g, 17.5 mmol, 1.0 eq) in a mixture 
of THF and water (3:1, 300 mL) was added lithium hydroxide monohydrate (2.20 g, 52.5 mmol, 
3.0 eq) and the resulting solution was stirred at room temperature for 35 min. The mixture was 
diluted with water (100 mL) and extracted with EtOAc (3 x 300 mL). The combined organic 
fractions were washed with brine (300 mL), then dried (MgSO4) and concentrated in vacuo to 
provide the crude carboxylic acid. Further azeotropic removal (toluene, 2 x 150 mL) of solvent 
residues provided dry acid, which was subsequently dissolved in CH2Cl2 (300 mL). 
1,1'-Carbonyldiimidazole (8.52 g, 52.5 mmol, 3.0 eq) was added in six equal portions, and the 
mixture was stirred at room temperature for 10 min after each addition. Complete consumption 
of carboxylic acid was monitored by TLC analysis ('mini-workup' with MeOH), thereafter 
N,O-dimethylhydroxylamine hydrochloride (5.12 g, 52.5 mmol, 3.0 eq) was added in one 
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portion and the mixture was stirred for an additional 4 h. The reaction was quenched with water 
(200 mL) and the organic phase was separated. The aqueous layer was extracted further with 
Et2O (3 x 300 mL). The combined organic fractions were washed with brine (300 mL), then 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 
9:14:11:1] afforded Weinreb amide 114 (12.5 g, 16.1 mmol, 92% over two steps) as a 
colorless oil. The 
1
H-NMR spectrum indicated traces of the second diastereomer resulting from 
the Sharpless dihydroxylation. 
 
1-[(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-one (115) and 1-[(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-
butyldimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-
dimethyl-1,3-dioxolan-4-yl]-3-[methoxy(methyl)amino]propan-1-one (116) 
 
A solution of Weinreb amide 114 (6.70 g, 8.65 mmol, 1.0 eq) in THF (300 mL) was cooled to 
‒10 °C and a solution of vinylmagnesium bromide in THF (1.0 M, 7.80 mL, 7.75 mmol, 1.2 eq) 
was added dropwise. After stirring for 30 min at ‒10 °C, the mixture was allowed to warm to 
room temperature and stirred for an additional 10 min. The reaction was quenched with water 
(300 mL) and the aqueous layer was extracted with Et2O (3 x 400 mL). The combined organic 
fractions were washed with brine (400 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [PE:EtOAc 19:19:14:1] afforded vinyl ketone 115 (3.72 g, 
5.02 mmol, 78%) and ketone 116 (1.14 g, 1.42 mmol, 22%), both as colorless oils. 
Vinyl ketone 115: 
Rf = 0.39 [PE:EtOAc 9:1]. 
    
   = 26.9 (c = 1.2, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.23 (m, 10H, 2 x H-
19, 2 x H-20, H-21, 2 x H-23, 2 x H-24, H-25), 6.88 (dd, 
J = 17.4, 10.6 Hz, 1H, H-2), 6.45 (dd, J = 17.4, 1.7 Hz, 1H, H-1a), 5.82 (dd, J = 10.6, 1.8 Hz, 
1H, H-1b), 4.90 (d, J = 11.2 Hz, 1H, H-16a or H-16b), 4.82 (d, J = 11.1 Hz, 1H, H-17a or H-
17b), 4.79 (d, J = 11.3 Hz, 1H, H-16a or H-16b), 4.59 (d, J = 11.0 Hz, 1H, H-17a or H-17b), 
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4.22 – 4.17 (m, 3H, H-4, H-5, H-7), 3.84 (dd, J = 9.4, 6.1 Hz, 1H, H-8), 3.77 (dd, J = 11.2, 
1.8 Hz, 1H, H-12a or H-12b), 3.70 (dd, J = 11.1, 5.0 Hz, 1H, H-12a or H-12b), 3.61 (dd, J = 9.1, 
9.1 Hz, 1H, H-9), 3.48 (ddd, J = 9.8, 5.0, 1.8 Hz, 1H, H-11), 3.42 (dd, J = 9.8, 8.9 Hz, 1H, H-
10), 2.18 – 2.12 (m, 1H, H-6a or H-6b), 2.02 – 1.95 (m, 1H, H-6a or H-6b), 1.45 (s, 3H, 3 x H-
14 or 3 x H-15), 1.42 (s, 3H, 3 x H-14 or 3 x H-15), 0.93 (s, 9H, 9 x H-29), 0.87 (s, 9H, 9 x H-
33), 0.12 (s, 3H, 3 x H-26 or 3 x H-27), 0.09 (s, 3H, 3 x H-26 or 3 x H-27), 0.03 (s, 3H, 3 x H-
30 or 3 x H-31), 0.02 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 198.10 (C-3), 138.98 (C-18), 138.54 (C-22), 131.16 (C-2), 
130.64 (C-1), 128.49 (2 x C-20 or 2 x C-24), 128.39 (2 x C-20 or 2 x C-24), 127.97 (2 x C-23), 
127.76 (C-25), 127.65 (2 x C-19), 127.48 (C-21), 110.61 (C-13), 84.70 (C-4), 83.28 (C-9), 
78.60 (C-10), 75.62 (C-16), 75.11 (C-17), 74.51 (C-5), 73.14 (C-7 or C-8 or C-11), 73.08 (C-7 
or C-8 or C-11), 73.04 (C-7 or C-8 or C-11), 63.16 (C-12), 28.56 (C-6), 27.34 (C-14 or C-15), 
26.38 (C-14 or C-15), 26.13 (3 x C-33), 26.06 (3 x C-29), 18.47 (C-32), 18.15 (C-28), 4.48 (C-
26 or C-27), 4.50 (C-26 or C-27), 4.97 (C-30 or C-31), 5.27 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 2929 (s), 1698 (w), 1252 (m), 1086 (s), 834 (s), 696 (w) cm‒1. 
HRMS (ESI): calcd. for C41H68NO8Si2
+
: 758.4478 [M+NH4]
+
    
  found:    758.4480 [M+NH4]
+
. 
Keton 116: 
Rf = 0.59 [PE:EtOAc 3:1]. 
    
   = 23.9 (c = 1.1, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.35 – 7.22 (m, 10H, 
2 x H-21, 2 x H-22, H-23, 2 x H-25, 2 x H-26, H-27), 4.88 
(d, J = 11.2 Hz, 1H, H-18a or H-18b), 4.81 (d, J = 11.0 Hz, 1H, H-19a or H-19b), 4.78 (d, 
J = 11.2 Hz, 1H, H-18a or H-18b), 4.60 (d, J = 11.0 Hz, 1H, H-19a or H-19b), 4.17 (ddd, 
J = 12.2, 6.1, 2.0 Hz, 1H, H-7), 4.12 (ddd, J = 10.5, 8.2, 2.2 Hz, 1H, H-5), 4.04 (d, J = 8.2 Hz, 
1H, H-4), 3.83 (dd, J = 9.4, 6.1 Hz, 1H, H-8), 3.76 (dd, J = 11.2, 1.7 Hz, 1H, H-12a or H-12b), 
3.73 (dd, J = 11.2, 4.1 Hz, 1H, H-12a or H-12b), 3.59 (dd, J = 8.8, 8.8 Hz, 1H, H-9), 3.51 (br s, 
3H, 3 x H-14), 3.50 – 3.42 (m, 2H, H-10, H-11), 3.03 – 2.84 (m, 4H, 2 x H-1, 2 x H-2), 2.60 (s, 
3H, 3 x H-13), 2.16 (ddd, J = 14.5, 12.3, 2.2 Hz, 1H, H-6a or H-6b), 1.93 (ddd, J = 14.8, 10.5, 
2.1 Hz, 1H, H-6a or H-6b), 1.42 (s, 3H, 3 x H-16 or 3 x H-17), 1.42 (s, 3H, 3 x H-16 or 3 x H-
17), 0.91 (s, 9H, 9 x H-31), 0.88 (s, 9H, 9 x H-35), 0.10 (s, 3H, 3 x H-28 or 3 x H-29), 0.08 (s, 
3H, 3 x H-28 or 3 x H-29), 0.04 (s, 3H, 3 x H-32 or 3 x H-33), 0.03 (s, 3H, 3 x H-32 or 3 x H-
33) ppm. 
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13
C-NMR (150 MHz, CDCl3): δ = 208.92 (C-3), 139.01 (C-20), 138.64 (C-24), 128.47 (2 x C-
22 or 2 x C-26), 128.39 (2 x C-22 or 2 x C-26), 127.90 (2 x C-25), 127.70 (C-27), 127.68 
(2 x C-21), 127.47 (C-23), 110.40 (C-15), 85.31 (C-4), 83.30 (C-9), 78.49 (C-10), 75.63 (C-18), 
75.05 (C-19), 74.17 (C-5), 73.14 (C-8), 73.08 (C-7), 72.91 (C-11), 63.06 (C-12), 60.10 (C-14), 
54.51 (C-1), 45.10 (C-13), 36.75 (C-2), 28.81 (C-6), 27.31 (C-16 or C-17), 26.50 (C-16 or C-
17), 26.12 (3 x C-31), 26.06 (3 x C-35), 18.47 (C-34), 18.15 (C-30), 4.48 (C-28 or C-29), 
4.50 (C-28 or C-29), 4.94 (C-32 or C-33), 5.26 (C-32 or C33) ppm. 
IR (ATR): ṽ = 2930 (s), 1715 (w), 1252 (m), 1086 (s), 834 (s), 696 (w) cm‒1. 
HRMS (ESI): calcd. for C43H72NO9Si2
+
: 802.4740 [M+H]
+
    
  found:    802.4743 [M+H]
+
. 
 
1-[(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-one (115): 
 
To a solution of ketone 116 (200 mg, 0.249 mmol, 1.0 eq) in THF (15 mL) was added N,N-
diisopropylethylamine (84.7 µL, 0.498 mmol, 2.0 eq) followed methyl iodide (0.23 mL, 
3.74 mmol, 15 eq), and the resulting mixture was heated to 50 °C for 7 d. The reaction was 
quenched with aq. NaHCO3 (20 mL of a saturated solution) and the mixture was extracted with 
Et2O (3 x 25 mL) and the combined organic fraction were washed with brine (40 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 19:19:1] 
afforded vinyl ketone 115 (103 mg, 0.139 mmol, 56%) and starting material 116 (48.1 mg, 
60.0 µmol, 24%), both as colorless oils. 
Vinyl ketone 115: 
Analytical data were identical with the material obtained 
earlier (vide supra). 
Rf = 0.39 [PE:EtOAc 9:1]. 
    
   = 26.9 (c = 1.2, CHCl3). 
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1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.23 (m, 10H, 2 x H-19, 2 x H-20, H-21, 2 x H-23, 
2 x H-24, H-25), 6.88 (dd, J = 17.4, 10.6 Hz, 1H, H-2), 6.45 (dd, J = 17.4, 1.7 Hz, 1H, H-1a), 
5.82 (dd, J = 10.6, 1.8 Hz, 1H, H-1b), 4.90 (d, J = 11.2 Hz, 1H, H-16a or H-16b), 4.82 (d, 
J = 11.1 Hz, 1H, H-17a or H-17b), 4.79 (d, J = 11.3 Hz, 1H, H-16a or H-16b), 4.59 (d, 
J = 11.0 Hz, 1H, H-17a or H-17b), 4.22 – 4.17 (m, 3H, H-4, H-5, H-7), 3.84 (dd, J = 9.4, 
6.1 Hz, 1H, H-8), 3.77 (dd, J = 11.2, 1.8 Hz, 1H, H-12a or H-12b), 3.70 (dd, J = 11.1, 5.0 Hz, 
1H, H-12a or H-12b), 3.61 (dd, J = 9.1, 9.1 Hz, 1H, H-9), 3.48 (ddd, J = 9.8, 5.0, 1.8 Hz, 1H, H-
11), 3.42 (dd, J = 9.8, 8.9 Hz, 1H, H-10), 2.18 – 2.12 (m, 1H, H-6a or H-6b), 2.02 – 1.95 (m, 
1H, H-6a or H-6b), 1.45 (s, 3H, 3 x H-14 or 3 x H-15), 1.42 (s, 3H, 3 x H-14 or 3 x H-15), 0.93 
(s, 9H, 9 x H-29), 0.87 (s, 9H, 9 x H-33), 0.12 (s, 3H, 3 x H-26 or 3 x H-27), 0.09 (s, 3H, 3 x H-
26 or 3 x H-27), 0.03 (s, 3H, 3 x H-30 or 3 x H-31), 0.02 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 198.10 (C-3), 138.98 (C-18), 138.54 (C-22), 131.16 (C-2), 
130.64 (C-1), 128.49 (2 x C-20 or 2 x C-24), 128.39 (2 x C-20 or 2 x C-24), 127.97 (2 x C-23), 
127.76 (C-25), 127.65 (2 x C-19), 127.48 (C-21), 110.61 (C-13), 84.70 (C-4), 83.28 (C-9), 
78.60 (C-10), 75.62 (C-16), 75.11 (C-17), 74.51 (C-5), 73.14 (C-7 or C-8 or C-11), 73.08 (C-7 
or C-8 or C-11), 73.04 (C-7 or C-8 or C-11), 63.16 (C-12), 28.56 (C-6), 27.34 (C-14 or C-15), 
26.38 (C-14 or C-15), 26.13 (3 x C-33), 26.06 (3 x C-29), 18.47 (C-32), 18.15 (C-28), 4.48 (C-
26 or C-27), 4.50 (C-26 or C-27), 4.97 (C-30 or C-31), 5.27 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 2929 (s), 1698 (w), 1252 (m), 1086 (s), 834 (s), 696 (w) cm‒1. 
HRMS (ESI): calcd. for C41H68NO8Si2
+
: 758.4478 [M+NH4]
+    
  found:    758.4480 [M+NH4]
+
. 
 
(1R)-1-[(4R,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-ol (112) and (1S)-1-[(4R,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-
[(tert-butyldimethylsilyl)oxy]-6-{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-
2,2-dimethyl-1,3-dioxolan-4-yl]prop-2-en-1-ol (113): 
 
Toluene was removed from a solution of (R)-(‒)-2-methyl-CBS-oxazaborolidine [(R)-117] in 
toluene (1.0 M, 4.24 mL, 4.24 mmol, 2.0 eq) and the residue was dried in vacuo. The CBS 
reagent was re-dissolved in THF (50 mL), and the resulting solution was added via cannula to a 
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stirred solution of vinyl ketone 115 (1.57 g, 2.12 mmol, 1.0 eq) in THF (110 mL), which had 
been pre-cooled to ‒30 °C. A solution of borane dimethyl sulfide complex in THF (2.0 M, 
1.17 mL, 2.33 mmol, 1.1 eq) was then added dropwise, and the mixture was stirred at ‒30 °C 
for 1.5 h. The reaction was quenched at ‒30 °C with MeOH (10 mL) and allowed to warm to 
room temperature. A mixture (2:1, 120 mL) of aq. NaOH (10 wt%) and aq. NaHCO3 (saturated 
solution) was added, and the resulting solution was extracted with Et2O (3 x 200 mL). The 
combined organic fractions were washed with brine (200 mL), dried (MgSO4) and concentrated 
in vacuo to afford crude alcohols 112 and 113 as a mixture of two diastereomers (d.r. 4.4:1, as 
determined by 
1
H-NMR spectroscopy). Flash column chromatography [PE:EtOAc 
19:19:14:1] afforded allylic alcohol 112 (1.19 g, 1.60 mmol, 75%) and the minor 
diastereomer 113 (267 mg, 0.359 mmol, 17%), both as colorless oils. 
Allylic alcohol 112: 
Rf = 0.73 [PE:EtOAc 3:1]. 
    
   = 32.2 (c = 1.1, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.21 (m, 10H, 2 x H-
19, 2 x H-20, H-21, 2 x H-23, 2 x H-24, H-25), 5.93 (ddd, 
J = 17.3, 10.6, 5.3 Hz, 1H, H-2), 5.39 (ddd, J = 17.3, 1.6, 1.6 Hz, 1H, H-1a), 5.25 (ddd, 
J = 10.6, 1.5, 1.5 Hz, 1H, H-1b), 4.89 (d, J = 11.3 Hz, 1H, H-16a or H-16b), 4.79 (d, 
J = 10.7 Hz, 1H, H-17a or H-17b), 4.78 (d, J = 11.0 Hz, 1H, H-16a or H-16b), 4.60 (d, 
J = 10.9 Hz, 1H, H-17a or H-17b), 4.28 – 4.25 (m, 1H, H-3), 4.18 – 4.13 (m, 2H, H-5, H-7), 
3.83 (dd, J = 9.3, 6.1 Hz, 1H, H-8), 3.80 – 3.75 (m, 1H, H-12a or H-12b), 3.75 – 3.69 (m, 2H, 
H-4, H-12a or H-12b), 3.55 (dd, J = 8.9, 8.9 Hz, 1H, H-9), 3.47 – 3.41 (m, 2H, H-10, H-11), 
2.33 (br s, 1H, H-34), 1.99 (ddd, J = 14.7, 12.1, 2.6 Hz, 1H, H-6a or H-6b), 1.89 (ddd, J = 14.8, 
10.0, 2.2 Hz, 1H, H-6a or H-6b), 1.40 (s, 3H, 3 x H-15), 1.38 (s, 3H, 3 x H-14), 0.91 (s, 9H, 
9 x H-29), 0.90 (s, 9H, 9 x H-33), 0.10 (s, 3H, 3 x H-26 or 3 x H-27), 0.07 (s, 3H, 3 x H-26 or 
3 x H-27), 0.07 (s, 3H, 3 x H-30 or 3 x H-31), 0.06 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 139.03 (C-18), 138.53 (C-22), 136.59 (C-2), 128.53 (2 x C-
20 or 2 x C-24), 128.40 (2 x C-20 or 2 x C-24), 128.09 (2 x C-23), 127.84 (C-25), 127.61 
(2 x C-19), 127.49 (C-21), 116.51 (C-1), 109.05 (C-13), 83.43 (C-9), 83.23 (C-4), 78.58 (C-10), 
75.58 (C-16), 74.15 (C-17), 74.09 (C-7), 73.62 (C-5), 73.21 (C-8), 72.02 (C-11), 72.61 (C-3), 
63.20 (C-12), 29.33 (C-6), 27.46 (C-14), 27.19 (C-15), 26.17 (3 x C-29 or 3 x C-33), 26.08 
(3 x C-29 or 3 x C-33), 18.58 (C-32), 18.16 (C-28), 4.42 (C-26 or C-27), 4.50 (C-26 or C-
27), 4.95 (C-30 or C-31), 5.20 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 3460 (br, w), 2929 (s), 1462 (w), 1252 (m), 1077 (s), 834 (s), 696 (w) cm‒1. 
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HRMS (ESI): calcd. for C41H70NO8Si2
+
: 760.4634 [M+NH4]
+
    
  found:    760.4636 [M+NH4]
+
. 
Alcohol 113: 
Rf = 0.67 [PE:EtOAc 3:1]. 
    
   = 57.5 (c = 0.41, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.21 (m, 10H, 2 x H-
19, 2 x H-20, H-21, 2 x H-23, 2 x H-24, H-25), 5.85 (ddd, 
J = 17.1, 10.5, 6.2 Hz, 1H, H-2), 5.40 (ddd, J = 17.2, 1.7, 1.7 Hz, 1H, H-1a), 5.27 (ddd, 
J = 10.5, 1.3, 1.3 Hz, 1H, H-1b), 4.89 (d, J = 11.3 Hz, 1H, H-16a or H-16b), 4.79 (d, 
J = 10.7 Hz, 1H, H-17a or H-17b), 4.78 (d, J = 11.1 Hz, 1H, H-16a or H-16b), 4.59 (d, 
J = 10.8 Hz, 1H, H-17a or H-17b), 4.17 – 4.13 (m, 1H, H-7), 4.13 – 4.09 (m, 1H, H-3), 4.09 –
 4.04 (m, 1H, H-5), 3.82 (dd, J = 9.3, 6.1 Hz, 1H, H-8), 3.77 (dd, J = 11.1, 1.8 Hz, 1H, H-12a or 
H-12b), 3.73 (dd, J = 11.1, 4.6 Hz, 1H, H-12a or H-12b), 3.68 (dd, J = 7.8, 5.4 Hz, 1H, H-4), 
3.54 (dd, J = 9.0, 9.0 Hz, 1H, H-9), 3.45 (dd, J = 9.3, 9.3 Hz, 1H, H-10), 3.39 (ddd, J = 9.8, 4.6, 
1.8 Hz, 1H, H-11), 2.35 (br d, J = 4.8 Hz, 1H, H-34), 1.93 – 1.87 (m, 2H, H-6a, H-6b), 1.41 (s, 
3H, 3 x H-15), 1.39 (s, 3H, 3 x H-14), 0.91 (s, 9H, 9 x H-29), 0.90 (s, 9H, 9 x H-33), 0.10 (s, 
3H, 3 x H-26 or 3 x H-27), 0.07 (s, 3H, 3 x H-26 or 3 x H-27), 0.06 (s, 3H, 3 x H-30 or 3 x H-
31), 0.05 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.99 (C-18), 138.46 (C-22), 136.83 (C-2), 128.56 (2 x C-
20 or 2 x C-24), 128.42 (2 x C-20 or 2 x C-24), 128.11 (2 x C-23), 127.88 (C-25), 127.60 
(2 x C-19), 127.51 (C-21), 117.68 (C-1), 109.29 (C-13), 83.89 (C-4), 83.33 (C-9), 78.49 (C-10), 
75.57 (C-16), 75.21 (C-17), 73.99 (C-5), 73.50 (C-3), 73.40 (C-7), 73.18 (C-11), 73.13 (C-8), 
63.10 (C-12), 28.57 (C-6), 27.59 (C-14), 27.30 (C-15), 26.15 (3 x C-29 or 3 x C-33), 26.07 
(3 x C-29 or 3 x C-33), 18.54 (C-32), 18.16 (C-28), 4.44 (C-26 or C-27), 4.49 (C-26 or C-
27), 4.95 (C-30 or C-31), 5.19 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 3458 (br, w), 2929 (s), 1462 (w), 1252 (m), 1083 (s), 834 (s), 696 (w) cm‒1. 
HRMS (ESI): calcd. for C41H70NO8Si2
+
: 760.4634 [M+NH4]
+
    
  found:    760.4635 [M+NH4]
+
. 
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(1R)-1-[(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-yl benzoate (264) 
 
A solution of allylic alcohol 112 (120 mg, 0.161 mmol, 1.0 eq), 4-(dimethylamino)pyridine 
(2.00 mg, 16.1 µmol, 10 mol%) and triethylamine (134 µL, 0.966 mmol, 6.0 eq) in CH2Cl2 
(3 mL) was cooled to 0 °C and benzoyl chloride (37.4 µL, 0.322 mmol, 2.0 eq) was added 
dropwise. The solution was stirred at 0 °C for 10 min, then at room temperature for a further 
20 h. The reaction was quenched with aq. NaHCO3 (5 mL of a saturated solution) and the 
mixture extracted with EtOAc (3 x 20 mL). The combined organic fractions were washed with 
brine (20 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 49:129:19:1] afforded benzoate ester 264 (132 mg, 0.156 mmol, 97%) as a 
colorless oil. 
Benzoate ester 264: 
Rf = 0.47 [PE:EtOAc 9:1]. 
    
   = 42.9 (c = 0.63, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.08 – 8.05 (m, 2H, 2 x H-
28), 7.44 – 7.40 (m, 1H, H-30), 7.37 – 7.24 (m, 10H, 2 x H-
20, 2 x H-21, H-22, 2 x H-25, H-26, 2 x H-29), 7.19 – 7.16 
(m, 2H, 2 x H-24), 6.00 (ddd, J = 17.2, 10.6, 6.0 Hz, 1H, H-2), 5.64 – 5.60 (m, 1H, H-3), 5.40 
(ddd, J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 5.33 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.84 (d, 
J = 11.2 Hz, 1H, H-16a or H-16b), 4.74 (d, J = 10.9 Hz,  1H, H-17a or H-17b), 4.73 (d, 
J = 11.2 Hz, 1H, H-16a or H-16b), 4.54 (d, J = 10.9 Hz, 1H, H-17a or H-17b), 4.21 – 4.13 (m, 
2H, H-5, H-7), 3.96 (dd, J = 7.7, 5.5 Hz, 1H, H-4), 3.81 – 3.77 (m, 1H, H-8), 3.59 – 3.54 (m, 
2H, H-12a, H-12b), 3.46 – 3.40 (m, 2H, H-9, H-10), 3.17 – 3.13 (m, 1H, H-11), 2.03 – 1.89 (m, 
2H, H-6a, H-6b), 1.40 (s, 3H, 3 x H-14), 1.36 (s, 3H, 3 x H-15), 0.91 (s, 9H, 9 x H-34), 0.87 (s, 
9H, 9 x H-38), 0.08 (s, 3H, 3 x H-31 or 3 x H-32), 0.06 (s, 3H, 3 x H-31 or 3 x H-32), 0.03 (s, 
3H, 3 x H-35 or 3 x H-36), 0.01 (s, 3H, 3 x H-35 or 3 x H-36) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 165.37 (C-18), 139.03 (C-19), 138.79 (C-23), 133.40 (C-30), 
133.05 (C-2), 129.86 (C-27), 129.78 (2 x C-28), 128.67 (2 x C-29), 128.40 (2 x C-21 or 2 x C-
25), 128.38 (2 x C-21 or 2 x C-25), 127.98 (2 x C-24), 127.66 (2 x C-20 and C-26), 127.49 (C-
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22), 118.68 (C-1), 109.77 (C-13), 83.36 (C-9), 81.99 (C-4), 78.15 (C-10), 75.58 (C-16), 74.91 
(C-17), 74.86 (C-3), 74.48 (C-5), 73.33 (C-7), 73.08 (C-8), 72.87 (C-11), 62.57 (C-12), 29.06 
(C-6), 27.67 (C-14), 27.13 (C-15), 26.15 (3 x C-38), 26.09 (3 x C-34), 18.53 (C-37), 18.17 (C-
33), 4.46 (C-31 or C-32), 4.51 (C-31 or C-32), 4.93 (C-35 or C-36), 5.28 (C-35 or C-
36) ppm. 
IR (ATR): ṽ = 2930 (m), 1726 (m), 1252 (m), 1085 (s), 834 (s), 697 (m) cm‒1. 
HRMS (ESI): calcd. for C48H74NO9Si2
+
: 864.4897 [M+NH4]
+
    
  found:    864.4896 [M+NH4]
+
. 
 
(1R)-1-[(4S,5R)-5-{[(2R,3S,4R,5R,6R)-4,5-bis(benzyloxy)-3-hydroxy-6-(hydroxymethyl) 
oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-yl]prop-2-en-1-yl benzoate (118) 
 
To a solution of benzoyl-protected alcohol 264 (936 mg, 1.10 mmol, 1.0 eq) in THF (50 mL) 
was added a solution of tetrabutylammonium fluoride in THF (1.0 M, 3.30 mL, 3.30 mmol, 
3.0 eq), and the resulting mixture was stirred at room temperature for 20 h. The reaction was 
quenched with aq. NaHCO3 (70 mL of a saturated solution), and the mixture was extracted with 
EtOAc (3 x 100 mL). The combined organic fractions were washed with brine (100 mL), then 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 3:1] 
afforded diol 118 (569 mg, 0.920 mmol, 84%) as a white sticky foam. 
Diol 118: 
Rf = 0.51 [PE:EtOAc 1:1]. 
    
   = 34.5 (c = 1.0, CHCl3).  
1
H-NMR (600 MHz, CDCl3): δ = 8.09 – 8.06 (m, 2H, 2 x H-
28), 7.54 – 7.51 (m, 1H, H-30), 7.44 – 7.40 (m, 2H, 2 x H-
29), 7.37 – 7.29 (m, 6H, 2 x H-21, H-22, 2 x H-25, H-26), 7.28 – 7.24 (m, 4H,  2 x H-20, 2 x H-
24) 5.98 (ddd, J = 17.1, 10.6, 6.3 Hz, 1H, H-2), 5.69 – 5.65 (m, 1H, H-3), 5.43 (ddd, J = 17.3, 
1.2, 1.2 Hz, 1H, H-1a), 5.35 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.61 – 4.52 (m, 4H, H-16a, 
H-16b, H-17a, H-17b), 4.32 (ddd, J = 10.9, 8.0, 3.3 Hz, 1H, H-5), 4.21 (ddd, J = 11.2, 2.9, 
2.9 Hz, 1H, H-7), 4.17 (dd, J = 12.3, 9.4 Hz, 1H, H-12a or H-12b), 3.96 (dd, J = 8.0, 4.8 Hz, 
1H, H-4), 3.95 – 3.90 (m, 1H, H-11), 3.73 – 3.70 (m, 1H, H-9), 3.59 – 3.55 (m, 1H, H-8), 3.38 
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(dd, J = 12.3, 3.9 Hz, 1H, H-12a or H-12b), 3.35 – 3.31 (m, 1H, H-10), 2.95 (br s, 1H, H-31 or 
H-32), 2.24 (ddd, J = 14.3, 11.2, 3.3 Hz, 1H, H-6a or H-6b), 1.65 (ddd, J = 13.9, 10.5, 3.3 Hz, 
1H, H-6a or H-6b), 1.43 (s, 3H, 3 x H-14), 1.37 (s, 3H, 3 x H-15) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 165.58 (C-18), 137.80 (C-19), 137.32 (C-23), 133.33 (C-30), 
132.46 (C-2), 130.00 (C-27), 129.89 (2 x C-28), 128.75 (2 x C-21 or 2 x C-25), 128.67 (2 x C-
21 or 2 x C-25), 128.60 (2 x C-29), 128.22 (C-22 or C-26), 128.21 (C-22 or C-26), 128.02 
(2 x C-20 or 2 x C-24), 127.82 (2 x C-20 or 2 x C-24), 119.31 (C-1), 109.53 (C-13), 82.60 (C-
4), 76.50 (C-9), 75.56 (C-11), 74.56 (C-5), 74.40 (C-3), 74.09 (C-10), 73.28 (C-16), 72.57 (C-
17), 69.32 (C-8), 66.15 (C-7), 59.47 (C-12), 33.21 (C-6), 27.59 (C-14), 26.92 (C-15) ppm. 
IR (ATR): ṽ = 3473 (s), 2880 (m), 1721 (m), 1267 (m), 1070 (s), 856 (w), 751 (m) cm‒1. 
HRMS (ESI): calcd. for C36H46NO9
+
: 636.3167 [M+NH4]
+
     
  found:   636.3169 [M+NH4]
+
. 
 
Methyl (2S,3S,4R,5S,6R)-6-{[(4R,5S)-5-[(1R)-1-(benzoyloxy)prop-2-en-1-yl]-2,2-dimethyl-
1,3-dioxolan-4-yl]methyl}-3,4-bis(benzyloxy)-5-hydroxyoxane-2-carboxylate (265): 
 
To a solution of diol 118 (110 mg, 0.178 mmol, 1.0 eq) in a mixture of CH2Cl2 and water (2:1, 
9 mL) was added 2,2,6,6-tetramethylpiperidine-1-oxyl (27.8 mg, 0.178 mmol, 1.0 eq) and 
(diacetoxyiodo)benzene (287 mg, 0.890 mmol, 5.0 eq), and the resulting biphasic system was 
stirred vigorously at room temperature for 5 h. A second equivalent of 2,2,6,6-
tetramethylpiperidine-1-oxyl (27.8 mg, 0.178 mmol, 1.0 eq) was added and the mixture was 
stirred at room temperature for an additional 2 h. The reaction was quenched with aq. Na2S2O3 
(10 mL of a half-saturated solution) and the mixture was extracted with EtOAc (3 x 20 mL). 
The combined organic fractions were washed with brine (20 mL), then dried (MgSO4) and 
concentrated in vacuo to provide the crude carboxylic acid, which was immediately re-dissolved 
in toluene/MeOH (7:1, 8 mL). To this mixture, a solution of (trimethylsilyl)diazomethane in 
hexanes (2.0 M, 107 µL, 0.214 mmol, 1.2 eq) was carefully added dropwise, and the resulting 
mixture was stirred at room temperature for 1 h. The reaction was quenched with acetic acid 
(100 µL) and diluted with water (15 mL). The mixture was extracted with EtOAc (3 x 20 mL), 
and the combined organic fractions were washed with brine (20 mL), dried (MgSO4) and 
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concentrated in vacuo. Flash column chromatography [PE:EtOAc 19:19:14:1] afforded 
ester 265 (78.4 mg, 0.121 mmol, 68% over two steps) as a colorless oil. 
Ester 265: 
Rf = 0.50 [PE:EtOAc 3:1]. 
    
   = 39.1 (c = 0.89, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.09 – 8.07 (m, 2H, 2 x H-29), 
7.49 – 7.54 (m, 1H, H-31), 7.40 – 7.27 (m, 10H, 2 x H-22, H-
23, 2 x H-25, 2 x H-26, H-27, 2 x H-30), 7.22 – 7.19 (m, 2H, 
2 x H-21), 5.74 (ddd, J = 17.2, 10.6, 6.6 Hz, 1H, H-2), 5.76 – 5.72 (m, 1H, H-3), 5.46 (ddd, 
J = 17.3, 1.3,  1.3 Hz, 1H, H-1a), 5.35 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.62 (d, 
J = 11.7 Hz, 1H, H-18a or H-18b), 4.53 (d, J = 11.7 Hz, 1H, H-18a or H-18b), 4.50 – 4.50 (m, 
3H, H-7, H-11, H-17a or H-17b), 4.40 (d, J = 11.8 Hz, 1H, H-17a or H-17b), 4.34 (ddd, J = 8.0, 
8.0, 3.4 Hz, 1H, H-5), 4.17 – 4.14 (m, 1H, H-10), 4.00 (dd, J = 7.9, 4.5 Hz, 1H, H-4), 3.77 (dd, 
J = 3.2, 3.2 Hz, 1H, H-9), 3.60 (s, 3H, 3 x H-13), 3.54 – 3.50 (m, 1H, H-8), 3.28 (br d, J = 11.4, 
1H, H-32), 2.23 (ddd, J = 14.5, 10.1, 3.4 Hz, 1H, H-6a or H-6b), 1.77 (ddd, J = 14.6, 8.1, 
2.8 Hz, 1H, H-6a or H-6b), 1.44 (s, 3H, 3 x H-15), 1.41 (s, 3H, 3 x H-16) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.25 (C-12), 165.61 (C-19), 137.49 (C-20), 136.85 (C-24), 
133.05 (C-31), 132.84 (C-2), 130.38 (C-28), 129.94 (2 x C-29), 128.76 (2 x C-22 or 2 x C-26 or 
2 x C-30), 128.54 (2 x C-22 or 2 x C-26 or 2 x C-30), 128.39 (2 x C-22 or 2 x C-26 or 2 x C-
30), 128.37 (C-27), 128.04 (2 x C-25), 128.03 (C-23), 127.73 (2 x C-21), 119.35 (C-1), 109.39 
(C-14), 82.50 (C-4), 75.77 (C-5), 75.11 (C-3), 74.15 (C-10), 73.29 (C-11), 72.90 (C-9), 72.27 
(C-18), 71.91 (C-17), 69.27 (C-8), 69.13 (C-7), 52.03 (C-13), 36.39 (C-6), 27.65 (C-15), 27.00 
(C-16) ppm. 
IR (ATR): ṽ = 3513 (br, w), 2932 (w), 1754 (w), 1720 (s), 1453 (w), 1266 (m), 1095 (s), 920 
(w), 711 (s) cm
‒1
. 
HRMS (ESI): calcd. for C37H42ClO10
‒
: 681.2472 [M+Cl]
‒
     
  found:   681.2471 [M+Cl]
‒
. 
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Methyl (2S,3S,4S,6R)-6-{[(4R,5S)-5-[(1R)-1-(benzoyloxy)prop-2-en-1-yl]-2,2-dimethyl-1,3-
dioxolan-4-yl]methyl}-3,4-bis(benzyloxy)-5-oxooxane-2-carboxylate (119) 
 
To a solution of alcohol 265 (78.4 mg, 0.121 mmol, 1.0 eq) in CH2Cl2 (7 mL) was added 
NaHCO3 (153 mg, 1.82 mmol, 15 eq), followed by Dess-Martin periodinane (128 mg, 
0.303 mmol, 2.5 eq) in one portion, and the resulting suspension was stirred at room 
temperature for 40 min. The reaction was quenched with a mixture (1:1, 14 mL) of aq. NaHCO3 
(saturated solution) and aq. Na2S2O3 (saturated solution) and the mixture was extracted with 
EtOAc (3 x 20 mL). The combined organic fractions were washed with brine (20 mL), dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 9:14:1] 
afforded ketone 119 (68.5 mg, 0.106 mmol, 88%) as a colorless oil. 
Ketone 119: 
Rf = 0.53 [PE:EtOAc 3:1]. 
    
   = .6 (c = 0.95, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.08 – 8.05 (m, 2H, 2 x H-29), 
7.54 – 7.50 (m, 1H, H-31), 7.42 – 7.39 (m, 2H, 2 x H-30), 7.36 –
 7.26 (m, 10H, 2 x H-21, 2 x H-22, H-23, 2 x H-25, 2 x H-26,  
H-27), 6.00 (ddd, J = 17.2, 10.6, 6.5 Hz, 1H, H-2), 5.72 – 5.68 (m, 1H, H-3), 5.44 (ddd, 
J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 5.34 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.75 – 4.68 (m, 
3H, H-7, H-17a or H-17b, H-18a or H-18b), 4.64 (d, J = 10.4 Hz, 1H, H-18a or H-18b), 4.53 –
 4.49 (m, 2H, H-11, H-17a or H-17b), 4.27 – 4.23 (m, 2H, H-5, H-10), 4.19 (d, J = 7.1 Hz, 1H, 
H-9), 3.98 (dd, J = 7.8, 4.5 Hz, 1H, H-4), 3.66 (s, 3H, 3 x H-13), 2.17 (ddd, J = 14.5, 8.8, 
3.0 Hz, 1H, H-6a or H-6b), 1.97 (ddd, J = 14.4, 10.1, 3.3 Hz, 1H, H-6a or H-6b), 1.41 (s, 3H, 
3 x H-15), 1.37 (s, 3H, 3 x H-16) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 206.34 (C-8), 170.13 (C-12), 165.51 (C-19), 137.47 (C-24), 
137.11 (C-20), 133.24 (C-31), 132.53 (C-2), 130.16 (C-28), 129.87 (2 x C-29), 128.59 (2 x C-
22 or 2 x C-26 or 2 x C-30), 128.56 (2 x C-22 or 2 x C-26 or 2 x C-30), 128.54 (2 x C-22 or 
2 x C-26 or 2 x C-30), 128.19 (C-23 or C-27), 128.12 (2 x C-21 or 2 x C-25), 128.10 (C-23 or 
C-27), 128.09 (2 x C-21 or 2 x C-25), 119.45 (C-1), 109.77 (C-14), 82.12 (C-4), 81.57 (C-9), 
79.22 (C-10), 75.93 (C-7), 75.25 (C-11), 74.56 (C-3), 74.30 (C-5), 73.43 (C-17), 73.38 (C-18), 
52.39 (C-13), 34.74 (C-6), 27.57 (C-15), 27.05 (C-16) ppm. 
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IR (ATR): ṽ = 2934 (w), 1722 (s), 1453 (w), 1268 (s), 1069 (s), 711 (s) cm‒1. 
HRMS (ESI): calcd. for C37H44NO10
+
: 662.2960 [M+NH4]
+
     
  found:   662.2958 [M+NH4]
+
. 
 
Methyl (1R,3S,4S,5R,7R,9R,11S,12S,13S)-5-(acetyloxy)-4-(benzoyloxy)-12,13-bis(benzyl-
oxy)-1-hydroxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (122) and Methyl 
(2R,3aR,5S,6S,7S,7aS)-2-[(1S,2R)-2-(benzoyloxy)-1-hydroxybut-3-en-1-yl]-6,7-
bis(benzyloxy)-7a-hydroxy-hexahydro-2H-furo[3,2-b]pyran-5-carboxylate (120) 
 
A solution of ketone 119 (64.0 mg, 99.3 µmol, 1.0 eq) in a TFA/CH2Cl2/H2O (9:1:1, 4 mL) 
mixture was stirred at room temperature for 15 min. The solvent was removed by azeotropic 
distillation with toluene (3 x 8 mL), the resulting residue was taken up in EtOAc (20 mL) and 
aq. NaHCO3 (15 mL of a saturated solution) was added. The organic phase was separated and 
the aqueous layer was extracted further with EtOAc (2 x 20 mL). The combined organic 
fractions were washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. The crude 
product was dissolved in CH2Cl2 (6 mL) and the resulting solution cooled to ‒78 °C. Ozone was 
bubbled through the reaction mixture until a slight blue color persisted. Excess ozone was 
discharged by bubbling argon through the mixture and dimethyl sulfide (0.29 mL, 3.97 mmol, 
40 eq) was added at ‒78 °C. The solution was allowed to warm to room temperature and stirred 
at this temperature for 3 h. Water (15 mL) was added and the mixture extracted with EtOAc 
(2 x 20 mL). The combined organic fractions were washed with brine (20 mL), dried (MgSO4) 
and concentrated in vacuo to provide the crude hemiacetal, which was subsequently dissolved in 
CH2Cl2 (5 mL). To this solution was added 4-(dimethylamino)pyridine (2.43 mg, 19.9 µmol, 
20 mol%), triethylamine (20.7 µL, 0.149 mmol, 1.5 eq), and acetic anhydride (11.2 µL, 
0.119 mmol, 1.2 eq), and the mixture was stirred at room temperature for 1 h. The reaction was 
quenched with aq. NH4Cl (15 mL of a saturated solution) and the mixture extracted with EtOAc 
(3 x 20 mL). The combined organic fractions were washed with brine (20 mL), then dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 4:13:11:1] 
afforded the tricyclic compound 122 (36.5 mg, 56.3 µmol, 57% over three steps) as a colorless 
oil and as a single diastereomer. 
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Tricyclic compound 122: 
Rf = 0.55 [PE:EtOAc 1:1]. 
    
   = .4 (c = 0.98, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.01 – 7.98 (m, 2H, 2 x H-
17), 7.57 – 7.53 (m, 1H, H-19), 7.39 – 7.35 (m, 2H, 2 x H-18), 
7.34 – 7.21 (m, 8H, 2 x H-23, H-24, 2 x H-27, 2 x H-28, H-29), 
7.10 – 7.04 (m, 2H, 2 x H-22), 6.46 (d, J = 3.8 Hz, 1H, H-1), 5.45 (dd, J = 4.9, 3.8 Hz, 1H, H-
2), 4.84 (dd, J = 4.9, 2.0 Hz, 1H, H-3), 4.80 (d, J = 11.8 Hz, 1H, H-20a or H-20b), 4.73 (dd, 
J = 11.6, 5.1 Hz, 1H, H-6), 4.60 – 4.51 (m, 4H, H-4, H-25a, H-25b, H-30), 4.47 (s, 1H, H-10), 
4.35 (d, J = 11.8 Hz, 1H, H-20a or H-20b), 4.25 (dd, J = 3.4, 1.2 Hz, 1H, H-9), 3.59 (s, 3H, 
3 x H-12), 3.50 (d, J = 3.4 Hz, 1H, H-8), 2.32 (ddd, J = 13.6, 5.1, 2.5 Hz, 1H, H-5a or H-5b), 
2.19 – 2.12 (m, 1H, H-5a or H-5b), 2.12 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.40 (C-13), 169.55 (C-11), 165.33 (C-15), 138.07 (C-21), 
136.21 (C-26), 133.54 (C-19), 130.02 (2 x C-17), 129.24 (C-16), 128.77 (2 x C-23 or 2 x C-28), 
128.57 (2 x C-18), 128.49 (C-29), 128.39 (2 x C-23 or 2 x C-28), 128.06 (2 x C-27), 127.71 (C-
24), 127.33 (2 x C-22), 99.88 (C-1), 93.78 (C-7), 79.95 (C-2), 78.27 (C-9), 78.01 (C-4), 74.12 
(C-10), 73.75 (C-8), 73.66 (C-20), 72.43 (C-25), 70.12 (C-3), 65.42 (C-6), 52.38 (C-12), 25.88 
(C-5), 21.33 (C-14) ppm. 
IR (ATR): ṽ = 3443 (br, w), 2952 (w), 1726 (s), 1453 (w), 1276 (m), 1096 (s), 1006 (s), 698 
(s) cm
‒1
. 
HRMS (ESI): calcd. for C35H40O12N
+
: 666.2545 [M+NH4]
+
     
  found:   666.2541 [M+NH4]
+
. 
Intermediate 120: 
In order to characterize intermediate 120, an analytical sample of the crude mixture obtained 
after acetonide deprotection was purified by HPLC [Dynamax Microsorb 60-8 C18 
(250 x 21.4 mm), isocratic elution, water (A)/MeOH (B); 80% B; flow rate 16 mL/min; 
detection 206 nm: tR(120) = 13.6 min] to yield the major intermediate 120 as a white crystalline 
solid. 
Rf = 0.17 [PE:EtOAc 3:1]. 
    
   = 32.1 (c = 0.79, CHCl3). 
mp: 71 – 73 °C. 
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1
H-NMR (300 MHz, CDCl3): δ = 8.10 – 8.05 (m, 2H, 2 x H-16), 
7.60 – 7.52 (m, 1H, H-18), 7.46 – 7.39 (m, 2H, 2 x H-17), 7.39 –
 7.28 (m, 8H, 2 x H-22, H-23, 2 x H-26, 2 x H-27, H-28), 7.25 –
 7.19 (m, 2H, 2 x H-21), 5.94 (ddd, J = 17.3, 10.7, 5.7 Hz, 1H, H-
2), 5.48 – 5.41 (m, 1H, H-3), 5.28 – 5.16 (m, 2H, H-1a, H-1b), 
4.70 – 4.62 (m, 2H, H-24a, H-24b), 4.62 – 4.52 (m, 3H, H-5, H-7, 
H-19a or H-19b),  4.48 – 4.42 (m, 2H, H-11, H-19a or H-19b), 4.18 
(dd, J = 5.4, 3.0 Hz, 1H, H-10), 3.80 (d, J = 4.5 Hz, 1H, H-9), 3.74 – 3.65 (m, 1H, H-4), 3.61 (s, 
3H, 3 x H-13), 3.55 – 3.46 (m, 1H, H-29), 3.21 (s, 1H, H-30), 2.59 (ddd, J = 15.0, 9.3, 5.8 Hz, 
1H, H-6a), 2.05 (dd, J = 13.9, 4.2 Hz, 1H, H-6b) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 170.26 (C-12), 165.42 (C-14), 136.90 (C-25), 136.55 (C-20), 
134.39 (C-2), 133.12 (C-18), 130.42 (C-15), 129.88 (2 x C-16), 128.80 (2 x C-22 or 2 x C-27), 
128.78 (2 x C-22 or 2 x C-27), 128.57 (C-23 or C-28), 128.50 (2 x C-17), 128.37 (C-23 or C-
28), 128.37 (2 x C-21 or 2 x C-26), 128.35 (2 x C-21 or 2 x C-26), 117.39 (C-1), 101.45 (C-8), 
77.74 (C-5), 76.86 (C-7), 75.55 (C-3), 74.97 (C-9), 74.07 (C-4), 73.94 (C-10), 73.61 (C-11 or 
C-19), 73.60 (C-11 or C-19), 72.95 (C-24), 52.22 (C-13), 34.13 (C-6) ppm. 
IR (ATR): ṽ = 3406 (br, w), 2937 (w), 1753 (w), 1714 (m), 1270 (s), 1093 (s), 714 (s) cm‒1. 
HRMS (ESI): calcd. for C34H36ClO10

: 639.2002 [M+Cl]

    
  found:    639.1998 [M+Cl]

. 
 
(1S)-1-[(4R,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-ol (113) 
 
Toluene was removed from a solution of (S)-(‒)-2-methyl-CBS-oxazaborolidine [(S)-117] in 
toluene (1.0 M, 675 µL, 0.675 mmol, 10 mol%) and the residue dried in vacuo. The CBS 
reagent was re-dissolved in THF (30 mL), and the resulting solution was added via cannula to a 
stirred solution of vinyl ketone 115 (5.00 g, 6.75 mmol, 1.0 eq) in THF (170 mL), pre-cooled to 
‒25 °C. A solution of borane dimethyl sulfide complex in THF (2.0 M, 3.71 mL, 7.42 mmol, 
1.1 eq) was added dropwise. The mixture was allowed to warm to 0 °C over 2 h and stirred at 
this temperature for an additional 30 min. The reaction was quenched with MeOH (10 mL) and 
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diluted with a mixture (2:1, 120 mL) of aq. NaOH (10 wt%) and aq. NaHCO3 (saturated 
solution). The resulting solution was extracted with Et2O (3 x 250 mL), and the combined 
organic fractions were washed with brine (200 mL), then dried (MgSO4) and concentrated in 
vacuo to provide crude alcohols 113 and 112 as a mixture of two diastereomers (d.r. 14:1, as 
determined by 
1
H-NMR spectroscopy). Flash column chromatography [PE:EtOAc 
19:19:14:1] afforded allylic alcohol 113 (3.43 g, 4.62 mmol, 68%) as colorless oil. 
Allylic Alcohol 113: 
Analytical data were identical with the material obtained 
earlier (vide supra). 
Rf = 0.67 [PE:EtOAc 3:1]. 
    
   = 57.5 (c = 0.41, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.21 (m, 10H, 2 x H-19, 2 x H-20, H-21, 2 x H-23, 
2 x H-24, H-25), 5.85 (ddd, J = 17.1, 10.5, 6.2 Hz, 1H, H-2), 5.40 (ddd, J = 17.2, 1.7, 1.7 Hz, 
1H, H-1a), 5.27 (ddd, J = 10.5, 1.3, 1.3 Hz, 1H, H-1b), 4.89 (d, J = 11.3 Hz, 1H, H-16a or H-
16b), 4.79 (d, J = 10.7 Hz, 1H, H-17a or H-17b), 4.78 (d, J = 11.1 Hz, 1H, H-16a or H-16b), 
4.59 (d, J = 10.8 Hz, 1H, H-17a or H-17b), 4.17 – 4.13 (m, 1H, H-7), 4.13 – 4.09 (m, 1H, H-3), 
4.09 – 4.04 (m, 1H, H-5), 3.82 (dd, J = 9.3, 6.1 Hz, 1H, H-8), 3.77 (dd, J = 11.1, 1.8 Hz, 1H, H-
12a or H-12b), 3.73 (dd, J = 11.1, 4.6 Hz, 1H, H-12a or H-12b), 3.68 (dd, J = 7.8, 5.4 Hz, 1H, 
H-4), 3.54 (dd, J = 9.0, 9.0 Hz, 1H, H-9), 3.45 (dd, J = 9.3, 9.3 Hz, 1H, H-10), 3.39 (ddd, 
J = 9.8, 4.6, 1.8 Hz, 1H, H-11), 2.35 (br d, J = 4.8 Hz, 1H, H-34), 1.93 – 1.87 (m, 2H, H-6a, H-
6b), 1.41 (s, 3H, 3 x H-15), 1.39 (s, 3H, 3 x H-14), 0.91 (s, 9H, 9 x H-29), 0.90 (s, 9H, 9 x H-
33), 0.10 (s, 3H, 3 x H-26 or 3 x H-27), 0.07 (s, 3H, 3 x H-26 or 3 x H-27), 0.06 (s, 3H, 3 x H-
30 or 3 x H-31), 0.05 (s, 3H, 3 x H-30 or 3 x H-31) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 138.99 (C-18), 138.46 (C-22), 136.83 (C-2), 128.56 (2 x C-
20 or 2 x C-24), 128.42 (2 x C-20 or 2 x C-24), 128.11 (2 x C-23), 127.88 (C-25), 127.60 
(2 x C-19), 127.51 (C-21), 117.68 (C-1), 109.29 (C-13), 83.89 (C-4), 83.33 (C-9), 78.49 (C-10), 
75.57 (C-16), 75.21 (C-17), 73.99 (C-5), 73.50 (C-3), 73.40 (C-7), 73.18 (C-11), 73.13 (C-8), 
63.10 (C-12), 28.57 (C-6), 27.59 (C-14), 27.30 (C-15), 26.15 (3 x C-29 or 3 x C-33), 26.07 
(3 x C-29 or 3 x C-33), 18.54 (C-32), 18.16 (C-28), 4.44 (C-26 or C-27), 4.49 (C-26 or C-
27), 4.95 (C-30 or C-31), 5.19 (C-30 or C-31) ppm. 
IR (ATR): ṽ = 3458 (br, w), 2929 (s), 1462 (w), 1252 (m), 1083 (s), 834 (s), 696 (w) cm‒1. 
HRMS (ESI): calcd. for C41H70NO8Si2
+
: 760.4634 [M+NH4]
+
    
  found:    760.4635 [M+NH4]
+
. 
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(1S)-1-[(4S,5R)-5-{[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-
{[(tert-butyldimethylsilyl)oxy]methyl}oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-
yl]prop-2-en-1-yl benzoate (266) 
 
A solution of allylic alcohol 113 (3.43 g, 4.62 mmol, 1.0 eq), 4-(dimethylamino)pyridine 
(56.4 mg, 0.462 mmol, 10 mol%) and triethylamine (3.86 mL, 27.7 mmol, 6.0 eq) in CH2Cl2 
(80 mL) was cooled to 0 °C, and benzoyl chloride (1.07 mL, 9.24 mmol, 2.0 eq) was added 
dropwise. The mixture was stirred at 0 °C for 10 min, then allowed to warm to room 
temperature and stirred at this temperature for 10 h. The reaction was quenched with aq. 
NaHCO3 (150 mL of a saturated solution) and extracted with EtOAc (3 x 200 mL). The 
combined organic fractions were washed with brine (250 mL), dried (MgSO4) and concentrated 
in vacuo. Flash column chromatography [PE:EtOAc 49:129:19:1] afforded benzoyl 
protected alcohol 266 (3.89 g, 4.59 mmol, 99%) as a colorless oil. 
Benzoate ester 266: 
Rf = 0.47 [PE:EtOAc 9:1]. 
    
   = 16.0 (c = 1.1, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.10 – 8.07 (m, 2H, 2 x H-
28), 7.52 – 7.49 (m, 1H, H-30), 7.42 – 7.38 (m, 2H, 2 x H-
29), 7.36 – 7.24 (m, 10H, 2 x H-20, 2 x H-21, H-22, 2 x H-
24, 2 x H-25, H-26), 5.98 (ddd, J = 17.1, 10.6, 6.4 Hz, 1H, H-2), 5.73 – 5.70 (m, 1H, H-3), 5.45 
(ddd, J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 5.35 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.86 (d, 
J = 11.2 Hz, 1H, H-16a or H-16b), 4.82 (d, J = 10.8 Hz, 1H, H-17a or H-17b), 4.76 (d, 
J = 11.2 Hz, 1H, H-16a or H-16b), 4.65 (d, J = 10.8 Hz, 1H, H-17a or H-17b), 4.16 (ddd, 
J = 12.0, 6.1, 2.1 Hz, 1H, H-7), 4.09 (ddd, J = 10.4, 8.1, 2.2 Hz, 1H, H-5), 3.94 (dd, J = 8.1, 
4.9 Hz, 1H, H-4), 3.84 – 3.79 (m, 2H, H-8, H-12a or H-12b), 3.68 (dd, J = 11.3, 1.7 Hz, 1H, H-
12a or H-12b), 3.55 – 3.51 (m, 2H, H-9, H-10), 3.47 – 3.42 (m, 1H, H-11), 2.01 (ddd, J = 14.3, 
12.1, 2.2 Hz, 1H, H-6a or H-6b), 1.91 (ddd, J = 14.7, 10.4, 2.1 Hz, 1H, H-6a or H-6b), 1.42 (s, 
3H, 3 x H-15), 1.40 (s, 3H, 3 x H-14), 0.90 (s, 9H, 9 x H-34), 0.89 (s, 9H, 9 x H-38), 0.10 (s, 
3H, 3 x H-31 or 3 x H-32), 0.07 (s, 3H, 3 x H-31 or 3 x H-32), 0.02 (s, 3H, 3 x H-35 or 3 x H-
36), 0.01 (s, 3H, 3 x H-35 or 3 x H-36) ppm. 
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13
C-NMR (150 MHz, CDCl3): δ = 165.55 (C-18), 139.02 (C-19), 138.71 (C-23), 133.27 (C-30), 
132.77 (C-2), 130.06 (C-27), 129.85 (2 x C-28), 128.66 (2 x C-29), 128.48 (2 x C-21 or 2 x C-
25), 128.41 (2 x C-21 or 2 x C-25), 128.05 (2 x C-24), 127.76 (C-26), 127.65 (2 x C-20), 127.49 
(C-22), 119.16 (C-1), 109.46 (C-13), 83.46 (C-9), 81.81 (C-4), 78.24 (C-10), 75.62 (C-16), 
75.11 (C-17), 74.07 (C-3), 73.28 (C-7), 73.24 (C-5), 73.14 (C-8), 72.95 (C-11), 62.79 (C-12), 
28.25 (C-6), 27.57 (C-14), 27.03 (C-15), 26.15 (3 x C-38), 26.07 (3 x C-34), 18.54 (C-37), 
18.16 (C-33), 4.47 (C-31 or C-32), 4.50 (C-31 or C-32), 4.96 (C-35 or C-36), 5.26 (C-35 
or C-36) ppm. 
IR (ATR): ṽ = 2929 (m), 1723 (m), 1251 (m), 1086 (s), 834 (s), 696 (m) cm‒1. 
HRMS (ESI): calcd. for C48H74NO9Si2
+
: 864.4897 [M+NH4]
+
    
  found:    864.4899 [M+NH4]
+
. 
 
(1S)-1-[(4S,5R)-5-{[(2R,3S,4R,5R,6R)-4,5-bis(benzyloxy)-3-hydroxy-6-(hydroxymethyl) 
oxan-2-yl]methyl}-2,2-dimethyl-1,3-dioxolan-4-yl]prop-2-en-1-yl benzoate (124) 
 
To a solution of benzoyl protected alcohol 266 (254 mg, 0.300 mmol, 1.0 eq) in THF (12 mL) 
was added a solution of tetrabutylammonium fluoride in THF (1.0 M, 900 µL, 0.900 mmol, 
3.0 eq), and the resulting mixture was stirred at room temperature for 16 h. The reaction was 
quenched with aq. NaHCO3 (20 mL of a saturated solution) and extracted with EtOAc 
(3 x 25 mL). The combined organic fractions were washed with brine (25 mL), dried (MgSO4) 
and concentrated in vacuo. Flash column chromatography [PE:EtOAc 3:1] afforded diol 124 
(143 mg, 0.231 mmol, 77%) as a white sticky foam. 
Diol 124: 
Rf = 0.51 [PE:EtOAc 1:1].  
    
   = 8.1 (c = 1.0, CHCl3). 
1
H-NMR (400 MHz, CDCl3): δ = 8.11 – 8.07 (m, 2H, 2 x H-
28), 7.58 – 7.53 (m, 1H, H-30), 7.46 – 7.41 (m, 2H, 2 x H-29), 
7.38 – 7.26 (m, 10H, 2 x H-20, 2 x H-21, H-22, 2 x H-24, 2 x H-25, H-26), 5.97 (ddd, J = 17.2, 
10.6, 6.3 Hz, 1H, H-2), 5.74 – 5.69 (m, 1H, H-3), 5.46 (ddd, J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 
5.36 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.66 – 4.56 (m, 4H, H-16a, H-16b, H-17a, H-17b), 
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4.27 – 4.15 (m, 3H, H-5, H-7, H-12a or H-12b), 4.02 – 3.95 (m, 2H, H-4, H-11), 3.75 (dd, 
J = 4.5, 4.5 Hz, 1H, H-9), 3.61 – 3.55 (br m, 1H, H-8), 3.42 (dd, J = 12.3, 3.6 Hz, 1H, H-12a or 
H-12b), 3.38 (dd, J = 4.0, 4.0 Hz, 1H, H-10), 3.02 (br d, J = 8.4 Hz, 1H, H-31), 2.79 (br s, 1H, 
H-32), 2.24 (ddd, J = 14.5, 11.3, 3.5 Hz, 1H, H-6a or H-6b), 1.65 (ddd, J = 13.6, 10.1, 3.2 Hz, 
1H, H-6a or H-6b), 1.45 (s, 3H, 3 x H-14 or 3 x H-15), 1.44 (s, 3H, 3 x H-14 or 3 x H-15) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 165.67 (C-18), 137.80 (C-19 or C-23), 137.32 (C-19 or C-
23), 133.33 (C-30), 132.48 (C-2), 129.98 (C-27), 129.89 (2 x C-28), 128.72 (2 x C-21 or 2 x C-
25), 128.69 (2 x C-21 or 2 x C-25), 128.59 (2 x C-29), 128.20 (C-22 or C-26), 128.16 (C-22 or 
C-26), 128.02 (2 x C-20 or 2 x C-24), 127.80 (2 x C-20 or 2 x C-24), 119.32 (C-1), 109.40 (C-
13), 82.26 (C-4), 76.74 (C-9), 75.45 (C-11), 74.34 (C-10), 73.77 (C-3 and C-5), 73.35 (C-16), 
72.72 (C-17), 69.43 (C-8), 66.51 (C-7), 59.62 (C-12), 32.58 (C-6), 27.58 (C-14 or C-15), 26.91 
(C-14 or C-15) ppm. 
IR (ATR): ṽ = 3449 (w), 2932 (w), 1719 (m), 1266 (m), 1068 (s), 851 (w), 696 (s) cm‒1. 
HRMS (ESI): calcd. for C36H46NO9
+
: 636.3167 [M+NH4]
+
     
  found:   636.3164 [M+NH4]
+
. 
 
Methyl (2S,3S,4R,5S,6R)-6-{[(4R,5S)-5-[(1S)-1-(benzoyloxy)prop-2-en-1-yl]-2,2-dimethyl-
1,3-dioxolan-4-yl]methyl}-3,4-bis(benzyloxy)-5-hydroxyoxane-2-carboxylate (267) 
 
To a solution of diol 124 (1.87 g, 3.02 mmol, 1.0 eq) in a mixture of CH2Cl2 and water (2:1, 
135 mL) was added 2,2,6,6-tetramethylpiperidine-1-oxyl (472 mg, 3.02 mmol, 1.0 eq) and 
(diacetoxyiodo)benzene (4.86 g, 15.1 mmol, 5.0 eq), and the resulting biphasic system was 
stirred vigorously at room temperature for 2 h. A second equivalent of 2,2,6,6-
tetramethylpiperidine-1-oxyl (472 mg, 3.02 mmol, 1.0 eq) was added, and the mixture was 
stirred for an additional 3.5 h. The reaction was quenched with aq. Na2S2O3 (100 mL of a half-
saturated solution) and the aqueous layer was extracted with EtOAc (3 x 150 mL). The 
combined organic fractions were washed with brine (200 mL), dried (MgSO4) and concentrated 
in vacuo to provide the crude carboxylic acid, which was immediately re-dissolved in 
toluene/MeOH (7:1, 120 mL). To this mixture, a solution of (trimethylsilyl)diazomethane in 
hexanes (2.0 M, 1.81 mL, 3.63 mmol, 1.2 eq) was added dropwise, and the resulting mixture 
stirred at room temperature for 1 h. The reaction was quenched with acetic acid (1.4 mL) and 
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diluted with water (100 mL). The mixture was extracted with EtOAc (3 x 150 mL) and the 
combined organic fractions were washed with brine (200 mL), then dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [PE:EtOAc 9:14:1] afforded ester 267 
(1.54 g, 2.38 mmol, 79% over two steps) as a white sticky foam. 
Ester 267: 
Rf = 0.28 [PE:EtOAc 3:1]. 
    
   = 5.4 (c = 1.1, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.12 – 8.09 (m, 2H, 2 x H-29), 
7.54 – 7.51 (m, 1H, H-31), 7.42 – 7.26 (m, 10H, 2 x H-22, H-23, 
2 x H-25, 2 x H-26, H-27, 2 x H-30), 7.21 – 7.19 (m, 2H, 2 x H-21), 5.99 (ddd, J = 17.2, 8.4, 
4.2 Hz, 1H, H-2), 5.75 – 5.72 (m, 1H, H-3), 5.42 (ddd, J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 5.32 
(ddd, J = 10.6, 1.3, 1.3 Hz, 1H, H-1b), 4.71 (d, J = 11.6 Hz, 1H, H-18a or H-18b), 4.61 (d, 
J = 11.6 Hz, 1H, H-18a or H-18b), 4.55 (s, 1H, H-11), 4.50 – 4.44 (m, 2H, H-7, H-17a or H-
17b), 4.40 (d, J = 11.7 Hz, 1H, H-17a or H-17b), 4.37 (ddd, J = 7.7, 7.7, 3.7 Hz, 1H, H-5), 4.19 
(ddd, J = 3.0, 1.4, 1.4 Hz, 1H, H-10), 3.96 (dd, J = 7.8, 4.3 Hz, 1H, H-4), 3.80 (dd, J = 3.3, 
3.3 Hz, 1H, H-9), 3.55 – 3.51 (m, 1H, H-8), 3.48 (s, 3H, 3 x H-13), 3.38 (d, J = 11.6 Hz, 1H, H-
32), 2.19 (ddd, J = 14.4, 10.0, 3.7 Hz, 1H, H-6a or H-6b), 1.77 (ddd, J = 14.4, 10.0, 3.7 Hz, 1H, 
H-6a or H-6b), 1.50 (s, 3H, 3 x H-16), 1.46 (s, 3H, 3 x H-15) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.12 (C-12), 165.60 (C-19), 137.43 (C-20), 136.82 (C-24), 
133.16 (C-2), 133.04 (C-31), 130.40 (C-28), 129.85 (2 x C-29), 128.76 (2 x C-22 or 2 x C-26), 
128.48 (2 x C-22 or 2 x C-26), 128.45 (2 x C-30), 128.38 (C-27), 128.08 (2 x C-25), 127.98 (C-
23), 127.69 (2 x C-21), 118.60 (C-1), 109.08 (C-14), 82.48 (C-4), 74.66 (C-5), 74.27 (C-10), 
73.77 (C-3), 73.31 (C-11), 72.85 (C-9), 72.37 (C-18), 71.88 (C-17), 69.31 (C-7), 69.15 (C-8), 
51.90 (C-13), 35.70 (C-6), 27.69 (C-15), 27.03 (C-16) ppm. 
IR (ATR): ṽ = 3507 (br, w), 2931 (w), 1755 (w), 1720 (s), 1452 (w), 1267 (m), 1069 (s), 921 
(w), 711 (s) cm
‒1
. 
HRMS (ESI): calcd. for C37H46NO10
+
:  664.3116 [M+NH4]
+
    
  found:    664.3114 [M+NH4]
+
. 
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Methyl (2S,3S,4S,6R)-6-{[(4R,5S)-5-[(1S)-1-(benzoyloxy)prop-2-en-1-yl]-2,2-dimethyl-1,3-
dioxolan-4-yl]methyl}-3,4-bis(benzyloxy)-5-oxooxane-2-carboxylate (82) 
 
To a solution of alcohol 267 (1.54 g, 2.38 mmol, 1.0 eq) in CH2Cl2 (120 mL) was added 
NaHCO3 (3.00 g, 35.7 mmol, 15 eq) and Dess-Martin periodinane (2.52 g, 5.95 mmol, 2.5 eq) 
in one portion, and the resulting suspension was stirred at room temperature for 1 h. The 
reaction was quenched with a mixture (1:1, 100 mL) of aq. NaHCO3 (saturated solution) and aq. 
Na2S2O3 (saturated solution) and diluted with water (100 mL). The mixture was extracted with 
EtOAc (3 x 150 mL) and the combined organic fractions were washed with brine (200 mL), 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 5:1] 
afforded ketone 82 (1.45 g, 2.25 mmol, 94%) as a colorless oil. 
Ketone 82: 
Rf = 0.40 [PE:EtOAc 3:1]. 
    
   = 25.2 (c = 1.0, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 8.10 – 8.06 (m, 2H, 2 x H-29), 
7.58 – 7.52 (m, 1H, H-31), 7.46 – 7.40 (m, 2H, 2 x H-30), 
7.38 – 7.27 (m, 10H, 2 x H-21, 2 x H-22, H-23, 2 x H-25, 2 x H-
26, H-27), 5.95 (ddd, J = 17.2, 10.6, 6.2 Hz, 1H, H-2), 5.72 – 5.65 (m, 1H, H-3), 5.43 (ddd, 
J = 17.3, 1.3, 1.3 Hz, 1H, H-1a), 5.33 (ddd, J = 10.6, 1.2, 1.2 Hz, 1H, H-1b), 4.76 – 4.70 (m, 
3H, H-7, H-17a or H-17b, H-18a or H-18b), 4.68 (d, J = 11.5 Hz, 1H, H-18a or H-18b), 4.57 (d, 
J = 4.2 Hz, 1H, H-11), 4.51 (d, J = 11.4 Hz, 1H, H-17a or H-17b), 4.28 (dd, J = 7.1, 4.2 Hz, 1H, 
H-10), 4.26 – 4.19 (m, 2H, H-5, H-9), 3.96 (dd, J = 7.7, 4.7 Hz, 1H, H-4), 3.60 (s, 3H, 3 x H-
13), 2.14 (ddd, J = 14.5, 8.5, 2.9 Hz, 1H, H-6a or H-6b), 1.95 (ddd, J = 13.7, 10.0, 3.4 Hz, 1H, 
H-6a or H-6b), 1.45 (s, 3H, 3 x H-16), 1.42 (s, 3H, 3 x H-15) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 206.27 (C-8), 170.04 (C-12), 165.59 (C-19), 137.42 (C-24), 
137.05 (C-20), 133.23 (C-31), 132.74 (C-2), 130.17 (C-28), 129.86 (2 x C-29), 128.58 (2 x C-
22 or 2 x C-26 or 2 x C-30), 128.57 (2 x C-22 or 2 x C-26 or 2 x C-30), 128.56 (2 x C-22 or 
2 x C-26 or 2 x C-30), 128.18 (C-23 or C-27), 128.13 (C-23 or C-27), 128.11 (2 x C-21, 2 x C-
25), 119.12 (C-1), 109.57 (C-14), 81.93 (C-4), 81.52 (C-9), 79.28 (C-10), 75.91 (C-7), 75.23 
(C-11), 73.84 (C-3), 73.43 (C-5 or C-17 or C-18), 73.40 (C-5 or C-17 or C-18), 73.37 (C-5 or 
C-17 or C-18), 52.37 (C-13), 34.14 (C-6), 27.62 (C-15), 27.06 (C-16) ppm. 
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IR (ATR): ṽ = 2934 (w), 1720 (s), 1452 (w), 1267 (s), 1066 (s), 711 (s) cm‒1. 
HRMS (ESI): calcd. for C37H44NO10
+
:  662.2960 [M+NH4]
+
    
  found:    662.2960 [M+NH4]
+
. 
 
Methyl (1R,3S,4R,7R,9R,11S,12S,13S)-5-(acetyloxy)-4-(benzoyloxy)-12,13-bis(benzyloxy)-
1-hydroxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (125) 
 
A solution of ketone 82 (880 mg, 1.36 mmol, 1.0 eq) in a TFA/CH2Cl2/H2O (9:1:1, 600 mL) 
mixture was stirred at room temperature for 15 min. The solvent was removed by azeotropic 
distillation with toluene (3 x 50 mL), the resulting residue was taken up in EtOAc (50 mL) and 
aq. NaHCO3 (50 mL of a saturated solution) was added. The organic phase was separated and 
the aqueous layer extracted further with EtOAc (2 x 50 mL). The combined organic fractions 
were washed with brine (100 mL), dried (MgSO4) and concentrated in vacuo. The crude product 
was dissolved in CH2Cl2 (70 mL) and the resulting solution cooled to ‒78 °C. Ozone was 
bubbled through the reaction mixture until a slight blue color persisted. Excess ozone was 
discharged by bubbling argon through the mixture and dimethyl sulfide (4.02 mL, 54.4 mmol, 
40 eq) was added at ‒78 °C. The solution was allowed to warm to room temperature and stirred 
at this temperature for 2.5 h. Water (80 mL) was added and the mixture extracted with EtOAc 
(3 x 150 mL). The combined organic fractions were washed with brine (150 mL), dried 
(MgSO4) and concentrated in vacuo to provide the crude hemiacetal, which was subsequently 
dissolved in CH2Cl2 (60 mL). To this solution was added 4-(dimethylamino)pyridine (33.2 mg, 
0.272 mmol, 20 mol%), triethylamine (377 µL, 2.72 mmol, 2.0 eq) and acetic anhydride 
(193 µL, 2.04 mmol, 1.5 eq), and the mixture was stirred at room temperature for 3 h. The 
reaction was quenched with aq. NH4Cl (100 mL of a saturated solution) and the mixture 
extracted with EtOAc (3 x 150 mL). The combined organic fractions were washed with brine 
(200 mL), then dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 4:13:12:11:1] afforded the tricyclic compound 125 (750 mg, 1.16 mmol, 
85% over three steps) as a white solid consisting of two diastereomers (d.r. 2.8:1, as determined 
by 
1
H-NMR spectroscopy) as an inseparable mixture. 
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Tricyclic compound 125: 
Rf = 0.15 [PE:EtOAc 3:1]. 
1
H-NMR (600 MHz, CDCl3) (mixture of isomers, major 
isomer quoted): δ = 8.05 – 8.02 (m, 2H, 2 x H-17), 7.61 – 7.58 
(m, 1H, H-19), 7.48 – 7.44 (m, 2H, 2 x H-18), 7.38 – 7.25 (m, 
10H, 2 x H-22, 2 x H-23, H-24, 2 x H-27, 2 x H-28, H-29), 
6.51 (d, J = 4.7 Hz, 1H, H-1), 5.47 (d, J = 4.7 Hz, 1H, H-2), 
4.74 (d, J = 11.8 Hz, 1H, H-20a or H-20b), 4.68 – 4.62 (m, 4H, H-3, H-6, H-25a, H-25b), 4.62 –
 4.58 (m, 1H, H-4), 4.55 – 4.53 (m, 1H, H-20a or H-20b), 4.49 (br s, 1H, H-10), 4.34 – 4.32 (m, 
1H, H-9), 3.60 (d, J = 4.7 Hz, 1H, H-8), 3.59 (s, 3H, 3 x H-12), 2.40 – 2.32 (m, 1H, H-5a or H-
5b), 2.21 – 2.13 (m, 1H, H-5a or H-5b), 1.91 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (150 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 169.52 (C-11), 
169.46 (C-13), 165.13 (C-15), 137.78 (C-21), 136.21 (C-26), 133.59 (C-19), 129.82 (2 x C-17), 
129.28 (C-16), 128.85 (2 x C-23 or 2 x C-28), 128.65 (2 x C-18), 128.60 (C-29), 128.50 (2 x C-
23 or 2 x C-28), 128.16 (2 x C-27), 127.91 (C-24), 127.64 (2 x C-22), 95.44 (C-1), 93.73 (C-7), 
78.01 (C-2), 77.88 (C-9), 76.95 (C-4), 75.31 (C-3), 74.18 (C-10), 74.07 (C-8), 73.70 (C-20), 
72.64 (C-25), 65.18 (C-6), 52.39 (C-12), 25.40 (C-5), 20.94 (C-14) ppm. 
IR (ATR): ṽ = 3442 (br, w), 2948 (w), 1752 (m), 1726 (s), 1452 (w), 1270 (m), 1107 (s), 1011 
(s), 713 (s) cm
‒1
. 
HRMS (ESI): calcd. for C35H36ClO12
‒
: 683.1901 [M+Cl]
‒
    
  found:    683.1894 [M+Cl]
‒
. 
 
Methyl (1R,3S,4R,5R,7R,9R,11S,12S,13S)-5-(6-amino-9H-purin-9-yl)-4-(benzoyloxy)-
12,13-bis(benzyloxy)-1-hydroxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-
carboxylate (127) 
 
To a suspension of acetate 125 (77.6 mg, 0.120 mmol, 1.0 eq) and adenine (24.2 mg, 
0.179 mmol, 1.5 eq) in MeCN (5.5 mL) was added dropwise trimethylsilyl 
trifluoromethanesulfonate (130 µL, 0.720 mmol, 6.0 eq). The resulting solution was stirred at 
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room temperature for 15 min, then diluted with aq. NaHCO3 (10 mL of a saturated solution). 
The mixture was extracted with CH2Cl2 (3 x 20 mL) and the combined organic fractions were 
washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. The crude product was 
re-dissolved in a mixture of MeOH and CH2Cl2 (2:1, 6 mL) and K2CO3 (16.6 mg, 0.120 mmol, 
1.0 eq) was added in one portion. The reaction mixture was stirred at room temperature for 
50 min, then quenched with aq. NaHCO3 (10 mL of a saturated solution). The mixture was 
extracted with CH2Cl2 (3 x 20 mL), and the combined organic fraction were washed with brine 
(20 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[CH2Cl2:MeOH 49:124:1] afforded glycoside 127 (39.1 mg, 63.1 µmol, 53% over two steps) 
as a white solid as a single diastereomer. 
Glycoside 127 
Rf = 0.47 [CH2Cl2:MeOH 9:1]. 
    
   = 20.4 (c = 1.29, CHCl3). 
mp: 128 °C (decomposition). 
1
H-NMR (600 MHz, CDCl3): δ = 8.36 (s, 1H, H-17), 8.26 (s, 
1H, H-13), 7.33 – 7.28 (m, 3H, 2 x H-22, H-23 or H-27), 7.21 – 7.14 (m, 5H, 2 x H-21, 2 x H-
26, H-23 or H-27 ), 7.05 – 7.01 (m, 2H, 2 x H-25), 6.18 (s, 2H, 2 x H-30), 6.14 (s, 1H, H-1), 
4.91 (s, 1H, H-29), 4.73 (dd, J = 11.6, 5.2 Hz, 1H, H-6), 4.60 (d, J = 2.3 Hz, 1H, H-4), 4.50 –
 4.41 (m, 6H, H-2, H-3, H-10, H-18a, H-18b, H-19a or H-19b), 4.27 (d, J = 12.7, 1H, H-19a or 
H-19b), 4.12 – 4.09 (m, 1H, H-9), 3.73 (s, 3H, 3 x H-12), 3.46 (d, J = 3.1 Hz, 1H, H-8), 2.76 (br 
s, 1H, H-28), 2.46 – 2.38 (m, 1H, H-5a or H-5b), 2.26 – 2.19 (m, 1H, H-5a or H-5b) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 169.63 (C-11), 155.63 (C-16), 152.64 (C-13), 148.99 (C-14), 
139.66 (C-17), 136.71 (C-24), 136.15 (C-20), 128.79 (2 x C-22), 128.55 (C-23 or C-27), 128.48 
(2 x C-21 or 2 x C-25 or 2 x C-26), 128.44 (2 x C-21 or 2 x C-25 or 2 x C-26), 128.17 (2 x C-21 
or 2 x C-26 and C-23 or C-27), 119.54 (C-15), 93.20 (C-7), 91.69 (C-1), 81.53 (C-2), 78.63 (C-
4), 76.65 (C-9), 76.32 (C-3), 74.07 (C-10), 73.26 (C-8), 73.10 (C-19), 72.42 (C-18), 65.56 (C-
6), 52.51 (C-12), 25.65 (C-5) ppm. 
IR (ATR): ṽ = 3338 (br w), 3130 (br w), 2941 (w), 1751 (br w), 1638 (m), 1598 (m), 1416 (w), 
1291 (w), 1206 (m), 1053 (br s), 964 (m), 856 (w), 741 (m), 698 (s) cm
‒1
. 
HRMS (ESI): calcd. for C31H34O9N5
+
: 620.2351 [M+H]
+
     
  found:   620.2352 [M+H]
+
. 
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Methyl (1S,3S,4R,7R,9R,11S,12S,13S)-5-(acetyloxy)-4-(benzoyloxy)-1,12,13-trihydroxy-
2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (268) and Methyl (1R,3S,4R,5S,7R, 
9R,11S,12S,13S)-5-(acetyloxy)-4-(benzoyloxy)-13-(benzyloxy)-1,12-dihydroxy-2,6,10-
trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (130) 
 
An autoclave apparatus was charged with a solution of tricyclic compound 125 (282 mg, 
0.435 mmol, 1.0 eq) in EtOAc (28 mL) and Pd(OH)2/C (20 wt%, 196 mg) was added. The 
autoclave apparatus was purged with hydrogen gas five times and the resulting suspension was 
stirred under hydrogen atmosphere (8 bar) at room temperature for 20 h. The catalyst was 
removed by filtration through a pad of Celite, the Celite was washed with EtOAc (40 mL) and 
the filtrate concentrated in vacuo. Flash column chromatography [PE:EtOAc 2:11:1] afforded 
the triol 268 (172 mg, 0.367 mmol, 84%) as a white solid representing a complex mixture of 
structurally unknown isomers (including two main diastereomers of 268 in a 5.5:1 ratio as 
determined by 
1
H-NMR spectroscopy). The mixture was used immediately in the next step. 
Furthermore, monobenzylated product 130 (30.6 mg, 54.6 µmol, 13%) was isolated as a white 
solid consisting of two diastereomers (d.r. 6.5:1, as determined by 
1
H-NMR spectroscopy) as an 
inseparable mixture. 
Triol 268: 
For full NMR-characterization, an analytical sample of the major 
isomer 268a was isolated, which was sufficiently clean to assign 
the NMR-signals conclusively. Configuration of 268a at C-1 
remained unclear. 
Rf = 0.15 [PE:EtOAc 1:2].  
1
H-NMR (600 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 7.99 – 7.95 (m, 
2H, 2 x H-17), 7.59 – 7.55 (m, 1H, H-19), 7.45 – 7.40 (m, 2H, 2 x H-18), 6.52 (d, J = 4.8 Hz, 
1H, H-1), 5.47 (d, J = 4.8 Hz, 1H, H-2), 4.69 (br s, 1H, H-20 or H-21 or H-22), 4.62 – 4.58 (m, 
1H, H-4), 4.57 (d, J = 2.5 Hz, 1H, H-3), 4.55 (dd, J = 12.5, 5.7 Hz, 1H, H-6), 4.51 – 4.47 (br m, 
1H, H-9), 4.44 (s, 1H, H-10), 4.08 (br s, 1H, H-20 or H-21 or H-22), 3.79 (d, J = 3.2 Hz, 1H, H-
8), 3.75 (s, 3H, 3 x H-12), 3.19 (br s, 1H, H-20, or H-21 or H-22), 2.38 – 2.32 (m, 1H, H-5a or 
H-5b), 2.24 – 2.18 (m, 1H, H-5a or H-5b), 1.93 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (150 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 170.08 (C-11), 
169.84 (C-13), 165.53 (C-15), 133.83 (C-19), 129.84 (2 x C-17), 128.97 (C-16), 128.71 (2 x C-
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18), 95.65 (C-1), 93.38 (C-7), 77.84 (C-2), 77.02 (C-4), 76.73 (C-10), 75.39 (C-3), 71.24 (C-9), 
70.69 (C-8), 63.89 (C-6), 52.47 (C-12), 25.17 (C-5), 20.95 (C-14) ppm. 
IR (ATR): ṽ = 3432 (br, m), 2951 (w), 1725 (s), 1222 (m), 1010 (s), 751 (m) cm‒1. 
HRMS (ESI): calcd. for C21H28NO12
+
:  486.1606 [M+NH4]
+
    
  found:    486.1613 [M+NH4]
+
. 
Monobenzylated product 130: 
For full characterization of the major isomer of monobenzylated product 130, an analytical 
sample of the diastereomeric mixture was purified by HPLC [Dynamax Microsorb 60-8 C18 
(250 x 21.4 mm), gradient, water (A)/MeCN (B) +0.1% formic acid; 0 min 50% B, 2 min 50% 
B, 25 min 90% B; flow rate 15 mL/min; detection 231 nm: tR(130b) = 15.4 min, 
tR(130a) = 16.1 min]. 
Major isomer 130a: 
Rf = 0.64 [PE:EtOAc 1:2]. 
    
   = 30.3 (c = 1.1, CHCl3).  
mp: 82 – 85 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 8.03 – 8.00 (m, 2H, 2 x H-17), 
7.63 – 7.59 (m, 1H, H-19), 7.49 – 7.44 (m, 2H, 2 x H-18), 7.33 – 7.22 (m, 5H, 2 x H-22, 2 x H-
23, H-24), 6.25 (s, 1H, H-1), 5.42 (s, 1H, H-2), 4.91 (d, J = 12.5 Hz, 1H, H-20a or H-20b), 
4.71 – 4.65 (m, 1H, H-6), 4.60 – 4.56 (m, 2H, H-4, H-20a or H-20b), 4.52 – 4.49 (m, 1H, H-9), 
4.44 (br s, 2H, H-3, H-10), 3.66 (s, 3H, 3 x H-12), 3.51 (d, J = 3.3 Hz, 1H, H-8), 2.42 – 2.36 (m, 
1H, H-5a or H-5b), 2.23 – 2.16 (m, 1H, H-5a or H-5b), 1.71 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.22 (C-13), 169.58 (C-11), 165.46 (C-15), 138.23 (C-21), 
134.10 (C-19), 130.00 (2 x C-17), 128.79 (2 x C-18), 128.73 (C-16), 128.41 (2 x C-23), 127.74 
(C-24), 127.15 (2 x C-22), 99.32 (C-1), 94.05 (C-7), 81.95 (C-2), 79.09 (C-4), 76.98 (C-8 and 
C-10), 73.54 (C-20), 73.05 (C-3), 70.95 (C-9), 64.73 (C-6), 52.07 (C-12), 25.93 (C-5), 20.64 
(C-14) ppm. 
IR (ATR): ṽ = 3387 (w), 2946 (w), 1725 (m), 1452 (w), 1221 (br m), 1107 (s), 1011 (s), 899 
(w), 739 (m), 712 (s) cm
‒1
. 
HRMS (ESI): calcd. for C28H34NO12
+
:  576.2076 [M+NH4]
+
    
  found:    576.2082 [M+NH4]
+
. 
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Methyl (1R,3S,4R,7R,9R,11S,12S,13S)-5,12,13-tris(acetyloxy)-4-(benzoyloxy)-1-hydroxy-
2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (129) 
 
To a solution of triol 268 (127 mg, 0.271 mmol, 1.0 eq) in CH2Cl2 (7 mL) was added 4-
(dimethylamino)pyridine (6.62 mg, 54.2 µmol, 20 mol%), triethylamine (94.0 µL, 0.678 mmol, 
2.5 eq) and acetic anhydride (56.3 µL, 0.596 mmol, 2.2 eq), and the mixture was stirred at room 
temperature for 8 min. The reaction was quenched with aq. NH4Cl (10 mL of a saturated 
solution), and the mixture was extracted with EtOAc (3 x 20 mL). The combined organic 
fractions were washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [PE:EtOAc 3:11:11:2] afforded triacetate 129 (112 mg, 
0.239 mmol, 88%) as a white solid consisting of two diastereomers (d.r. 9.5:1, as determined by 
1
H-NMR spectroscopy) as an inseparable mixture. 
Triacetate 129: 
Rf = 0.47 [PE:EtOAc 1:2]. 
1
H-NMR (600 MHz, CDCl3) (mixture of isomers, major isomer 
quoted): δ = 8.03 – 8.00 (m, 2H, 2 x H-17), 7.61 – 7.57 (m, 1H, 
H-19), 7.47 – 7.44 (m, 2H, 2 x H-18), 6.48 (d, J = 4.6 Hz, 1H, H-
1), 5.53 – 5.52 (m, 1H, H-9), 5.39 (d, J = 4.6 Hz, 1H, H-2), 4.97 (d, J = 2.9 Hz, 1H, H-8), 4.62 –
 4.58 (m, 2H, H-3, H-4), 4.49 (s, 1H, H-10), 4.40 (dd, J = 11.6, 5.3 Hz, 1H, H-6), 3.84 (s, 3H, 
3 x H-12), 3.39 (s, 1H, H-24), 2.42 – 2.38 (m, 1H, H-5a or H-5b), 2.18 (s, 3H, 3 x H-23), 2.19 –
 2.15 (m, 1H, H-5a or H-5b), 2.06 (s, 3H, 3 x H-21), 1.90 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (150 MHz, CDCl3) (mixture of isomers, major isomer quoted): δ = 169.53 (C-13), 
168.86 (C-22), 168.52 (C-20), 168.43 (C-11), 165.13 (C-15), 133.68 (C-19), 129.84 (2 x C-17), 
129.17 (C-16), 128.68 (2 x C-18), 95.18 (C-1), 91.33 (C-7), 77.72 (C-2), 76.54 (C-3), 75.33 (C-
4), 74.67 (C-10), 70.36 (C-9), 68.37 (C-8), 65.40 (C-6), 52.89 (C-12), 25.22 (C-5), 21.15 (C-
23), 20.95 (C-14), 20.82 (C-21) ppm. 
IR (ATR): ṽ = 3446 (br, w), 2947 (w), 1730 (s), 1370 (w), 1222 (s), 1012 (s), 713 (s) cm‒1. 
HRMS (ESI): calcd. for C25H28ClO14
‒
: 587.1173 [M+Cl]
‒
    
  found:    587.1178 [M+Cl]
‒
. 
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Methyl (1S,3S,4R,5R,7R,9R,11S,12S,13S)-12,13-bis(acetyloxy)-5-(6-amino-9H-purin-9-yl)-
4-(benzoyloxy)-1-[(trimethylsilyl)oxy]-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-
carboxylate (131) 
 
To a suspension of triacetate 129 (112 mg, 0.239 mmol, 1.0 eq) and adenine (48.5 mg, 
0.359 mmol, 1.5 eq) in MeCN (11 mL) was added dropwise trimethylsilyl 
trifluoromethanesulfonate (260 µL, 1.43 mmol, 6.0 eq). The resulting solution was stirred at 
room temperature for 5 min, then diluted with aq. NaHCO3 (20 mL of a saturated solution). The 
mixture was extracted with CH2Cl2 (3 x 25 mL) and the combined organic fractions were 
washed with brine (25 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [CH2Cl2:MeOH 99:149:129:1] afforded glycoside 131 (92.3 mg, 
0.132 mmol, 55%) as a white solid as a single diastereomer. 
Glycoside 131: 
Rf = 0.39 [EtOAc]. 
    
   = 18.8 (c = 0.88, CHCl3). 
mp: 138 – 140 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 8.34 (s, 1H, H-13), 8.28 (s, 1H, 
H-17), 8.07 – 8.02 (m, 2H, 2 x H-20), 7.65 – 7.59 (m, 1H, H-22), 7.50 – 7.45 (m, 2H, 2 x H-21), 
6.45 (d, J = 1.5 Hz, 1H, H-1), 5.83 (s, 2H, 2 x H-28), 5.52 – 5.50 (m, 2H, H-9, H-2), 5.13 (d, 
J = 2.5 Hz, 1H, H-8), 4.58 – 4.55 (m, 1H, H-4), 4.51 (s, 1H, H-10), 4.44 – 4.37 (m, 2H, H-3, H-
6), 3.78 (s, 3H, 3 x H-12), 2.42 – 2.35 (m, 1H, H-5a or H-5b), 2.30 (s, 3H, 3 x H-24), 2.29 –
 2.21 (m, 1H, H-5a or H-5b), 2.19 (s, 3H, 3 x H-26), 0.35 (s, 9H, 9 x H-27) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 169.96 (C-25), 169.29 (C-23), 168.97 (C-11), 165.00 (C-18), 
155.54 (C-16), 153.35 (C-13), 150.04 (C-14), 139.25 (C-17), 134.09 (C-22), 130.04 (2 x C-20), 
128.78 (2 x C-21), 128.60 (C-19), 119.31 (C-15), 93.89 (C-7), 86.86 (C-1), 83.05 (C-2), 77.83 
(C-4), 75.45 (C-3), 74.75 (C-10), 70.43 (C-9), 69.59 (C-8), 66.45 (C-6), 52.86 (C-12), 25.28 (C-
5), 21.65 (C-26), 21.17 (C-24), 2.50 (3 x C-27) ppm. 
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IR (ATR): ṽ = 3374 (br, w), 2953 (w), 1733 (s), 1634 (m), 1594 (w), 1253 (s), 1045 (s), 843 
(m) cm
‒1
. 
HRMS (ESI): calcd. for C31H38O12N5Si
+
: 700.2281 [M+H]
+
    
  found:    700.2287 [M+H]
+
. 
 
Methyl (1S,3R,4R,5R,7R,9R,11S,12S,13S)-5-(6-amino-9H-purin-9-yl)-1,4,12,13-
tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (8) 
 
To a solution of glycoside 131 (10.6 mg, 15.1 µmol, 1.0 eq) in MeOH (1 mL) was added 
sodium methoxide (3.27 mg, 60.6 µmol, 4.0 eq), and the resulting mixture was stirred at room 
temperature for 90 min. The reaction was quenched with aq. HCl (1 N, 1 mL) and the mixture 
concentrated in vacuo. RP-18 flash column chromatography [H2O:MeOH 
100:09:14:12:11:1] afforded herbicidin C (8) (3.10 mg, 7.06 µmol, 48%) as a white 
solid. 
Herbicidin C (8): 
Rf = 0.22 [CH2Cl2:MeOH 6:1]. 
    
   = 26.9 (c = 0.70, MeOH). 
mp: 152 °C (decomposition). 
1
H-NMR (600 MHz, CD3OD): δ = 8.70 (s, 1H, H-17), 8.21 (s, 1H, 
H-13), 6.11 (d, J = 1.0 Hz, 1H, H-1), 4.66 (dd, J = 10.6, 6.3 Hz, 1H, H-6), 4.53 (ddd, J = 2.8, 
2.8, 2.7 Hz, 1H, H-4), 4.36 (br s, 1H, H-10), 4.34 (dd, J = 3.5, 1.5 Hz, 1H, H-9), 4.32 (s, 1H, H-
2), 4.31 (d, J = 2.3 Hz, 1H, H-3), 3.71 (s, 3H, 3 x H-12), 3.70 (d, J = 3.5 Hz, 1H, H-8), 2.25 –
 2.21 (m, 2H, H-5a, H-5b) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 171.80 (C-11), 157.15 (C-16), 153.87 (C-13), 150.37 (C-
14), 142.56 (C-17), 119.38 (C-15), 94.51 (C-7), 91.63 (C-1), 82.78 (C-2), 79.72 (C-4), 78.01 
(C-10), 77.33 (C-3), 73.80 (C-9), 71.22 (C-8), 65.57 (C-6), 52.30 (C-12), 26.52 (C-5) ppm. 
IR (ATR): ṽ = 3212 (m), 2924 (m), 1732 (w), 1623 (s), 1220 (m), 1049 (s) cm‒1. 
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HRMS (ESI): calcd. for C17H22N5O9
+
:  440.1412 [M+H]
+
    
  found:    440.1418 [M+H]
+
. 
 
Table 5. NMR-data [including 
1
H (600 MHz), 
13
C (150 MHz), HSQC, COSY, HMBC and 
NOESY] of herbicidin C (8) in CD3OD. 
position δC [ppm] δH [ppm] HSQC COSY HMBC NOESY 
1 91.63 6.11 C-1 H-2 C-2, C-3, C-4, C-14, C-17 H-2, H-4 
2 82.78 4.33 C-2 H-1 C-3, C-4 H-1, H-17 
3 77.33 4.31 C-3 H-4 C-1, C-2, C-4 H-4 
4 79.72 4.55 – 4.52 C-4 H-3, H-5a,b C-6 H-1, H-3, H-5a,b 
5a,b 26.52 2.25 – 2.21 C-5 H-4, H-6 C-3, C-4, C-6, C-7 H-4, H-6 
6 65.57 4.66 C-6 H-5a,b C-5 H-5a,b, H-17 
7 94.51 - - - - - 
8 71.22 3.71 C-8 H-9 C-6, C-7, C-9, C-10 H-9 
9 73.80 4.35 – 4.34 C-9 H-8 C-7, C-8 H-8 
10 78.01 4.36 C-10 - C-6, C-8, C-9, C-11, - 
11 171.80 - - - - - 
12 52.30 3.71 C-12 - C-11 - 
13 153.87 8.21 C-13 - C-14, C-15, C-16 - 
14 150.37 - - - - - 
15 119.38 - - - - - 
16 157.15 - - - - - 
17 142.56 8.70 C-17 - C-14, C-15, C-16 H-2, H-6 
18 - - - - - - 
19 - - - - - - 
20 - - - - - - 
21 - - - - - - 
22 - - - - - - 
 
 
Structural Verification of Herbicidin C (8) by Comparison with an Authentic Sample 
A solution of synthetic material 8 (2.22 mg) in MeOH-d4 (0.6 mL) was added in four 
portions (0.15 mL each) to a solution of natural herbicidin C (nat-8)
xviii
 (2.18 mg) in MeOH-d4 
(0.6 mL). After every addition, a 
1
H-NMR spectrum (600 MHz) was recorded. Comparison of 
the data unambiguously verified that the synthetic herbicidin C (8) was identical to the authentic 
material nat-8, since a second set of signals was not detected. In addition to this, a presumably 
pH- or residual solvent-dependent chemical shift of the protons of 8 was observed, which was 
most distinctive for the adenine protons H-13 and H-17 (Figure 22). 
 
 
xviii
 A sample of natural herbicidin C (nat-8) was provided by Bayer CropScience AG. 
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Figure 22. Comparison of 
1
H-NMR data derived from the titration experiment with synthetic 3 
and natural herbicidin C nat-3. 
 
(1S,3R,4R,5R,7R,9R,11S,12S,13S)-5-(6-amino-9H-purin-9-yl)-1,4,12,13-tetrahydroxy-
2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylic acid (14) 
 
A solution of herbicidin C (8) (4.70 mg, 10.7 µmol, 1.0 eq) and lithium hydroxide (0.38 mg, 
16.0 µmol, 1.5 eq) in a mixture of THF and water (3:1, 1 mL) was stirred at room temperature 
for 15 min. The reaction was quenched with one drop of acetic acid and the mixture 
concentrated in vacuo. RP-18 flash column chromatography [H2O:MeCN 
100:099:19:14:1] afforded aureonuclemycin (14) (1.50 mg, 3.53 µmol, 33%) as a white 
solid. 
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Aureonuclemycin (14): 
Rf = 0.52 [RP, H2O]. 
    
   = 32.0 (c = 0.08, MeOH). 
mp: 195 °C (decomposition). 
1
H-NMR (600 MHz, CD3OD): δ = 8.78 (s, 1H, H-17), 8.20 (s, 1H, H-13), 6.09 (d, J = 0.9 Hz, 
1H, H-1), 4.60 (dd, J = 11.7, 5.2 Hz, 1H, H-6), 4.53 – 4.50 (m, 1H, H-4), 4.41 (d, J = 3.1 Hz, 
1H, H-9), 4.32 (s, 1H, H-2), 4.30 (d, J = 2.2 Hz, 1H, H-3), 4.25 (br s, 1H, H-10), 3.70 (d, 
J = 3.2 Hz, 1H, H-8), 2.31 – 2.26 (m, 1H, H-5a), 2.22 – 2.16 (m, 1H, H-5b) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 175.17 (inferred from HMBC, C-11), 157.16 (C-16), 153.78 
(C-13), 150.41 (C-14), 142.87 (C-17), 119.40 (C-15), 94.83 (C-7), 91.38 (C-1), 82.86 (C-2), 
79.99 (br, C-10), 79.63 (C-4), 77.21 (C-3), 73.25 (C-9), 71.96 (C-8), 65.24 (C-6), 26.52 (C-
5) ppm. 
IR (ATR): ṽ = 3198 (m), 1603 (m), 1418 (m), 1080 (s) cm‒1. 
HRMS (ESI): calcd. for C16H20N5O9
+
:  426.1256 [M+H]
+
    
  found:    426.1257 [M+H]
+
. 
 
Table 6. NMR-data [including 
1
H (600 MHz), 
13
C (150 MHz), HSQC, COSY, HMBC and 
NOESY] of aureonuclemycin (14) in CD3OD. 
position δC [ppm] δH [ppm] HSQC COSY HMBC NOESY 
1 91.38 6.09 C-1 H-2 C-2, C-14, C-17 H-2, H-4 
2 82.86 4.32 C-2 H-1 C-3, C-4 H-1, H-17 
3 77.21 4.30 C-3 H-4 C-1, C-2, C-4 H-4, H-5b 
4 79.63 4.53 – 4.50 C-4 H-3, H-5a, H-5b C-6 H-1, H-3, H-5a, H-5b 
5a 26.52 2.31 – 2.26 C-5 H-4, H-6 C-6 H-4, H-6 
5b 26.52 2.22 – 2.16 C-5 H-4, H-6 - H-4 
6 65.24 4.60 C-6 H-5a, H-5b - H-5a, H-17 
7 94.83 - - - - - 
8 71.96 3.70 C-8 H-9 C-7, C-10 H-9 
9 73.25 4.41 C-9 H-8, H-10 C-7, C-8 H-8, H-10 
10 79.99 4.25 C-10 H-9 C-6, C-8, C-9, C-11 H-9 
11 175.17 - - - - - 
12 - - - - - - 
13 153.78 8.20 C-13 - C-14, C-16 - 
14 150.41 - - - - - 
15 119.40 - - - - - 
16 157.16 - - - - - 
17 142.87 8.78 C-17 - C-14, C-15 H-2, H-6 
18 - - - - - - 
19 - - - - - - 
20 - - - - - - 
21 - - - - - - 
22 - - - - - - 
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Methyl (1R,3S,4R,5R,7R,9R,11S,12S,13S)-5-(6-amino-9H-purin-9-yl)-1,12-dihydroxy-4-
methoxy-13-[(2-methylbutanoyl)oxy]-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-
carboxylate (140): 
 
To a solution of herbicidin A (8) (151 mg, 0.274 mmol, 1.0 eq) in MeOH (7.5 mL) was added 
platinum(IV) oxide (6.22 mg, 27.4 µmol, 10 mol%) and the flask was purged with hydrogen gas 
five times. The mixture was then stirred under hydrogen atmosphere at room temperature for 
20 h. The catalyst was removed by filtration through a pad of Celite, and the Celite was washed 
with MeOH (20 mL). The filtrate was then concentrated in vacuo, and flash column 
chromatography [CH2Cl2:MeOH 49:124:119:1] afforded glycoside 140 (99.5 mg, 
0.185 mmol, 68%) as a white solid consisting of two diastereomers of 140 and a third, 
structurally unknown, minor compound (4:4:1 ratio, as determined by 
1
H-NMR spectroscopy) 
as an inseparable mixture. 
Glycoside 140: 
Rf = 0.51 [CH2Cl2:MeOH 9:1]. 
1
H-NMR (400 MHz, CDCl3) (mixture of isomers, both isomers 
quoted, one isomer primed): δ = 8.22 (s, 1H, H-13 or H-13'), 8.21 
(s, 1H, H-13 or H-13'), 8.21 (s, 1H, H-17'), 8.17 (s, 1H, H-17), 6.09 
(d, J = 1.4 Hz, 1H, H-1'), 6.07 (d, J = 1.3 Hz, 1H, H-1), 4.90 – 4.89 
(m, 1H, H-8), 4.86 – 4.84 (m, 1H, H-8'), 4.54 – 4.46 (m, 8H, H-3, H-4, H-6, H-10, H-3', H-4', 
H-6', H-10'), 4.33 (dd, J = 3.0, 1.4 Hz, 1H, H-9'), 4.26 (dd, J = 3.0, 1.4 Hz, 1H, H-9), 4.08 (d, 
J = 1.4 Hz, 1H, H-2), 4.01 (d, J = 1.4 Hz, 1H, H-2'), 3.78 (s, 6H, 3 x H-12, 3 x H-12'), 3.52 (s, 
3H, 3 x H-18), 3.51 (s, 3H, 3 x H-18'), 2.50 – 2.44 (m, 1H, H-20'), 2.42 – 2.36 (m, 1H, H-20), 
2.33 – 2.28 (m, 4H, H-5a, H-5b, H-5a', H-5b'), 1.66 – 1.28 (m, 4H, H-21a, H-21b, H-21a', H-
21b'), 1.13 (d, J = 7.0 Hz, 3H, 3 x H-23'), 0.93 (dd, J = 7.5, 7.5 Hz, 3H, 3 x H-22), 0.86 (d, 
J = 6.9 Hz, 3H, 3 x H-23), 0.65 (dd, J = 7.4, 7.4 Hz, 3H, 3 x H-22') ppm. 
13
C-NMR (100 MHz, CDCl3) (mixture of isomers, both isomers quoted, one isomer primed): 
δ = 177.05 (C-19'), 176.96 (C-19), 171.47 (C-11 or C-11'), 171.45 (C-11 or C-11'), 157.32 (C-
16 or C-16'), 157.30 (C-16 or C-16'), 154.04 (C-13 or C-13'), 154.01 (C-13 or C-13'), 150.36 
(C-14 or C-14'), 150.29 (C-14 or C-14'), 140.11 (C-17'), 139.89 (C-17), 120.19 (C-15 and C-
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15'), 92.61 (C-7 or C-7'), 92.57 (C-7 or C-7'), 91.98 (C-2'), 91.78 (C-2), 90.20 (C-1), 90.01 (C-
1'), 79.62 (C-4 or C-4'), 79.57 (C-4 or C-4'), 78.28 (C-10 and C-10'), 74.88 (C-3 or C-3'), 74.82 
(C-3 or C-3'), 72.44 (C-8'), 72.20 (C-8), 70.52 (C-9), 70.10 (C-9'), 66.88 (C-6 or C-6'), 66.77 
(C-6 or C-6'), 58.56 (C-18 and C-18'), 52.87 (C-12 or C-12'), 52.82 (C-12 or C-12'), 41.50 (C-
20), 41.33 (C-20'), 27.75 (C-21'), 27.50 (C-21), 26.96 (C-5 and C-5'), 17.24 (C-23'), 16.80 (C-
23), 11.61 (C-22), 11.34 (C-22') ppm. 
IR (ATR): ṽ = 3344 (w), 2939 (w), 1734 (m), 1637 (m), 1463 (w), 1299 (w), 1201 (m), 1139 (s), 
1060 (s), 999 (m), 908 (w), 714 (w) cm
‒1
. 
HRMS (ESI): calcd. for C23H32N5O10
+
: 538.2144 [M+H]
+
    
  found:    538.2141 [M+H]
+
. 
 
Methyl (1S,3S,4R,5R,7R,9R,11S,12S,13S)-5-(6-amino-9H-purin-9-yl)-1,12,13-trihydroxy-4-
methoxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (7): 
 
A solution of herbicidin A (6) (50.6 mg, 91.7 µmol, 1.0 eq) in MeOH (5 mL) was cooled to 
 °C and hydrazine hydrate (51 wt% hydrazine, 11.4 µL, 187 µmol, 2.0 eq) was added. The 
mixture was allowed to warm to room temperature and stirred at this temperature for 22 h. The 
reaction was quenched with aq. HCl (1 M, 2 mL) and CH2Cl2 (5 mL) was added. The aqueous 
layer was separated and the organic phase was extracted further with aq. HCl (1 M, 2 x 2 mL). 
The combined aqueous fractions were concentrated in vacuo, and RP-18 flash column 
chromatography [H2O:MeOH 100:049:124:114:19:16:14:13:12:11:11:2 
1:31:41:50:100] afforded herbicidin B (7) (30.2 mg, 66.6 µmol, 73%) as a white solid. 
Herbicidin B (7): 
Rf = 0.34 [CH2Cl2:MeOH 6:1]. 
    
   = 47.5 (c = 1.0, MeOH). 
mp: 146 °C (decomposition). 
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1
H-NMR (600 MHz, CD3OD): δ = 8.68 (s, 1H, H-17), 8.21 (s, 1H, 
H-13), 6.17 (d, J = 1.1 Hz, 1H, H-1), 4.67 (dd, J = 9.4, 7.6 Hz, 1H, 
H-6), 4.44 (d, J = 2.3 Hz, 1H, H-3), 4.44 – 4.41 (m, 1H, H-4), 4.37 
(s, 1H, H-10), 4.37 – 4.34 (m, 1H, H-9), 4.00 (s, 1H, H-2), 3.73 –
 3.71 (m, 1H, H-8), 3.71 (s, 3H, 3 x H-12), 3.46 (s, 3H, 3 x H-18), 
2.25 – 2.21 (m, 2H, H-5a, H-5b) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 171.78 (C-11), 157.14 (C-16), 153.96 (C-13), 150.27 (C-
14), 142.42 (C-17), 119.35 (C-15), 94.64 (C-7), 92.15 (C-2), 89.10 (C-1), 79.71 (C-4), 78.01 
(C-10), 74.34 (C-3), 73.79 (C-9), 71.24 (C-8), 65.47 (C-6), 58.39 (C-18), 52.32 (C-12), 26.41 
(C-5) ppm. 
IR (ATR): ṽ = 3328 (w), 2937 (w), 1734 (w), 1640 (m), 1599 (m), 1419 (w), 1298 (w), 1045 (s), 
997 (s), 857 (w), 709 (w) cm
‒1
. 
HRMS (ESI): calcd. for C18H24N5O9
+
: 454.1569 [M+H]
+     
  found:   454.1571 [M+H]
+
. 
 
6-Amino-9-[(1R,3S,4R,5R,7R,9R,11S,12S,13S)-1,12-dihydroxy-13-{[(2E)-2-(hydroxy-
methyl)but-2-enoyl]oxy}-4-methoxy-11-(methoxycarbonyl)-2,6,10-trioxatricyclo[7.4.0.0
3,7
] 
tridecan-5-yl]-9H-purin-1-ium-1-olate (134): 
 
To a solution of herbicidin A (6) (51.3 mg, 93.0 µmol, 1.0 eq) in a mixture of CH2Cl2 and 
MeOH (4:1, 2.5 mL) was added 3-chloroperbenzoic acid (48.1 mg, 0.279 mmol, 3.0 eq) in one 
portion, and the resulting solution was stirred at room temperature for 21 h. The reaction 
mixture was concentrated in vacuo, and flash column chromatography [CH2Cl2:MeOH 
6:14:1] provided the crude product, which was further purified by HPLC [Dynamax 
Microsorb 60-8 C18 (250 x 21.4 mm), gradient, water (A)/MeCN (B) +0.1% formic acid; 0 min 
5% B, 2 min 5% B, 25 min 95% B; flow rate 15 mL/min; detection 227 nm: tR(134) = 12.6 min] 
to afford N-oxide 134 (28.1 mg, 49.5 µmol, 53%) as a white solid. 
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N-oxide 134: 
Rf = 0.21 [CH2Cl2:MeOH 6:1]. 
    
   = 42.1 (c = 0.57, MeOH). 
mp: 130 °C (decomposition). 
1
H-NMR (400 MHz, CDCl3): δ = 8.61 (s, 1H, H-13), 8.10 (s, 1H, 
H-17), 6.80 (q, J = 7.2 Hz, 1H, H-21), 6.06 (d, J = 1.6 Hz, 1H, H-1), 5.07 (d, J = 3.2 Hz, 1H, H-
8), 4.54 (dd, J = 10.9, 6.0 Hz, 1H, H-6), 4.49 (d, J = 2.2 Hz, 1H, H-3), 4.48 (s, 1H, H-10), 4.43 –
 4.38 (m, 3H, H-4, H-23a, H-23b), 4.33 (dd, J = 3.3, 1.2 Hz, 1H, H-9), 4.06 (d, J = 1.5 Hz, 1H, 
H-2), 3.64 (s, 3H, 3 x H-12), 3.41 (s, 3H, 3 x H-18), 2.33 – 2.22 (m, 2H, H-5a, H-5b), 2.02 (d, 
J = 7.2 Hz, 3H, 3 x H-22) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 171.32 (C-11), 166.05 (C-19), 150.13 (C-16), 145.71 (C-13 
or C-21), 145.62 (C-13 or C-21), 144.77 (C-14), 143.59 (C-17), 132.44 (C-20), 119.55 (C-15), 
93.30 (C-7), 91.53 (C-2), 88.63 (C-1), 79.35 (C-4), 78.25 (C-10), 74.49 (C-3), 71.87 (C-8), 
70.60 (C-9), 66.47 (C-6), 58.39 (C-18), 56.28 (C-23), 52.83 (C-12), 26.53 (C-5), 15.10 (C-
22) ppm. 
IR (ATR): ṽ = 3283 (w), 2949 (w), 1715 (m), 1665 (m), 1497 (w), 1214 (m), 1061 (s), 830 (w), 
700 (w) cm
‒1
. 
HRMS (ESI): calcd. for C23H30N5O12
+
: 568.1885 [M+H]
+
    
  found:    568.1882 [M+H]
+
. 
 
Methyl (1R,3S,4R,5R,7R,9R,11S,12S,13S)-1,12-dihydroxy-13-{[(2E)-2-(hydroxymethyl) 
but-2-enoyl]oxy}-4,5-dimethoxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
]tridecane-11-
carboxylate (135a) and Methyl (1R,3S,4R,5S,7R,9R,11S,12S,13S)-1,12-dihydroxy-13-
{[(2E)-2-(hydroxymethyl)but-2-enoyl]oxy}-4,5-dimethoxy-2,6,10-
trioxatricyclo[7.4.0.0
3,7
]tridecane-11-carboxylate (135b): 
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To a solution of herbicidin A (6) (108 mg, 0.196 mmol, 1.0 eq) in MeOH (10 mL) was added 
amberlyst 15 resin (hydrogen form, dry, 50 mg). The resulting mixture was refluxed at 90 °C for 
2 h until complete consumption of the starting material (as indicated by TLC analysis). The 
reaction mixture was cooled to room temperature, diluted with CH2Cl2 (10 mL) and stirred for 
48 h to remove absorbed material from the resin. The resin was then removed by filtration over 
cotton wool and the filtrate concentrated in vacuo. Flash column chromatography 
[CH2Cl2:MeOH 99:120:1] afforded acetals 130 (47.9 mg, 0.104 mmol, 53%) as white solid 
consisting of two diastereomers (d.r. 2:1, as determined by 
1
H-NMR spectroscopy) as an 
inseparable mixture. An analytical sample of the mixture was purified by HPLC [Dynamax 
Microsorb 60-8 C18 (250 x 21.4 mm), gradient, water (A)/MeOH (B); 0 min 20% B, 2 min 20% 
B, 30 min 73% B; flow rate 15 mL/min; detection 222 nm: tR(135b) = 17.9 min, 
tR(135a) = 22.3 min] for full characterization of both isomers. 
Major acetal 135a: 
Rf = 0.53 [CH2Cl2:MeOH 9:1]. 
    
   = 54.4 (c = 0.58, MeOH). 
mp: 51 – 52 °C. 
1
H-NMR (600 MHz, CD3OD): δ = 6.94 (q, J = 7.2 Hz, 1H, H-17), 4.86 – 4.85 (m, 1H, H-8), 
4.79 (s, 1H, H-1), 4.50 (dd, J = 11.1, 5.7 Hz, 1H, H-6), 4.43 (br s, 1H, H-10), 4.36 (dd, J = 3.3, 
1.4 Hz, 1H, H-9), 4.30 (br s, 2H, H-19a, H-19b), 4.29 – 4.27 (m, 1H, H-4), 4.18 (d, J = 3.0 Hz, 
1H, H-3), 3.65 (s, 3H, 3 x H-12), 3.55 (br s, 1H, H-2), 3.36 (s, 3H, 3 x H-13), 3.35 (s, 3H, 
3 x H-14), 2.21 – 2.12 (m, 2H, H-5a, H-5b), 1.95 (d, J = 7.2 Hz, 3H, 3 x H-18) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 171.32 (C-11), 166.62 (C-15), 143.79 (C-17), 133.21 (C-
16), 109.94 (C-1), 92.57 (C-7), 90.94 (C-2), 78.23 (C-4), 78.10 (C-10), 73.79 (C-3), 71.73 (C-
8), 70.28 (C-9), 66.80 (C-6), 57.96 (C-13), 56.11 (C-19), 55.93 (C-14), 52.73 (C-12), 27.26 (C-
5), 14.52 (C-18) ppm. 
IR (ATR): ṽ = 3422 (m), 2940 (m), 1716 (s), 1438 (w), 1271 (m), 1114 (s), 1012 (s), 962 (m), 
759 (w) cm
‒1
. 
HRMS (ESI): calcd. for C19H28NaO12
+
: 471.1473 [M+Na]
+
    
  found:    471.1471 [M+Na]
+
. 
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Minor acetal 135b: 
Rf = 0.53 [CH2Cl2:MeOH 9:1]. 
    
   = 132.0 (c = 0.25, MeOH). 
mp: 63 – 65 °C. 
1
H-NMR (600 MHz, CD3OD): δ = 6.88 (q, J = 7.2 Hz, 1H, H-17), 4.98 (d, J = 4.4 Hz, 1H, H-1), 
4.90 (d, J = 3.3 Hz, 1H, H-8), 4.44 – 4.40 (m, 2H, H-6, H-10), 4.33 – 4.32 (m, 1H, H-9), 4.30 –
 4.26 (m, 3H, H-4, H-19a, H-9b), 4.20 (d, J = 2.6 Hz, 1H, H-3), 3.65 (s, 3H, 3 x H-12), 3.65 –
 3.63 (m, 1H, H-2),  3.42 (s, 3H, 3 x H-14), 3.36 (s, 3H, 3 x H-13), 2.13 – 2.10 (m, 2H, H-5a, H-
5b), 1.94 (d, J = 7.2 Hz, 3H, 3 x H-18) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 171.34 (C-11), 166.33 (C-15), 143.73 (C-17), 133.44 (C-
16), 105.10 (C-1), 92.66 (C-7), 87.21 (C-2), 78.27 (C-10), 75.91 (C-3), 75.78 (C-4), 71.66 (C-
8), 70.47 (C-9), 66.59 (C-6), 59.31 (C-13), 56.60 (C-14), 56.05 (C-19), 52.73 (C-12), 26.62 (C-
5), 14.51 (C-18) ppm. 
IR (ATR): ṽ = 3407 (m), 2936 (m), 1718 (s), 1438 (w), 1269 (m), 1197 (m), 1137 (s), 1015 (s), 
965 (m), 774 (w) cm
‒1
. 
HRMS (ESI): calcd. for C19H28NaO12
+
: 471.1473 [M+Na]
+
    
  found:    471.1471 [M+Na]
+
. 
 
Methyl (1S,3S,4R,5S,7R,9R,11S,12S,16S)-5-(6-amino-9H-purin-9-yl)-16-{[(2E)-2-(hydroxy-
methyl)but-2-enoyl]oxy}-4-methoxy-14-oxo-2,6,10,13,15-pentaoxa-14λ4-thiatetracyclo 
[10.3.1.0
1,9
.0
3,7
]hexadecane-11-carboxylate (136): 
 
To a solution of herbicidin A (6) (46.3 mg, 84.0 µmol, 1.0 eq) and 4-(dimethylamino)pyridine 
(1.03 mg, 8.40 µmol, 10 mol%) in a CH2Cl2/acetone/MeCN (3:1:1, 5 mL) mixture was added 
1,1'-thiocarbonyldiimidazole (90%, 18.3 mg, 92.3 µmol, 1.1 eq) in one portion, and the 
resulting mixture was stirred at room temperature for 72 h. The reaction was quenched with aq. 
NH4Cl (5 mL of a saturated solution) and the mixture was extracted with CH2Cl2 (3 x 10 mL). 
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The combined organic fractions were washed with brine (20 mL), then dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [CH2Cl2:MeOH 14:1] afforded 
thiocarbonate 136 (14.3 mg, 24.1 µmol, 29%) as a white solid. 
Thiocarbonate 136: 
Rf = 0.66 [CH2Cl2:MeOH 6:1]. 
    
   = 101.1 (c = 0.46, DMSO). 
mp: 153 °C (decomposition).  
1
H-NMR (400 MHz, DMSO-d6): δ = 8.18 (s, 1H, H-13), 7.71 (s, 1H, H-17), 7.30 (s, 2H, 2 x H-
25), 6.65 (q, J = 7.2 Hz, 1H, H-22), 5.95 (d, J = 2.4 Hz, 1H, H-1), 5.66 (d, J = 4.3 Hz, 1H, H-8), 
5.35 (dd, J = 4.4, 2.2 Hz, 1H, H-9), 5.13 (d, J = 2.0 Hz, 1H, H-10), 4.84 (dd, J = 5.5, 5.5 Hz, 
1H, H-26), 4.65 (d, J = 2.3 Hz, 1H, H-3), 4.57 (dd, J = 11.6, 5.5 Hz, 1H, H-6), 4.55 – 4.52 (m, 
1H, H-4), 4.47 (d, J = 2.4 Hz, 1H, H-2), 4.25 – 4.20 (m, 2H, H-24a, H-24b), 3.55 (s, 3H, 3 x H-
12), 3.38 (s, 3H, 3 x H-18), 2.41 – 2.34 (m, 1H, H-5a or H-5b), 2.08 – 1.98 (m, 1H, H-5a or H-
5b), 1.95 (d, J = 7.2 Hz, 3H, 3 x H-23) ppm. 
13
C-NMR (100 MHz, DMSO-d6): δ = 185.54 (C-19), 166.73 (C-11), 163.45 (C-20), 156.00 (C-
16), 153.19 (C-13), 149.23 (C-14), 145.39 (C-22), 137.76 (C-17), 130.26 (C-21), 118.03 (C-15), 
100.76 (C-7), 88.21 (C-2), 86.55 (C-1), 75.60 (C-9), 75.08 (C-4), 74.98 (C-3), 72.85 (C-10), 
64.77 (C-6), 62.33 (C-8), 57.65 (C-18), 54.25 (C-24), 52.79 (C-12), 24.70 (C-5), 14.73 (C-
23) ppm. 
IR (ATR): ṽ = 3546 (w), 3146 (w), 2328 (w), 1740 (m), 1728 (m), 1630 (w), 1438 (w), 1286 (s), 
1210 (s), 1166 (s), 1002 (s), 957 (m), 850 (w), 699 (w) cm
‒1
. 
HRMS (FAB): calcd. for C24H28N5O11S
+
: 594.1501 [M+H]
+
    
  found:    594.1501 [M+H]
+
. 
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Methyl (2S,3S,4R,5E,6R)-6-{[(2R,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-
methoxyoxolan-2-yl]methyl}-3-hydroxy-5-(hydroxyimino)-4-{[(2E)-2-(hydroxymethyl)but-
2-enoyl]oxy}oxane-2-carboxylate (138) 
 
A solution of herbicidin A (6) (71.9 mg, 0.130 mmol, 1.0 eq), pyridine (210 µL, 2.60 mmol, 
20 eq) and hydroxylamine hydrochloride (10.8 mg, 0.156 mmol, 1.2 eq) in MeOH (5 mL) was 
stirred at room temperature for 47 h. In order to drive the reaction to completion, hydroxylamine 
hydrochloride (10.8 mg, 0.156 mmol, 1.2 eq) was added, and the reaction mixture was stirred at 
room temperature for an additional 21 h. Volatile material was removed in vacuo and the 
residue subjected to flash column chromatography [CH2Cl2:MeOH 9:1] to afford major 
oxime 138a (26.4 mg, 46.6 µmol, 36%) as a white solid and a mixture of minor oxime 138b and 
major oxime 134a (4:1, as determined by 
1
H-NMR spectroscopy, 15.1 mg, 26.7 µmol, 21%), as 
well as recovered starting material 6 (6.60 mg, 12.0 µmol, 9%). The stereochemistry of major 
and minor oxime 138a and 138b remained unclear. 
Major oxime 138: 
Rf = 0.55 [CH2Cl2:MeOH 4:1]. 
    
   = 36.5 (c = 0.46, MeOH). 
mp: 130 °C (decomposition). 
1
H-NMR (600 MHz, CD3OD): δ = 8.30 (s, 1H, H-23), 8.21 (s, 1H, H-19), 7.09 (q, J = 7.2 Hz, 
1H, H-16), 6.03 (d, J = 1.2 Hz, 1H, H-1), 5.65 (d, J = 9.1, 1H, H-8), 5.43 (dd, J = 10.4, 3.9 Hz, 
1H, H-6), 4.47 (d, J = 7.7 Hz, 1H, H-10), 4.38 (d, J = 12.1 Hz, 1H, H-18a or H-18b), 4.35 (d, 
J = 12.1 Hz, 1H, H-18a or H-18b), 4.33 – 4.30 (m, 1H, H-4), 4.23 (d, J = 3.2 Hz, 1H, H-3), 
4.11 – 4.06 (m, 2H, H-2, H-9), 3.79 (s, 3H, 3 x H-12), 3.52 (s, 3H, 3 x H-13), 2.45 – 2.39 (m, 
1H, H-5a or H-5b), 2.28 – 2.22 (m, 1H, H-5a or H-5b), 1.94 (d, J = 7.3, 3H, 3 x H-17) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 171.42 (C-11), 167.63 (C-14), 157.33 (C-22), 153.58 (C-
19), 153.09 (C-7), 149.65 (C-20), 143.69 (C-16), 141.81 (C-23), 133.29 (C-15), 120.35 (C-21), 
92.69 (C-2), 89.92 (C-1), 81.52 (C-4), 76.32 (C-10), 74.89 (C-3), 73.33 (C-8), 72.51 (C-9), 
69.83 (C-6), 58.32 (C-13), 56.31 (C-18), 52.94 (C-12), 29.11 (C-5), 14.40 (C-18) ppm. 
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IR (ATR): ṽ = 3202 (w), 2923 (w), 1716 (m), 1641 (m), 1476 (w), 1334 (w), 1273 (m), 1206 
(m), 1082 (s), 989 (s), 831 (w) cm
‒1
. 
HRMS (ESI): calcd. for C23H31N6O11
+
: 567.2045 [M+H]
+    
  found:    567.2044 [M+H]
+
. 
 
Methyl (1R,3S,4R,5S,7R,9R,11S,12S,13S)-13-{[(2E)-2-[(acetyloxy)methyl]but-2-enoyl]oxy}-
5-(6-acetamido-9H-purin-9-yl)-1,12-dihydroxy-4-methoxy-2,6,10-trioxatricyclo[7.4.0.0
3,7
] 
tridecane-11-carboxylate (142) 
 
A solution of herbicidin A (6) (45.7 mg, 82.9 µmol, 1eq) in a mixture of acetic acid and acetic 
anhydride (1:1, 4 mL) was heated to 40 °C and stirred at this temperature for 50 h. The reaction 
was quenched with water (15 mL) and the mixture stirred at 40 °C for an additional 30 min, 
then allowed to cool to room temperature. The mixture was extracted with EtOAc (3 x 20 mL) 
and the combined organic fractions were washed with aq. NaHCO3 (20 mL of a saturated 
solution) and brine (20 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [CH2Cl2:acetone 5:1] afforded acetate 142 (33.8 mg, 53.1 µmol, 64%) as a 
white solid. 
Acetate 142: 
Rf = 0.51 [CH2Cl2:MeOH 9:1].  
    
   = 34.0 (c = 0.10, acetone). 
mp: 93 – 95 °C. 
1
H-NMR (600 MHz, DMSO-d6): δ = 10.55 (s, 1H, H-30), 8.69 (s, 1H, H-13), 8.07 (s, 1H, H-
17), 6.96 (s, 1H, H-28), 6.89 (q, J = 7.2 Hz, 1H, H-21), 6.07 (d, J = 1.7 Hz, 1H, H-1), 5.66 (d, 
J = 7.8 Hz, 1H, H-29), 4.97 (d, J = 3.1 Hz, 1H, H-8), 4.84 (d, J = 12.0 Hz, 1H, H-23a or H-23b), 
4.80 (d, J = 12.0 Hz, 1H, H-23a or H-23b), 4.48 (s, 1H, H-10), 4.42 (d, J = 2.3 Hz, 1H, H-3), 
4.40 – 4.35 (m, 2H, H-4, H-6), 4.22 (d, J = 1.7 Hz, 1H, H-2), 4.17 (ddd, J = 7.8, 3.2, 1.3 Hz, 1H, 
H-9), 3.51 (s, 3H, 3 x H-12), 3.35 (s, 3H, 3 x H-18), 2.25 (s, 3H, 3 x H-27), 2.19 – 2.13 (m, 1H, 
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H-5a or H-5b), 2.11 – 2.06 (m, 1H, H-5a or H-5b), 2.04 (d, J = 7.2 Hz, 3H, 3 x H-22), 1.96 (s, 
3H, 3 x H-25) ppm. 
13
C-NMR (100 MHz, DMSO-d6): δ = 170.65 (C-24), 169.94 (C-11), 169.26 (C-26), 164.27 (C-
19), 152.57 (C-13), 151.99 (C-14), 150.14 (C-16), 147.93 (C-21), 141.78 (C-17), 126.54 (C-20), 
123.76 (C-15), 91.90 (C-7), 89.62 (C-2), 86.92 (C-1), 77.72 (C-4), 76.57 (C-10), 73.01 (C-3), 
71.00 (C-8), 69.11 (C-9), 65.17 (C-6), 57.84 (C-18), 57.71 (C-23), 52.30 (C-12), 25.85 (C-5), 
24.45 (C-27), 21.02 (C-25), 15.30 (C-22) ppm. 
IR (ATR): ṽ = 3249 (w), 2948 (w), 1719 (m), 1607 (m), 1586 (m), 1457 (m), 1371 (m), 1224 
(s), 1134 (s), 1064 (s), 1001 (s), 964 (m), 856 (w), 747 (w) cm
‒1
. 
HRMS (ESI): calcd. for C27H34N5O13
+
: 636.2148 [M+H]
+
    
  found:    636.2145 [M+H]
+
. 
 
(3R,3aR,7aR)-2-(acetyloxy)-3a,7a-dimethyl-5-oxo-2H,3H,3aH,5H,7aH-furo[3,2-b]pyran-3-
yl acetate (143) 
 
To a solution of unsaturated lactone 63 (402 mg, 1.89 mmol, 1.0 eq) in acetic acid (13.5 mL) 
was added conc. H2SO4 (15.0 µL), followed by acetic anhydride (448 µL, 4.74 mmol, 2.5 eq). 
The reaction mixture was stirred at room temperature for 20 h, then carefully quenched with 
NaHCO3 (20 g) and diluted with water (20 mL). Aq. NaHCO3 (40 mL of a saturated solution) 
was added and the mixture extracted with CH2Cl2 (4 x 50 mL). The combined organic fractions 
were washed with brine (50 mL), then dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [PE:EtOAc 4:13:12:11:1] afforded acetate 143 (481 mg, 1.88 mmol, 
99%) as a colorless oil consisting of two diastereomers (d.r. 4:1, as determined by 
1
H-NMR 
spectroscopy) as inseparable mixture. 
Acetate 143: 
Rf = 0.57 [PE:EtOAc 1:1].  
1
H-NMR (400 MHz, CDCl3) (mixture of isomer, both isomers quoted, minor isomer 
primed): 6.89 (dd, J = 10.0, 4.9 Hz, 1H, H-5), 6.80 (dd, J = 10.1, 4.1 Hz, 1H, H-5'), 6.42 (d, 
J = 4.6, 1H, H-1'), 6.18 – 6.13 (m, 3H, H-1, H-6, H-6'), 5.42 – 5.40 (m, 1H, H-2), 5.34 – 5.30 
(m, 1H, H-2'), 5.18 (dd, J = 6.9, 5.3 Hz, 1H, H-3'), 5.03 (dd, J = 6.0, 1.3 Hz, 1H, H-3), 4.84 –
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 4.78 (m, 2H, H-4, H-4'), 2.12 (s, 3H, 3 x H-11), 2.10 (s, 3H, 3 x H-11'), 2.07 (s, 3H, 3 x H-9'), 
2.00 (s, 3H, 3 x H-9) ppm. 
13
C-NMR (75 MHz, CDCl3) (mixture of isomer, both isomers quoted, minor isomer primed): 
δ = 169.48 (C-10'), 169.30 (C-10), 169.12 (C-8'), 169.11 (C-8), 159.47 (C-7), 159.42 (C-7'), 
140.16 (C-5), 139.97 (C-5'), 122.96 (C-6), 122.90 (C-6'), 98.70 (C-1), 92.23 (C-1'), 80.99 (C-3), 
80.52 (C-2), 79.93 (C-3'), 77.48 (C-2'), 70.26 (C-4), 66.58 (C-4'), 20.92 (C-9 and C-9'), 20.67 
(C-11), 20.37 (C-11') ppm. 
IR (ATR): ṽ = 3004 (w), 1732 (s), 1370 (m), 1208 (s), 1159 (w), 1110 (m), 1013 (m), 862 (w), 
818 (w), 754 (w) cm
‒1
. 
HRMS (ESI): calcd. for C11H12NaO7
+
: 279.0475 [M+Na]
+
     
  found:   279.0475 [M+Na]
+
. 
 
(2R,3R,3aR,7aR)-2-(6-amino-9H-purin-9-yl)-3a,7a-dimethyl-5-oxo-2H,3H,3aH,5H,7aH-
furo[3,2-b]pyran-3-yl acetate (144) 
 
To a suspension of acetate 143 (53.7 mg, 0.210 mmol, 1.0 eq) and adenine (42.6 mg, 
0.315 mmol, 1.5 eq) in MeCN (5 mL) was added tin(IV) chloride (49.1 µL, 0.420 mmol, 
2.0 eq), and the resulting solution was heated to 60 °C and stirred at this temperature for 4.5 h. 
After cooling to room temperature, the reaction mixture was quenched with aq. NaHCO3 
(1.4 mL of a saturated solution) and the mixture extracted with CH2Cl2 (3 x 20 mL). The 
combined organic fractions were washed with brine (20 mL), dried (MgSO4) and concentrated 
in vacuo. Flash column chromatography [CH2Cl2:AcOH 19:11:1] afforded glycoside 144 
(44.0 mg, 0.133 mmol, 63%) as a white solid. 
Glycoside 144: 
Rf = 0.57 [PE:EtOAc 1:1]. 
    
   = 100.0 (c = 0.98, AcOH). 
mp: 179 – 181 °C (decomposition). 
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1
H-NMR (400 MHz, acetic acid-d4): 8.38 (br s, 1H, H-8), 8.28 (s, 1H, H-12), 7.12 (dd, J = 9.8, 
5.4 Hz, 1H, H-5), 6.45 (d, J = 2.1 Hz, 1H, H-1), 6.38 (d, J = 9.8 Hz, 1H, H-6), 5.81 (s, 1H, H-2), 
5.26 (dd, J = 4.1, 1.1 Hz, 1H, H-3), 4.97 – 4.91 (m, 1H, H-4), 2.18 (s, 3H, 3 x H-14) ppm. 
13
C-NMR (100 MHz, acetic acid-d4): δ = 171.88 (C-13), 162.70 (C-7), 156.15 (C-11), 152.11 
(C-8), 150.14 (C-9), 141.60 (C-12), 140.67 (C-5), 126.30 (C-6), 119.51 (C-10), 89.54 (C-1), 
83.24 (C-3), 82.82 (C-2), 71.66 (C-4), 21.29 (C-14) ppm. 
IR (ATR): ṽ = 3428 (s), 3276 (s), 3170 (s), 2924 (m), 1732 (m), 1550 (s), 1408 (s), 1300 (w), 
1201 (s), 1100 (m), 1055 (m)m, 961 (w), 798 (w) cm
‒1
. 
HRMS (ESI): calcd. for C14H14N5O5
+
: 332.0989 [M+H]
+
     
  found:   332.0990 [M+H]
+
. 
 
2-[(2R,3S,4S,5R,6R)-4,5-bis(benzyloxy)-3-[(tert-butyldimethylsilyl)oxy]-6-{[(tert-
butyldimethylsilyl)oxy]methyl}oxan-2-yl]ethan-1-ol (149) 
 
A solution of alkene 98 (100 mg, 0.163 mmol, 1.0 eq) in a mixture of CH2Cl2 and MeOH (1:1, 
10 mL) was cooled to 78 °C and ozone was bubbled through the reaction mixture until a slight 
blue color persisted. Excess ozone was discharged by bubbling argon through the mixture, and 
then the solution was warmed to 0 °C. Sodium borohydride (34.0 mg, 0.978 mmol, 6.0 eq) was 
added in one portion, and the reaction mixture was allowed to warm to room temperature. After 
stirring at room temperature for 40 min, the reaction was quenched with water (10 mL) and the 
mixture was extracted with CH2Cl2 (3 x 20 mL). The combined organic fractions were washed 
with brine (10 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 49:119:19:1] afforded alcohol 149 (100 mg, 0.162 mmol, 99%) as a colorless 
oil. 
Alcohol 149: 
Rf = 0.28 [PE:EtOAc 9:1]. 
    
   = +4.48 (c = 0.71, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.25 (m, 8H, 2 x H-12, 
2 x H-13, H-14, 2 x H-17, H-18), 7.23 – 7.20 (m, 2H, 2 x H-16), 
4.89 (d, J = 11.3 Hz, 1H, H-9a or H-9b), 4.79 (d, J = 11.1 Hz, 2H, H-9a or H-9b, H-10a or H-
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10b), 4.54 (d, J = 11.1 Hz, 1H, H-10a or H-10b), 4.07 (ddd, J = 11.9, 6.0, 3.0 Hz, 1H, H-3), 
3.84 – 3.77 (m, 4H, H-1a, H-1b, H-4, H-8a or H-8b), 3.77 – 3.72 (m, 1H, H-7), 3.64 (dd, 
J = 9.0, 9.0 Hz, 1H, H-5), 3.54 (dd, J = 10.7, 6.9 Hz, 1H, H-8a or H-8b), 3.32 (dd, J = 9.8, 
8.8 Hz, 1H, H-6), 2.11 – 2.03 (m, 1H, H-2a or H-2b), 1.87 – 1.81 (m, 1H, H-2a or H-2b), 0.90 
(s, 9H, 9 x H-22), 0.89 (s, 9H, 9 x H-26), 0.07 (s, 3H, 3 x H-19 or 3 x H-20), 0.07 (s, 3H, 3 x H-
19 or 3 x H-20), 0.04 (s, 3H, 3 x H-23 or 3 x H-24), 0.03 (s, 3H, 3 x H-23 or 3 x H-24) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 138.87 (C-11), 138.30 (C-15), 128.56 (2 x C-13 or 2 x C-17), 
128.42 (2 x C-13 or 2 x C-17), 128.07 (2 x C-16), 127.92 (C-14 or C-18), 127.60 (2 x C-12), 
127.54 (C-14 or C-18), 83.21 (C-5), 78.86 (C-6), 77.49 (C-3), 75.56 (C-9), 75.06 (C-10), 73.28 
(C-4), 73.08 (C-7), 63.63 (C-8), 62.29 (C-1), 27.03 (C-2), 26.09 (3 x C-22 or 3 x C-26), 26.02 
(3 x C-22 or 3 x C-26), 18.54 (C-25), 18.10 (C-21), 4.41 (C-19 or C-21), 4.52 (C-19 or C-
21), 5.17 (C-23 or C-24), 5.31 (C-23 or C-24) ppm. 
IR (ATR): ṽ = 3480 (w), 2929 (s), 1472 (w), 1252 (m), 1089 (s), 833 (s), 776 (m) cm‒1. 
HRMS (ESI): calcd. for C34H56NaO6Si2
+
: 639.3508 [M+Na]
+
    
  found:    639.3504 [M+Na]
+
. 
 
[(2R,3R,4S,5S,6R)-5-(acetyloxy)-3,4-bis(benzyloxy)-6-(prop-2-en-1-yl)oxan-2-yl]methyl 
acetate (151) 
 
A solution of diol 96 (38.2 mg, 99.4 µmol, 1.0 eq) in pyridine (1.5 mL) was cooled to  °C and 
acetic anhydride (1.5 mL) was added. The reaction mixture was allowed to warm to room 
temperature and stirred at this temperature for 2 h. The solvent was removed by azeotropic 
distillation with toluene (3 x 6 mL), and the residue was subjected to flash column 
chromatography [PE:EtOAc 9:15:13:1] to afford diacetate 151 (45.3 mg, 96.7 µmol, 97%) 
as a white solid. 
Diacetate 151: 
Rf = 0.57 [PE:EtOAc 2:1]. 
    
   = +36.0 (c = 1.1, CHCl3).  
mp: 91 – 93 °C. 
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1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.24 (m, 10H, 2 x H-13, 2 x H-14, H-15, 2 x H-17, 
2 x H-18, H-19), 5.75 (dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, 1H, H-2), 5.14 – 5.06 (m, 2H, H-1a, H-
1b), 5.04 (dd, J = 8.3, 5.2 Hz, 1H, H-5), 4.81 – 4.72 (m, 3H, H-10a, H-10b, H-11a or H-11b), 
4.55 (d, J = 11.0 Hz, 1H, H-11a or H-11b), 4.30 – 4.21 (m, 2H, H-9a, H-9b), 4.18 (ddd, 
J = 10.1, 5.0, 5.0 Hz, 1H, H-4), 3.86 (dd, J = 8.0, 8.0 Hz, 1H, H-6), 3.79 (ddd, J = 8.4, 4.9, 
3.3 Hz, 1H, H-8), 3.52 (dd, J = 8.7, 7.7 Hz, 1H, H-7), 2.52 – 2.42 (m, 1H, H-3a or H-3b), 2.30 –
 2.22 (m, 1H, H-3a or H-3b), 2.04 (s, 3H, 3 x H-23), 2.00 (s, 3H, 3 x H-21) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 170.86 (C-22), 170.15 (C-20), 138.21 (C-12), 137.68 (C-16), 
133.68 (C-2), 128.64 (2 x C-14 or 2 x C-18), 128.62 (2 x C-14 or 2 x C-18), 128.26 (2 x C-17), 
128.15 (C-15 or C-19), 127.96 (C-15 or C-19), 127.81 (2 x C-13), 117.57 (C-1), 79.58 (C-6), 
77.07 (C-7), 74.78 (C-10), 74.62 (C-11), 72.43 (C-5), 71.49 (C-4), 70.65 (C-8), 63.12 (C-9), 
31.53 (C-3), 21.06 (C-21), 20.97 (C-23) ppm. 
IR (ATR): ṽ = 2910 (w), 1739 (s), 1454 (w), 1367 (m) 1227 (s), 1028 (s), 910 (w), 741 (m), 695 
(s) cm
‒1
. 
HRMS (ESI): calcd. for C27H36NO7
+
: 486.2486 [M+NH4]
+
     
  found:   486.2491 [M+NH4]
+
. 
 
[(2R,3R,4S,5S,6R)-5-(acetyloxy)-3,4-bis(benzyloxy)-6-(2-hydroxyethyl)oxan-2-yl]methyl 
acetate (152): 
 
A solution of alkene 151 (563 mg, 1.20 mmol, 1.0 eq) in a mixture of CH2Cl2 and MeOH (1:1, 
48 mL) was cooled to 78 °C and ozone was bubbled through the reaction mixture until a slight 
blue color persisted. Excess ozone was discharged by bubbling argon through the mixture, and 
then the solution was warmed to 0 °C. Sodium borohydride (273 mg, 7.22 mmol, 6.0 eq) was 
added in one portion, and the reaction mixture was allowed to warm to room temperature. After 
stirring at room temperature for 1 h, the reaction was quenched with water (40 mL) and the 
mixture was extracted with CH2Cl2 (3 x 50 mL). The combined organic fractions were washed 
with brine (100 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 9:15:13:12:11:11:21:3] afforded alcohol 152 (423 mg, 0.895 mmol, 
75%) as a white solid. 
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Alcohol 152: 
Rf = 0.37 [PE:EtOAc 1:2]. 
    
   = +42.9 (c = 1.0, CHCl3). 
mp: 93 – 95 °C.  
1
H-NMR (600 MHz, CDCl3): δ = 7.38 – 7.27 (m, 8H, 2 x H-12, 2 x H-13, H-14, 2 x H-17, H-
18), 7.26 – 7.23 (m, 2H, 2 x H-16), 4.98 (dd, J = 7.3, 4.6 Hz, 1H, H-4), 4.75 – 4.70 (m, 2H, H-
9a, H-9b), 4.70 (d, J = 11.3 Hz, 1H, H-10a or H-10b), 4.52 (d, J = 11.3 Hz, 1H, H-10a or H-
10b), 4.38 (dd, J = 11.9, 7.3 Hz, 1H, H-8a or H-8b), 4.32 (ddd, J = 11.4, 4.4, 3.0 Hz, 1H, H-3), 
4.18 (dd, J = 11.9, 2.7 Hz, 1H, H-8a or H-8b), 3.96 (ddd, J = 7.4, 7.4, 2.7 Hz, 1H, H-7), 3.84 
(dd, J = 7.0, 7.0 Hz, 1H, H-5), 3.78 – 3.72 (m, 2H, 2 x H-1), 3.43 (dd, J = 7.1, 7.1 Hz, 1H, H-6), 
2.28 (br s, 1H, H-23), 2.06 (s, 3H, 3 x H-22), 2.01 (s, 3H, 3 x H-20), 2.04 – 1.97 (m, 1H, H-2a 
or H-2b), 1.65 – 1.58 (m, 1H, H-2a or H-2b) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 171.00 (C-21), 170.32 (C-19), 137.98 (C-11), 137.57 (C-15), 
128.65 (2 x C-13 or 2 x C-17), 128.64 (2 x C-13 or 2 x C-17), 128.16 (C-14 or C-18), 128.14 
(2 x C-16), 128.05 (C-14 or C-18), 127.87 (2 x C-12), 77.93 (C-5), 76.24 (C-6), 74.35 (C-9), 
74.07 (C-10), 71.86 (C-4), 71.80 (C-7), 70.18 (C-3), 62.87 (C-8), 60.44 (C-1), 29.76 (C-2), 
21.07 (C-20), 20.95 (C-22) ppm. 
IR (ATR): ṽ = 3477 (w), 2897 (w), 1713 (s), 1369 (w), 1239 (s), 1119 (m), 1043 (s), 858 (w), 
751 (s) cm
‒1
. 
HRMS (ESI): calcd. for C26H36NO8
+
: 490.2241 [M+NH4]
+
     
  found:   490.2240 [M+NH4]
+
. 
 
[(2R,3R,4S,5S,6R)-5-(acetyloxy)-3,4-bis(benzyloxy)-6-{2-[(methylsulfanyl)methoxy]ethyl} 
oxan-2-yl]methyl acetate (153) 
 
A solution of alcohol 152 (423 mg, 0.895 mmol, 1.0 eq) in a mixture of dimethyl sulfoxide, 
acetic anhydride and acetic acid (5:3:1, 10 mL) was stirred at room temperature for 19 h. The 
reaction mixture was diluted with EtOAc (25 mL) and water (10 mL), followed by separation of 
the phases. The aqueous layer was extracted further with EtOAc (2 x 15 mL). The combined 
organic fractions were washed with aq. NaHCO3 (50 mL of a saturated solution), dried (MgSO4) 
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and concentrated in vacuo. Flash column chromatography [PE:EtOAc 9:15:13:1] afforded 
methoxythiomethyl ether 153 (367 mg, 0.688 mmol, 77%) as a white solid. 
Methoxythiomethyl ether 153: 
Rf = 0.29 [PE:EtOAc 3:1]. 
    
   = +44.3 (c = 1.0, CHCl3). 
mp: 60 – 62 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 7.36 – 7.27 (m, 8H, 2 x H-12, 2 x H-13, H-14, 2 x H-17, H-
18), 7.27 – 7.24 (m, 2H, 2 x H-16), 5.04 (dd, J = 8.1, 5.1 Hz, 1H, H-4), 4.78 – 4.71 (m, 3H, H-
9a, H-9b, H-10a or H-10b), 4.62 (d, J = 11.4 Hz, 1H, H-23a or H-23b), 4.59 (d, J = 11.4 Hz, 1H, 
H-23a or H-23b), 4.54 (d, J = 11.1 Hz, 1H, H-10a or H-10b), 4.31 – 4.22 (m, 3H, H-3, H-8a, H-
8b), 3.83 (dd, J = 7.8, 7.8 Hz, 1H, H-5), 3.82 – 3.78 (m, 1H, H-7), 3.64 – 3.53 (m, 2H, H-1a, H-
1b), 3.51 (dd, J = 8.4, 7.6 Hz, 1H, H-6), 2.13 (s, 3H, 3 x H-24), 2.05 (s, 3H, 3 x H-22), 2.00 (s, 
3H, 3 x H-20), 2.00 – 1.93 (m, 1H, H-2a or H-2b), 1.80 – 1.74 (m, 1H, H-2a or H-2b) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.87 (C-21), 170.14 (C-19), 138.13 (C-11), 137.66 (C-15), 
128.63 (2 x C-13 or 2 x C-17), 128.61 (2 x C-13 or 2 x C-17), 128.21 (2 x C-16), 128.14 (C-14 
or C-18), 127.97 (C-14 or C-18), 127.83 (2 x C-12), 79.28 (C-5), 76.90 (C-6), 75.56 (C-23), 
74.67 (C-9), 74.52 (C-10), 72.22 (C-4), 70.94 (C-7), 69.09 (C-3), 64.16 (C-1), 63.17 (C-8), 
26.82 (C-2), 21.08 (C-20), 21.00 (C-22), 14.06 (C-24) ppm. 
IR (ATR): ṽ = 2908 (m), 1739 (s), 1366 (m), 1280 (w), 1222 (s), 1044 (s), 864 (w), 695 
(m) cm
‒1
. 
HRMS (ESI): calcd. for C28H36NaO8S
+
: 555.2023 [M+Na]
+    
  
found:    555.2027 [M+Na]
+
. 
 
{2-[(2R,3S,4S,5R,6R)-3-(acetyloxy)-6-[(acetyloxy)methyl]-4,5-bis(benzyloxy)oxan-2-
yl]ethoxy}methyl acetate (154) 
 
A mixture of acetic acid (13.5 µL, 0.236 mmol, 1.25 eq) and activated molecular sieve (30 mg, 
powdered, 3Å) in THF (1 mL) was stirred at room temperature for 2 h, then N-iodosuccinimide 
(53.3 mg, 0.236 mmol, 1.25 eq) was added. Separately, a suspension of methoxythiomethyl 
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ether 153 (101 mg, 0.189 mmol, 1.0 eq) and activated molecular sieve (100 mg, powdered, 3Å) 
in CH2Cl2 (12 mL) was stirred at room temperature for 1.5 h, then cooled to 0 °C. To this 
suspension, the previously prepared acetic acid/ N-iodosuccinimide mixture was added via 
cannula and the reaction mixture was stirred at 0 °C for 45 min. The suspension was diluted 
with CH2Cl2 (15 mL) and the molecular sieve was removed by suction filtration. The filtrate 
was washed with aq. Na2S2O3 (30 mL of a saturated solution), aq. NaHCO3 (30 mL of a 
saturated solution) and water (30 mL), then dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [PE:EtOAc 9:15:13:11:1] afforded acetate 154 (71.4 mg, 
0.131 mmol, 70%) as a colorless oil. 
Acetate 154: 
Rf = 0.70 [PE:EtOAc 1:1]. 
    
   = +42.3 (c = 1.0, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.37 – 7.27 (m, 8H, 
2 x H-12, 2 x H-13, H-14, 2 x H-17, H-18), 7.27 – 7.23 (m, 2H, 2 xH-16), 5.28 (d, J = 6.2 Hz, 
1H, H-23a or H-23b), 5.20 (d, J = 6.2 Hz, 1H, H-23a or H-23b), 5.03 (dd, J = 8.0, 5.1 Hz, 1H, 
H-4), 4.77 – 4.71 (m, 3H, H-9a, H-9b, H-10a or H-10b), 4.53 (d, J = 11.1 Hz, 1H, H-10a or H-
10b), 4.29 – 4.20 (m, 3H, H-3, H-8a, H-8b), 3.82 (dd, J = 7.7, 7.7 Hz, 1H, H-5), 3.80 – 3.76 (m, 
1H, H-7), 3.75 – 3.70 (m, 1H, H-1a or H-1b), 3.70 – 3.64 (m, 1H, H-1a or H-1b), 3.50 (dd, 
J = 8.2, 7.6 Hz, 1H, H-6), 2.08 (s, 3H, 3 x H-25), 2.05 (s, 3H, 3 x H-22), 2.00 (s, 3H, 3 x H-20), 
1.99 – 1.92 (m, 1H, H-2a or H-2b), 1.80 – 1.73 (m, 1H, H-2a or H-2b) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 170.83 (C-21), 170.68 (C-24), 170.14 (C-19), 138.09 (C-11), 
137.65 (C-15), 128.63 (2 x C-13 or 2 x C-17), 128.62 (2 x C-13 or 2 x C-17), 128.20 (2 x C-16), 
128.14 (C-14 or C-18), 127.99 (C-14 or C-18), 127.84 (2 x C-12), 89.36 (C-23), 79.13 (C-5), 
76.74 (C-6), 74.63 (C-9), 74.46 (C-10), 72.07 (C-4), 71.03 (C-7), 68.76 (C-3), 66.51 (C-1), 
63.09 (C-8), 26.97 (C-2), 21.14 (C-25), 21.06 (C-20), 20.95 (C-22) ppm. 
IR (ATR): ṽ = 2957 (w), 1738 (s), 1454 (w), 1366 (m), 1224 (s), 1099 (m), 1011 (s), 941 (m), 
738 (m), 698 (m) cm
‒1
. 
HRMS (ESI): calcd. for C29H36NaO10
+
: 567.2206 [M+Na]
+    
  found:    567.2204 [M+Na]
+
. 
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[(2R,3R,4S,5S,6R)-5-(acetyloxy)-6-{2-[(6-amino-9H-purin-9-yl)methoxy]ethyl}-3,4-
bis(benzyloxy)oxan-2-yl]methyl acetate (155): 
 
To a suspension of triacetate 154 (38.6 mg, 70.9 µmol, 1.0 eq) and adenine (14.4 mg, 
0.106 mmol, 1.5 eq) in MeCN (4 mL) was added dropwise trimethylsilyl 
trifluoromethanesulfonate (77.0 µL, 0.425 mmol, 6.0 eq). The resulting solution was stirred at 
room temperature for 5 min, then diluted with aq. NaHCO3 (15 mL of a saturated solution). The 
mixture was extracted with CH2Cl2 (3 x 15 mL) and the combined organic fractions were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [CH2Cl2:MeOH 100:149:124:114:1] afforded glycoside 155 (15.7 mg, 
25.3 mmol, 36%) as a white solid. 
Glycoside 155: 
Rf = 0.40 [CH2Cl2:MeOH 9:1]. 
    
   = +43.3 (c = 0.84, MeOH). 
mp: 102 °C. 
1
H-NMR (600 MHz, CD3OD): δ = 8.23 (s, 1H, H-28), 8.22 (s, 1H, H-24), 7.33 – 7.23 (m, 10H, 
2 x H-12, 2 x H-13, H-14, 2 x H-16, 2 x H-17, H-18), 5.63 – 5.58 (m, 2H, H-23a, H-23b), 4.87 –
 4.84 (m, 1H, H-4), 4.72 – 4.68 (m, 2H, H-9a, 9b), 4.68 (d, J = 11.3 Hz, 1H, H-10a or H-10b), 
4.53 (d, J = 11.3 Hz, 1H, H-10a or H-10b), 4.18 – 4.07 (m, 3H, H-3, H-8a, H-8b), 3.83 (dd, 
J = 7.6, 7.6 Hz, 1H, H-5), 3.74 – 3.70 (m, 1H, H-7), 3.61 – 3.58 (m, 2H, H-1a, H-1b), 3.43 (dd, 
J = 7.9, 7.7 Hz, 1H, H-6), 1.97 (s, 3H, 3 x H-22), 1.96 – 1.90 (m, 1H, H-2a or H-2b), 1.93 (s, 
3H, 3 x H-20), 1.72 – 1.65 (m, 1H, H-2a or H-2b) ppm. 
13
C-NMR (150 MHz, CD3OD): δ = 172.49 (C-21), 171.73 (C-19), 157.40 (C-27), 154.19 (C-
24), 150.99 (C-25), 142.90 (C-28), 139.63 (C-11), 139.31 (C-15), 129.44 (2 x C-13 or 2 x C-
17), 129.40 (2 x C-13 or 2 x C-17), 129.14 (2 x C-16), 128.93 (2 x C-12), 128.87 (C-14 or C-
18), 128.81 (C-14 or C-18), 119.96 (C-26), 79.82 (C-5), 77.92 (C-6), 75.40 (C-9), 75.07 (C-10), 
74.07 (C-23), 73.33 (C-4), 72.26 (C-7), 69.69 (C-3), 66.46 (C-1), 64.07 (C-8), 27.64 (C-2), 
20.83 (C-20), 20.74 (C-22) ppm. 
IR (ATR): ṽ = 3320 (w), 3160 (w), 2940 (w), 1739 (s), 1643 (m), 1475 (w), 1368 (w), 1232 (s), 
1100 (s), 1038 (m), 906 (w), 754 (w), 698 (w) cm
‒1
. 
Chapter V: Experimental Procedures and Analytical Data 
172 
HRMS (ESI): calcd. for C32H38N5O8
+
: 620.2715 [M+H]
+     
 
 found:   620.2713 [M+H]
+
. 
 
21.2. Experimental Data of Chapter II 
Tert-butyl 3-[3,4-dimethoxy-2-(2-methoxy-2-oxoethyl)phenyl]propanoate (190) and 2-{6-
[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]-2,3-dimethoxyphenyl}acetic acid (189) 
 
An autoclave apparatus was charged with a suspension of 2,3-dimethoxyphenylacetic acid (180) 
(10.0 g, 51.0 mmol, 1.0 eq), para-benzoquinone (276 mg, 1.28 mmol, 5 mol%), KHCO3 
(10.2 g, 102 mmol, 2.0 eq), tert-butyl acrylate (22.4 mL, 153 mmol, 3.0 eq) and Pd(OAc)2 
(1.15 g, 5.10 mmol, 10 mol%) in tert-amylalcohol (100 mL). The autoclave apparatus was 
purged with oxygen gas five times and the reaction mixture was stirred under oxygen 
atmosphere (3 bar) at 85 °C for 96 h. After cooling to room temperature, aq. HCl (2 M, 150 mL) 
was added and the mixture extracted with Et2O (3 x 200 mL). The combined organic fractions 
were dried (MgSO4), and all solid material was removed by filtering the suspension through a 
pad of Celite. The Celite was washed with Et2O (100 mL) and the filtrate was concentrated in 
vacuo to afford crude 189, which was immediately re-dissolved in MeOH (300 mL). To this 
solution, palladium on charcoal (10 wt%, 2.00 g) was added and the flask was purged with 
hydrogen gas five times. The mixture was then stirred under hydrogen atmosphere at room 
temperature for 16 h. The catalyst was removed by filtration through a pad of Celite, and the 
Celite was washed with MeOH (200 mL). The filtrate was concentrated in vacuo to afford crude 
saturated ester, which was immediately re-dissolved in toluene/MeOH (7:1, 314 mL). This 
mixture was cooled to 0 °C and a solution of (trimethylsilyl)diazomethane in hexanes (2.0 M, 
30.6 mL, 61.2 mmol, 1.2 eq) was added dropwise. After stirring for 15 min at 0 °C, the reaction 
mixture was allowed to warm to room temperature and stirred for an additional 40 min. The 
reaction was quenched with acetic acid (15 mL) and diluted with aq. NaHCO3 (600 mL of a 
saturated solution). The mixture was extracted with EtOAc (3 x 400 mL) and the combined 
organic fractions were washed with brine (500 mL), then dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [PE:EtOAc 19:19:16:14:1] afforded methyl 
ester 190 (14.5 g, 42.8 mmol, 84% over 3 steps) as a colorless oil. 
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Compound 190: 
Rf = 0.27 [PE:EtOAc 9:1].  
1
H-NMR (300 MHz, CDCl3): δ = 6.90 (d, J = 8.5 Hz, 1H, H-7), 6.80 (d, 
J = 8.5 Hz, 1H, H-6), 3.84 (s, 3H, 3 x H-13), 3.81 (s, 3H, 3 x H-12), 3.75 
(s, 2H, 2 x H-2), 3.69 (s, 3H, 3 x H-14), 2.86 – 2.79 (m, 2H, 2 x H-9), 2.48 – 2.41 (m, 2H, 
2 x H-10), 1.43 (s, 9H, 9 x H-16) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 172.36 (C-1 and C-11), 151.08 (C-5), 147.76 (C-4), 132.50 (C-
8), 127.21 (C-3), 124.20 (C-7), 111.60 (C-6), 80.53 (C-15), 60.61 (C-12), 55.85 (C-13), 52.12 
(C-14), 36.64 (C-10), 32.12 (C-2), 28.25 (3 x C-16), 27.94 (C-9) ppm. 
IR (ATR): ṽ = 2976 (w), 1726 (s), 1492 (m), 1366 (m), 1275 (s), 1145 (s), 1083 (s), 753 
(s) cm
‒1
. 
HRMS (EI): calcd. for C18H26O6
+
: 338.1724 [M]
+
      
  found:   338.1718 [M]
+
. 
Carboxylic Acid 189: 
In order to fully characterize carboxylic acid 189, an analytical sample of the crude mixture, 
obtained after palladium-catalyzed CH activation, was purified by flash column 
chromatography [PE:EtOAc 3:1 + 1% AcOH] to yield 189 as a white solid. 
Rf = 0.20 [PE:EtOAc 3:1 + 1% AcOH]. 
mp: 115 – 117 °C.  
1
H-NMR (300 MHz, CDCl3): δ = 7.73 (d, J = 15.7 Hz, 1H, H-9), 7.34 (d, 
J = 8.7 Hz, 1H, H-7), 6.87 (d, J = 8.7 Hz, 1H, H-6), 6.20 (d, J = 15.6 Hz, 
1H, H-10), 3.90 – 3.86 (m, 5H, 2 x H-2, 3 x H-13), 3.83 (s, 3H, 3 x H-12), 1.51 (s, 9H, 9 x H-
16) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 176.71 (C-1), 166.45 (C-11), 153.83 (C-5), 147.65 (C-4), 
140.32 (C-9), 127.82 (C-3), 127.64 (C-8), 122.88 (C-7), 120.96 (C-10), 111.85 (C-6), 80.65 (C-
15), 60.81 (C-13), 55.88 (C-12), 31.80 (C-2), 28.34 (3 x C-16) ppm. 
IR (ATR): ṽ = 2983 (w), 1734 (m), 1700 (s) 1494 (s), 1255 (m), 1145 (s), 1078 (s), 801 
(m) cm
‒1
. 
HRMS (EI): calcd. for C17H22O6
+
: 322.1411 [M]
+      
  found:   322.1400 [M]
+
. 
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7,8-Dimethoxy-1,2,3,4-tetrahydronaphthalen-2-one (179) 
 
To a solution of diester 190 (8.07 g, 23.8 mmol, 1.0 eq) in Et2O (300 mL) was added potassium 
tert-butoxide (3.34 g, 29.8 mmol, 1.25 eq) in one portion, and the resulting mixture was stirred 
at room temperature for 35 min. The reaction mixture was cooled to 0 °C and aq. HCl (1 M, 
300 mL) was carefully added. The mixture was allowed to warm to room temperature and 
extracted with Et2O (3 x 200 mL). The combined organic fractions were washed with brine 
(200 mL), then dried (MgSO4) and concentrated in vacuo. The crude product was immediately 
re-dissolved in acetic acid (190 mL) and conc. aq. HCl (50 mL) was added. The mixture was 
heated to 110 °C for 3 h and then cooled to 0 °C. After the reaction was quenched carefully with 
solid NaHCO3 (280 g), water (700 mL) was added and the mixture was extracted with Et2O 
(3 x 300 mL). The combined organic fractions were washed with aq. NaHCO3 (2 x 500 mL) and 
brine (500 mL), then dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 19:19:13:1] afforded -tetralone 179 (3.45 g, 16.7 mmol, 70%) as a white 
solid. 
-Tetralone 179: 
Rf = 0.43 [PE:EtOAc 3:1]. 
mp: 75 – 76 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 6.93 (d, J = 8.3 Hz, 1H, H-7), 6.79 (d, J = 8.3 Hz, 1H, H-6), 
3.86 (s, 3H, 3 x H-12), 3.81 (s, 3H, 3 x H-11), 3.60 (s, 2H, 2 x H-2), 3.04 – 2.97 (m, 2H, 2 x H-
9), 2.58 – 2.51 (m, 2H, H-10) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 210.58 (C-1), 151.41 (C-5), 146.48 (C-4), 129.66 (C-8), 
127.47 (C-3), 122.96 (C-7), 110.89 (C-6), 60.58 (C-11), 56.05 (C-12), 38.91 (C-10), 38.71 (C-
2), 28.25 (C-9) ppm. 
IR (ATR): ṽ = 2998 (w), 2944 (w), 1702 (s), 1492 (s), 1350 (w), 1273 (s), 1155 (w), 1080 (s), 
802 (s) cm
‒1
. 
HRMS (EI): calcd. for C12H14O3
+
: 206.0937 [M]
+
      
  found:   206.0942 [M]
+
. 
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7',8'-Dimethoxy-3',4'-dihydro-2'H-spiro[cyclopropane-1,1'-naphthalene]-2'-one (191) 
 
A solution of -tetralone 179 (2.92 g, 14.2 mmol, 1.0 eq) and 1,2-dibromoethane (1.81 mL, 
21.3 mmol, 1.5 eq) in DMF (50 mL) was cooled to 0 °C and sodium hydride (60 wt% in mineral 
oil, 1.25 g, 31.2 mmol, 2.2 eq) was added. The reaction mixture was stirred at 0 °C for 1.5 h, 
then quenched at 0 °C with MeOH (90 mL) and diluted with water (300 mL). The mixture was 
extracted with Et2O (4 x 250 mL) and the combined organic layers dried (Na2SO4), then 
concentrated in vacuo. Flash column chromatography [PE:EtOAc 3:1] afforded cyclopropane 
191 (2.92 g, 12.5 mmol, 88%) as a white solid. 
Cyclopropane 191: 
Rf = 0.57 [PE:EtOAc 3:1]. 
mp: 59  61 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 6.92 – 6.88 (m, 1H, H-7), 6.73 (d, J = 8.2 Hz, 1H, H-6), 3.84 
(s, 3H, 3 x H-13), 3.73 (s, 3H, 3 x H-12), 3.03 – 2.96 (m, 2H, 2 x H-9), 2.66 – 2.59 (m, 2H, 
2 x H-10), 1.90 – 1.85 (m, 2H, 2 x H-11b), 1.69 – 1.64 (m, 2H, 2 x H-11a) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 210.26 (C-1), 152.17 (C-5), 146.91 (C-4), 131.94 (C-8), 
130.36 (C-3), 122.91 (C-7), 109.90 (C-6), 61.49 (C-12), 55.98 (C-13), 39.34 (C-10), 31.28 (C-
2), 28.16 (C-9), 21.28 (2 x C-11) ppm. 
IR (ATR): ṽ = 2936 (m), 1686 (m), 1575 (w), 1478 (m), 1263 (s), 1045 (s), 883 (w), 797 
(m) cm
‒1
. 
HRMS (EI): calcd. for C14H16O3
+
: 232.1094 [M]
+
      
  found:   232.1097 [M]
+
. 
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1-(2-Chloroethyl)-7,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-one (198) 
 
To a solution of cyclopropane 191 (10.0 mg, 43.0 µmol, 1.0 eq) in THF (0.5 mL) was added a 
solution of methylamine in THF (2.0 M, 177 µL, 0.344 mmol, 8.0 eq), followed by a solution of 
titanium(IV) chloride in toluene (1.0 M, 21.5 µL, 21.5 µmol, 0.5 eq). The reaction mixture was 
stirred at room temperature for 5 d, then quenched with aq. NaHCO3 (5 mL of a saturated 
solution). The mixture was extracted with EtOAc (3 x 10 mL) and the combined organic 
fractions were washed with brine (10 mL), then dried (Na2SO4) and concentrated in vacuo. 
Flash column chromatography [PE:EtOAc 19:19:14:1] afforded chloride 198 (3.3 mg, 
12.3 µmol, 29%) as a colorless oil. 
Chloride 198: 
Rf = 0.36 [PE:EtOAc 3:1].  
1
H-NMR (600 MHz, CDCl3): δ = 6.92 (br d, J = 8.3 Hz, 1H, H-7), 6.81 (d, 
J = 8.3 Hz, 1H, H-6), 3.87 (s, 3H, 3 x H-14), 3.87 – 3.85 (m, 1H, H-2), 
3.84 (s, 3H, 3 x H-13), 3.58 (ddd, J = 10.9, 8.5, 5.7 Hz, 1H, H-12a or H-12b), 3.48 (ddd, 
J = 10.9, 8.4, 7.1 Hz, 1H, H-12a or H-12b), 3.18 – 3.11 (m, 1H, H-9a or H-9b), 2.91 (ddd, 
J = 15.6, 6.4, 2.7 Hz, 1H, H-9a or H-9b), 2.74 (ddd, J = 17.3, 5.0, 2.7 Hz, 1H, H-10a or H-10b), 
2.48 – 2.41 (m, 1H, H-10a or H-10b), 2.28 – 2.17 (m, 2H, H-11a, H-11b) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 212.33 (C-1), 151.48 (C-5), 146.72 (C-4), 130.37 (C-3), 
129.33 (C-8), 123.40 (C-7), 111.36 (C-6), 60.91 (C-13), 55.98 (C-14), 46.26 (C-2), 42.46 (C-
12), 38.40 (C-10), 36.47 (C-11), 27.25 (C-9) ppm. 
IR (ATR): ṽ = 2942 (w), 1706 (s), 1606 (w), 1491 (s), 1278 (s), 1087 (s), 807 (m) cm‒1. 
HRMS (ESI): calcd. for C14H16ClO3
+
: 267.0782 [MH]+     
  found:   267.0781 [MH]+. 
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21.3. Experimental Data of Chapter III 
5-(Prop-2-en-1-yloxy)pent-1-ene (230)
[142]
 
 
A suspension of sodium hydride (60 wt% in mineral oil, 4.36 g, 109 mmol, 2.0 eq) in THF 
(50 mL) was cooled to 0 °C and 4-penten-1-ol (229) (5.60 mL, 54.6 mmol, 1.0 eq) added 
dropwise. The mixture was stirred at 0 °C for 10 min until gas evolution had ceased, and then 
allyl bromide (9.43 mL, 109 mmol, 2.0 eq) was added. The reaction mixture was stirred at 0 °C 
for an additional 5 min, then allowed to warm to room temperature and stirred at this 
temperature for 15 h. The reaction mixture was carefully quenched with water (30 mL) and 
extracted with Et2O (3 x 50 mL). The combined organic fractions were washed with brine 
(100 mL), dried (MgSO4) and concentrated in vacuo. Vacuum distillation (80 °C oil bath 
temperature, 30 mbar) of the residue afforded ether 230 (5.37 g, 42.6 mmol, 78%) as a colorless 
liquid. 
Ether 230: 
Rf = 0.59 [PE:EtOAc 9:1]. 
bp: 45 °C (30 mbar). 
1
H-NMR (300 MHz, CDCl3): δ = 5.99 – 5.74 (m, 2H, H-2, H-7), 5.32 – 5.22 (m, 1H, H-8a), 
5.19 – 5.14 (m, 1H, H-8b), 5.07 – 4.92 (m, 2H, H-1a, H-1b), 3.98 – 3.94 (m, 2H, 2 x H-6), 3.44 
(t, J = 6.6 Hz, 2H, 2 x H-5), 2.18 – 2.08 (m, 2H, 2 x H-3), 1.74 – 1.63 (m, 2H, 2 x H-4) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 138.42 (C-2), 135.14 (C-7), 116.87 (C-8), 114.84 (C-1), 71.95 
(C-6), 69.82 (C-5), 30.46 (C-3), 29.06 (C-4) ppm. 
IR (ATR): ṽ = 3079 (w), 2938 (w), 2852 (m), 1642 (w), 1449 (w), 1345 (w), 1104 (br s), 992 
(m), 912 (s) cm
‒1
. 
HRMS (EI): calcd. for C8H13O
+
: 125.0961 [MH]+     
  found:   125.0969 [MH]+. 
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Ethyl (2R)-5-oxopyrrolidine-2-carboxylate (234)
[122-123]
 
 
A solution of D-pyroglutamic acid 234 (39.1 g, 303 mmol, 1eq) in EtOH (560 mL) was cooled 
to 0 °C and thionyl chloride (33.0 mL, 454 mmol, 1.5 eq) was added dropwise. After complete 
addition, the reaction mixture was heated to 80 °C and refluxed for 1.5 h. The solution was 
cooled to room temperature and volatile material was removed in vacuo. Vacuum distillation 
(180 °C oil bath temperature, 7·101 mbar) of the residue afforded D-pyroglutamic acid ethyl 
ester 234 (34.7 g, 221 mmol, 73%) as a colorless oil. Flash column chromatography 
[CH2Cl2:MeOH 24:1] of the distillation residue provided additional material of 234 (8.92 g, 
56.8 mmol), raising the total yield to 92%. 
D-pyroglutamic acid ethyl ester 234: 
Rf = 0.40 [CH2Cl2:MeOH 9:1]. 
    
   = 5.6 (c = 0.99, EtOH),     
   = 1.4 (c = 0.99, CHCl3). 
bp: 144 °C (7·101 mbar). 
1
H-NMR (300 MHz, CDCl3): δ = 7.21 (br s, 1H, H-8), 4.20 – 4.09 (m, 3H, H-4, H-6a, H-6b), 
2.45 – 2.20 (m, 3H, H-2a, H-2b, H-3a or H-3b), 2.19 – 2.05 (m, 1H, H-3a or H-3b), 1.21 (dd, 
J = 7.1, 7.1 Hz, 3H, 3 x H-7) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 178.40 (C-1), 172.12 (C-5), 61.48 (C-6), 55.60 (C-4), 29.31 
(C-2), 24.74 (C-3), 14.06 (C-7) ppm. 
IR (ATR): ṽ = 3227 (br, w), 2980 (w), 1692 (s), 1420 (w), 1379 (w), 1192 (s), 1027 (m), 860 
(w), 662 (br, w) cm
‒1
. 
HRMS (EI): calcd. for C7H11NO3
+
: 157.0733 [M]
+
      
  found:   157.0731 [M]
+
. 
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(5R)-5-(hydroxymethyl)pyrrolidin-2-one (235)
[122-123]
 
 
To a solution of D-pyroglutamic acid ethyl ester 234 (8.90 g, 56.6 mmol, 1eq) in THF (90 mL) 
was added sodium borohydride (4.28 g, 113 mmol, 2.0 eq), lithium chloride (4.80 g, 113 mmol, 
2.0 eq) followed by EtOH (20 mL), and the resulting mixture was stirred at room temperature 
for 20 h. The reaction was quenched with aq. citric acid (5 wt%, 110 mL) and volatile material 
removed in vacuo. The remaining solid was suspended in a mixture of EtOAc and MeOH (3:1, 
ca. 200 mL) and filtered through a pad of Celite. The Celite was washed with a mixture of 
EtOAc and MeOH (3:1, ca. 100 mL) and the filtrate concentrated in vacuo. Flash column 
chromatography [CH2Cl2:MeOH 9:1] afforded alcohol 235 (8.92 g, 54.9 mmol, 97%) as a white 
solid. 
Alcohol 235: 
Rf = 0.22 [CH2Cl2:MeOH 9:1]. 
    
   = 86.0 (c = 1.0, CHCl3). 
mp: 79 – 83 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 7.35 (br s, 1H, H-7), 4.36 – 4.25 (m, 1H, H-6), 3.85 – 3.72 (m, 
1H, H-4), 3.65 (ddd, J = 11.4, 5.8, 3.2 Hz, 1H, H-5a or H-5b), 3.50 – 3.37 (m, 1H, H-5a or H-
5b), 2.44 – 2.23 (m, 2H, H-2a, H-2b), 2.22 – 2.08 (m, 1H, H-3a or H-3b), 1.85 – 1.70 (m, 1H, 
H-3a or H-3b) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 179.53 (C-1), 65.94 (C-5), 56.64 (C-4), 30.42 (C-2), 22.73 (C-
3) ppm. 
IR (ATR): ṽ = 3189 (br, m), 2827 (w), 1650 (br, s), 1422 (m), 1230 (w), 1080 (m), 1018 (m), 
969 (m), 786 (s), 641 (s) cm
‒1
. 
HRMS (EI): calcd. for C5H9NO2
+
: 115.0628 [M]
+      
  found:   115.0621 [M]
+
. 
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(5R)-5-[(triphenylmethoxy)methyl]pyrrolidin-2-one (236)
[143]
 
 
To a solution of alcohol 235 (3.47 g, 30.1 mmol, 1eq), triethylamine (6.30 mL, 45.2 mmol, 
1.5 eq) and 4-(dimethylamino)pyridine (368 mg, 3.01 mmol, 10 mol%) in CH2Cl2 (300 mL) was 
added triphenylmethyl chloride (10.1 g, 36.1 mmol, 1.2 eq) in three portions, and the mixture 
was stirred at room temperature for 5 min after each addition. The reaction mixture was stirred 
for an additional 6 h, then quenched with water (150 mL). The organic phase was separated, 
washed further with water (2 x 150 mL), then dried (MgSO4) and concentrated in vacuo. Flash 
column chromatography [CH2Cl2:MeOH 100:119:1] afforded auxiliary 236 (8.56 g, 
23.9 mmol, 79%) as a white solid. 
Koga's auxiliary 236: 
Rf = 0.56 [CH2Cl2:MeOH 6:1], 0.27 [PE:EtOAc 1:2] 
    
   = 12.2 (c = 1.0, CHCl3). 
mp: 161 – 163 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.43 – 7.38 (m, 6H, 6 x H-8), 7.34 – 7.28 (m, 6H, 6 x H-9), 
7.28 – 7.22 (m, 3H, 3 x H-10), 5.97 (br s, 1H, H-11), 3.90 – 3.82 (m, 1H, H-4), 3.20 (dd, 
J = 9.3, 4.0 Hz, 1H, H-5a or H-5b), 3.00 (dd, J = 9.3, 8.0 Hz, 1H, H-5a or H-5b), 2.33 – 2.27 
(m, 2H, H-2a, H-2b), 2.19 – 2.08 (m, 1H, H-3a or H-3b), 1.72 – 1.61 (m, 1H, H-3a or H-
3b) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 177.94 (C-1), 143.72 (C-7), 128.70 (6 x C-8), 128.05 (6 x C-
9), 127.33 (3 x C-10), 86.99 (C-6), 67.32 (C-5), 54.15 (C-4), 29.74 (C-2), 23.44 (C-3) ppm. 
IR (ATR): ṽ = 3189 (br, w), 3057 (w), 2911 (w), 1686 (s), 1489 (w), 1447 (m), 1284 (w), 1081 
(m), 1002 (w), 899 (w), 760 (m), 692 (s), 631 (m) cm
‒1
. 
HRMS (EI): calcd. for C24H23NO2
+
: 357.1723 [M]
+
      
  found:   357.1713 [M]
+
. 
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(5R)-1-[(2E)-pent-2-enoyl]-5-[(triphenylmethoxy)methyl]pyrrolidin-2-one (237) 
 
A solution of auxiliary 236 (16.7 g, 46.7 mmol, 1.0 eq) in THF (200 mL) was cooled to 78 °C 
and a solution of n-butyllithium in hexanes (2.5 M, 23.4 mL, 58.4 mmol, 1.25 eq) was added 
dropwise. The reaction mixture was stirred at 78 °C for 30 min. In a separate flask, a solution 
of trans-2-pentenoic acid (5.90 mL, 58.4 mmol, 1.25 eq) and triethylamine (11.4 mL, 
81.7 mmol, 1.75 eq) was cooled to 0 °C and pivaloyl chloride (7.90 mL, 64.1 mmol, 1.37 eq) 
was added dropwise. The solution was stirred at 0 °C for 30 min, then added slowly via cannula 
to the previously prepared amide anion solution at 78 °C. The reaction was allowed to warm to 
room temperature over a period of 2 h, then quenched with aq. NH4Cl (500 mL of a saturated 
solution). The mixture was extracted with EtOAc (3 x 300 mL) and the combined organic 
fractions were washed with aq. NaHCO3 (400 mL of a saturated solution), water (400 mL) and 
brine (400 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 9:16:14:1] afforded imide 237 (17.6 g, 40.0 mmol, 86%) as a white solid. 
Imide 237: 
Rf = 0.50 [PE:EtOAc 3:1] 
    
   = 84.7 (c = 1.0, CH2Cl2). 
mp: 107 – 108 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 7.40 – 7.33 (m, 6H, 6 x H-8), 7.32 – 7.19 (m, 10H, 6 x H-9, 
3 x H-10, H-12), 7.13 (ddd, J = 15.4, 6.4, 6.4 Hz, 1H, H-13), 4.60 – 4.50 (m, 1H, H-4), 3.57 (dd, 
J = 9.7, 4.0 Hz, 1H, H-5a or H-5b), 3.16 (dd, J = 9.7, 2.7 Hz, 1H, H-5a or H-5b), 2.97 (ddd, 
J = 17.9, 11.0, 10.0 Hz, 1H, H-2a or H-2b), 2.50 (ddd, J = 17.9, 9.7, 2.2 Hz, 1H, H-2a or H-2b), 
2.39 – 2.27 (m, 2H, H-14a, H-14b), 2.17 – 1.91 (m, 2H, H-3a, H-3b), 1.14 (dd, J = 7.4, 7.4 Hz, 
3H, 3 x H-15) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 176.54 (C-1), 166.16 (C-11), 152.00 (C-13), 143.84 (3 x C-7), 
128.70 (6 x C-8), 128.00 (6 x C-9), 127.23 (3 x C-10), 121.89 (C-12), 87.16 (C-6), 64.28 (C-5), 
56.91 (C-4), 33.53 (C-2), 25.99 (C-14), 21.24 (C-3), 12.60 (C-15) ppm. 
IR (ATR): ṽ = 3100 (br, w), 2967 (w), 2929 (w), 1728 (s), 1675 (s), 1621 (m), 1490 (m), 1356 
(m), 1291 (m), 1193 (s), 1151 (m), 1080 (m) cm
‒1
. 
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HRMS (ESI): calcd. for C29H29NO3Na
+
: 462.2040 [M+Na]
+
    
  found:    462.2035 [M+Na]
+
. 
 
(5R)-1-[(3R)-3-ethylpent-4-enoyl]-5-[(triphenylmethoxy)methyl]pyrrolidin-2-one (238) 
 
To a suspension of copper(I) bromide dimethyl sulfide complex (9.40 g, 45.7 mmol, 1.5 eq) and 
dimethyl sulfide (135 mL, 1.83 mol, 60 eq) in THF (770 mL) was added activated molecular 
sieve (12 g, pellets, 3Å), and the resulting mixture was cooled to 45 °C. A solution of 
vinylmagnesium bromide in THF (1.0 M, 91.5 mL, 91.5 mmol, 3.0 eq) was added dropwise and 
the solution stirred at 45 °C for 20 min. Then, a solution of imide 237 (13.4 g, 30.5 mmol, 
1.0 eq) in THF (130 mL) was added via cannula, and the reaction mixture was stirred at 45 °C 
for an additional 60 min. The reaction was quenched with aq. NH4Cl (300 mL of a saturated 
solution), warmed to room temperature and diluted with water (200 mL). The mixture was 
extracted with EtOAc (3 x 500 mL), and the combined organic fractions were divided into two 
parts. Each part (ca. 750 mL) was washed with water (2 x 500 mL) and brine (500 mL), then 
dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 8:1] 
afforded alkene 238 (12.1 g, 25.9 mmol, 85%) as a white solid. 
Alkene 238: 
Rf = 0.31 [PE:EtOAc 5:1] 
    
   = 64.7 (c = 1.0, CH2Cl2).  
mp: 108 – 109 °C. 
1
H-NMR (300 MHz, CDCl3): δ = 7.38 – 7.33 (m, 6H, 6 x H-8), 7.32 – 7.19 (m, 9H, 6 x H-9, 
3 x H-10), 5.67 (ddd, J = 17.2, 10.2, 8.4 Hz, 1H, H-14), 5.05 – 4.93 (m, 2H, H-15a, H-15b), 
4.51 – 4.42 (m, 1H, H-4), 3.52 (dd, J = 9.7, 4.1 Hz, 1H, H-5a or H-5b), 3.16 (dd, J = 9.7, 
2.7 Hz, 1H, H-5a or H-5b), 3.08 – 2.83 (m, 3H, H-2a or H-2b, H-12a, H-12b), 2.57 – 2.39 (m, 
2H, H-2a or H-2b, H-13), 2.14 – 1.85 (m, 2H, H-3a, H-3b), 1.57 – 1.23 (m, 2H, H-16a, H-16b), 
0.87 (dd, J = 7.4, 7.4 Hz, 3H, 3 x H-17) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 176.33 (C-1), 172.87 (C-11), 143.83 (3 x C-7), 141.50 (C-14), 
128.71 (6 x C-8), 128.03 (6 x C-9), 127.28 (3 x C-10), 114.97 (C-15), 87.17 (C-6), 64.06 (C-5), 
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56.87 (C-4), 42.08 (C-12), 41.34 (C-13), 33.38 (C-2), 27.53 (C-16), 21.46 (C-3), 11.67 (C-
17) ppm. 
IR (ATR): ṽ = 2959 (w), 2876 (w), 1733 (s), 1691 (s), 1489 (m), 1370 (m), 1280 (m), 1219 (m), 
1198 (m), 1074 (m) cm
‒1
. 
HRMS (ESI): calcd. for C31H33NO3Na
+
: 490.2353 [M+Na]
+
    
  found:    462.2348 [M+Na]
+
. 
 
(3R)-5-bromo-3-ethylpent-1-ene (224) and (3R)-3-ethylpent-4-en-1-ol (239) 
 
A solution of methanol (3.12 mL, 77.0 mmol, 9.0 eq) in THF (2 mL) was cooled to 0 °C and a 
solution of n-butyllithium in hexanes (2.35 M, 21.8 mL, 51.3 mmol, 6.0 eq) was added carefully. 
The resulting mixture was allowed to warm to room temperature and stirred at this temperature 
for 15 min. A solution of alkene 238 (4.00 g, 8.55 mmol, 1.0 eq) in THF (8 mL) was added via 
cannula, and the reaction mixture was stirred at room temperature for 20 h. Then, the solution 
was cooled to 0 °C and lithium aluminum hydride (973 mg, 25.7 mmol, 3.0 eq) was added. The 
mixture was stirred at 0 °C for 10 min, then allowed to warm to room temperature and stirred at 
this temperature for an additional 5.5 h. The reaction was quenched by adding carefully aq. 
Rochelle salt (30 mL of a saturated solution), diluted with water (30 mL) and stirred at room 
temperature for 1 h. The mixture was extracted with Et2O (3 x 20 mL), and the combined 
organic fractions were washed with brine (20 mL), then dried (MgSO4) and concentrated to a 
volume of ca. 20 mL by removing the solvent through careful distillation (20 cm vacuum 
isolated Vigreux condenser, 1000 mbar, 4580 °C oil bath temperature). The distillation 
residue was subjected to flash column chromatography [n-pentane:Et2O 7:1] and the resulting 
fraction were concentrated by removing the solvent through careful distillation (20 cm vacuum 
isolated Vigreux condenser, 1000 mbar, 50 °C oil bath temperature) to yield a mixture of 
volatile alcohol 239, Et2O and n-pentane (1.76 g, 1:2:0.4, as determined by 
1
H-NMR 
spectroscopy, 7.71 mmol of 239, 90%). The mixture was diluted with CH2Cl2 (10 mL), then 
triphenylphosphine (2.70 g, 10.3 mmol, 1.2 eq) was added and the solution cooled to 0 °C. N-
bromosuccinimide (1.83 g, 10.3 mmol, 1.2 eq) was added in one portion and the resulting 
mixture stirred at 0 °C for 15 min. The reaction was quenched with water (20 mL) and the 
mixture extracted with Et2O (3 x 20 mL). The combined organic fractions were washed with 
brine (20 mL), then dried (MgSO4) and concentrated to a volume of ca. 15 mL by removing the 
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solvent through careful distillation (20 cm vacuum isolated Vigreux condenser, 1000 mbar, 
45 °C oil bath temperature). The distillation residue was subjected to flash column 
chromatography [n-pentane] and the product containing fractions were concentrated by 
removing the solvent through careful distillation (20 cm vacuum isolated Vigreux condenser, 
1000 mbar, 5080 °C oil bath temperature) to yield a mixture of volatile bromide 224 and n-
pentane (1.13 g, 2:1, as determined by 
1
H-NMR spectroscopy, 5.33 mmol of 224, 62% over 2 
steps) as a colorless liquid. A stock solution of bromide 224 in THF (0.36 M) was prepared and 
stored over molecular sieve (pellets, 3Å). 
Bromide 224: 
Rf = 0.80 [n-pentane]. 
    
   = 46.0 (c = 0.45, n-pentane).  
1
H-NMR (300 MHz, CDCl3): δ = 5.52 – 5.41 (m, 1H, H-4), 5.09 – 5.02 (m, 2H, H-5a, H-5b), 
3.48 – 3.41 (m, 1H, H-1a or H-1b), 3.33 (ddd, J = 9.8, 8.3, 7.3 Hz, 1H, H-1a or H-1b), 2.16 –
 2.05 (m, 1H, H-3), 1.99 – 1.89 (m, 1H, H-2a or H-2b), 1.82 – 1.71 (m, 1H, H-2a or H-2b), 
1.48 – 1.37 (m, 1H, H-6a or H-6b), 1.36 – 1.23 (m, 1H, H-6a or H-6b), 0.88 (dd, J = 7.4, 7.4 Hz, 
3H, 3 x H-7) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 141.12 (C-4), 116.17 (C-5), 44.57 (C-3), 37.63 (C-2), 32.19 
(C-1), 27.69 (C-6), 11.64 (C-7) ppm. 
IR (ATR): ṽ = 3078 (w), 2964 (m), 1641 (w), 1461 (w), 1252 (m), 1100 (w), 996 (m), 915 (s), 
756 (w), 676 (w) cm
‒1
. 
HRMS (EI): calcd. for C7H13Br
+
: 176.0195 [M]
+
      
  found:   176.0189 [M]
+
. 
Alcohol 239: 
For the purpose of full characterization of volatile alcohol 239, an analytical sample was 
concentrated in vacuo. 
Rf = 0.70 [PE: EtOAc 3:1]. 
    
   = 11.1 (c = 0.50, Et2O). 
1
H-NMR (400 MHz, CD2Cl2): δ = 5.63 – 5.52 (m, 1H, H-4), 5.04 – 4.96 (m, 2H, H-5a, H-5b), 
3.67 – 3.53 (m, 2H, H-1a, H-1b), 2.08 – 1.97 (m, 1H, H-3), 1.70 – 1.60 (m, 1H, H-2a or H-2b), 
1.52 – 1.39 (m, 2H, H-2a or H-2b, H-6a or H-6b), 1.32 – 1.23 (m, 1H, H-6a or H-6b), 0.86 (dd, 
J = 7.4, 7.4 Hz, 3H, 3 x H-7) ppm.  
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13
C-NMR (100 MHz, CD2Cl2): δ = 143.25 (C-4), 114.90 (C-5), 61.45 (C-1), 43.18 (C-3), 38.00 
(C-2), 28.27 (C-6), 11.72 (C-7) ppm. 
IR (ATR): ṽ = 3319 (m), 2960 (m), 2924 (m), 1640 (w), 1463 (w), 1420 (w), 1379 (w), 1057 (s), 
994 (s) cm
‒1
. 
HRMS (EI): calcd. for C7H14O
+
: 114.1045 [M]
+
      
  found:   114.1039 [M]
+
. 
 
(3R)-3-ethylpent-4-en-1-yl methanesulfonate (269) 
 
A solution of alcohol 239 (25.8 mg, 0.226 mmol, 1.0 eq) and triethylamine (62.7 µL, 
0.452 mmol, 2.0 eq) in CH2Cl2 (1 mL) was cooled to 0 °C and methanesulfonyl chloride 
(19.2 µL, 0.249 mmol, 1.1 eq) was added dropwise. The resulting solution was stirred at 0 °C 
for 2 h. The reaction mixture was then quenched with aq. NH4Cl (5 mL of a saturated solution) 
and extracted with Et2O (3 x 10 mL). The combined organic fractions were washed with brine 
(10 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography [n-
pentane:Et2O 7:1] afforded mesylate 269 (33.0 mg, 0.172 mmol, 76%) as a colorless liquid. 
Mesylate 269: 
Rf = 0.39 [PE:EtOAc 3:1]. 
    
   = 12.4 (c = 0.88, n-pentane).  
1
H-NMR (300 MHz, CDCl3): δ = 5.57 – 5.42 (m, 1H, H-4), 5.12 – 4.98 (m, 2H, H-5a, H-5b), 
4.30 – 4.12 (m, 2H, H-1a, H-1b), 2.99 (s, 3H, 3 x H-8), 2.13 – 1.99 (m, 1H, H-3), 1.96 – 1.82 
(m, 1H, H-2a or H-2b), 1.69 – 1.55 (m, 1H, H-2a or H-2b), 1.52 – 1.22 (m, 2H, H-6a, H-6b), 
0.87 (ddd, J = 7.3, 7.3, 1.3 Hz, 3H, 3 x H-7) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 141.05 (C-4), 116.35 (C-5), 68.69 (C-1), 42.22 (C-3), 37.44 
(C-8), 33.80 (C-2), 27.89 (C-6), 11.55 (C-7) ppm. 
IR (ATR): ṽ = 2964 (w), 2934 (w), 1739 (w), 1464 (w), 1350 (s), 1171 (s), 956 (s), 916 (s), 828 
(m), 677 (w) cm
‒1
. 
HRMS:  not detected with EI or ESI methods. 
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Tert-butyl N-[5-formyl-1,4-dimethoxy-6-(methoxymethoxy)-7-methylnaphthalen-2-yl] 
carbamate (223) and tert-butyl N-[1,4-dimethoxy-6-(methoxymethoxy)-7-methyl-
naphthalen-2-yl]carbamate (240) 
 
A solution of bromide 226 (250 mg, 0.548 mmol, 1.0 eq) in THF (12 mL) was cooled to 
78 °C, and a solution of methyllithium in Et2O (1.6 M, 688 µL, 1.10 mmol, 2.0 eq) was added 
dropwise. The resulting mixture was stirred at 78 °C for 30 min, and then a solution of 
n-butyllithium in hexanes (2.35 M, 515 µL, 1.21 mmol, 2.2 eq) was added. After additional 
30 min at 78 °C, dimethylformamide (424 µL, 5.48 mmol, 10 eq) was added and the reaction 
mixture stirred further at 78 °C for 30 min, then allowed to warm to room temperature within 
10 min. The reaction was quenched with aq. NH4Cl (10 mL of a saturated solution) and the 
mixture extracted with Et2O (3 x 20 mL). The combined organic fractions were washed with 
brine (20 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 9:16:1] afforded aldehyde 223 (190 mg, 0.469 mmol, 86%) as a yellowish solid 
and protodemetallated naphthalene 240 (21.3 mg, 56.4 µmol, 10%) as a white solid. 
Naphthaldehyde 223: 
Rf = 0.40 [PE:EtOAc 3:1]. 
mp: 107 – 108 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 10.64 (s, 1H, H-11), 7.83 (br s, 1H, H-20), 7.80 (s, 1H, H-7), 
7.14 (br s, 1H, H-3), 5.06 (s, 2H, 2 x H-13), 3.94 (s, 3H, 3 x H-18), 3.84 (s, 3H, 3 x H-19), 3.58 
(s, 3H, 3 x H-14), 2.48 (s, 3H, 3 x H-12), 1.56 (s, 9H, 9 x H-17) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 194.34 (C-11), 152.93 (C-15), 151.95 (C-4), 151.14 (C-9), 
135.64 (C-1), 133.18 (C-8), 128.74 (C-10), 128.43 (C-3), 125.52 (C-6), 124.79 (C-7), 119.08 
(C-5), 102.22 (C-13), 99.27 (C-2), 81.07 (C-16), 61.65 (C-19), 57.72 (C-14), 56.34 (C-18), 
28.54 (3 x C-17), 17.93 (C-12) ppm. 
IR (ATR): ṽ = 3301 (w), 2941 (w), 1722 (m), 1694 (m), 1625 (w), 1364 (w), 1231 (m), 1149 (s), 
966 (s), 876 (w), 706 (w) cm
‒1
. 
HRMS (ESI): calcd. for C21H27NNaO7
+
: 428.1680 [M+Na]
+
    
  found:    428.1679 [M+Na]
+
. 
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Naphthalene 240: 
Rf = 0.62 [PE: EtOAc 3:1]. 
mp: 109 – 111 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 7.70 (br s, 1H, H-19), 7.67 (s, 1H, H-7), 7.64 (s, 1H, H-10), 
7.10 (br s, 1H, H-3), 5.33 (s, 2H, 2 x H-12), 3.99 (s, 3H, 3 x H-17), 3.85 (s, 3H, 3 x H-18), 3.53 
(s, 3H, 3 x H-13), 2.42 (s, 3H, 3 x H-11), 1.56 (s, 9H, 9 x H-16) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 152.99 (C-14), 152.87 (C-9), 151.27 (C-4), 135.37 (C-1), 
129.59 (C-8), 126.27 (C-3), 123.31 (C-6), 121.99 (C-7), 121.83 (C-5), 103.51 (C-10), 97.30 (C-
3), 94.41 (C-12), 80.44 (C-15), 61.39 (C-18), 56.19 (C-13), 55.68 (C-17), 28.41 (C-16), 17.25 
(C-11) ppm. 
IR (ATR): ṽ = 3299 (m), 2974 (m), 2924 (m), 1725 (m), 1613 (m), 1502 (m), 1461 (m), 1410 
(w), 1331 (m), 1216 (m), 1151 (s), 1045 (m), 987 (s), 880 (w), 726 (w) cm
‒1
. 
HRMS (ESI): calcd. for C20H27NNaO6
+
: 400.1731 [M+Na]
+
    
  found:    400.1730 [M+Na]
+
. 
 
Tert-butyl N-[5-(2,2-dimethylpropanoyl)-1,4-dimethoxy-6-(methoxymethoxy)-7-methyl-
naphthalen-2-yl]carbamate (241) 
 
A solution of bromide 224 in THF (0.36 M, 303 µL, 0.109 mmol, 2.2 eq) was diluted with THF 
(0.5 mL) and cooled to 78 °C. A solution of t-butyllithium in pentane (1.7 M, 131 µL, 
0.222 mmol, 4.5 eq) was added dropwise and the resulting mixture stirred at 78 °C for 15 min. 
A solution of aldehyde 223 (20.0 mg, 49.3 µmol, 1.0 eq) in THF (1.5 mL) was added via 
cannula and the reaction mixture stirred at 78 °C for an additional 20 min. The reaction 
mixture was quenched with aq. NH4Cl (5 mL of a saturated solution), allowed to warm to room 
temperature, and then extracted with Et2O (3 x 10 mL). The combined organic fractions were 
washed with brine (10 mL), dried (MgSO4) and concentrated in vacuo. The crude product was 
immediately dissolved in CH2Cl2 (2 mL) and the resulting solution cooled to 0 °C. Solid 
NaHCO3 (62.1 mg, 0.740 mmol, 15 eq) was added followed by Dess-Martin periodinane 
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(41.8 mg, 98.6 µmol, 2.0 eq). The resulting suspension was stirred at 0 °C for 10 min, was then 
allowed to warm to room temperature and stirred at this temperature for an additional 70 min. 
The reaction was quenched with a mixture (1:1, 5 mL) of aq. NaHCO3 (saturated solution) and 
aq. Na2S2O3 (saturated solution) and the mixture was extracted with Et2O (3 x 10 mL). The 
combined organic fractions were washed with brine (10 mL), dried (MgSO4) and concentrated 
in vacuo. Flash column chromatography [PE:EtOAc 9:16:1] afforded ketone 241 (16.8 mg, 
36.4 µmol, 74% over two steps) as a thick, yellow oil. 
Naphthalene building block 241: 
Rf = 0.37 [PE:EtOAc 3:1].  
1
H-NMR (600 MHz, CDCl3): δ = 7.76 (br s, 1H, H-22), 7.72 
(d, J = 1.0, 1H, H-7), 7.13 (br s, 1H, H-3), 4.92 – 4.89 (m, 
2H, H-15a, H-15b), 3.86 (s, 3H, 3 x H-20), 3.84 (s, 3H, 3 x H-21), 3.56 (s, 3H, 3 x H-16), 2.51 
(d, J = 0.9 Hz, 3H, 3 x H-14), 1.56 (s, 9H, 9 x H-19), 1.18 (s, 9H, 9 x H-13) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 214.06 (C-11), 152.97 (C-17), 151.25 (C-4), 149.36 (C-9), 
135.58 (C-1), 133.17 (C-8), 129.80 (C-6 or C-10), 128.06 (C-3), 125.48 (C-6 or C-10), 122.94 
(C-7), 119.11 (C-5), 101.80 (C-15), 98.88 (C-2), 80.97 (C-18), 61.56 (C-21), 57.91 (C-16), 
56.26 (C-20), 46.03 (C-12), 28.55 (3 x C-19), 27.83 (3 x C-13), 17.98 (C-14) ppm. 
IR (ATR): ṽ = 2976 (w), 1726 (m), 1626 (m), 1495 (m), 1367 (m), 1230 (m), 1153 (s), 1046 
(m), 925 (m), 875 (w), 754 (m) cm
‒1
. 
HRMS (ESI): calcd. for C25H36NO7
+
: 462.2486 [M+H]
+
     
  found:   462.2486 [M+H]
+
. 
 
Tert-butyl N-{5-[(4R)-4-ethylhex-5-enoyl]-1,4-dimethoxy-6-(methoxymethoxy)-7-methyl-
naphthalen-2-yl}carbamate (228) and tert-butyl N-[5-(4,4-dimethylpentanoyl)-1,4-
dimethoxy-6-(methoxymethoxy)-7-methyl-naphthalen-2-yl]carbamate (242) 
 
A solution of bromide 224 in THF (0.36 M, 494 µL, 0.178 mmol, 5.0 eq) was diluted with THF 
(0.5 mL) and cooled to 78 °C. A solution of t-butyllithium in pentane (1.7 M, 209 µL, 
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0.355 mmol, 10 eq) was added dropwise and the resulting mixture stirred at 78 °C for 30 min. 
The reaction mixture was warmed to 0 °C and stirred at this temperature for an additional 
30 min. After cooling to 78 °C, a solution of aldehyde 223 (14.4 mg, 35.5 µmol, 1.0 eq) in 
THF (1.5 mL) was added via cannula and the reaction mixture stirred at 78 °C for an 
additional 30 min. The reaction mixture was quenched with aq. NH4Cl (5 mL of a saturated 
solution), allowed to warm to room temperature and then extracted with Et2O (3 x 10 mL). The 
combined organic fractions were washed with brine (10 mL), dried (MgSO4) and concentrated 
in vacuo. The crude product was immediately dissolved in CH2Cl2 (2 mL), and NaHCO3 
(44.7 mg, 0.533 mmol, 15 eq) was added followed by Dess-Martin periodinane (30.1 mg, 
71.0 µmol, 2.0 eq). The resulting suspension was stirred at room temperature for 60 min. Then, 
the reaction was quenched with a mixture (1:1, 5 mL) of aq. NaHCO3 (saturated solution) and 
aq. Na2S2O3 (saturated solution), and the mixture was extracted with Et2O (3 x 10 mL). The 
combined organic fractions were washed with brine (10 mL), dried (MgSO4) and concentrated 
in vacuo. Flash column chromatography [PE:EtOAc 9:1] afforded ketone 228 (11.7 mg, 
23.3 µmol, 67% over two steps) as a white solid consisting of two atropisomers (d.r. 1:1, as 
determined by 
1
H-NMR spectroscopy) as an inseparable mixture. 
Naphthalene building block 228: 
Rf = 0.44 [PE:EtOAc 3:1].  
1
H-NMR (400 MHz, CDCl3) (mixture of isomers, both 
isomers quoted, one isomer primed): δ = 7.76 (s, 2H, H-27, 
H-27'), 7.72 – 7.70 (m, 2H, H-7, H-7'), 7.13 (br s, 2H, H-3, 
H-3'), 5.58 – 5.44 (m, 2H, H-15, H-15'), 5.00 – 4.89 (m, 8H, H-16a, H-16b, H-16a', H-16b', H-
20a, H-20b, H-20a', H-20b'), 3.87 (s, 3H, 3 x H-25 or 3 x H-25'), 3.86 (s, 3H, 3 x H-25 or 3 x H-
25'), 3.83 (br s, 6H, 3 x H-26, 3 x H-26'), 3.57 (s, 3H, 3 x H-21 or 3 x H-21'), 3.56 (s, 3H, 3 x H-
21 or 3 x H-21'), 2.97 – 2.86 (m, 1H, H-12a or H-12b), 2.84 – 2.74 (m, 1H, H-12a' or H-12b'), 
2.72 – 2.62 (m, 1H, H-12a' or H-12b'), 2.61 – 2.51 (m, 1H, H-12a or H-12b), 2.50 – 2.47 (m, 
6H, 3 x H-19, 3 x H-19'), 2.03 – 1.93 (m, 1H, H-13a or H-13b), 1.93 – 1.83 (m, 2H, H-14, H-
14'), 1.83 – 1.73 (m, 2H, H-13a', H-13b'), 1.66 – 1.58 (m, 1H, H-13a or H-13b), 1.55 (br s, 18H, 
9 x H-24, 9 x H-24'), 1.50 – 1.38 (m, 2H, H-17a or H-17b, H-17a' or H-17b'), 1.38 – 1.24 (m, 
2H, H-17a or H-17b, H-17a' or H-17b'), 0.89 – 0.84 (m, 6H, 3 x H-18, 3 x H-18') ppm. 
13
C-NMR (100 MHz, CDCl3) (mixture of isomers, both isomers quoted, one isomer primed): 
δ = 207.03 (C-11 or C-11'), 206.97 (C-11 or C-11'), 152.95 (C-22 and C-22'), 151.29 (C-4 or C-
4'), 151.28 (C-4 or C-4'), 149.09 (C-9 or C-9'), 149.01 (C-9 or C-9'), 142.60 (C-15 or C-15'), 
142.56 (C-15 or C-15'), 135.62 (C-1 or C-1'), 135.58 (C-1 or C-1'), 132.93 (C-8 or C-8'), 132.91 
(C-8 or C-8'), 131.63 (C-3 or C-6 or C-10 or C-3' or C-6' or C-10'), 131.58 (C-3 or C-6 or C-10 
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or C-3' or C-6' or C-10'), 128.19 (C-3 and C-3', or C-6 and C-6', or C-10 and C-10'), 125.72 (C-
3 and C-3', or C-6 and C-6', or C-10 and C-10'), 123.05 (C-7 or C-7'), 123.02 (C-7 or C-7'), 
118.19 (C-5 or C-5'), 118.15 (C-5 or C-5'), 115.11 (C-16 or C-16'), 114.99 (C-16 or C-16'), 
101.68 (C-20 or C-20'), 101.59 (C-20 or C-20'), 98.97 (C-2 or C-2'), 98.85 (C-2 or C-2'), 80.98 
(C-23 and C-23'), 61.56 (C-26 and C-26'), 57.75 (C-21 and C-21'), 56.44 (C-25 or C-25'), 56.38 
(C-25 or C-25'), 45.45 (C-14 or C-14'), 45.42 (C-14 or C-14'), 43.24 (C-12 or C-12'), 43.16 (C-
12 or C-12'), 28.52 (3 x C-24 and 3 x C-24'), 28.24 (C-13 or C-13'), 28.21 (C-13 or C-13'), 
27.94 (C-17 or C-17'), 27.73 (C-17 or C-17'), 17.80 (C-19 or C-19'), 17.79 (C-19 or C-19'), 
11.78 (C-18 or C-18'), 11.76 (C-18 or C-18') ppm. 
IR (ATR): ṽ = 3431 (w), 2955 (m), 1707 (m), 1626 (m), 1605 (w), 1495 (m), 1456 (m), 1366 
(m), 1229 (m), 1146 (s), 1046 (m), 986 (m), 930 (m), 880 (w), 753 (s) cm
‒1
. 
HRMS (ESI): calcd. for C28H40NO7
+
: 502.2799 [M+H]
+
     
  found:   502.2796 [M+H]
+
. 
Ketone 242: 
Side product 242 was obtained as a yellowish solid when 15 eq of tert-butyllithium and 5.0 eq 
of bromide 224 was used. Compound 242 could be separated from the product 224 by HPLC 
[Dynamax Microsorb 60-8 C18 (250 x 21.4 mm), gradient, water (A)/MeCN (B); 0 min 80% B, 
2 min 80% B, 40 min 100% B; flow rate 15 mL/min; detection 255 nm: tR(242) = 27.0 min, 
tR(228) = 28.5 min]. 
Rf = 0.44 [PE:EtOAc 3:1]. 
mp: 44 – 45 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.77 (br s, 1H, H-24), 7.72 
(d, J = 1.0 Hz, 1H, H-7), 7.14 (br s, 1H, H-3), 5.00 (d, 
J = 5.5 Hz, 1H, H-17a or H-17b), 4.93 (d, J = 5.5 Hz, 1H, H-17a or H-17b), 3.88 (s, 3H, 3 x H-
22), 3.84 (s, 3H, 3 x H-23), 3.57 (s, 3H, 3 x H-18), 2.88 (ddd, J = 18.0, 12.3, 4.0 Hz, 1H, H-12a 
or H-12b), 2.67 – 2.56 (m, 1H, H-12a or H-12b), 2.49 (d, J = 0.9 Hz, 3H, 3 x H-16), 1.83 – 1.74 
(m, 1H, H-13a or H-13b), 1.64 – 1.56 (m, 1H, H-13a or H-13b), 1.55 (s, 9H, 9 x H-21), 0.90 (s, 
9H, 9 x H-15) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 207.18 (C-11), 152.95 (C-19), 151.26 (C-4), 148.94 (C-9), 
135.60 (C-1), 132.91 (C-8), 131.75 (C-3 or C-6 or C-10), 128.21 (C-3 or C-6 or C-10), 125.74 
(C-3 or C-6 or C-10), 123.05 (C-7), 118.15 (C-5), 101.58 (C-17), 98.83 (C-2), 80.98 (C-20), 
61.56 (C-23), 57.76 (C-18), 56.41 (C-22), 40.98 (C-12), 37.13 (C-13), 29.86 (C-14), 29.40 
(3 x C-15), 28.52 (3 x C-21), 17.79 (C-16) ppm. 
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IR (ATR): ṽ = 2954 (w), 1708 (br m), 1626 (m), 1495 (m), 1366 (m), 1229 (m), 1146 (s), 1046 
(m), 985 (m), 930 (m), 880 (w), 759 (w) cm
‒1
. 
HRMS (ESI): calcd. for C27H39NNaO7

: 512.2619 [M+Na]

    
  found:    512.2617 [M+Na]

. 
 
1-(6-Amino-2-hydroxy-5,8-dimethoxy-3-methylnaphthalen-1-yl)-4-ethylhex-5-en-1-
one (245) 
 
To a solution of protected aminonaphthalene 228 (21.7 mg, 43.3 µmol, 1.0 eq) in MeOH (1 mL) 
was added dropwise a solution of HCl in MeOH (1 mL), prepared by bubbling HCl gas (NaCl, 
conc. H2SO4) through MeOH for 30 min, and the resulting mixture was stirred at room 
temperature for 1.5 h. The reaction was quenched with aq. NaHCO3 (10 mL of a saturated 
solution) and the mixture extracted with Et2O (3 x 10 mL). The combined organic fractions 
were dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EtOAc 3:1] 
afforded aminonaphthalene 245 (15.5 mg, 43.3 µmol, quant.) as a yellow oil. 
Aminonaphthalene 245: 
Rf = 0.59 [PE:EtOAc 1:1].  
    
   = 7.1 (c = 0.20, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.70 (d, J = 1.0 Hz, 1H, H-7), 6.39 
(s, 1H, H-3), 5.42 (ddd, J = 17.2, 10.1, 8.8 Hz, 1H, H-15), 4.88 (dd, 
J = 10.2, 1.8 Hz, 1H, H-16a), 4.83 – 4.73 (m, 1H, H-16b), 3.84 (s, 3H, 3 x H-21), 3.80 (s, 3H, 
3 x H-20), 3.52 – 2.43 (br m, 2H, H-12a, H-12b), 2.38 (d, J = 1.0 Hz, 3H, 3 x H-19), 1.76 (br s, 
2H, H-13a or H-13b, H-14), 1.58 (br s, 1H, H-13a or H-13b), 1.40 – 1.32 (m, 1H, H-17a or 
17b), 1.27 – 1.19 (m, 1H, H-17a or 17b), 0.81 (dd, J = 7.4, 7.4 Hz, 3H, 3 x H-18). 
13
C-NMR (150 MHz, CDCl3): δ = 210.31 (C-11), 151.74 (C-9), 150.85 (C-4), 142.35 (C-15), 
134.27 (C-1), 128.72 (C-8), 125.20 (C-7), 124.38 (C-2 or C-6 or C-10), 116.68 (C-2 or C-6 or 
C-10), 116.34 (C-5), 115.06 (C-16), 99.53 (C-3), 60.47 (C-21), 55.99 (C-22), 45.79 (C-14), 
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42.81 (C-12), 30.33 (C-13), 27.83 (C-17), 17.10 (C-19), 11.75 (C-18), one aromatic carbon (C-2 
or C-6 or C-10) not observed. 
IR (ATR): ṽ = 3362 (br w), 2927 (m), 1688 (w), 1626 (s), 1442 (w), 1391 (m), 1228 (s), 992 
(m), 753 (s) cm
‒1
. 
HRMS (ESI): calcd. for C21H28NO4
+
: 358.2013 [M+H]
+
     
 found:    358.2008 [M+H]
+
. 
 
(3S,4S)-3-(methoxymethoxy)-6-methylhepta-1,5-dien-4-yl (2E)-4-({5-[(4R)-4-ethylhex-5-
enoyl]-6-hydroxy-1,4-dimethoxy-7-methylnaphthalen-2-yl}carbamoyl)-2-methylbut-2-
enoate (246) 
 
To a solution of carboxylic acid 225 (12.5 mg, 40.1 µmol, 1.2 eq) in DMF (0.35 mL) was added 
1-hydroxybenzotriazole hydrate (86 wt%, 10.4 mg, 66.8 µmol, 2.0 eq), and the mixture was 
cooled to 0 °C. N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide (11.8 µL, 66.8 µmol, 2.0 eq) 
was added followed by a solution of aminonaphthalene 245 (11.9 mg, 33.4 µmol, 1.0 eq) in 
DMF (0.50 mL). The reaction mixture was stirred at 0 °C for 1h and was then allowed to warm 
to room temperature. After stirring at this temperature for an additional 19 h, the reaction was 
diluted with Et2O (10 mL). The organic phase was washed with aq. LiCl (10 wt%, 3 x 10 mL) 
and brine (10 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
[PE:EtOAc 3:1] afforded naphthalene 246 (14.0 mg, 21.5 µmol, 64%) as a yellow oil consisting 
of a mixture of isomers. 
Aminonaphthalene 246: 
Rf = 0.83 [PE:EtOAc 1:1].  
HRMS (ESI): calcd. for C37H49NNaO9
+
: 674.3300 [M+Na]
+
    
  found:    674.3293 [M+Na]
+
. 
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Tert-butyl[(2S,3S)-3-(methoxymethoxy)-2-(2-methylprop-1-en-1-yl)pent-4-en-1-
yl]dimethylsilane (250) 
 
To a solution of alcohol 247 (184 mg, 0.988 mmol, 1.0 eq) in CH2Cl2 (8 mL) was added 
triethylamine (219 µL, 1.58 mmol, 1.6 eq), followed by tert-butyldimethylsilyl 
trifluoromethanesulfonate (340 µL, 1.48 mmol, 1.5 eq), and the resulting solution was stirred at 
room temperature for 5 min. The reaction mixture was quenched with aq. NH4Cl (10 mL of a 
saturated solution) and extracted with Et2O (3 x 20 mL). The combined organic fractions were 
washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [PE:EtOAc 49:1] afforded tert-butyldimethylsilyl ether 250 (291 mg, 
0.968 mmol, 98%) as a colorless liquid. 
TBS ether 250: 
Rf = 0.46 [PE:EtOAc 9:1].  
    
   = 25.0 (c = 1.1, CHCl3). 
1
H-NMR (300 MHz, CDCl3): δ = 5.75 (ddd, J = 17.2, 10.5, 6.7 Hz, 1H, H-2), 5.29 – 5.16 (m, 
2H, H-1a, H-1b), 5.16 – 5.10 (m, 1H, H-5), 4.70 – 4.64 (m, 2H, H-9a, H-9b), 4.35 (dd, J = 9.2, 
6.1 Hz, 1H, H-4), 3.99 – 3.92 (m, 1H, H-3), 3.36 (s, 3H, 3 x H-10), 1.70 (d, J = 1.4 Hz, 3H, 
3 x H-7 or 3 x H-8), 1.63 (d, J = 1.3 Hz, 3H, 3 x H-7 or 3 x H-8), 0.87 (s, 9H, 9 x H-14), 0.04 (s, 
3H, 3 x H-11 or 3 x H-12), 0.01 (s, 3H, 3 x H-11 or 3 x H-12) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 135.34 (C-2), 133.81 (C-6), 125.48 (C-5), 117.55 (C-1), 94.96 
(C-9), 81.01 (C-3), 72.38 (C-4), 55.55 (C-10), 26.01 (3 x C-14), 25.84 (C-7 or C-8), 18.76 (C-7 
or C-8), 18.38 (C-13), 4.24 (C-11 or C-12), 4.59 (C-11 or C-12) ppm. 
IR (ATR): ṽ = 2927 (m), 2856 (m), 1677 (w), 1472 (w), 1249 (m), 1037 (br s), 921 (m), 831 (s), 
774 (s), 667 (m) cm
‒1
. 
HRMS (ESI): calcd. for C16H32NaO3Si
+
: 323.2013 [M+Na]
+
    
  found:    323.2015 [M+Na]
+
. 
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Tert-butyl[(2S,3S)-3-(methoxymethoxy)-2-(2-methylprop-1-en-1-yl)pent-4-en-1-
yl]diphenylsilane (252) 
 
To a solution of alcohol 247 (160 mg, 0.859 mmol, 1.0 eq), imidazole (93.3 mg, 1.37 mmol, 
1.6 eq) and 4-(dimethylamino)pyridine (10.5 mg, 85.9 µmol, 10 mol%) in DMF (6 mL) was 
added tert-butyldiphenylsilyl chloride (335 µL, 1.29 mmol, 1.5 eq), and the resulting solution 
was stirred at room temperature for 24 h. The reaction mixture was diluted with Et2O (30 mL) 
and washed with aq. LiCl (10 wt%, 3 x 10 mL), dried (MgSO4) and concentrated in vacuo. 
Flash column chromatography [PE:EtOAc 99:149:119:14:1] afforded tert-
butyldiphenylsilyl ether 252 (242 mg, 0.570 mmol, 66%) as a colorless oil, as well as remaining 
starting material 247 (20.1 mg, 0.108 mmol, 13%). 
TBDPS ether 252: 
Rf = 0.75 [PE:EtOAc 3:1]. 
    
   = 13.8 (c = 1.2, CHCl3).  
1
H-NMR (600 MHz, CDCl3): δ = 7.74 – 7.71 (m, 2H, 2 x H-12 or 2 x H-
16), 7.68 – 7.66 (m, 2H, 2 x H-12 or 2 x H-16), 7.43 – 7.32 (m, 6H, 2 x H-
13, H-14, 2 x H-17, H-18), 5.88 – 5.81 (m, 1H, H-2), 5.31 – 5.26 (m, 1H, 
H-1a), 5.25 – 5.22 (m, 1H, H-1b), 5.15 – 5.11 (m, 1H, H-5), 4.62 (dd, J = 6.6, 0.4 Hz, 1H, H-9a 
or H-9b), 4.56 (d, J = 6.6 Hz, 1H, H-9a or H-9b), 4.43 (dd, J = 9.4, 5.6 Hz, 1H, H-4), 4.07 (dd, 
J = 6.1, 6.1 Hz, 1H, H-3), 3.26 (s, 3H, 3 x H-10), 1.51 (d, J = 1.3 Hz, 3H, 3 x H-7 or 3 x H-8), 
1.09 (d, J = 1.4 Hz, 3H, 3 x H-7 or 3 x H-8), 1.05 (s, 9H, 9 x H-20) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 136.15 (2 x C-12 or 2 x C-16), 136.11 (2 x C-12 or 2 x C-16), 
135.43 (C-6), 134.97 (C-2), 134.52 (C-11 or C-15), 134.31 (C-11 or C-15), 129.60 (C-14 or C-
18), 129.42 (C-14 or C-18), 127.58 (2 x C-13 or 2 x C-17), 127.32 (2 x C-13 or 2 x C-17), 
124.22 (C-5), 117.76 (C-1), 94.78 (C-9), 80.59 (C-3), 72.19 (C-4), 55.52 (C-10), 27.14 (3 x C-
20), 25.87 (C-7 or C-8), 19.50 (C-19), 18.25 (C-7 or C-8) ppm. 
IR (ATR): ṽ = 3072 (w), 2931 (m), 2858 (m), 1473 (w), 1428 (m), 1376 (w), 1150 (w), 1104 
(m), 1034 (s), 920 (m), 822 (m), 798 (m), 739 (m), 700 (s) cm
‒1
. 
HRMS (ESI): calcd. for C26H36NaO3Si
+
: 447.2326 [M+Na]
+
    
  found:    447.2323 [M+Na]
+
. 
21. Experimental Procedures 
195 
21.4. Experimental Data of Chapter IV 
(2S)-2-(2,2-dimethyl-1,1-diphenylpropoxy)butanoic acid (258) 
 
A solution of (S)-2-hydroxybutyric acid (257) (1.00 g, 9.61 mmol, 1.0 eq) in DMF (4 mL) was 
cooled to 0 °C and a solution of tert-butyldiphenylsilyl chloride (7.91 mL, 30.8 mmol, 3.2 eq) 
and imidazole (6.90 g, 101 mmol, 10.5 eq) in DMF (6 mL) was added dropwise. After complete 
addition, stirring was continued at room temperature for 21 h. The reaction was quenched with 
brine (100 mL) and the mixture extracted with PE:Et2O (3:1, 5 x 50 mL). The combined organic 
fractions were washed with water (50 mL), then dried (MgSO4) and concentrated in vacuo. The 
crude product was dissolved in a mixture of MeOH and THF (3:2, 75 mL) and the solution 
cooled to 0 °C. A solution of K2CO3 (2.98 g, 21.6 mmol, 2.2 eq) in water (17 mL) was added 
dropwise. After complete addition, stirring was continued at room temperature for 17 h. The 
reaction was quenched with brine (100 mL), and the pH of the mixture was lowered to 1 by 
carefully adding conc. H2SO4. The mixture was extracted with PE:Et2O (3:1, 4 x 100 mL) and 
the combined organic fractions were re-extracted with aq. NaOH (2 wt%, 4 x 100 mL). The 
combined basic aqueous fractions were cooled to 0 °C and the pH was lowered to 1 by carefully 
adding conc. H2SO4. The mixture was then extracted with CH2Cl2 (5 x 100 mL) and the 
combined organic fractions were dried (MgSO4) and concentrated in vacuo to afford the 
protected alcohol 258 (2.56 g, 7.48 mmol, 78%) as white solid. 
TBDPS ether 258: 
Rf = 0.78 [PE:EtOAc 1:1]. 
    
   = ‒14.0 (c = 1.8, CHCl3). 
mp: 56 °C. 
1
H-NMR (400 MHz, CDCl3): δ = 7.68 – 7.60 (m, 4H, 2 x H-6, 2 x H-10), 7.49 – 7.43 (m, 2H, 
H-8, H-12), 7.43 – 7.36 (m, 4H, 2 x H-7, 2 x H-11), 4.31 (dd, J = 5.6, 4.2 Hz, 1H, H-2), 1.79 –
 1.68 (m, 1H, H-3a or H-3b), 1.64 – 1.52 (m, 1H, H-3a or H-3b), 1.13 (s, 9H, 9 x H-14), 0.89 (t, 
J = 7.4, 3H, 3 x H-4) ppm. 
13
C-NMR (100 MHz, CDCl3): δ = 174.74 (C-1), 135.85 (2 x C-6 or 2 x C-10), 135.83 (2 x C-6 
or 2 x C-10), 132.66 (C-5 or C-9), 132.12 (C-5 or C-9), 130.44 (C-8 or C-12), 130.43 (C-8 or C-
12), 128.11 (2 x C-7 or 2 x C-11), 128.04 (2 x C-7 or 2 x C-11), 73.77 (C-2), 27.62 (C-3), 27.07 
(3 x C-14), 19.45 (C-13), 8.24 (C-4). 
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IR (ATR): ṽ = 3226 (s), 2935 (s), 1760 (s), 1427 (m), 1092 (s), 1012 (m), 702 (m) cm‒1. 
HRMS (ESI): calcd. for C20H25O3Si
+
: 341.1578 [MH]     
  found:   341.1575 [MH]. 
 
(2S)-2-(2,2-dimethyl-1,1-diphenylpropoxy)-N-methoxy-N-methylbutanamide (259) 
 
A solution of acid 258 (2.46 g, 7.18 mmol, 1.0 eq) in CH2Cl2 (19 mL) was cooled to 0 °C and 
1,1'-carbonyldiimidazole (2.33 g, 14.4 mmol, 2.0 eq) was added in one portion. The solution 
was allowed to warm to room temperature and stirred at this temperature for 25 h. The mixture 
was then cooled to 0 °C and N,O-dimethylhydroxylamine hydrochloride (1.40 g, 14.4 mmol, 
2.0 eq), imidazole (980 mg, 14.4 mmol, 2.0 eq) and 4-(dimethylamino)pyridine (26.4 mg, 
0.216 mmol, 3 mol%) were added. After warming to room temperature, the reaction mixture 
was stirred at this temperature for an additional 23 h. The mixture was diluted with CH2Cl2 
(100 mL) and the organic phase was washed with aq. HCl (2 N, 2 x 100 mL) and brine (50 mL), 
then dried (MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EA 
19:19:15:1] afforded Weinreb amide 259 (2.57 g, 6.66 mmol, 93%) as a colorless solid. 
Weinreb amide 259: 
Rf = 0.83 [PE:EtOAc 1:1]. 
    
   = ‒0.7 (c = 1.7, CHCl3). 
mp: 69 °C. 
1
H-NMR (600 MHz, CDCl3): δ = 7.72 – 7.68 (m, 4H, 2 x H-8, 2 x H-12), 7.44 – 7.32 (m, 6H, 
2 x H-9, H-10, 2 x H-13, H-14), 4.46 – 4.40 (m, 1H, H-2), 3.11 (br s, 3H, 3 x H-6), 2.99 (s, 3H, 
3 x H-5), 1.79 – 1.69 (m, 2H, H-3a, H-3b), 1.09 (s, 9H, 9 x H-16), 0.91 (t, J = 7.5, 3H, 3 x H-
4) ppm. 
13
C-NMR (75 MHz, CDCl3): δ = 173.52 (inferred from HMBC, C-1), 136.29 (2 x C-8 or 2 x C-
12), 136.08 (2 x C-8 or 2 x C-12), 133.98 (H-7 or C-11), 133.67 (C-7 or C-11), 129.74 (C-10 or 
C-14), 129.69 (C-10 or C-14), 127.64 (2 x C-9 or 2 x C-13), 127.52 (2 x C-9 or 2 x C-13), 71.31 
(inferred from HSQC, C-2), 60.69 (C-6), 32.35 (inferred from HSQC, C-5), 27.92 (C-3), 27.05 
(C-16), 19.58 (C-15), 9.59 (C-4). 
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IR (ATR): ṽ = 2937 (m), 1668 (s), 1430 (w), 1111 (m), 704 (m) cm‒1. 
HRMS (ESI): calcd. for C22H31NNaO3Si
+
: 408.1965 [MNa]   

 found:    408.1964 [MNa]. 
 
(3S)-3-(2,2-dimethyl-1,1-diphenylpropoxy)pentadecan-4-one (260) 
 
Magnesium turnings (61.9 mg, 2.55 mmol, 4.9 eq) were dried at 650 °C (heat gun) in vacuo 
(10
3
 mbar) for 10 min. After cooling to room temperature, Et2O (0.5 mL) and 1,2-
dibromoethane (6.79 µL, 78.8 µmol, 20 mol%) were added. A solution of 1-bromoundecane 
(470 µL, 2.11 mmol, 4.1 eq) in Et2O (2 mL) was added dropwise over a period of 15 min, and 
the resulting mixture was stirred at room temperature for an additional 30 min. This freshly 
prepared Grignard solution was added dropwise to a 0 °C cold solution of Weinreb amide 259 
(200 mg, 0.519 mmol, 1.0 eq) in Et2O (5 mL). The reaction mixture was stirred at 0 °C for 1 h, 
then allowed to warm to room temperature and stirred at this temperature for an additional 21 h. 
The mixture was diluted with Et2O (10 mL) and the reaction quenched at 0 °C with water 
(10 mL). The mixture was allowed to warm to room temperature, the organic phase was 
separated and washed with aq. KHSO4 (10 wt%, 2 x 20 mL) and brine (20 mL), then dried 
(MgSO4) and concentrated in vacuo. Flash column chromatography [PE:EA 
100:049:119:1] afforded ketone 260 (94.2 mg, 0.200 mmol, 38%) as a colorless liquid. 
Ketone 260: 
Rf = 0.50 [PE:EtOAc 19:1]. 
    
   = ‒21.6 (c = 0.75, CHCl3). 
1
H-NMR (600 MHz, CDCl3): δ = 7.66 – 7.59 (m, 4H, 
2 x H-17, 2 x H-21), 7.45 – 7.40 (m, 2H, H-19, H-23), 7.39 – 7.33 (m, 4H, 2 x H-18, 2 x H-22), 
4.11 (dd, J = 6.2, 5.4 Hz, 1H, H-3), 2.44 (ddd, J = 17.8, 8.4, 6.3 Hz, 1H, H-5a or H-5b), 2.35 
(ddd, J = 17.8, 8.4, 6.4 Hz, 1H, H-5a or H-5b), 1.68 – 1.56 (m, 2H, H-2a, H-2b), 1.45 – 1.34 (m, 
2H, H-6a, H-6b), 1.33 – 1.14 (m, 16H, H-7a, H-7b, H-8a, H-8b, H-9a, H-9b, H-10a, H-10b, H-
11a, H-11b, H-12a, H-12b, H-13a, H-13b, H-14a, H-14b), 1.11 (s, 9H, 9 x H-25), 0.88 (dd, 
J = 7.1, 7.1 Hz, 3H, 3 x H-15), 0.81 (dd, J = 7.5, 7.5 Hz, 3H, 3 x H-1) ppm. 
13
C-NMR (150 MHz, CDCl3): δ = 213.04 (C-4), 135.99 (2 x C-17 or 2 x C-21), 135.95 (2 x C-
17 or 2 x C-21), 133.82 (C-16 or C-20), 133.36 (C-16 or C-20), 129.99 (C-19 or C-23), 129.96 
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(C-19 or C-23), 127.83 (2 x C-18 or 2 x C-22), 127.77 (2 x C-18 or 2 x C-22), 80.16 (C-3), 
38.16 (C-5), 32.07 (C-13), 29.78 (C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.77 (C-7 or C-
8 or C-9 or C-10 or C-11 or C-12), 29.62 (C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.58 
(C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.50 (C-7 or C-8 or C-9 or C-10 or C-11 or C-
12), 29.39 (C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 27.96 (C-2), 27.16 (3 x C-25), 23.10 
(C-6), 22.85 (C-14), 19.54 (C-24), 14.28 (C-15), 8.96 (C-1) ppm. 
IR (ATR): ṽ = 2925 (m), 2855 (m), 1716 (w), 1428 (w), 1106 (m), 700 (s) cm‒1. 
HRMS (EI): calcd. for C30H45O2Si
+
: 465.3183 [MCH3]

     
  found:   465.3184 [MCH3]

. 
 
(3S)-3-hydroxypentadecan-4-one (256) 
 
A solution of silyl ether 260 (128 mg, 0.266 mmol, 1.0 eq) in THF (4.5 mL) was cooled to 0 °C 
and a solution of tetrabutylammonium fluoride in THF (1.0 M, 772 µL, 0.772 mmol, 2.9 eq) was 
added dropwise. The resulting mixture was allowed to warm to room temperature and stirred at 
this temperature for 3 h. The reaction was quenched with aq. NaHCO3 (15 mL of a saturated 
solution) and the mixture extracted with Et2O (2 x 20 mL). The combined organic fractions 
were washed with water (15 mL), dried (MgSO4) and concentrated in vacuo. Flash column 
chromatography [PE:EtOAc 100:019:1] and further purification by HPLC [Dynamax 
Microsorb 60-8 C18 (250 x 21.4 mm), isocratic elution, water (A)/MeCN (B); 78% B; flow rate 
16.8 mL/min; detection 200 nm: tR (256) = 27.3 min] afforded LAI-1 (256) (36.2 mg, 
0.149 mmol, 56%) as a colorless liquid. 
LAI-1 (256): 
Rf = 0.43 [PE:EtOAc 9:1]. 
    
   = ‒51.6 (c = 0.90, CHCl3). 
1
H-NMR (400 MHz, CDCl3): δ = 4.15 (dd, J = 6.8, 4.0 Hz, 1H, H-3), 3.44 (br s, 1H, H-16), 
2.50 – 2.38 (m, 2H, H-5a, H-5b), 1.96 – 1.83 (m, 1H, H-2a or H-2b), 1.66 – 1.52 (m, 3H, H-2a 
or H-2b, H-6a, H6b), 1.34 – 1.17 (m, 16H, H-7a, H-7b, H-8a, H-8b, H-9a, H-9b, H-10a, H-10b, 
H-11a, H-11b, H-12a, H-12b, H-13a, H-13b, H-14a, H-14b), 0.93 (dd, J = 7.4, 7.4 Hz, 3H, 
3 x H-1), 0.87 (dd, J = 6.9, 6.9 Hz, 3H, 3 x H-15) ppm. 
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13
C-NMR (100 MHz, CDCl3): δ = 212.58 (C-4), 77.30 (C-3), 38.03 (C-5), 32.05 (C-13), 29.73 
(C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.73 (C-7 or C-8 or C-9 or C-10 or C-11 or C-
12), 29.58 (C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.49 (C-7 or C-8 or C-9 or C-10 or C-
11 or C-12), 29.47 (C-7 or C-8 or C-9 or C-10 or C-11 or C-12), 29.39 (C-7 or C-8 or C-9 or C-
10 or C-11 or C-12), 26.90 (C-2), 23.76 (C-6), 22.83 (C-14), 14.26 (C-15), 9.02 (C-1) ppm. 
IR (ATR): ṽ = 3482 (br, w), 2923 (s), 2854 (m), 1710 (s), 1464 (m), 1075 (w), 981 (m), 722 
(w) cm
‒1
. 
HRMS (EI): calcd. for C15H30ClO2

: 277.1940 [MCl]     
  found:   277.1936 [MCl]. 
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22.3. NMR Spectra of Chapter III 
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22.4. NMR Spectra of Chapter IV 
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22.5. Single-Crystal X-Ray Analysis 
All single-crystal X-ray analyses were carried out by P. Mayer and Prof. Karaghiosoff in the 
analytic department. 
22.5.1. Single-Crystal X-Ray Analysis of Compound 67 
 
 
Figure 23. Molecular structure of 67 (one molecule out of the asymmetric unit). 
Details are summarized in Table 7 and are available from the Crystallographic Data Centre 
under the depository numbers CCDC 894249. Copies of the data can be obtained free of charge 
upon application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 7. Crystallographic data for 67. 
net formula C14H21BrO7 
Mr/g mol
−1
 381.216 
crystal size/mm 0.30 × 0.23 × 0.10 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system monoclinic 
space group P21 
a/Å 13.1405(5) 
b/Å 9.1003(3) 
c/Å 14.1366(4) 
α/° 90 
β/° 97.090(3) 
γ/° 90 
V/Å
3
 1677.56(10) 
Z 4 
calc. density/g cm
−3
 1.50942(9) 
μ/mm
−1
 2.480 
absorption correction 'multi-scan' 
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transmission factor range 0.77095–1.00000 
refls. measured 6923 
Rint 0.0251 
mean σ(I)/I 0.0887 
θ range 4.24–26.33 
observed refls. 3547 
x, y (weighting scheme) 0.0373, 0 
hydrogen refinement constr 
Flack parameter 0.016(9) 
refls in refinement 5174 
parameters 405 
restraints 1 
R(Fobs) 0.0397 
Rw(F
2
) 0.0788 
S 0.869 
shift/errormax 0.001 
max electron density/e Å
−3
 1.125 
min electron density/e Å
−3
 −0.393 
 
22.5.2. Single-Crystal X-Ray Analysis for Compound 60 
 
 
Figure 24. Molecular structure of 60. 
Correct structure derived from synthesis. 1484 Friedel pairs measured. Further details are 
summarized in Table 8 and are available from the Crystallographic Data Centre under the 
depository numbers CCDC 894255. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 8. Crystallographic data for 60. 
net formula C10H14O5 
Mr/g mol
−1
 214.215 
crystal size/mm 0.35 × 0.30 × 0.20 
T/K 200(2) 
radiation MoKα 
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diffractometer 'Oxford XCalibur' 
crystal system orthorhombic 
space group P212121 
a/Å 7.1089(3) 
b/Å 7.2805(3) 
c/Å 20.2476(8) 
α/° 90 
β/° 90 
γ/° 90 
V/Å
3
 1047.94(7) 
Z 4 
calc. density/g cm
−3
 1.35778(9) 
μ/mm
−1
 0.109 
absorption correction 'multi-scan' 
transmission factor range 0.92429–1.00000 
refls. measured 15607 
Rint 0.0313 
mean σ(I)/I 0.0413 
θ range 4.13–32.73 
observed refls. 2560 
x, y (weighting scheme) 0.0381, 0 
hydrogen refinement constr 
Flack parameter 0.0(7) 
refls in refinement 3595 
parameters 138 
restraints 0 
R(Fobs) 0.0339 
Rw(F
2
) 0.0717 
S 0.878 
shift/errormax 0.001 
max electron density/e Å
−3
 0.195 
min electron density/e Å
−3
 −0.156 
 
22.5.3. Single-Crystal X-Ray Analysis for Compound 71 
 
 
Figure 25. Molecular structure of 71. 
Flack parameter meaningless, absolute structure deduced from synthesis. Further details are 
summarized in Table 9 and are available from the Crystallographic Data Centre under the 
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depository numbers CCDC 894251. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 9. Crystallographic data for 71. 
net formula C10H16O5 
Mr/g mol
−1
 216.231 
crystal size/mm 0.27 × 0.22 × 0.17 
T/K 200(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system triclinic 
space group P1 
a/Å 6.0447(3) 
b/Å 6.9522(4) 
c/Å 7.2801(5) 
α/° 72.905(4) 
β/° 71.641(3) 
γ/° 69.728(4) 
V/Å
3
 266.45(3) 
Z 1 
calc. density/g cm
−3
 1.34759(15) 
μ/mm
−1
 0.108 
absorption correction none 
refls. measured 2259 
Rint 0.0000 
mean σ(I)/I 0.0381 
θ range 3.70–27.42 
observed refls. 2158 
x, y (weighting scheme) 0.0661, 0.0301 
hydrogen refinement constr 
Flack parameter 0.6(8) 
refls in refinement 2259 
parameters 139 
restraints 3 
R(Fobs) 0.0387 
Rw(F
2
) 0.1066 
S 1.059 
shift/errormax 0.001 
max electron density/e Å
−3
 0.288 
min electron density/e Å
−3
 −0.201 
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22.5.4. Single-Crystal X-Ray Analysis for Compound 72 
 
 
Figure 26. Molecular structure of 72. 
Flack parameter meaningless, absolute structure deduced from synthesis. Further details are 
summarized in Table 10 and are available from the Crystallographic Data Centre under the 
depository numbers CCDC 894252. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 10. Crystallographic data for 72. 
net formula C10H14O4 
Mr/g mol
−1
 198.216 
crystal size/mm 0.38 × 0.21 × 0.07 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system monoclinic 
space group P21 
a/Å 8.4976(5) 
b/Å 5.2988(3) 
c/Å 11.0339(7) 
α/° 90 
β/° 93.476(5) 
γ/° 90 
V/Å
3
 495.91(5) 
Z 2 
calc. density/g cm
−3
 1.32746(13) 
μ/mm
−1
 0.102 
absorption correction 'multi-scan' 
transmission factor range 0.90715–1.00000 
refls. measured 3177 
Rint 0.0191 
mean σ(I)/I 0.0456 
θ range 4.27–26.33 
observed refls. 1430 
x, y (weighting scheme) 0.0261, 0 
hydrogen refinement constr 
Flack parameter −1.0(10) 
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refls in refinement 1841 
parameters 129 
restraints 1 
R(Fobs) 0.0330 
Rw(F
2
) 0.0620 
S 0.957 
shift/errormax 0.001 
max electron density/e Å
−3
 0.125 
min electron density/e Å
−3
 −0.151 
 
22.5.5. Single-Crystal X-Ray Analysis for Compound 74 
 
 
Figure 27. Molecular structure of 74. 
Flack parameter meaningless, absolute structure deduced from synthesis. 5956 Friedel pairs 
merged. Further details are summarized in Table 11 and are available from the Crystallographic 
Data Centre under the depository numbers CCDC 894250. Copies of the data can be obtained 
free of charge upon application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 11. Crystallographic data for 74. 
net formula C20H30O9 
Mr/g mol
−1
 414.447 
crystal size/mm 0.47 × 0.35 × 0.26 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system monoclinic 
space group P21 
a/Å 10.7518(3) 
b/Å 17.8960(6) 
c/Å 16.0933(4) 
α/° 90 
β/° 90.165(2) 
γ/° 90 
V/Å
3
 3096.57(16) 
Z 6 
22. Appendices 
305 
calc. density/g cm
−3
 1.33350(7) 
μ/mm
−1
 0.105 
absorption correction 'multi-scan' 
transmission factor range 0.99210–1.00000 
refls. measured 23608 
Rint 0.0301 
mean σ(I)/I 0.0440 
θ range 4.24–26.33 
observed refls. 4858 
x, y (weighting scheme) 0.0311, 0 
hydrogen refinement constr 
Flack parameter 0.1(5) 
refls in refinement 6461 
parameters 796 
restraints 1 
R(Fobs) 0.0289 
Rw(F
2
) 0.0554 
S 0.878 
shift/errormax 0.001 
max electron density/e Å
−3
 0.148 
min electron density/e Å
−3
 −0.132 
 
22.5.6. Single-Crystal X-Ray Analysis for Compound 86 
 
 
Figure 28. Molecular structure of 86. 
1908 Friedel pairs measured. Correct structure derived from synthesis. One benzyl group is 
disordered, split model applied, sof ratio 0.51/0.49. Only one of the disordered parts is shown in 
the figure. Further details are summarized in Table 12 and are available from the 
Crystallographic Data Centre under the depository numbers CCDC 894257. Copies of the data 
can be obtained free of charge upon application to CCDC, 12, Union Road, Cambridge CB2 
1EZ, U.K., E-mail: deposit@ccdc.cam.ac.uk. 
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Table 12. Crystallographic data for 86. 
net formula C27H28O5 
Mr/g mol
−1
 432.508 
crystal size/mm 0.40 × 0.10 × 0.05 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system monoclinic 
space group P21 
a/Å 10.6997(6) 
b/Å 9.6647(7) 
c/Å 10.9106(6) 
α/° 90 
β/° 91.772(5) 
γ/° 90 
V/Å
3
 1127.72(12) 
Z 2 
calc. density/g cm
−3
 1.27373(14) 
μ/mm
−1
 0.087 
absorption correction 'multi-scan' 
transmission factor range 0.84473–1.00000 
refls. measured 13363 
Rint 0.0666 
mean σ(I)/I 0.1042 
θ range 4.19–25.25 
observed refls. 2329 
x, y (weighting scheme) 0.0238, 0 
hydrogen refinement constr 
Flack parameter −0.4(10) 
refls in refinement 4072 
parameters 283 
restraints 1 
R(Fobs) 0.0400 
Rw(F
2
) 0.0700 
S 0.782 
shift/errormax 0.001 
max electron density/e Å
−3
 0.160 
min electron density/e Å
−3
 −0.136 
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22.5.7. Single-Crystal X-Ray Analysis for Compound 98 
 
 
Figure 29. Molecular structure of 98. 
5111 Friedel pairs measured. Further details are summarized in Table 13 and are available 
from the Crystallographic Data Centre under the depository numbers CCDC 894256. Copies of 
the data can be obtained free of charge upon application to CCDC, 12, Union Road, Cambridge 
CB2 1EZ, U.K., E-mail: deposit@ccdc.cam.ac.uk. 
 
Table 13. Crystallographic data for 98. 
net formula C35H56O5Si2 
Mr/g mol
−1
 612.987 
crystal size/mm 0.45 × 0.20 × 0.10 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system orthorhombic 
space group P212121 
a/Å 8.7850(3) 
b/Å 10.6361(4) 
c/Å 38.7310(19) 
α/° 90 
β/° 90 
γ/° 90 
V/Å
3
 3619.0(3) 
Z 4 
calc. density/g cm
−3
 1.12507(9) 
μ/mm
−1
 0.135 
absorption correction 'multi-scan' 
transmission factor range 0.86410–1.00000 
refls. measured 43906 
Rint 0.0651 
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mean σ(I)/I 0.0872 
θ range 4.14–32.41 
observed refls. 7653 
x, y (weighting scheme) 0.0453, 0 
hydrogen refinement constr 
Flack parameter −0.05(8) 
refls in refinement 11978 
parameters 390 
restraints 0 
R(Fobs) 0.0509 
Rw(F
2
) 0.1001 
S 0.928 
shift/errormax 0.001 
max electron density/e Å
−3
 0.328 
min electron density/e Å
−3
 −0.237 
 
22.5.8. Single-Crystal X-Ray Analysis for Compound 123 
 
 
Figure 30. Molecular structure of 123. 
Methyl groups disordered, split model applied, sof ratio 0.25/0.75. Further details are 
summarized in Table 14 and are available from the Crystallographic Data Centre under the 
depository numbers CCDC 894253. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 14. Crystallographic data for 123. 
net formula C29H38O8 
Mr/g mol
−1
 514.607 
crystal size/mm 0.30 × 0.09 × 0.04 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
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crystal system monoclinic 
space group P21 
a/Å 14.6591(6) 
b/Å 5.2307(2) 
c/Å 18.5204(8) 
α/° 90 
β/° 105.576(2) 
γ/° 90 
V/Å
3
 1367.94(10) 
Z 2 
calc. density/g cm
−3
 1.24938(9) 
μ/mm
−1
 0.090 
absorption correction none 
refls. measured 9302 
Rint 0.0684 
mean σ(I)/I 0.0858 
θ range 3.16–25.33 
observed refls. 3634 
x, y (weighting scheme) 0.0356, 0.1295 
hydrogen refinement constr 
Flack parameter −0.1(11) 
refls in refinement 4873 
parameters 360 
restraints 1 
R(Fobs) 0.0484 
Rw(F
2
) 0.1048 
S 1.055 
shift/errormax 0.001 
max electron density/e Å
−3
 0.200 
min electron density/e Å
−3
 −0.206 
 
22.5.9. Single-Crystal X-Ray Analysis for Compound 120 
 
 
Figure 31. Molecular structure of 120 (of the disordered parts only the main components are 
shown).  
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The data collection was performed on a Nonius KappaCCD diffractometer equipped with a 
rotating anode generator at 173 K using MoKα-radiation (λ = 0.71073 Å, graded multilayer X-
ray optics). The structure was solved by direct methods with SIR97
[144]
 and refined by least-
squares methods against F
2
 with SHELXL-97.
[145]
 The disorder of the benzyl group, a phenyl 
ring and the ethyl group has been handled by split models. All non-disordered non-hydrogen 
atoms were refined anisotropically, all disordered atoms have been refined isotropically. The 
hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further details are 
summarized in Table 15 and are available from the Crystallographic Data Centre under the 
depository numbers CCDC 859056. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 15. Crystallographic data for 120. 
net formula C34H36O10 
Mr/g mol
−1
 604.644 
crystal size/mm 0.38 × 0.14 × 0.12 
crystal system tetragonal 
space group P43 
a/Å 13.3203(3) 
b/Å 13.3203(3) 
c/Å 18.4658(3) 
α/° 90 
β/° 90 
γ/° 90 
V/Å
3
 3276.39(11) 
Z 4 
calc. density/g cm
−3
 1.22580(4) 
μ/mm
−1
 0.090 
absorption correction none 
refls. measured 20777 
Rint 0.0395 
mean σ(I)/I 0.0338 
θ range 3.25–25.32 
observed refls. 4680 
x, y (weighting scheme) 0.0961, 1.1933 
hydrogen refinement constr 
Flack parameter 0.5(13) 
refls in refinement 5911 
parameters 360 
restraints 2 
R(Fobs) 0.0606 
Rw(F
2
) 0.1727 
S 1.021 
shift/errormax 0.004 
max electron density/e Å
−3
 0.309 
min electron density/e Å
−3
 −0.205 
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22.5.10. Single-Crystal X-Ray Analysis for Compound 142 
 
 
Figure 32. Molecular structure of 142. 
Disordered chloroform molecules have been fixed to a sof of 0.25 each. Further details are 
summarized in Table 16 and are available from the Crystallographic Data Centre under the 
depository numbers CCDC 894254. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 16. Crystallographic data for 142. 
net formula C29.25H34.25Cl6.75N5O13 
Mr/g mol
−1
 903.167 
crystal size/mm 0.28 × 0.051 × 0.048 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system triclinic 
space group P1 
a/Å 9.0009(3) 
b/Å 13.4703(5) 
c/Å 18.7290(5) 
α/° 105.394(2) 
β/° 98.332(2) 
γ/° 102.3890(10) 
V/Å
3
 2088.63(12) 
Z 2 
calc. density/g cm
−3
 1.43612(8) 
μ/mm
−1
 0.522 
absorption correction none 
refls. measured 14383 
Rint 0.0000 
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mean σ(I)/I 0.0638 
θ range 3.21–25.29 
observed refls. 8947 
x, y (weighting scheme) 0.1928, 2.7333 
hydrogen refinement constr 
Flack parameter 0.07(12) 
refls in refinement 14383 
parameters 1000 
restraints 9 
R(Fobs) 0.0987 
Rw(F
2
) 0.3140 
S 1.029 
shift/errormax 0.001 
max electron density/e Å
−3
 1.325 
min electron density/e Å
−3
 −0.567 
 
22.5.11. Single-Crystal X-Ray Analysis for Compound 191 
 
 
Figure 33. Molecular structure of 191. 
Details are summarized in Table 17 and are available from the Crystallographic Data Centre 
under the depository numbers CCDC 893995. Copies of the data can be obtained free of charge 
upon application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 17. Crystallographic data for 191. 
net formula C14H16O3 
Mr/g mol
−1
 232.275 
crystal size/mm 0.38 × 0.20 × 0.17 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system triclinic 
space group P1bar 
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a/Å 8.2043(10) 
b/Å 8.9981(11) 
c/Å 9.7491(12) 
α/° 64.913(12) 
β/° 70.609(11) 
γ/° 66.139(12) 
V/Å
3
 584.81(13) 
Z 2 
calc. density/g cm
−3
 1.3191(3) 
μ/mm
−1
 0.092 
absorption correction 'multi-scan' 
transmission factor range 0.82941–1.00000 
refls. measured 3141 
Rint 0.0264 
mean σ(I)/I 0.0429 
θ range 4.34–26.37 
observed refls. 1931 
x, y (weighting scheme) 0.0613, 0.1358 
hydrogen refinement constr 
refls in refinement 2345 
parameters 156 
restraints 0 
R(Fobs) 0.0496 
Rw(F
2
) 0.1369 
S 1.062 
shift/errormax 0.001 
max electron density/e Å
−3
 0.248 
min electron density/e Å
−3
 −0.226 
 
22.5.12. Single-Crystal X-Ray Analysis for Compound 237 
 
 
Figure 34. Molecular structure of 237. 
Flack parameter meaningless, correct structure deduced from synthesis. Further details are 
summarized in Table 18 and are available from the Crystallographic Data Centre under the 
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depository numbers CCDC 894000. Copies of the data can be obtained free of charge upon 
application to CCDC, 12, Union Road, Cambridge CB2 1EZ, U.K., E-mail: 
deposit@ccdc.cam.ac.uk. 
 
Table 18. Crystallographic data for 237. 
net formula C29H29NO3 
Mr/g mol
−1
 439.546 
crystal size/mm 0.28 × 0.19 × 0.12 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system triclinic 
space group P1 
a/Å 6.9353(7) 
b/Å 9.0952(19) 
c/Å 10.104(2) 
α/° 76.081(18) 
β/° 77.509(13) 
γ/° 71.231(15) 
V/Å
3
 579.00(18) 
Z 1 
calc. density/g cm
−3
 1.2606(4) 
μ/mm
−1
 0.081 
absorption correction 'multi-scan' 
transmission factor range 0.92857–1.00000 
refls. measured 3203 
Rint 0.0369 
mean σ(I)/I 0.0433 
θ range 4.43–26.37 
observed refls. 2617 
x, y (weighting scheme) 0.0623, 0.0058 
hydrogen refinement constr 
Flack parameter 1.0(12) 
refls in refinement 2792 
parameters 299 
restraints 3 
R(Fobs) 0.0371 
Rw(F
2
) 0.1016 
S 1.062 
shift/errormax 0.001 
max electron density/e Å
−3
 0.163 
min electron density/e Å
−3
 −0.177 
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22.5.13. Single-Crystal X-Ray Analysis for Compound 238 
 
 
Figure 35. Molecular structure of 238. 
Absolute structure deduced from synthesis. Further details are summarized in Table 19 and 
are available from the Crystallographic Data Centre under the depository numbers CCDC 
894001. Copies of the data can be obtained free of charge upon application to CCDC, 12, Union 
Road, Cambridge CB2 1EZ, U.K., E-mail: deposit@ccdc.cam.ac.uk. 
 
Table 19. Crystallographic data for 23. 
net formula C31H33NO3 
Mr/g mol
−1
 467.599 
crystal size/mm 0.23 × 0.07 × 0.04 
T/K 173(2) 
radiation MoKα 
diffractometer 'KappaCCD' 
crystal system monoclinic 
space group P21 
a/Å 9.1381(5) 
b/Å 14.9979(5) 
c/Å 9.6298(4) 
α/° 90 
β/° 106.100(2) 
γ/° 90 
V/Å
3
 1268.02(10) 
Z 2 
calc. density/g cm
−3
 1.22471(10) 
μ/mm
−1
 0.078 
absorption correction none 
refls. measured 8252 
Rint 0.0356 
mean σ(I)/I 0.0545 
θ range 3.50–25.37 
observed refls. 3483 
x, y (weighting scheme) 0.0614, 0.0936 
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hydrogen refinement constr 
Flack parameter 2.3(14) 
refls in refinement 4486 
parameters 317 
restraints 1 
R(Fobs) 0.0469 
Rw(F
2
) 0.1195 
S 1.028 
shift/errormax 0.001 
max electron density/e Å
−3
 0.187 
min electron density/e Å
−3
 −0.217 
 
22.6. Compounds Sent to Bayer CropScience AG for SAR Study 
 
Verbindung Supplier ID: Vial number:  Amount:  Purity: 
 
MR10 015001552076 16.11 mg 99% (by NMR) 
 
DH01 015001552063 11.80 mg 99% (by NMR) 
 
DH16 015001552039 10.34 mg >99% (NMR clean) 
 
DH15 015001552040 10.15 mg >99% (NMR clean) 
 
DH29C_B_C 015001552038 13.43 mg >99% (NMR clean) 
 
MR26 015001552052 11.83 mg >99% (NMR clean) 
 
DH136RP 015001552051 11.00 mg 99% (by NMR) 
 
DH65I 015001552050 10.48 mg 99% (by NMR) 
 
DH88A 015001552088 10.77 mg 99% (by NMR) 
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DH65_2A 015001552050 11.53 mg 99% (by NMR) 
 
DH183A 015001552048 45.32 mg 95% (by NMR) 
 
DH167C_FS 015001552037 10.86 mg 99% (by NMR) 
 
DH175A_A_A 015001552062 8.90 mg 99% (by NMR) 
 
DH238_An 015001552100 13.70 mg  >99% (by NMR) 
 
DH191A_2 015001552074 8.70 mg 99% (by NMR) 
 
DH194A_2 015001552073 10.45 mg 98% (by NMR) 
 
DH177A 015001552075 12.61 mg >99% (by NMR) 
 
DH186A 015001552049 12.20 mg 98% (by NMR) 
 
DH188B 015001552060 15.87 mg 99% (by NMR) 
 
DH239A_A 015001552098 17.60 mg >99% (by NMR) 
 
DH198A 015001552086 19.58 mg 99% (by NMR) 
 
DH242B_A_A 015001552059 9.33 mg 99% (by NMR) 
 
DH253A 015001552034 7.92 mg 98% (by NMR) 
 
DH244B_A 015001552099 7.60 mg 98% (by NMR) 
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DH264C 015001552047 10.20 mg >99% (by NMR) 
 
DH357C 015001552084 9.36 mg 99% (by NMR) 
 
DH358A 015001552030 10.04 mg 99% (by NMR) 
 
DH401B_A 015001552029 13.65 mg >99% (by NMR) 
 
DH290A-D 015001552033 7.27 mg 97% (by NMR) 
 
DH291A 
DH530B 
015001552085 
015001552044 
7.12 mg 
17.45 mg 
99% (by NMR) 
>99% (by NMR) 
 
DH288AB_B 015001552072 5.70 mg 97% (by NMR) 
 
DH389A_A 015001552071 10.65 mg 99% (by NMR) 
 
DH388A 015001552058 9.76 mg 99% (by NMR) 
 
DH431A_F1 015001552042 13.77 mg >99% (by NMR) 
 
DH444A 015001552054 8.92 mg 99% (by NMR) 
 
DH447A 015001552065 10.19 mg >99% (by NMR) 
 
DH450B 015001552089 11.32 mg >99% (by NMR) 
 
DH453A 015001552043 10.96 mg 99% (by NMR) 
 
DH454A 015001552101 9.67 mg 98% (by NMR) 
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DH499B 015001552113 9.33 mg 99% (by NMR) 
 
monoBn 
MIX_F2 
015001552045 9.92 mg 98% (by NMR) 
 
DH541B 015001552066 10.22 mg 95% (by NMR) 
 
DH542A 015001552114 10.45 mg 98% (by NMR) 
 
DH544A 015001552102 10.84 mg 99% (by NMR) 
 
DH554A_F1 015001552055 14.47 mg 99% (by NMR) 
 
GS28A_F1 015001552069 11.00 mg 98% (by NMR) 
 
GS37A_F1 015001552083 10.44 mg 98% (by NMR) 
 
DH152A_A1 015001552035 6.99 mg 99% (by NMR) 
 
DH152A_A2 015001552036 17.80 mg 99% (by NMR) 
 
DH573A 
GS02A 
DWT-19A_A 
015001552070 
015001552097 
015001552068 
9.00 mg 
20.20 mg 
10.53 mg 
99% (by NMR) 
99% (by NMR) 
99% (by NMR) 
 
DH417B_F1 015001552041 9.69 mg 98% (by NMR) 
 
DH446A 015001552077 10.24 mg 97% (by NMR) 
 
MH06A 015001552046 7.17 mg >99% (by NMR) 
 
MH19B 015001552032 7.30 mg 98% (by NMR) 
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FF12B_A 015001552031 14.45 mg >99% (by NMR) 
 
SL30B 015001552078 11.37 mg >99% (by NMR) 
 
SL34B 015001552090 10.12 mg >99% (by NMR) 
 
SL44 015001552056 10.33 mg >99% (by NMR) 
 
SL49A 015001552057 10.35 mg 99% (by NMR) 
 
SL54 015001552067 15.13 mg >99% (by NMR) 
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